group_id,max_val,apul,peve,ptua,type,avg_identity,query,accession,id,reviewed,protein_name,organism,pident,length,evalue,bitscore,title,go_ids,go_bp,go_cc,go_mf,goslim_ids,goslim_names
OG_00001,1.2871366038772292,FUN_000185-T1,Peve_00037402,Pocillopora_meandrina_HIv1___RNAseq.g28886.t1,three_way,71.059,FUN_000185-T1,Q32LQ0,AMPE_BOVIN,,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249),Bos taurus (Bovine),41.5,881.0,1.4e-197,691.4,sp|Q32LQ0|AMPE_BOVIN Glutamyl aminopeptidase OS=Bos taurus OX=9913 GN=ENPEP PE=2 SV=1,GO:0003081; GO:0004177; GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0008283; GO:0016477; GO:0042277; GO:0043171; GO:0070006,cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],aminopeptidase activity [GO:0004177]; glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0048870; GO:0050886; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; cell motility; endocrine process; catalytic activity, acting on a protein"
OG_00017,1.27682643347357,FUN_000212-T1,Peve_00007289,Pocillopora_meandrina_HIv1___RNAseq.g28915.t1,three_way,63.1635,FUN_000212-T1,Q95334,AMPE_PIG,,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (CD antigen CD249),Sus scrofa (Pig),37.8,898.0,2.4999999999999997e-173,610.9,sp|Q95334|AMPE_PIG Glutamyl aminopeptidase OS=Sus scrofa OX=9823 GN=ENPEP PE=1 SV=1,GO:0003081; GO:0004177; GO:0004230; GO:0005615; GO:0005737; GO:0005886; GO:0006508; GO:0008217; GO:0008270; GO:0008283; GO:0016477; GO:0042277; GO:0043171; GO:0070006,cell migration [GO:0016477]; cell population proliferation [GO:0008283]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508]; regulation of blood pressure [GO:0008217]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081],cytoplasm [GO:0005737]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],aminopeptidase activity [GO:0004177]; glutamyl aminopeptidase activity [GO:0004230]; metalloaminopeptidase activity [GO:0070006]; peptide binding [GO:0042277]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005886; GO:0016787; GO:0048870; GO:0050886; GO:0140096,"catalytic activity; extracellular space; plasma membrane; hydrolase activity; cell motility; endocrine process; catalytic activity, acting on a protein"
OG_00020,1.052192475924782,FUN_000216-T1,Peve_00018873,Pocillopora_meandrina_HIv1___RNAseq.g28926.t1,three_way,52.28366666666667,,,,,,,,,,,,,,,,,
OG_00028,1.0270109245360215,FUN_000231-T1,Peve_00012025,Pocillopora_meandrina_HIv1___RNAseq.g28946.t1,three_way,54.33083333333334,FUN_000231-T1,Q1ZXH8,GXCDD_DICDI,,Guanine exchange factor for Rac 30,Dictyostelium discoideum (Social amoeba),36.5,203.0,4.3e-26,122.5,sp|Q1ZXH8|GXCDD_DICDI Guanine exchange factor for Rac 30 OS=Dictyostelium discoideum OX=44689 GN=gxcDD PE=4 SV=3,GO:0005085; GO:0005096; GO:0005547; GO:0005737; GO:0005856; GO:0005938; GO:0008270; GO:0016020; GO:0030587; GO:0030670; GO:0031152; GO:0031267; GO:0032009; GO:0035556,aggregation involved in sorocarp development [GO:0031152]; intracellular signal transduction [GO:0035556]; sorocarp development [GO:0030587],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; early phagosome [GO:0032009]; membrane [GO:0016020]; phagocytic vesicle membrane [GO:0030670],"GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; phosphatidylinositol-3,4,5-trisphosphate binding [GO:0005547]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]",GO:0005856; GO:0008289; GO:0031410; GO:0043226; GO:0048856; GO:0098772,cytoskeleton; lipid binding; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_00085,1.7980641813488305,FUN_000433-T1,Peve_00011195,Pocillopora_meandrina_HIv1___RNAseq.g2325.t1,three_way,73.84433333333334,FUN_000433-T1,P26714,,,,,33.7,291.0,2.3e-51,204.9,sp|P26714|GBRB_LYMST Gamma-aminobutyric acid receptor subunit beta OS=Lymnaea stagnalis OX=6523 PE=2 SV=1,,,,,,
OG_00087,1.029196362468434,FUN_000440-T1,Peve_00003439,Pocillopora_meandrina_HIv1___RNAseq.g2328.t2,three_way,87.82716666666667,FUN_000440-T1,P11029,,,,,63.2,2251.0,0.0,2921.0,sp|P11029|ACAC_CHICK Acetyl-CoA carboxylase OS=Gallus gallus OX=9031 GN=ACAC PE=1 SV=1,,,,,,
OG_00092,1.2725569963446854,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),34.1,695.0,4.9e-100,368.2,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_00092,1.2725569963446854,FUN_000466-T1,Peve_00005613,Pocillopora_meandrina_HIv1___TS.g4928.t1,three_way,56.57183333333334,FUN_000466-T1,Q9UPX8,SHAN2_HUMAN,,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),Homo sapiens (Human),47.9,71.0,4.6e-13,79.3,sp|Q9UPX8|SHAN2_HUMAN SH3 and multiple ankyrin repeat domains protein 2 OS=Homo sapiens OX=9606 GN=SHANK2 PE=1 SV=4,GO:0001750; GO:0001917; GO:0005829; GO:0005886; GO:0007416; GO:0007612; GO:0008284; GO:0014069; GO:0016324; GO:0017124; GO:0030160; GO:0030426; GO:0030534; GO:0031526; GO:0035176; GO:0035255; GO:0035331; GO:0043005; GO:0043025; GO:0043197; GO:0060170; GO:0060291; GO:0060292; GO:0071625,adult behavior [GO:0030534]; learning [GO:0007612]; long-term synaptic depression [GO:0060292]; long-term synaptic potentiation [GO:0060291]; negative regulation of hippo signaling [GO:0035331]; positive regulation of cell population proliferation [GO:0008284]; social behavior [GO:0035176]; synapse assembly [GO:0007416]; vocalization behavior [GO:0071625],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; ciliary membrane [GO:0060170]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; growth cone [GO:0030426]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ionotropic glutamate receptor binding [GO:0035255]; SH3 domain binding [GO:0017124]; synaptic receptor adaptor activity [GO:0030160],GO:0005829; GO:0005886; GO:0034330; GO:0043226; GO:0050877; GO:0060090,cytosol; plasma membrane; cell junction organization; organelle; nervous system process; molecular adaptor activity
OG_00107,1.3468679000417072,FUN_000499-T1,Peve_00024155,Pocillopora_meandrina_HIv1___RNAseq.g2414.t1,three_way,82.06683333333332,FUN_000499-T1,Q14432,PDE3A_HUMAN,,"cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A) (cGMP-inhibited cAMP phosphodiesterase) (cGI-PDE)",Homo sapiens (Human),37.6,1034.0,2.2e-143,511.5,"sp|Q14432|PDE3A_HUMAN cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A OS=Homo sapiens OX=9606 GN=PDE3A PE=1 SV=3",GO:0001556; GO:0004114; GO:0004115; GO:0004119; GO:0005829; GO:0006629; GO:0007186; GO:0009410; GO:0016020; GO:0019933; GO:0019934; GO:0030284; GO:0040020; GO:0043066; GO:0043116; GO:0043117; GO:0046872; GO:0047555; GO:0060282; GO:0060700; GO:0071321; GO:0071560; GO:0097190; GO:0099130; GO:0106072; GO:0141162,apoptotic signaling pathway [GO:0097190]; cAMP-mediated signaling [GO:0019933]; cellular response to cGMP [GO:0071321]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cGMP-mediated signaling [GO:0019934]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of vascular permeability [GO:0043116]; oocyte maturation [GO:0001556]; positive regulation of oocyte development [GO:0060282]; positive regulation of vascular permeability [GO:0043117]; regulation of meiotic nuclear division [GO:0040020]; regulation of ribonuclease activity [GO:0060700]; response to xenobiotic stimulus [GO:0009410],cytosol [GO:0005829]; membrane [GO:0016020],"3',5'-cGMP-inhibited cyclic-nucleotide phosphodiesterase activity [GO:0004119]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; estrogen binding [GO:0099130]; metal ion binding [GO:0046872]; nuclear estrogen receptor activity [GO:0030284]",GO:0003013; GO:0003824; GO:0005829; GO:0006629; GO:0016787; GO:0022414; GO:0060089; GO:0140110,circulatory system process; catalytic activity; cytosol; lipid metabolic process; hydrolase activity; reproductive process; molecular transducer activity; transcription regulator activity
OG_00119,2.436006466855112,FUN_000537-T1,Peve_00039797,Pocillopora_meandrina_HIv1___RNAseq.g2375.t1,three_way,66.51866666666668,FUN_000537-T1,Q56A06,,,,,51.3,710.0,5.7e-140,500.0,sp|Q56A06|TMTC2_MOUSE Protein O-mannosyl-transferase TMTC2 OS=Mus musculus OX=10090 GN=Tmtc2 PE=2 SV=1,,,,,,
OG_00164,1.223232210120236,FUN_000639-T1,Peve_00011494,Pocillopora_meandrina_HIv1___RNAseq.g1868.t2,three_way,79.212,FUN_000639-T1,Q9EQQ9,,,,,39.0,918.0,1.2000000000000001e-180,635.2,sp|Q9EQQ9|OGA_MOUSE Protein O-GlcNAcase OS=Mus musculus OX=10090 GN=Oga PE=1 SV=2,,,,,,
OG_00174,1.2375129187976803,FUN_000862-T1,Peve_00004534,Pocillopora_meandrina_HIv1___RNAseq.g1860.t1,three_way,73.89966666666666,FUN_000862-T1,Q9NTM9,CUTC_HUMAN,,Copper homeostasis protein cutC homolog,Homo sapiens (Human),62.0,245.0,3.3e-85,316.2,sp|Q9NTM9|CUTC_HUMAN Copper homeostasis protein cutC homolog OS=Homo sapiens OX=9606 GN=CUTC PE=1 SV=1,GO:0005507; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005829; GO:0006825; GO:0051262; GO:0055070,copper ion homeostasis [GO:0055070]; copper ion transport [GO:0006825]; protein tetramerization [GO:0051262],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],copper ion binding [GO:0005507],GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0043226; GO:0065003,nucleus; nucleoplasm; nucleolus; cytosol; organelle; protein-containing complex assembly
OG_00214,1.337227699423754,FUN_000933-T1,Peve_00009727,Pocillopora_meandrina_HIv1___RNAseq.g29459.t1,three_way,43.35483333333333,,,,,,,,,,,,,,,,,
OG_00234,2.037211682398893,FUN_000988-T1,Peve_00022149,Pocillopora_meandrina_HIv1___RNAseq.g29209.t1,three_way,82.41166666666666,FUN_000988-T1,Q92828,,,,,47.6,401.0,3.4e-101,370.5,sp|Q92828|COR2A_HUMAN Coronin-2A OS=Homo sapiens OX=9606 GN=CORO2A PE=1 SV=2,,,,,,
OG_00240,1.4531988356940682,FUN_000996-T1,Peve_00004446,Pocillopora_meandrina_HIv1___RNAseq.g29189.t1,three_way,48.307833333333335,,,,,,,,,,,,,,,,,
OG_00243,1.41104652100208,FUN_001006-T1,Peve_00015278,Pocillopora_meandrina_HIv1___RNAseq.g29174.t1,three_way,60.991,FUN_001006-T1,Q498G2,,,,,27.4,727.0,1.3e-40,171.0,sp|Q498G2|CE152_XENLA Centrosomal protein of 152 kDa OS=Xenopus laevis OX=8355 GN=cep152 PE=2 SV=1,,,,,,
OG_00245,1.1356425800216392,FUN_001008-T1,Peve_00015281,Pocillopora_meandrina_HIv1___RNAseq.g29171.t1,three_way,51.759,,,,,,,,,,,,,,,,,
OG_00286,1.4350923861490297,FUN_001076-T1,Peve_00037405,Pocillopora_meandrina_HIv1___RNAseq.g2716.t1,three_way,76.12899999999999,FUN_001076-T1,Q75V66,ANO5_HUMAN,,Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E),Homo sapiens (Human),42.4,850.0,1.3999999999999999e-187,658.3,sp|Q75V66|ANO5_HUMAN Anoctamin-5 OS=Homo sapiens OX=9606 GN=ANO5 PE=1 SV=1,GO:0001778; GO:0005229; GO:0005254; GO:0005789; GO:0005886; GO:0031982; GO:0034220; GO:0046983; GO:1902476,chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220]; plasma membrane repair [GO:0001778],endoplasmic reticulum membrane [GO:0005789]; plasma membrane [GO:0005886]; vesicle [GO:0031982],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; plasma membrane; organelle; transmembrane transport; membrane organization
OG_00308,1.7677340705923446,FUN_001110-T1,Peve_00029335,Pocillopora_meandrina_HIv1___RNAseq.g29363.t1,three_way,71.534,FUN_001110-T1,P15384,,,,,49.9,407.0,2.3e-84,314.7,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_00313,1.2186111425974162,FUN_001116-T2,Peve_00029365,Pocillopora_meandrina_HIv1___RNAseq.g29354.t1,three_way,60.4465,FUN_001116-T2,Q12912,IRAG2_HUMAN,,"Inositol 1,4,5-triphosphate receptor associated 2 (Lymphoid-restricted membrane protein) (Protein Jaw1) [Cleaved into: Processed inositol 1,4,5-triphosphate receptor associated 2]",Homo sapiens (Human),29.0,217.0,9e-15,84.7,"sp|Q12912|IRAG2_HUMAN Inositol 1,4,5-triphosphate receptor associated 2 OS=Homo sapiens OX=9606 GN=IRAG2 PE=1 SV=3",GO:0000922; GO:0002376; GO:0005635; GO:0005694; GO:0005789; GO:0005813; GO:0005886; GO:0006903; GO:0006906; GO:0006997; GO:0007338; GO:0008017; GO:0016020; GO:0035577,immune system process [GO:0002376]; nucleus organization [GO:0006997]; single fertilization [GO:0007338]; vesicle fusion [GO:0006906]; vesicle targeting [GO:0006903],azurophil granule membrane [GO:0035577]; centrosome [GO:0005813]; chromosome [GO:0005694]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; plasma membrane [GO:0005886]; spindle pole [GO:0000922],microtubule binding [GO:0008017],GO:0002376; GO:0005635; GO:0005694; GO:0005815; GO:0005886; GO:0008092; GO:0022414; GO:0043226; GO:0061024,immune system process; nuclear envelope; chromosome; microtubule organizing center; plasma membrane; cytoskeletal protein binding; reproductive process; organelle; membrane organization
OG_00361,1.6735146384488682,FUN_001195-T1,Peve_00006935,Pocillopora_meandrina_HIv1___RNAseq.g29525.t1,three_way,41.97683333333333,,,,,,,,,,,,,,,,,
OG_00381,1.0109942288114897,FUN_001233-T1,Peve_00022952,Pocillopora_meandrina_HIv1___RNAseq.g29020.t1,three_way,84.606,FUN_001233-T1,Q32L68,,,,,36.4,349.0,3.4e-46,187.2,sp|Q32L68|HM20B_BOVIN SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related OS=Bos taurus OX=9913 GN=HMG20B PE=2 SV=1,,,,,,
OG_00386,1.7158259723211284,FUN_001238-T1,Peve_00002842,Pocillopora_meandrina_HIv1___RNAseq.g2515.t2,three_way,45.375,FUN_001238-T1,Q8IVU1,,,,,32.5,517.0,1.1e-67,260.4,sp|Q8IVU1|IGDC3_HUMAN Immunoglobulin superfamily DCC subclass member 3 OS=Homo sapiens OX=9606 GN=IGDCC3 PE=1 SV=2,,,,,,
OG_00392,1.152706012595276,FUN_001251-T1,Peve_00004681,Pocillopora_meandrina_HIv1___RNAseq.g2309.t1,three_way,55.928666666666665,,,,,,,,,,,,,,,,,
OG_00400,1.5085852076787791,FUN_001271-T1,Peve_00008757,Pocillopora_meandrina_HIv1___RNAseq.g2184.t1,three_way,83.30966666666667,FUN_001271-T1,P0C605,KGP1_MOUSE,,cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI),Mus musculus (Mouse),58.6,630.0,9.7e-210,731.5,sp|P0C605|KGP1_MOUSE cGMP-dependent protein kinase 1 OS=Mus musculus OX=10090 GN=Prkg1 PE=1 SV=1,GO:0001669; GO:0001764; GO:0004672; GO:0004674; GO:0004692; GO:0005246; GO:0005524; GO:0005654; GO:0005737; GO:0005794; GO:0005886; GO:0006468; GO:0007165; GO:0007204; GO:0007286; GO:0010920; GO:0014050; GO:0016358; GO:0019934; GO:0021549; GO:0030553; GO:0030900; GO:0042383; GO:0042753; GO:0042802; GO:0043087; GO:0045986; GO:0048273; GO:0048668; GO:0060087; GO:0061049; GO:0090331; GO:0106310; GO:1904706; GO:1904753; GO:2000224,cell growth involved in cardiac muscle cell development [GO:0061049]; cerebellum development [GO:0021549]; cGMP-mediated signaling [GO:0019934]; collateral sprouting [GO:0048668]; dendrite development [GO:0016358]; forebrain development [GO:0030900]; negative regulation of glutamate secretion [GO:0014050]; negative regulation of inositol phosphate biosynthetic process [GO:0010920]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; neuron migration [GO:0001764]; positive regulation of circadian rhythm [GO:0042753]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; protein phosphorylation [GO:0006468]; regulation of GTPase activity [GO:0043087]; regulation of testosterone biosynthetic process [GO:2000224]; relaxation of vascular associated smooth muscle [GO:0060087]; signal transduction [GO:0007165]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasm [GO:0005737]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383],ATP binding [GO:0005524]; calcium channel regulator activity [GO:0005246]; cGMP binding [GO:0030553]; cGMP-dependent protein kinase activity [GO:0004692]; identical protein binding [GO:0042802]; mitogen-activated protein kinase p38 binding [GO:0048273]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003012; GO:0003824; GO:0005654; GO:0005794; GO:0005886; GO:0016740; GO:0022414; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0098772; GO:0140096,"muscle system process; catalytic activity; nucleoplasm; Golgi apparatus; plasma membrane; transferase activity; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular function regulator activity; catalytic activity, acting on a protein"
OG_00418,1.2457037192528506,FUN_001323-T1,Peve_00036961,Pocillopora_meandrina_HIv1___RNAseq.g2265.t1,three_way,51.98283333333333,,,,,,,,,,,,,,,,,
OG_00449,1.09540553536577,FUN_001369-T1,Peve_00035683,Pocillopora_meandrina_HIv1___RNAseq.g2141.t1,three_way,82.50766666666667,FUN_001369-T1,A0A1L8F5J9,NMDZ1_XENLA,,"Glutamate receptor ionotropic, NMDA 1 (GluN1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)",Xenopus laevis (African clawed frog),50.5,876.0,2.8e-243,843.2,"sp|A0A1L8F5J9|NMDZ1_XENLA Glutamate receptor ionotropic, NMDA 1 OS=Xenopus laevis OX=8355 GN=grin1 PE=1 SV=1",GO:0004972; GO:0005886; GO:0007268; GO:0010043; GO:0015280; GO:0017146; GO:0022849; GO:0035235; GO:0035725; GO:0038023; GO:0042391; GO:0043005; GO:0045202; GO:0045211; GO:0046872; GO:0048167; GO:0070588; GO:0098839,calcium ion transmembrane transport [GO:0070588]; chemical synaptic transmission [GO:0007268]; ionotropic glutamate receptor signaling pathway [GO:0035235]; regulation of membrane potential [GO:0042391]; regulation of synaptic plasticity [GO:0048167]; response to zinc ion [GO:0010043]; sodium ion transmembrane transport [GO:0035725],neuron projection [GO:0043005]; NMDA selective glutamate receptor complex [GO:0017146]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202],glutamate-gated calcium ion channel activity [GO:0022849]; ligand-gated sodium channel activity [GO:0015280]; metal ion binding [GO:0046872]; NMDA glutamate receptor activity [GO:0004972]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0023052; GO:0055085; GO:0060089,transporter activity; plasma membrane; signaling; transmembrane transport; molecular transducer activity
OG_00480,1.0015754545925146,FUN_001422-T3,Peve_00008797,Pocillopora_meandrina_HIv1___RNAseq.g2170.t1,three_way,83.918,FUN_001422-T3,Q6A078,CE290_MOUSE,,Centrosomal protein of 290 kDa (Cep290) (Bardet-Biedl syndrome 14 protein homolog) (Nephrocystin-6),Mus musculus (Mouse),38.2,2233.0,0.0,1093.6,sp|Q6A078|CE290_MOUSE Centrosomal protein of 290 kDa OS=Mus musculus OX=10090 GN=Cep290 PE=1 SV=2,GO:0000226; GO:0001750; GO:0001822; GO:0005634; GO:0005813; GO:0005814; GO:0005829; GO:0007163; GO:0007368; GO:0007507; GO:0008104; GO:0015031; GO:0030902; GO:0030916; GO:0031410; GO:0032391; GO:0032991; GO:0034451; GO:0034976; GO:0035869; GO:0036038; GO:0042462; GO:0045494; GO:0045893; GO:0048793; GO:0060041; GO:0060271; GO:0070201; GO:0090316; GO:0097711; GO:0120200; GO:0120205; GO:0120206; GO:1905349; GO:1905515,ciliary basal body-plasma membrane docking [GO:0097711]; ciliary transition zone assembly [GO:1905349]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; establishment or maintenance of cell polarity [GO:0007163]; eye photoreceptor cell development [GO:0042462]; heart development [GO:0007507]; hindbrain development [GO:0030902]; kidney development [GO:0001822]; microtubule cytoskeleton organization [GO:0000226]; non-motile cilium assembly [GO:1905515]; otic vesicle formation [GO:0030916]; photoreceptor cell maintenance [GO:0045494]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intracellular protein transport [GO:0090316]; pronephros development [GO:0048793]; protein localization [GO:0008104]; protein transport [GO:0015031]; regulation of establishment of protein localization [GO:0070201]; response to endoplasmic reticulum stress [GO:0034976]; retina development in camera-type eye [GO:0060041],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary transition zone [GO:0035869]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; MKS complex [GO:0036038]; nucleus [GO:0005634]; photoreceptor connecting cilium [GO:0032391]; photoreceptor distal connecting cilium [GO:0120206]; photoreceptor outer segment [GO:0001750]; photoreceptor proximal connecting cilium [GO:0120205]; protein-containing complex [GO:0032991]; rod photoreceptor outer segment [GO:0120200],,GO:0005634; GO:0005815; GO:0005829; GO:0006355; GO:0007010; GO:0007163; GO:0031410; GO:0043226; GO:0044782; GO:0048856,nucleus; microtubule organizing center; cytosol; regulation of DNA-templated transcription; cytoskeleton organization; establishment or maintenance of cell polarity; cytoplasmic vesicle; organelle; cilium organization; anatomical structure development
OG_00500,1.3265862543808815,FUN_001473-T1,Peve_00029354,Pocillopora_meandrina_HIv1___TS.g4480.t1,three_way,91.325,FUN_001473-T1,Q5ZLT0,,,,,70.9,1080.0,0.0,1511.1,sp|Q5ZLT0|XPO7_CHICK Exportin-7 OS=Gallus gallus OX=9031 GN=XPO7 PE=2 SV=1,,,,,,
OG_00514,1.811300996070756,FUN_001507-T1,Peve_00012118,Pocillopora_meandrina_HIv1___TS.g4396.t1a,three_way,54.123666666666665,FUN_001507-T1,Q96RW7,HMCN1_HUMAN,,Hemicentin-1 (Fibulin-6) (FIBL-6),Homo sapiens (Human),42.2,398.0,5.3e-88,328.2,sp|Q96RW7|HMCN1_HUMAN Hemicentin-1 OS=Homo sapiens OX=9606 GN=HMCN1 PE=1 SV=2,GO:0005201; GO:0005509; GO:0005604; GO:0005737; GO:0005912; GO:0005927; GO:0005938; GO:0007156; GO:0007157; GO:0007601; GO:0009617; GO:0030036; GO:0032154; GO:0051301; GO:0062023; GO:0070062; GO:0071711,actin cytoskeleton organization [GO:0030036]; basement membrane organization [GO:0071711]; cell division [GO:0051301]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; response to bacterium [GO:0009617]; visual perception [GO:0007601],adherens junction [GO:0005912]; basement membrane [GO:0005604]; cell cortex [GO:0005938]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; muscle tendon junction [GO:0005927],calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201],GO:0005198; GO:0007010; GO:0007155; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0050877,structural molecule activity; cytoskeleton organization; cell adhesion; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; nervous system process
OG_00530,1.2410971475950392,FUN_001535-T1,Peve_00014195,Pocillopora_meandrina_HIv1___RNAseq.g2057.t1,three_way,71.78833333333333,FUN_001535-T1,Q9Y4D2,,,,,34.3,829.0,1.0999999999999999e-127,459.5,sp|Q9Y4D2|DGLA_HUMAN Diacylglycerol lipase-alpha OS=Homo sapiens OX=9606 GN=DAGLA PE=1 SV=3,,,,,,
OG_00575,1.2771522232883736,FUN_001636-T1,Peve_00030249,Pocillopora_meandrina_HIv1___RNAseq.g2156.t1,three_way,45.20433333333334,,,,,,,,,,,,,,,,,
OG_00631,1.3578472899124765,FUN_001853-T1,Peve_00018078,Pocillopora_meandrina_HIv1___RNAseq.g2603.t1,three_way,57.54833333333333,FUN_001853-T1,O60494,CUBN_HUMAN,,Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor),Homo sapiens (Human),32.9,237.0,3.9e-29,130.6,sp|O60494|CUBN_HUMAN Cubilin OS=Homo sapiens OX=9606 GN=CUBN PE=1 SV=5,GO:0001894; GO:0005509; GO:0005765; GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005905; GO:0006898; GO:0008203; GO:0009235; GO:0009617; GO:0015889; GO:0016020; GO:0016324; GO:0030139; GO:0031232; GO:0031419; GO:0031526; GO:0031528; GO:0038023; GO:0038024; GO:0042803; GO:0042953; GO:0043202; GO:0043235; GO:0051649; GO:0070062,cholesterol metabolic process [GO:0008203]; cobalamin metabolic process [GO:0009235]; cobalamin transport [GO:0015889]; establishment of localization in cell [GO:0051649]; lipoprotein transport [GO:0042953]; receptor-mediated endocytosis [GO:0006898]; response to bacterium [GO:0009617]; tissue homeostasis [GO:0001894],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; lysosomal lumen [GO:0043202]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],calcium ion binding [GO:0005509]; cargo receptor activity [GO:0038024]; cobalamin binding [GO:0031419]; protein homodimerization activity [GO:0042803]; signaling receptor activity [GO:0038023],GO:0005768; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006629; GO:0016192; GO:0031410; GO:0038024; GO:0043226; GO:0060089,endosome; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; lipid metabolic process; vesicle-mediated transport; cytoplasmic vesicle; cargo receptor activity; organelle; molecular transducer activity
OG_00655,1.4264855131073904,FUN_001941-T1,Peve_00024483,Pocillopora_meandrina_HIv1___TS.g6439.t1,three_way,68.33433333333333,FUN_001941-T1,Q6IPM2,IQCE_HUMAN,,IQ domain-containing protein E,Homo sapiens (Human),30.0,433.0,1.4e-21,107.1,sp|Q6IPM2|IQCE_HUMAN IQ domain-containing protein E OS=Homo sapiens OX=9606 GN=IQCE PE=1 SV=2,GO:0005929; GO:0035108; GO:0060170,limb morphogenesis [GO:0035108],ciliary membrane [GO:0060170]; cilium [GO:0005929],,GO:0005929; GO:0043226,cilium; organelle
OG_00682,1.138738682119615,FUN_002200-T1,Peve_00043658,Pocillopora_meandrina_HIv1___RNAseq.g30301.t1,three_way,78.49766666666667,FUN_002200-T1,Q14746,,,,,39.1,750.0,7.1e-144,512.7,sp|Q14746|COG2_HUMAN Conserved oligomeric Golgi complex subunit 2 OS=Homo sapiens OX=9606 GN=COG2 PE=1 SV=1,,,,,,
OG_00694,1.0148025796036289,FUN_002404-T1,Peve_00034027,Pocillopora_meandrina_HIv1___RNAseq.g14812.t1,three_way,68.69066666666666,FUN_002404-T1,G5E8P0,,,,,33.2,1574.0,2.5e-156,555.1,sp|G5E8P0|GCP6_MOUSE Gamma-tubulin complex component 6 OS=Mus musculus OX=10090 GN=Tubgcp6 PE=1 SV=1,,,,,,
OG_00746,1.0101805362161442,FUN_002736-T1,Peve_00041437,Pocillopora_meandrina_HIv1___RNAseq.g14951.t1,three_way,65.202,FUN_002736-T1,Q9BXT6,M10L1_HUMAN,,RNA helicase Mov10l1 (EC 3.6.4.13) (Moloney leukemia virus 10-like protein 1) (MOV10-like protein 1),Homo sapiens (Human),39.3,1153.0,1.3999999999999999e-221,771.5,sp|Q9BXT6|M10L1_HUMAN RNA helicase Mov10l1 OS=Homo sapiens OX=9606 GN=MOV10L1 PE=1 SV=1,GO:0000287; GO:0003723; GO:0003724; GO:0005524; GO:0005829; GO:0007141; GO:0007281; GO:0007283; GO:0016887; GO:0034587; GO:0035194; GO:0043186; GO:0071546; GO:0141196,germ cell development [GO:0007281]; male meiosis I [GO:0007141]; piRNA processing [GO:0034587]; regulatory ncRNA-mediated post-transcriptional gene silencing [GO:0035194]; spermatogenesis [GO:0007283]; transposable element silencing by piRNA-mediated DNA methylation [GO:0141196],cytosol [GO:0005829]; P granule [GO:0043186]; pi-body [GO:0071546],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005829; GO:0006325; GO:0016787; GO:0016853; GO:0022414; GO:0031047; GO:0043226; GO:0048856; GO:0140013; GO:0140098; GO:0140657,"RNA binding; catalytic activity; cytosol; chromatin organization; hydrolase activity; isomerase activity; reproductive process; regulatory ncRNA-mediated gene silencing; organelle; anatomical structure development; meiotic nuclear division; catalytic activity, acting on RNA; ATP-dependent activity"
OG_00757,1.1998749823933457,FUN_003163-T1,Peve_00013072,Pocillopora_meandrina_HIv1___RNAseq.g6226.t1,three_way,84.06066666666666,FUN_003163-T1,P54996,,,,,66.8,479.0,3.9e-200,699.1,sp|P54996|G6PD_TAKRU Glucose-6-phosphate 1-dehydrogenase OS=Takifugu rubripes OX=31033 GN=g6pd PE=3 SV=1,,,,,,
OG_00769,1.527944647840341,FUN_003713-T1,Peve_00001357,Pocillopora_meandrina_HIv1___RNAseq.g17373.t2,three_way,74.59033333333333,FUN_003713-T1,A7RX69,TIKI1_NEMVE,,Metalloprotease TIKI homolog (EC 3.4.-.-),Nematostella vectensis (Starlet sea anemone),59.5,373.0,5.4999999999999996e-129,462.6,sp|A7RX69|TIKI1_NEMVE Metalloprotease TIKI homolog OS=Nematostella vectensis OX=45351 GN=v1g27680 PE=2 SV=2,GO:0004222; GO:0006508; GO:0016020; GO:0030178; GO:0046872,negative regulation of Wnt signaling pathway [GO:0030178]; proteolysis [GO:0006508],membrane [GO:0016020],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0016787; GO:0140096,"catalytic activity; hydrolase activity; catalytic activity, acting on a protein"
OG_00772,2.039938504297752,FUN_003840-T1,Peve_00003890,Pocillopora_meandrina_HIv1___RNAseq.g11708.t1,three_way,63.461333333333336,FUN_003840-T1,A7MBJ4,PTPRF_BOVIN,,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48),Bos taurus (Bovine),31.0,1540.0,1.8000000000000001e-162,575.5,sp|A7MBJ4|PTPRF_BOVIN Receptor-type tyrosine-protein phosphatase F OS=Bos taurus OX=9913 GN=PTPRF PE=2 SV=1,GO:0004725; GO:0007165; GO:0008201; GO:0016020; GO:0016477; GO:0035335; GO:0099560; GO:1900121,cell migration [GO:0016477]; negative regulation of receptor binding [GO:1900121]; peptidyl-tyrosine dephosphorylation [GO:0035335]; signal transduction [GO:0007165]; synaptic membrane adhesion [GO:0099560],membrane [GO:0016020],heparin binding [GO:0008201]; protein tyrosine phosphatase activity [GO:0004725],GO:0003824; GO:0007155; GO:0016787; GO:0048870; GO:0140096,"catalytic activity; cell adhesion; hydrolase activity; cell motility; catalytic activity, acting on a protein"
OG_00775,1.3199612722745913,FUN_003847-T1,Peve_00009243,Pocillopora_meandrina_HIv1___RNAseq.g11165.t1,three_way,62.71566666666666,FUN_003847-T1,Q80TL4,PHF24_MOUSE,,PHD finger protein 24,Mus musculus (Mouse),30.2,268.0,2.8e-31,137.9,sp|Q80TL4|PHF24_MOUSE PHD finger protein 24 OS=Mus musculus OX=10090 GN=Phf24 PE=1 SV=2,GO:0007214; GO:0008270; GO:0008277; GO:0030672; GO:0032228; GO:0050966; GO:0098978,"detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; gamma-aminobutyric acid signaling pathway [GO:0007214]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of synaptic transmission, GABAergic [GO:0032228]",glutamatergic synapse [GO:0098978]; synaptic vesicle membrane [GO:0030672],zinc ion binding [GO:0008270],GO:0023052,signaling
OG_00787,1.850968447259031,FUN_003900-T1,Peve_00025157,Pocillopora_meandrina_HIv1___RNAseq.g17184.t1,three_way,80.535,FUN_003900-T1,Q69ZJ7,RIC1_MOUSE,,Guanine nucleotide exchange factor subunit RIC1 (Protein RIC1 homolog) (RAB6A-GEF complex partner protein 1),Mus musculus (Mouse),40.0,1396.0,3.9000000000000003e-284,979.5,sp|Q69ZJ7|RIC1_MOUSE Guanine nucleotide exchange factor subunit RIC1 OS=Mus musculus OX=10090 GN=Ric1 PE=1 SV=2,GO:0005085; GO:0005829; GO:0006886; GO:0016020; GO:0031267; GO:0032991; GO:0034066; GO:0042147; GO:0042177; GO:0043547,"intracellular protein transport [GO:0006886]; negative regulation of protein catabolic process [GO:0042177]; positive regulation of GTPase activity [GO:0043547]; retrograde transport, endosome to Golgi [GO:0042147]",cytosol [GO:0005829]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; Ric1-Rgp1 guanyl-nucleotide exchange factor complex [GO:0034066],guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],GO:0005829; GO:0006886; GO:0016192; GO:0098772,cytosol; intracellular protein transport; vesicle-mediated transport; molecular function regulator activity
OG_00797,1.087560830100191,FUN_003985-T1,Peve_00038452,Pocillopora_meandrina_HIv1___RNAseq.g12629.t1,three_way,66.10633333333334,FUN_003985-T1,O75970,MPDZ_HUMAN,,Multiple PDZ domain protein (Multi-PDZ domain protein 1),Homo sapiens (Human),36.1,183.0,4.6e-26,120.2,sp|O75970|MPDZ_HUMAN Multiple PDZ domain protein OS=Homo sapiens OX=9606 GN=MPDZ PE=1 SV=2,GO:0005737; GO:0005886; GO:0005923; GO:0014069; GO:0016324; GO:0016327; GO:0030425; GO:0045177; GO:0120192,tight junction assembly [GO:0120192],apical part of cell [GO:0045177]; apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; bicellular tight junction [GO:0005923]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],,GO:0005886; GO:0034330; GO:0043226,plasma membrane; cell junction organization; organelle
OG_00807,1.1598070116354662,FUN_004006-T1,Peve_00044933,Pocillopora_meandrina_HIv1___RNAseq.g11690.t1,three_way,87.45700000000001,FUN_004006-T1,P03967,RASD_DICDI,,Ras-like protein rasD (EC 3.6.5.2) (Transforming protein p23 homolog),Dictyostelium discoideum (Social amoeba),39.9,193.0,7.1e-35,148.7,sp|P03967|RASD_DICDI Ras-like protein rasD OS=Dictyostelium discoideum OX=44689 GN=rasD PE=1 SV=2,GO:0000281; GO:0003924; GO:0003925; GO:0004860; GO:0005525; GO:0005811; GO:0005829; GO:0005886; GO:0006935; GO:0009617; GO:0019003; GO:0019887; GO:0031005; GO:0042331; GO:0043052; GO:0043422; GO:0046956; GO:0051019; GO:0070371; GO:0070685; GO:0140582; GO:1905301,adenylate cyclase-activating G protein-coupled cAMP receptor signaling pathway [GO:0140582]; chemotaxis [GO:0006935]; ERK1 and ERK2 cascade [GO:0070371]; mitotic cytokinesis [GO:0000281]; phototaxis [GO:0042331]; positive phototaxis [GO:0046956]; regulation of macropinocytosis [GO:1905301]; response to bacterium [GO:0009617]; thermotaxis [GO:0043052],cytosol [GO:0005829]; lipid droplet [GO:0005811]; macropinocytic cup [GO:0070685]; plasma membrane [GO:0005886],filamin binding [GO:0031005]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; mitogen-activated protein kinase binding [GO:0051019]; protein kinase B binding [GO:0043422]; protein kinase inhibitor activity [GO:0004860]; protein kinase regulator activity [GO:0019887],GO:0000910; GO:0003824; GO:0003924; GO:0005811; GO:0005829; GO:0005886; GO:0008092; GO:0016787; GO:0043226; GO:0098772,cytokinesis; catalytic activity; GTPase activity; lipid droplet; cytosol; plasma membrane; cytoskeletal protein binding; hydrolase activity; organelle; molecular function regulator activity
OG_00808,1.124434806992222,FUN_004007-T1,Peve_00044893,Pocillopora_meandrina_HIv1___RNAseq.g11703.t1b,three_way,74.065,FUN_004007-T1,O95405,,,,,43.3,743.0,2.8000000000000003e-161,571.2,sp|O95405|ZFYV9_HUMAN Zinc finger FYVE domain-containing protein 9 OS=Homo sapiens OX=9606 GN=ZFYVE9 PE=1 SV=2,,,,,,
OG_00833,1.296921650446056,FUN_004078-T1,Peve_00006662,Pocillopora_meandrina_HIv1___RNAseq.g17237.t1,three_way,69.94466666666666,FUN_004078-T1,B1AS42,NB5R5_MOUSE,,NADH-cytochrome b5 reductase-like (EC 1.6.2.2),Mus musculus (Mouse),39.5,311.0,9.999999999999999e-64,245.4,sp|B1AS42|NB5R5_MOUSE NADH-cytochrome b5 reductase-like OS=Mus musculus OX=10090 GN=Cyb5rl PE=2 SV=1,GO:0004128; GO:0005654; GO:0005789,,endoplasmic reticulum membrane [GO:0005789]; nucleoplasm [GO:0005654],"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]",GO:0003824; GO:0005654; GO:0016491,catalytic activity; nucleoplasm; oxidoreductase activity
OG_00843,2.26394865924997,FUN_004094-T1,Peve_00003934,Pocillopora_meandrina_HIv1___RNAseq.g12638.t1,three_way,54.284,FUN_004094-T1,Q91062,,,,,21.7,927.0,2.1e-50,203.4,sp|Q91062|VIT_ICHUN Vitellogenin OS=Ichthyomyzon unicuspis OX=30308 PE=1 SV=1,,,,,,
OG_00867,1.7716425215084917,FUN_004142-T1,Peve_00004368,Pocillopora_meandrina_HIv1___RNAseq.g144.t1,three_way,51.94683333333333,FUN_004142-T1,Q5T890,ER6L2_HUMAN,,DNA excision repair protein ERCC-6-like 2 (EC 3.6.4.-) (DNA repair and recombination protein RAD26-like) (Excision repair cross-complementation group 6-like 2),Homo sapiens (Human),31.5,1000.0,5.9999999999999986e-93,344.0,sp|Q5T890|ER6L2_HUMAN DNA excision repair protein ERCC-6-like 2 OS=Homo sapiens OX=9606 GN=ERCC6L2 PE=1 SV=3,GO:0000775; GO:0003677; GO:0004386; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005813; GO:0006974; GO:0016787; GO:0019901; GO:0032991; GO:0034614; GO:0036297; GO:0097680,cellular response to reactive oxygen species [GO:0034614]; DNA damage response [GO:0006974]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; interstrand cross-link repair [GO:0036297],"centrosome [GO:0005813]; chromosome, centromeric region [GO:0000775]; cytoplasm [GO:0005737]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; hydrolase activity [GO:0016787]; protein kinase binding [GO:0019901],GO:0003677; GO:0003824; GO:0005634; GO:0005739; GO:0005815; GO:0006281; GO:0016787; GO:0016853; GO:0043226; GO:0140657,DNA binding; catalytic activity; nucleus; mitochondrion; microtubule organizing center; DNA repair; hydrolase activity; isomerase activity; organelle; ATP-dependent activity
OG_00872,1.602141885579874,FUN_004160-T1,Peve_00031557,Pocillopora_meandrina_HIv1___RNAseq.g16770.t1,three_way,82.089,FUN_004160-T1,Q6QI06,RICTR_MOUSE,,Rapamycin-insensitive companion of mTOR (AVO3 homolog) (mAVO3) (Protein pianissimo),Mus musculus (Mouse),48.6,1035.0,4.7e-280,966.5,sp|Q6QI06|RICTR_MOUSE Rapamycin-insensitive companion of mTOR OS=Mus musculus OX=10090 GN=Rictor PE=1 SV=2,GO:0001932; GO:0001938; GO:0005524; GO:0005764; GO:0005765; GO:0005783; GO:0005789; GO:0005886; GO:0007010; GO:0008270; GO:0008610; GO:0009792; GO:0010468; GO:0019901; GO:0030036; GO:0030307; GO:0030335; GO:0030838; GO:0031669; GO:0031932; GO:0032008; GO:0038203; GO:0043022; GO:0043066; GO:0043539; GO:0050727; GO:0051896; GO:0051897; GO:0140767; GO:1902554; GO:2000114,actin cytoskeleton organization [GO:0030036]; cellular response to nutrient levels [GO:0031669]; cytoskeleton organization [GO:0007010]; embryo development ending in birth or egg hatching [GO:0009792]; lipid biosynthetic process [GO:0008610]; negative regulation of apoptotic process [GO:0043066]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of TOR signaling [GO:0032008]; regulation of establishment of cell polarity [GO:2000114]; regulation of gene expression [GO:0010468]; regulation of inflammatory response [GO:0050727]; regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051896]; regulation of protein phosphorylation [GO:0001932]; TORC2 signaling [GO:0038203],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; serine/threonine protein kinase complex [GO:1902554]; TORC2 complex [GO:0031932],ATP binding [GO:0005524]; enzyme-substrate adaptor activity [GO:0140767]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activator activity [GO:0043539]; ribosome binding [GO:0043022]; zinc ion binding [GO:0008270],GO:0005764; GO:0005773; GO:0005783; GO:0005886; GO:0006629; GO:0007010; GO:0043226; GO:0048856; GO:0060090; GO:0098772,lysosome; vacuole; endoplasmic reticulum; plasma membrane; lipid metabolic process; cytoskeleton organization; organelle; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_00877,1.2335933003819337,FUN_004170-T1,Peve_00031564,Pocillopora_meandrina_HIv1___RNAseq.g16738.t1,three_way,85.395,,,,,,,,,,,,,,,,,
OG_00898,1.069337663185029,FUN_004213-T1,Peve_00008868,Pocillopora_meandrina_HIv1___RNAseq.g11223.t1,three_way,82.36266666666667,FUN_004213-T1,Q16739,CEGT_HUMAN,,Ceramide glucosyltransferase (EC 2.4.1.80) (GLCT-1) (Glucosylceramide synthase) (GCS) (Glycosylceramide synthase) (UDP-glucose ceramide glucosyltransferase) (UDP-glucose:N-acylsphingosine D-glucosyltransferase),Homo sapiens (Human),43.0,386.0,1e-91,338.6,sp|Q16739|CEGT_HUMAN Ceramide glucosyltransferase OS=Homo sapiens OX=9606 GN=UGCG PE=1 SV=1,GO:0000139; GO:0006497; GO:0006679; GO:0006688; GO:0008120; GO:0008544; GO:0009966; GO:0016020; GO:0030154; GO:0030216; GO:0033210; GO:0048666; GO:0061436; GO:0098856; GO:1903575,cell differentiation [GO:0030154]; cornified envelope assembly [GO:1903575]; epidermis development [GO:0008544]; establishment of skin barrier [GO:0061436]; glucosylceramide biosynthetic process [GO:0006679]; glycosphingolipid biosynthetic process [GO:0006688]; intestinal lipid absorption [GO:0098856]; keratinocyte differentiation [GO:0030216]; leptin-mediated signaling pathway [GO:0033210]; neuron development [GO:0048666]; protein lipidation [GO:0006497]; regulation of signal transduction [GO:0009966],Golgi membrane [GO:0000139]; membrane [GO:0016020],ceramide glucosyltransferase activity [GO:0008120],GO:0003824; GO:0006629; GO:0016740; GO:0022600; GO:0030154; GO:0048856; GO:0061024; GO:1901135,catalytic activity; lipid metabolic process; transferase activity; digestive system process; cell differentiation; anatomical structure development; membrane organization; carbohydrate derivative metabolic process
OG_00992,1.2650391465471624,FUN_004379-T1,Peve_00008069,Pocillopora_meandrina_HIv1___TS.g17623.t1,three_way,59.47683333333333,FUN_004379-T1,A2AJ76,HMCN2_MOUSE,,Hemicentin-2,Mus musculus (Mouse),31.6,190.0,1.7e-16,89.7,sp|A2AJ76|HMCN2_MOUSE Hemicentin-2 OS=Mus musculus OX=10090 GN=Hmcn2 PE=1 SV=1,GO:0005509; GO:0005576; GO:0005604; GO:0005938; GO:0030054; GO:0032154; GO:0062023,,basement membrane [GO:0005604]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cleavage furrow [GO:0032154]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576],calcium ion binding [GO:0005509],GO:0005576; GO:0030312; GO:0031012,extracellular region; external encapsulating structure; extracellular matrix
OG_01002,1.9855938208955115,FUN_004421-T1,Peve_00026932,Pocillopora_meandrina_HIv1___RNAseq.g16665.t1,three_way,58.136,FUN_004421-T1,F1NWE3,,,,,29.1,1542.0,2.5e-170,601.7,sp|F1NWE3|PTPRS_CHICK Receptor-type tyrosine-protein phosphatase S OS=Gallus gallus OX=9031 GN=PTPRS PE=1 SV=3,,,,,,
OG_01007,1.3638369643393131,FUN_004431-T1,Peve_00033220,Pocillopora_meandrina_HIv1___RNAseq.g11379.t1,three_way,81.504,FUN_004431-T1,Q7ZW46,,,,,57.3,321.0,2.5e-101,370.2,sp|Q7ZW46|S35B4_DANRE UDP-xylose and UDP-N-acetylglucosamine transporter OS=Danio rerio OX=7955 GN=slc35b4 PE=2 SV=1,,,,,,
OG_01014,1.2005965480212917,FUN_004442-T1,Peve_00033209,Pocillopora_meandrina_HIv1___RNAseq.g11479.t1,three_way,73.821,FUN_004442-T1,A7MB63,CTNS_BOVIN,,Cystinosin,Bos taurus (Bovine),50.5,333.0,2.9e-91,337.0,sp|A7MB63|CTNS_BOVIN Cystinosin OS=Bos taurus OX=9913 GN=CTNS PE=2 SV=1,GO:0005765; GO:0015031; GO:0015184; GO:0015295; GO:0015811; GO:0033162; GO:0042438; GO:0042470; GO:0048021,L-cystine transport [GO:0015811]; melanin biosynthetic process [GO:0042438]; protein transport [GO:0015031]; regulation of melanin biosynthetic process [GO:0048021],lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; melanosome membrane [GO:0033162],L-cystine transmembrane transporter activity [GO:0015184]; solute:proton symporter activity [GO:0015295],GO:0005215; GO:0031410; GO:0043226,transporter activity; cytoplasmic vesicle; organelle
OG_01018,1.6966921280383502,FUN_004447-T1,Peve_00024327,Pocillopora_meandrina_HIv1___RNAseq.g11246.t1,three_way,84.03683333333333,FUN_004447-T1,Q9UPU5,UBP24_HUMAN,,Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24),Homo sapiens (Human),45.2,2673.0,0.0,2190.2,sp|Q9UPU5|UBP24_HUMAN Ubiquitin carboxyl-terminal hydrolase 24 OS=Homo sapiens OX=9606 GN=USP24 PE=1 SV=3,GO:0004843; GO:0005634; GO:0005654; GO:0005829; GO:0006508; GO:0016579; GO:0031647,protein deubiquitination [GO:0016579]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cysteine-type deubiquitinase activity [GO:0004843],GO:0003824; GO:0005634; GO:0005654; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; nucleoplasm; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01081,1.713937504571302,FUN_004569-T1,Peve_00041475,Pocillopora_meandrina_HIv1___RNAseq.g6640.t1,three_way,60.735166666666665,FUN_004569-T1,Q535K8,GON4L_RAT,,GON-4-like protein (GON-4 homolog) (Protein GON4),Rattus norvegicus (Rat),27.6,757.0,3.2999999999999997e-41,172.6,sp|Q535K8|GON4L_RAT GON-4-like protein OS=Rattus norvegicus OX=10116 GN=Gon4l PE=1 SV=1,GO:0003712; GO:0003714; GO:0005634; GO:0006355; GO:0030183; GO:0045892,B cell differentiation [GO:0030183]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_01081,1.713937504571302,FUN_004569-T1,Peve_00041475,Pocillopora_meandrina_HIv1___RNAseq.g6640.t1,three_way,60.735166666666665,FUN_004569-T1,Q535K8,GON4L_RAT,,GON-4-like protein (GON-4 homolog) (Protein GON4),Rattus norvegicus (Rat),34.8,224.0,3.6e-27,125.9,sp|Q535K8|GON4L_RAT GON-4-like protein OS=Rattus norvegicus OX=10116 GN=Gon4l PE=1 SV=1,GO:0003712; GO:0003714; GO:0005634; GO:0006355; GO:0030183; GO:0045892,B cell differentiation [GO:0030183]; negative regulation of DNA-templated transcription [GO:0045892]; regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],GO:0002376; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0060090; GO:0140110,immune system process; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; molecular adaptor activity; transcription regulator activity
OG_01098,1.2435307259430697,FUN_004598-T1,Peve_00012407,Pocillopora_meandrina_HIv1___RNAseq.g6588.t1,three_way,65.93233333333333,,,,,,,,,,,,,,,,,
OG_01107,1.6137048078649885,FUN_004626-T1,Peve_00039247,Pocillopora_meandrina_HIv1___TS.g19833.t1,three_way,41.262166666666666,,,,,,,,,,,,,,,,,
OG_01118,1.4579317644345051,FUN_004663-T1,Peve_00035116,Pocillopora_meandrina_HIv1___RNAseq.g8745.t1,three_way,40.65533333333333,,,,,,,,,,,,,,,,,
OG_01134,1.083046147670936,FUN_004711-T1,Peve_00005084,Pocillopora_meandrina_HIv1___RNAseq.g8798.t1,three_way,84.41083333333333,FUN_004711-T1,Q8CFW7,C2D2A_MOUSE,,Coiled-coil and C2 domain-containing protein 2A,Mus musculus (Mouse),42.9,1526.0,8.4e-310,1065.1,sp|Q8CFW7|C2D2A_MOUSE Coiled-coil and C2 domain-containing protein 2A OS=Mus musculus OX=10090 GN=Cc2d2a PE=1 SV=1,GO:0001822; GO:0001843; GO:0005737; GO:0005856; GO:0007224; GO:0007368; GO:0007507; GO:0035082; GO:0035869; GO:0036038; GO:0043010; GO:0044458; GO:0060271; GO:1904491; GO:1905515; GO:1990403,axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic brain development [GO:1990403]; heart development [GO:0007507]; kidney development [GO:0001822]; motile cilium assembly [GO:0044458]; neural tube closure [GO:0001843]; non-motile cilium assembly [GO:1905515]; protein localization to ciliary transition zone [GO:1904491]; smoothened signaling pathway [GO:0007224],ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; MKS complex [GO:0036038],,GO:0005856; GO:0007010; GO:0043226; GO:0044782; GO:0048856,cytoskeleton; cytoskeleton organization; organelle; cilium organization; anatomical structure development
OG_01136,1.1947144370634768,FUN_004714-T1,Peve_00005079,Pocillopora_meandrina_HIv1___RNAseq.g8807.t1,three_way,78.63366666666667,FUN_004714-T1,Q5R5N8,,,,,54.3,1021.0,0.0,1082.0,sp|Q5R5N8|DI3L1_PONAB DIS3-like exonuclease 1 OS=Pongo abelii OX=9601 GN=DIS3L PE=2 SV=1,,,,,,
OG_01141,2.1580385070789805,FUN_004721-T1,Peve_00005068,Pocillopora_meandrina_HIv1___RNAseq.g8837.t2,three_way,47.232,,,,,,,,,,,,,,,,,
OG_01167,1.9735798025154767,FUN_004787-T1,Peve_00010251,Pocillopora_meandrina_HIv1___RNAseq.g8521.t1,three_way,75.73400000000001,FUN_004787-T1,Q6TFL3,,,,,37.2,807.0,6.2e-84,313.9,sp|Q6TFL3|CC171_HUMAN Coiled-coil domain-containing protein 171 OS=Homo sapiens OX=9606 GN=CCDC171 PE=1 SV=1,,,,,,
OG_01172,1.6239676666718228,FUN_004797-T1,Peve_00010271,Pocillopora_meandrina_HIv1___RNAseq.g8564.t1,three_way,55.6755,FUN_004797-T1,Q9DBN1,STR6L_MOUSE,,Stimulated by retinoic acid gene 6 protein-like (STRA6-like protein) (Retinol-binding protein 4 receptor 2) (RBP4 receptor 2),Mus musculus (Mouse),28.0,633.0,1.8e-62,242.3,sp|Q9DBN1|STR6L_MOUSE Stimulated by retinoic acid gene 6 protein-like OS=Mus musculus OX=10090 GN=Stra6l PE=1 SV=1,GO:0005886; GO:0034632; GO:0034633; GO:0038023; GO:0051649; GO:0071939,establishment of localization in cell [GO:0051649]; retinol transport [GO:0034633]; vitamin A import into cell [GO:0071939],plasma membrane [GO:0005886],retinol transmembrane transporter activity [GO:0034632]; signaling receptor activity [GO:0038023],GO:0005215; GO:0005886; GO:0055085; GO:0060089,transporter activity; plasma membrane; transmembrane transport; molecular transducer activity
OG_01201,1.3632947885237938,FUN_004865-T1,Peve_00043712,Pocillopora_meandrina_HIv1___RNAseq.g8628.t1,three_way,55.48716666666667,FUN_004865-T1,Q5F416,,,,,38.2,228.0,8.000000000000001e-29,129.8,sp|Q5F416|TIPIN_CHICK TIMELESS-interacting protein OS=Gallus gallus OX=9031 GN=TIPIN PE=2 SV=1,,,,,,
OG_01210,3.801557697479093,FUN_004887-T1,Peve_00005850,Pocillopora_meandrina_HIv1___RNAseq.g10661.t1,three_way,61.143166666666666,FUN_004887-T1,A0A0R4IBK5,R213A_DANRE,,E3 ubiquitin-protein ligase rnf213-alpha (EC 2.3.2.27) (EC 3.6.4.-) (E3 ubiquitin-lipopolysaccharide ligase rnf213-alpha) (EC 2.3.2.-) (Mysterin-A) (Mysterin-alpha) (RING finger protein 213-A) (RING finger protein 213-alpha),Danio rerio (Zebrafish) (Brachydanio rerio),31.4,1097.0,1.9e-124,450.7,sp|A0A0R4IBK5|R213A_DANRE E3 ubiquitin-protein ligase rnf213-alpha OS=Danio rerio OX=7955 GN=rnf213a PE=3 SV=1,GO:0002040; GO:0002376; GO:0004842; GO:0005524; GO:0005730; GO:0005811; GO:0005829; GO:0006511; GO:0008015; GO:0008270; GO:0016887; GO:0019216; GO:0042742; GO:0045765; GO:0061630; GO:0070534; GO:0098792; GO:0120323; GO:0140042; GO:2000051,blood circulation [GO:0008015]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; lipid droplet formation [GO:0140042]; lipid ubiquitination [GO:0120323]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; protein K63-linked ubiquitination [GO:0070534]; regulation of angiogenesis [GO:0045765]; regulation of lipid metabolic process [GO:0019216]; sprouting angiogenesis [GO:0002040]; ubiquitin-dependent protein catabolic process [GO:0006511]; xenophagy [GO:0098792],cytosol [GO:0005829]; lipid droplet [GO:0005811]; nucleolus [GO:0005730],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0002376; GO:0003013; GO:0003824; GO:0005730; GO:0005811; GO:0005829; GO:0006629; GO:0006914; GO:0016740; GO:0016787; GO:0043226; GO:0140096,"immune system process; circulatory system process; catalytic activity; nucleolus; lipid droplet; cytosol; lipid metabolic process; autophagy; transferase activity; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_01275,1.0588481195569688,FUN_005053-T1,Peve_00016727,Pocillopora_meandrina_HIv1___RNAseq.g8306.t2,three_way,75.827,FUN_005053-T1,Q9BRS8,LARP6_HUMAN,,La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6),Homo sapiens (Human),30.5,442.0,8e-37,156.4,sp|Q9BRS8|LARP6_HUMAN La-related protein 6 OS=Homo sapiens OX=9606 GN=LARP6 PE=1 SV=1,GO:0003729; GO:0005634; GO:0005737; GO:0006396; GO:0006417; GO:0017022; GO:0032967; GO:0035613; GO:0048027; GO:1990825; GO:1990904,positive regulation of collagen biosynthetic process [GO:0032967]; regulation of translation [GO:0006417]; RNA processing [GO:0006396],cytoplasm [GO:0005737]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; myosin binding [GO:0017022]; RNA stem-loop binding [GO:0035613]; sequence-specific mRNA binding [GO:1990825],GO:0003723; GO:0005634; GO:0008092; GO:0043226,RNA binding; nucleus; cytoskeletal protein binding; organelle
OG_01276,1.3366486996238236,FUN_005056-T1,Peve_00016747,Pocillopora_meandrina_HIv1___RNAseq.g8303.t1,three_way,56.921,FUN_005056-T1,P42568,AF9_HUMAN,,Protein AF-9 (ALL1-fused gene from chromosome 9 protein) (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein) (YEATS domain-containing protein 3),Homo sapiens (Human),38.0,92.0,2.1e-09,65.1,sp|P42568|AF9_HUMAN Protein AF-9 OS=Homo sapiens OX=9606 GN=MLLT3 PE=1 SV=2,GO:0003677; GO:0003682; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0007379; GO:0008023; GO:0009952; GO:0010467; GO:0042393; GO:0045893; GO:0060090; GO:0060218; GO:0070062; GO:0070577; GO:0090090; GO:0140030; GO:0140044; GO:0140072; GO:0140119; GO:1902275; GO:2000035; GO:2000096,"anterior/posterior pattern specification [GO:0009952]; gene expression [GO:0010467]; hematopoietic stem cell differentiation [GO:0060218]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of chromatin organization [GO:1902275]; regulation of stem cell division [GO:2000035]; segment specification [GO:0007379]",chromosome [GO:0005694]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription elongation factor complex [GO:0008023],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; histone H3K18ac reader activity [GO:0140044]; histone H3K27ac reader activity [GO:0140119]; histone H3K9ac reader activity [GO:0140072]; lysine-acetylated histone binding [GO:0070577]; modification-dependent protein binding [GO:0140030]; molecular adaptor activity [GO:0060090],GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005829; GO:0006355; GO:0030154; GO:0042393; GO:0043226; GO:0060090,DNA binding; nucleus; nucleoplasm; chromosome; cytosol; regulation of DNA-templated transcription; cell differentiation; histone binding; organelle; molecular adaptor activity
OG_01318,1.520793911228466,FUN_005183-T2,Peve_00017162,Pocillopora_meandrina_HIv1___RNAseq.g8095.t1,three_way,55.7445,FUN_005183-T2,A0JMF1,,,,,26.8,358.0,7.6e-14,81.6,sp|A0JMF1|CTC1_DANRE CST complex subunit CTC1 OS=Danio rerio OX=7955 GN=ctc1 PE=2 SV=1,,,,,,
OG_01330,1.3499341693261842,FUN_005220-T1,Peve_00035492,Pocillopora_meandrina_HIv1___TS.g19865.t1,three_way,97.09066666666666,FUN_005220-T1,Q9TTR8,,,,,73.7,266.0,5e-111,402.1,sp|Q9TTR8|COT1_BOVIN COUP transcription factor 1 OS=Bos taurus OX=9913 GN=NR2F1 PE=2 SV=1,,,,,,
OG_01343,1.109960361773653,FUN_005244-T1,Peve_00003366,Pocillopora_meandrina_HIv1___RNAseq.g8140.t2,three_way,77.56250000000001,FUN_005244-T1,Q8TDJ6,,,,,34.9,3319.0,0.0,1533.5,sp|Q8TDJ6|DMXL2_HUMAN DmX-like protein 2 OS=Homo sapiens OX=9606 GN=DMXL2 PE=1 SV=2,,,,,,
OG_01346,1.029193553684575,FUN_005247-T1,Peve_00003363,Pocillopora_meandrina_HIv1___RNAseq.g8143.t1,three_way,51.63783333333333,FUN_005247-T1,P59926,,,,,27.9,287.0,1.6e-12,75.9,sp|P59926|SYT15_RAT Synaptotagmin-15 OS=Rattus norvegicus OX=10116 GN=Syt15 PE=2 SV=1,,,,,,
OG_01384,1.2037633004713113,FUN_005352-T1,Peve_00016030,Pocillopora_meandrina_HIv1___TS.g19950.t1,three_way,73.10666666666667,FUN_005352-T1,A2ASI5,SCN3A_MOUSE,,Sodium channel protein type 3 subunit alpha (Sodium channel protein brain III subunit alpha) (Sodium channel protein type III subunit alpha) (Voltage-gated sodium channel subtype III) (Voltage-gated sodium channel subunit alpha Nav1.3),Mus musculus (Mouse),34.4,1484.0,1.1e-178,629.4,sp|A2ASI5|SCN3A_MOUSE Sodium channel protein type 3 subunit alpha OS=Mus musculus OX=10090 GN=Scn3a PE=1 SV=1,GO:0001518; GO:0005248; GO:0005272; GO:0005886; GO:0009925; GO:0016020; GO:0016528; GO:0048266; GO:0086010,behavioral response to pain [GO:0048266]; membrane depolarization during action potential [GO:0086010],basal plasma membrane [GO:0009925]; membrane [GO:0016020]; plasma membrane [GO:0005886]; sarcoplasm [GO:0016528]; voltage-gated sodium channel complex [GO:0001518],sodium channel activity [GO:0005272]; voltage-gated sodium channel activity [GO:0005248],GO:0005215; GO:0005886,transporter activity; plasma membrane
OG_01411,1.6737041327164328,FUN_005697-T1,Peve_00008482,Pocillopora_meandrina_HIv1___RNAseq.g19565.t1,three_way,83.81866666666667,FUN_005697-T1,O93308,,,,,50.9,1241.0,1.7e-278,960.7,sp|O93308|SMC1A_XENLA Structural maintenance of chromosomes protein 1A OS=Xenopus laevis OX=8355 GN=smc1a PE=1 SV=1,,,,,,
OG_01428,1.100959718942402,FUN_005821-T1,Peve_00034064,Pocillopora_meandrina_HIv1___TS.g29038.t2,three_way,69.24366666666667,FUN_005821-T1,Q9JLG8,,,,,50.0,640.0,1.2000000000000001e-182,641.7,sp|Q9JLG8|CAN15_MOUSE Calpain-15 OS=Mus musculus OX=10090 GN=Capn15 PE=1 SV=1,,,,,,
OG_01436,1.5144405274733153,FUN_005858-T1,Peve_00015774,Pocillopora_meandrina_HIv1___RNAseq.g19665.t1,three_way,77.938,FUN_005858-T1,Q8IV35,,,,,25.4,906.0,2.2e-77,292.4,sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2,,,,,,
OG_01446,1.0587952095370736,FUN_005894-T1,Peve_00035818,Pocillopora_meandrina_HIv1___RNAseq.g19682.t1,three_way,75.725,FUN_005894-T1,Q9BVK2,ALG8_HUMAN,,"Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.265) (Asparagine-linked glycosylation protein 8 homolog) (Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase)",Homo sapiens (Human),55.1,296.0,6.5e-84,312.4,"sp|Q9BVK2|ALG8_HUMAN Dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase OS=Homo sapiens OX=9606 GN=ALG8 PE=1 SV=2",GO:0004583; GO:0005789; GO:0006487; GO:0006488; GO:0018279; GO:0042283; GO:0098553,dolichol-linked oligosaccharide biosynthetic process [GO:0006488]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279],endoplasmic reticulum membrane [GO:0005789]; lumenal side of endoplasmic reticulum membrane [GO:0098553],"dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO:0042283]; dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity [GO:0004583]",GO:0003824; GO:0009101; GO:0016740; GO:1901135,catalytic activity; glycoprotein biosynthetic process; transferase activity; carbohydrate derivative metabolic process
OG_01452,1.1571025166264242,FUN_005908-T1,Peve_00038389,Pocillopora_meandrina_HIv1___RNAseq.g19573.t1,three_way,84.7165,FUN_005908-T1,P23634,AT2B4_HUMAN,,Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 7.2.2.10) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4),Homo sapiens (Human),59.0,1089.0,0.0,1226.8,sp|P23634|AT2B4_HUMAN Plasma membrane calcium-transporting ATPase 4 OS=Homo sapiens OX=9606 GN=ATP2B4 PE=1 SV=2,GO:0003407; GO:0005388; GO:0005516; GO:0005524; GO:0005739; GO:0005886; GO:0005901; GO:0005929; GO:0006357; GO:0006874; GO:0007283; GO:0010629; GO:0014832; GO:0015085; GO:0016020; GO:0016323; GO:0016525; GO:0016887; GO:0017080; GO:0019901; GO:0021766; GO:0030018; GO:0030165; GO:0030315; GO:0030317; GO:0030346; GO:0032991; GO:0034220; GO:0036064; GO:0036126; GO:0036487; GO:0038060; GO:0043231; GO:0043537; GO:0045019; GO:0045121; GO:0046872; GO:0048787; GO:0050998; GO:0051480; GO:0051599; GO:0070588; GO:0070885; GO:0071872; GO:0071878; GO:0097110; GO:0097228; GO:0097553; GO:0098703; GO:0098736; GO:0098978; GO:0150104; GO:1900082; GO:1901660; GO:1902305; GO:1902548; GO:1902806; GO:1903078; GO:1903243; GO:1903249; GO:1903779; GO:1905145,calcium ion export [GO:1901660]; calcium ion import across plasma membrane [GO:0098703]; calcium ion transmembrane import into cytosol [GO:0097553]; calcium ion transmembrane transport [GO:0070588]; cellular response to acetylcholine [GO:1905145]; cellular response to epinephrine stimulus [GO:0071872]; flagellated sperm motility [GO:0030317]; hippocampus development [GO:0021766]; intracellular calcium ion homeostasis [GO:0006874]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071878]; negative regulation of angiogenesis [GO:0016525]; negative regulation of arginine catabolic process [GO:1900082]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to vascular endothelial growth factor stimulus [GO:1902548]; negative regulation of citrulline biosynthetic process [GO:1903249]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of the force of heart contraction [GO:0098736]; neural retina development [GO:0003407]; nitric oxide-cGMP-mediated signaling [GO:0038060]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of cardiac conduction [GO:1903779]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hydrostatic pressure [GO:0051599]; spermatogenesis [GO:0007283]; transport across blood-brain barrier [GO:0150104]; urinary bladder smooth muscle contraction [GO:0014832],basolateral plasma membrane [GO:0016323]; caveola [GO:0005901]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; sperm flagellum [GO:0036126]; sperm principal piece [GO:0097228]; T-tubule [GO:0030315]; Z disc [GO:0030018],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calcium ion transmembrane transporter activity [GO:0015085]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; nitric-oxide synthase binding [GO:0050998]; nitric-oxide synthase inhibitor activity [GO:0036487]; P-type calcium transporter activity [GO:0005388]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase 2B binding [GO:0030346]; scaffold protein binding [GO:0097110]; sodium channel regulator activity [GO:0017080],GO:0003012; GO:0003013; GO:0003824; GO:0005215; GO:0005739; GO:0005815; GO:0005886; GO:0005929; GO:0006355; GO:0007018; GO:0016787; GO:0022414; GO:0043226; GO:0048856; GO:0048870; GO:0055085; GO:0098772; GO:0140657,muscle system process; circulatory system process; catalytic activity; transporter activity; mitochondrion; microtubule organizing center; plasma membrane; cilium; regulation of DNA-templated transcription; microtubule-based movement; hydrolase activity; reproductive process; organelle; anatomical structure development; cell motility; transmembrane transport; molecular function regulator activity; ATP-dependent activity
OG_01489,1.1902542014220896,FUN_006165-T1,Peve_00023607,Pocillopora_meandrina_HIv1___RNAseq.g20426.t1,three_way,60.60533333333333,FUN_006165-T1,Q2PZL6,FAT4_MOUSE,,Protocadherin Fat 4 (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),Mus musculus (Mouse),33.7,5014.0,0.0,2299.2,sp|Q2PZL6|FAT4_MOUSE Protocadherin Fat 4 OS=Mus musculus OX=10090 GN=Fat4 PE=1 SV=2,GO:0001658; GO:0001736; GO:0001822; GO:0003007; GO:0005509; GO:0005886; GO:0007009; GO:0007156; GO:0007157; GO:0007219; GO:0008543; GO:0021987; GO:0022008; GO:0035329; GO:0043931; GO:0045177; GO:0048565; GO:0060122; GO:0072006; GO:0072137; GO:0072307,branching involved in ureteric bud morphogenesis [GO:0001658]; cerebral cortex development [GO:0021987]; condensed mesenchymal cell proliferation [GO:0072137]; digestive tract development [GO:0048565]; establishment of planar polarity [GO:0001736]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear receptor cell stereocilium organization [GO:0060122]; kidney development [GO:0001822]; nephron development [GO:0072006]; neurogenesis [GO:0022008]; Notch signaling pathway [GO:0007219]; ossification involved in bone maturation [GO:0043931]; plasma membrane organization [GO:0007009]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307],apical part of cell [GO:0045177]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509],GO:0005886; GO:0007155; GO:0030154; GO:0048856; GO:0061024,plasma membrane; cell adhesion; cell differentiation; anatomical structure development; membrane organization
OG_01504,1.6790705303774605,FUN_006236-T1,Peve_00011453,Pocillopora_meandrina_HIv1___RNAseq.g20448.t1,three_way,65.54733333333333,,,,,,,,,,,,,,,,,
OG_01507,1.1092001548689323,FUN_006242-T1,Peve_00011455,Pocillopora_meandrina_HIv1___RNAseq.g20444.t1,three_way,65.56483333333334,FUN_006242-T1,Q6GQJ2,JADE1_XENLA,,Protein Jade-1 (Jade family PHD finger protein 1) (PHD finger protein 17),Xenopus laevis (African clawed frog),44.8,511.0,5.6e-120,433.7,sp|Q6GQJ2|JADE1_XENLA Protein Jade-1 OS=Xenopus laevis OX=8355 GN=jade1 PE=2 SV=1,GO:0000123; GO:0005634; GO:0005737; GO:0005856; GO:0006357; GO:0006915; GO:0008270; GO:0042995,apoptotic process [GO:0006915]; regulation of transcription by RNA polymerase II [GO:0006357],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; histone acetyltransferase complex [GO:0000123]; nucleus [GO:0005634],zinc ion binding [GO:0008270],GO:0005634; GO:0005856; GO:0006355; GO:0012501; GO:0043226,nucleus; cytoskeleton; regulation of DNA-templated transcription; programmed cell death; organelle
OG_01510,1.007537188902672,FUN_006245-T1,Peve_00002946,Pocillopora_meandrina_HIv1___RNAseq.g20390.t1b,three_way,45.26566666666667,,,,,,,,,,,,,,,,,
OG_01524,1.206966960455654,FUN_006320-T1,Peve_00021264,Pocillopora_meandrina_HIv1___RNAseq.g20359.t1,three_way,67.9575,FUN_006320-T1,Q8BV79,,,,,30.9,2660.0,1.4999999999999998e-286,988.8,sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3,,,,,,
OG_01541,1.031941385504435,FUN_006411-T1,Peve_00018195,Pocillopora_meandrina_HIv1___RNAseq.g20262.t1,three_way,76.773,FUN_006411-T1,Q9NTJ4,,,,,49.9,1007.0,1.9e-293,1010.0,sp|Q9NTJ4|MA2C1_HUMAN Alpha-mannosidase 2C1 OS=Homo sapiens OX=9606 GN=MAN2C1 PE=1 SV=1,,,,,,
OG_01550,1.8957177357247448,FUN_006425-T1,Peve_00043546,Pocillopora_meandrina_HIv1___TS.g29666.t1,three_way,69.39816666666667,FUN_006425-T1,Q96P50,,,,,30.0,253.0,1.1e-26,124.4,"sp|Q96P50|ACAP3_HUMAN Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 OS=Homo sapiens OX=9606 GN=ACAP3 PE=1 SV=2",,,,,,
OG_01566,1.103053544681296,FUN_006448-T1,Peve_00038420,Pocillopora_meandrina_HIv1___RNAseq.g20307.t1a,three_way,70.55933333333333,,,,,,,,,,,,,,,,,
OG_01591,1.1953806473765545,FUN_006631-T1,Peve_00040841,Pocillopora_meandrina_HIv1___TS.g29548.t1a,three_way,67.0835,,,,,,,,,,,,,,,,,
OG_01618,1.1019285460136432,FUN_006727-T1,Peve_00039555,Pocillopora_meandrina_HIv1___RNAseq.g20013.t1,three_way,71.43566666666666,FUN_006727-T1,Q3UTQ8,CDKL5_MOUSE,,Cyclin-dependent kinase-like 5 (EC 2.7.11.22),Mus musculus (Mouse),44.0,616.0,8.800000000000001e-125,449.5,sp|Q3UTQ8|CDKL5_MOUSE Cyclin-dependent kinase-like 5 OS=Mus musculus OX=10090 GN=Cdkl5 PE=1 SV=1,GO:0004672; GO:0004693; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0016301; GO:0034504; GO:0036064; GO:0097542; GO:0106310; GO:1902017,protein localization to nucleus [GO:0034504]; regulation of cilium assembly [GO:1902017],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasm [GO:0005737]; nucleus [GO:0005634],ATP binding [GO:0005524]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; kinase activity [GO:0016301]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0005634; GO:0005815; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; transferase activity; organelle; catalytic activity, acting on a protein"
OG_01632,1.478856755449735,FUN_006750-T1,Peve_00029281,Pocillopora_meandrina_HIv1___RNAseq.g20533.t1,three_way,80.3975,FUN_006750-T1,Q9H3E2,,,,,37.7,871.0,3.8e-161,570.5,sp|Q9H3E2|SNX25_HUMAN Sorting nexin-25 OS=Homo sapiens OX=9606 GN=SNX25 PE=1 SV=2,,,,,,
OG_01704,1.6207683495244982,FUN_006949-T1,Peve_00001501,Pocillopora_meandrina_HIv1___RNAseq.g20122.t1,three_way,65.41066666666667,FUN_006949-T1,Q9D4H7,,,,,35.5,617.0,9e-100,365.9,sp|Q9D4H7|LONF3_MOUSE LON peptidase N-terminal domain and RING finger protein 3 OS=Mus musculus OX=10090 GN=Lonrf3 PE=2 SV=1,,,,,,
OG_01715,1.1593299530490446,FUN_006995-T1,Peve_00035637,Pocillopora_meandrina_HIv1___RNAseq.g20064.t1,three_way,61.722166666666666,,,,,,,,,,,,,,,,,
OG_01752,1.188636004009721,FUN_007092-T1,Peve_00019879,Pocillopora_meandrina_HIv1___RNAseq.g19058.t1,three_way,57.32516666666667,FUN_007092-T1,Q8CDI6,,,,,27.6,174.0,1.1e-07,61.2,sp|Q8CDI6|CD158_MOUSE Coiled-coil domain-containing protein 158 OS=Mus musculus OX=10090 GN=Ccdc158 PE=2 SV=1,,,,,,
OG_01825,1.015784332804574,FUN_007699-T1,Peve_00030615,Pocillopora_meandrina_HIv1___RNAseq.g17995.t1,three_way,69.25383333333333,FUN_007699-T1,G3M4F8,,,,,26.0,315.0,2.5e-17,91.3,sp|G3M4F8|OCTB2_CHISP Octopamine receptor beta-2R OS=Chilo suppressalis OX=168631 GN=OA2B2 PE=2 SV=1,,,,,,
OG_01838,1.0830102624300095,FUN_007775-T1,Peve_00032268,Pocillopora_meandrina_HIv1___TS.g24628.t2,three_way,66.44866666666667,FUN_007775-T1,Q9HAV4,XPO5_HUMAN,,Exportin-5 (Exp5) (Ran-binding protein 21),Homo sapiens (Human),34.6,1233.0,3.5e-196,687.2,sp|Q9HAV4|XPO5_HUMAN Exportin-5 OS=Homo sapiens OX=9606 GN=XPO5 PE=1 SV=1,GO:0000049; GO:0003723; GO:0003729; GO:0005049; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006405; GO:0006611; GO:0010586; GO:0016442; GO:0031267; GO:0035281; GO:0042565; GO:0070883; GO:1905172,miRNA metabolic process [GO:0010586]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; RNA export from nucleus [GO:0006405],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RISC complex [GO:0016442]; RNA nuclear export complex [GO:0042565],mRNA binding [GO:0003729]; nuclear export signal receptor activity [GO:0005049]; pre-miRNA binding [GO:0070883]; RISC complex binding [GO:1905172]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; tRNA binding [GO:0000049],GO:0003723; GO:0005634; GO:0005654; GO:0005829; GO:0006886; GO:0006913; GO:0043226; GO:0140104,RNA binding; nucleus; nucleoplasm; cytosol; intracellular protein transport; nucleocytoplasmic transport; organelle; molecular carrier activity
OG_01839,2.320081882050073,FUN_007785-T1,Peve_00032269,Pocillopora_meandrina_HIv1___RNAseq.g5904.t3,three_way,77.73566666666667,FUN_007785-T1,Q7ZZC8,NEK9_XENLA,,Serine/threonine-protein kinase Nek9 (xNek9) (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9),Xenopus laevis (African clawed frog),45.7,637.0,6e-157,556.2,sp|Q7ZZC8|NEK9_XENLA Serine/threonine-protein kinase Nek9 OS=Xenopus laevis OX=8355 GN=nek9 PE=2 SV=1,GO:0000278; GO:0004674; GO:0005524; GO:0005737; GO:0005813; GO:0019901; GO:0030295; GO:0046872; GO:0051301; GO:0106310,cell division [GO:0051301]; mitotic cell cycle [GO:0000278],centrosome [GO:0005813]; cytoplasm [GO:0005737],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0000278; GO:0003824; GO:0005815; GO:0016740; GO:0098772; GO:0140096,"mitotic cell cycle; catalytic activity; microtubule organizing center; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01845,1.4273446677982728,FUN_007791-T1,Peve_00022040,Pocillopora_meandrina_HIv1___TS.g24621.t1,three_way,47.446,FUN_007791-T1,Q9UHC1,MLH3_HUMAN,,DNA mismatch repair protein Mlh3 (MutL protein homolog 3),Homo sapiens (Human),27.8,1446.0,1.3e-121,439.5,sp|Q9UHC1|MLH3_HUMAN DNA mismatch repair protein Mlh3 OS=Homo sapiens OX=9606 GN=MLH3 PE=1 SV=3,GO:0000795; GO:0001673; GO:0003682; GO:0003696; GO:0005524; GO:0005634; GO:0005654; GO:0005712; GO:0006298; GO:0007130; GO:0007131; GO:0007140; GO:0007144; GO:0008104; GO:0016887; GO:0019237; GO:0030983; GO:0032300; GO:0140664,female meiosis I [GO:0007144]; male meiotic nuclear division [GO:0007140]; mismatch repair [GO:0006298]; protein localization [GO:0008104]; reciprocal meiotic recombination [GO:0007131]; synaptonemal complex assembly [GO:0007130],chiasma [GO:0005712]; male germ cell nucleus [GO:0001673]; mismatch repair complex [GO:0032300]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent DNA damage sensor activity [GO:0140664]; centromeric DNA binding [GO:0019237]; chromatin binding [GO:0003682]; mismatched DNA binding [GO:0030983]; satellite DNA binding [GO:0003696],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0006281; GO:0006310; GO:0016787; GO:0022414; GO:0043226; GO:0098772; GO:0140013; GO:0140097; GO:0140299; GO:0140657,"DNA binding; catalytic activity; nucleus; nucleoplasm; DNA repair; DNA recombination; hydrolase activity; reproductive process; organelle; molecular function regulator activity; meiotic nuclear division; catalytic activity, acting on DNA; molecular sensor activity; ATP-dependent activity"
OG_01846,1.3227290215833156,FUN_007795-T1,Peve_00022050,Pocillopora_meandrina_HIv1___TS.g21334.t1,three_way,60.86366666666667,FUN_007795-T1,Q9NR09,BIRC6_HUMAN,,Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 (EC 2.3.2.24) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (Baculoviral IAP repeat-containing protein 6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON),Homo sapiens (Human),29.0,4083.0,0.0,1173.3,sp|Q9NR09|BIRC6_HUMAN Dual E2 ubiquitin-conjugating enzyme/E3 ubiquitin-protein ligase BIRC6 OS=Homo sapiens OX=9606 GN=BIRC6 PE=1 SV=3,GO:0000922; GO:0004842; GO:0004869; GO:0005634; GO:0005768; GO:0005802; GO:0005813; GO:0005815; GO:0005829; GO:0006468; GO:0006915; GO:0008283; GO:0008284; GO:0016020; GO:0016567; GO:0030496; GO:0032465; GO:0042127; GO:0043066; GO:0046872; GO:0051301; GO:0060711; GO:0061631; GO:0090543; GO:2001237,apoptotic process [GO:0006915]; cell division [GO:0051301]; cell population proliferation [GO:0008283]; labyrinthine layer development [GO:0060711]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of cell population proliferation [GO:0008284]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of cell population proliferation [GO:0042127]; regulation of cytokinesis [GO:0032465],centrosome [GO:0005813]; cytosol [GO:0005829]; endosome [GO:0005768]; Flemming body [GO:0090543]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; nucleus [GO:0005634]; spindle pole [GO:0000922]; trans-Golgi network [GO:0005802],cysteine-type endopeptidase inhibitor activity [GO:0004869]; metal ion binding [GO:0046872]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],GO:0003824; GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0012501; GO:0016740; GO:0031410; GO:0043226; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; nucleus; endosome; microtubule organizing center; cytosol; programmed cell death; transferase activity; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_01889,1.3438725693019116,FUN_007871-T1,Peve_00009886,Pocillopora_meandrina_HIv1___RNAseq.g18307.t1,three_way,66.36216666666667,FUN_007871-T1,Q13613,,,,,32.8,466.0,6.600000000000003e-60,234.2,sp|Q13613|MTMR1_HUMAN Phosphatidylinositol-3-phosphate phosphatase MTMR1 OS=Homo sapiens OX=9606 GN=MTMR1 PE=1 SV=4,,,,,,
OG_01911,1.1617118789928802,FUN_007927-T1,Peve_00040689,Pocillopora_meandrina_HIv1___RNAseq.g18108.t1,three_way,68.03966666666666,FUN_007927-T1,Q10AZ7,GPA3_ORYSJ,,Protein GLUTELIN PRECURSOR ACCUMULATION 3,Oryza sativa subsp. japonica (Rice),24.2,194.0,2.9e-12,75.1,sp|Q10AZ7|GPA3_ORYSJ Protein GLUTELIN PRECURSOR ACCUMULATION 3 OS=Oryza sativa subsp. japonica OX=39947 GN=GPA3 PE=1 SV=1,GO:0000325; GO:0000326; GO:0005802; GO:0006886,intracellular protein transport [GO:0006886],plant-type vacuole [GO:0000325]; protein storage vacuole [GO:0000326]; trans-Golgi network [GO:0005802],,GO:0005773; GO:0006886; GO:0043226,vacuole; intracellular protein transport; organelle
OG_01966,1.5172112257242056,FUN_008049-T1,Peve_00045150,Pocillopora_meandrina_HIv1___RNAseq.g30360.t1,three_way,52.505,,,,,,,,,,,,,,,,,
OG_02040,1.6405898537954344,FUN_008245-T1,Peve_00031789,Pocillopora_meandrina_HIv1___RNAseq.g17949.t1,three_way,80.146,,,,,,,,,,,,,,,,,
OG_02115,1.3665849498639906,FUN_008400-T1,Peve_00043703,Pocillopora_meandrina_HIv1___TS.g24890.t1,three_way,85.94066666666667,FUN_008400-T1,O00180,KCNK1_HUMAN,,Potassium channel subfamily K member 1 (Inward rectifying potassium channel protein TWIK-1) (Potassium channel K2P1) (Potassium channel KCNO1),Homo sapiens (Human),39.4,246.0,1.8000000000000002e-44,181.4,sp|O00180|KCNK1_HUMAN Potassium channel subfamily K member 1 OS=Homo sapiens OX=9606 GN=KCNK1 PE=1 SV=1,GO:0005242; GO:0005267; GO:0005272; GO:0005886; GO:0006813; GO:0008076; GO:0014047; GO:0016020; GO:0016324; GO:0022834; GO:0022841; GO:0030425; GO:0031526; GO:0034705; GO:0035094; GO:0035725; GO:0042802; GO:0043204; GO:0043231; GO:0046982; GO:0055037; GO:0060075; GO:0071468; GO:0071805; GO:0097060; GO:1902476; GO:1902937; GO:1905030,cellular response to acidic pH [GO:0071468]; chloride transmembrane transport [GO:1902476]; glutamate secretion [GO:0014047]; potassium ion transmembrane transport [GO:0071805]; potassium ion transport [GO:0006813]; regulation of resting membrane potential [GO:0060075]; response to nicotine [GO:0035094]; sodium ion transmembrane transport [GO:0035725],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; inward rectifier potassium channel complex [GO:1902937]; membrane [GO:0016020]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; potassium channel complex [GO:0034705]; recycling endosome [GO:0055037]; synaptic membrane [GO:0097060]; voltage-gated potassium channel complex [GO:0008076],identical protein binding [GO:0042802]; inward rectifier potassium channel activity [GO:0005242]; ligand-gated channel activity [GO:0022834]; potassium channel activity [GO:0005267]; potassium ion leak channel activity [GO:0022841]; protein heterodimerization activity [GO:0046982]; sodium channel activity [GO:0005272]; voltage-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential [GO:1905030],GO:0005215; GO:0005768; GO:0005886; GO:0031410; GO:0043226; GO:0055085,transporter activity; endosome; plasma membrane; cytoplasmic vesicle; organelle; transmembrane transport
OG_02176,1.084778205604907,FUN_008525-T2,Peve_00019201,Pocillopora_meandrina_HIv1___TS.g3901.t1,three_way,50.440666666666665,FUN_008525-T2,Q9P2N4,ATS9_HUMAN,,A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-),Homo sapiens (Human),35.7,1772.0,0.0,1103.6,sp|Q9P2N4|ATS9_HUMAN A disintegrin and metalloproteinase with thrombospondin motifs 9 OS=Homo sapiens OX=9606 GN=ADAMTS9 PE=1 SV=4,GO:0002088; GO:0003179; GO:0003229; GO:0004222; GO:0005615; GO:0005783; GO:0006508; GO:0008237; GO:0008270; GO:0009617; GO:0009986; GO:0010596; GO:0015031; GO:0016192; GO:0030198; GO:0030318; GO:0031012; GO:0035909; GO:0043231; GO:0045636; GO:0048593; GO:0061303; GO:0090673; GO:1903671,aorta morphogenesis [GO:0035909]; camera-type eye morphogenesis [GO:0048593]; cornea development in camera-type eye [GO:0061303]; endothelial cell-matrix adhesion [GO:0090673]; extracellular matrix organization [GO:0030198]; heart valve morphogenesis [GO:0003179]; lens development in camera-type eye [GO:0002088]; melanocyte differentiation [GO:0030318]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of sprouting angiogenesis [GO:1903671]; positive regulation of melanocyte differentiation [GO:0045636]; protein transport [GO:0015031]; proteolysis [GO:0006508]; response to bacterium [GO:0009617]; ventricular cardiac muscle tissue development [GO:0003229]; vesicle-mediated transport [GO:0016192],cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231],metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005783; GO:0007155; GO:0016192; GO:0016787; GO:0030154; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; extracellular space; endoplasmic reticulum; cell adhesion; vesicle-mediated transport; hydrolase activity; cell differentiation; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02181,1.18368570355392,FUN_008534-T1,Peve_00014007,Pocillopora_meandrina_HIv1___RNAseq.g14740.t1,three_way,62.36966666666667,FUN_008534-T1,Q28E45,MCM10_XENTR,,Protein MCM10 homolog,Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),36.7,645.0,4.0999999999999996e-92,340.9,sp|Q28E45|MCM10_XENTR Protein MCM10 homolog OS=Xenopus tropicalis OX=8364 GN=mcm10 PE=2 SV=1,GO:0003690; GO:0003697; GO:0005634; GO:0006270; GO:0006974; GO:0008270,DNA damage response [GO:0006974]; DNA replication initiation [GO:0006270],nucleus [GO:0005634],double-stranded DNA binding [GO:0003690]; single-stranded DNA binding [GO:0003697]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0043226,DNA binding; nucleus; organelle
OG_02200,1.5407807595889087,FUN_008569-T1,Peve_00044727,Pocillopora_meandrina_HIv1___RNAseq.g12789.t1,three_way,62.34433333333333,,,,,,,,,,,,,,,,,
OG_02207,1.16477296944345,FUN_008583-T1,Peve_00028408,Pocillopora_meandrina_HIv1___RNAseq.g12778.t1,three_way,81.406,FUN_008583-T1,Q5RB35,MKLN1_PONAB,,Muskelin,Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),61.2,738.0,2.1e-273,943.0,sp|Q5RB35|MKLN1_PONAB Muskelin OS=Pongo abelii OX=9601 GN=MKLN1 PE=2 SV=1,GO:0000151; GO:0001726; GO:0002090; GO:0005654; GO:0005829; GO:0005938; GO:0007160; GO:0008360; GO:0030036; GO:0042803; GO:0098895; GO:0098968; GO:0098982; GO:0099003; GO:0099164,actin cytoskeleton organization [GO:0030036]; cell-matrix adhesion [GO:0007160]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; regulation of cell shape [GO:0008360]; regulation of receptor internalization [GO:0002090]; vesicle-mediated transport in synapse [GO:0099003],cell cortex [GO:0005938]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; nucleoplasm [GO:0005654]; postsynaptic endosome membrane [GO:0098895]; postsynaptic specialization membrane of symmetric synapse [GO:0099164]; ruffle [GO:0001726]; ubiquitin ligase complex [GO:0000151],protein homodimerization activity [GO:0042803],GO:0005654; GO:0005829; GO:0007010; GO:0007155; GO:0016192,nucleoplasm; cytosol; cytoskeleton organization; cell adhesion; vesicle-mediated transport
OG_02216,1.6751270448916291,FUN_008605-T1,Peve_00020826,Pocillopora_meandrina_HIv1___RNAseq.g12755.t1,three_way,59.71116666666666,FUN_008605-T1,Q4V8X0,,,,,39.7,267.0,3e-41,170.6,sp|Q4V8X0|TPRA1_DANRE Transmembrane protein adipocyte-associated 1 homolog OS=Danio rerio OX=7955 GN=tpra1 PE=2 SV=1,,,,,,
OG_02220,1.6342078611356472,FUN_008615-T1,Peve_00015389,Pocillopora_meandrina_HIv1___RNAseq.g12744.t1,three_way,73.05916666666667,FUN_008615-T1,O35161,CELR1_MOUSE,,Cadherin EGF LAG seven-pass G-type receptor 1,Mus musculus (Mouse),33.5,2618.0,0.0,1375.5,sp|O35161|CELR1_MOUSE Cadherin EGF LAG seven-pass G-type receptor 1 OS=Mus musculus OX=10090 GN=Celsr1 PE=1 SV=3,GO:0001736; GO:0001843; GO:0001942; GO:0004930; GO:0005509; GO:0005654; GO:0005886; GO:0007156; GO:0007166; GO:0007266; GO:0007626; GO:0009952; GO:0016020; GO:0032956; GO:0042060; GO:0042249; GO:0042472; GO:0045176; GO:0048105; GO:0060488; GO:0060489; GO:0060490; GO:0090251; GO:0097475,anterior/posterior pattern specification [GO:0009952]; apical protein localization [GO:0045176]; cell surface receptor signaling pathway [GO:0007166]; establishment of body hair planar orientation [GO:0048105]; establishment of planar polarity [GO:0001736]; establishment of planar polarity of embryonic epithelium [GO:0042249]; hair follicle development [GO:0001942]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; inner ear morphogenesis [GO:0042472]; lateral sprouting involved in lung morphogenesis [GO:0060490]; locomotory behavior [GO:0007626]; motor neuron migration [GO:0097475]; neural tube closure [GO:0001843]; orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060488]; planar dichotomous subdivision of terminal units involved in lung branching morphogenesis [GO:0060489]; protein localization involved in establishment of planar polarity [GO:0090251]; regulation of actin cytoskeleton organization [GO:0032956]; Rho protein signal transduction [GO:0007266]; wound healing [GO:0042060],membrane [GO:0016020]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930],GO:0005654; GO:0005886; GO:0007155; GO:0042060; GO:0048856; GO:0048870; GO:0060089,nucleoplasm; plasma membrane; cell adhesion; wound healing; anatomical structure development; cell motility; molecular transducer activity
OG_02227,1.48588110509431,FUN_008633-T1,Peve_00012386,Pocillopora_meandrina_HIv1___RNAseq.g14915.t1,three_way,74.2705,FUN_008633-T1,Q8VDT1,,,,,45.9,573.0,4.5e-140,500.0,sp|Q8VDT1|SC5A9_MOUSE Sodium/glucose cotransporter 4 OS=Mus musculus OX=10090 GN=Slc5a9 PE=1 SV=3,,,,,,
OG_02228,1.060029946411929,FUN_008634-T1,Peve_00021941,Pocillopora_meandrina_HIv1___RNAseq.g14919.t2,three_way,51.94316666666667,FUN_008634-T1,P42166,LAP2A_HUMAN,,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin); Thymopentin (TP5)]",Homo sapiens (Human),35.0,197.0,9.1e-16,85.9,"sp|P42166|LAP2A_HUMAN Lamina-associated polypeptide 2, isoform alpha OS=Homo sapiens OX=9606 GN=TMPO PE=1 SV=2",GO:0000785; GO:0003677; GO:0005521; GO:0005634; GO:0005635; GO:0045296,,chromatin [GO:0000785]; nuclear envelope [GO:0005635]; nucleus [GO:0005634],cadherin binding [GO:0045296]; DNA binding [GO:0003677]; lamin binding [GO:0005521],GO:0003677; GO:0005634; GO:0005635; GO:0043226,DNA binding; nucleus; nuclear envelope; organelle
OG_02229,1.338142883669062,FUN_008635-T1,Peve_00024235,Pocillopora_meandrina_HIv1___RNAseq.g14918.t1,three_way,76.26733333333334,FUN_008635-T1,Q6NWJ4,DNJC2_DANRE,,DnaJ homolog subfamily C member 2,Danio rerio (Zebrafish) (Brachydanio rerio),55.8,618.0,1.4000000000000002e-124,448.4,sp|Q6NWJ4|DNJC2_DANRE DnaJ homolog subfamily C member 2 OS=Danio rerio OX=7955 GN=dnajc2 PE=2 SV=1,GO:0003682; GO:0005634; GO:0005829; GO:0006450; GO:0030544; GO:0042393; GO:0043022; GO:0045893; GO:0051083; GO:0061649,'de novo' cotranslational protein folding [GO:0051083]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of translational fidelity [GO:0006450],cytosol [GO:0005829]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; ribosome binding [GO:0043022]; ubiquitin-modified histone reader activity [GO:0061649],GO:0005634; GO:0005829; GO:0006355; GO:0006457; GO:0042393; GO:0043226; GO:0060090,nucleus; cytosol; regulation of DNA-templated transcription; protein folding; histone binding; organelle; molecular adaptor activity
OG_02280,1.8716632326026668,FUN_008772-T1,Peve_00036716,Pocillopora_meandrina_HIv1___RNAseq.g12702.t1,three_way,55.00416666666666,FUN_008772-T1,P30974,,,,,26.0,412.0,1.6e-18,95.9,sp|P30974|TLR1_DROME Tachykinin-like peptides receptor 86C OS=Drosophila melanogaster OX=7227 GN=TkR86C PE=2 SV=2,,,,,,
OG_02292,1.1985175554256249,FUN_008860-T1,Peve_00002936,Pocillopora_meandrina_HIv1___RNAseq.g30.t1,three_way,63.93383333333333,FUN_008860-T1,Q96M96,,,,,41.2,556.0,2.9e-110,401.4,"sp|Q96M96|FGD4_HUMAN FYVE, RhoGEF and PH domain-containing protein 4 OS=Homo sapiens OX=9606 GN=FGD4 PE=1 SV=2",,,,,,
OG_02298,1.2204987854433018,FUN_008877-T1,Peve_00043352,Pocillopora_meandrina_HIv1___TS.g30031.t1,three_way,72.87216666666667,FUN_008877-T1,Q8IZQ1,WDFY3_HUMAN,,WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy),Homo sapiens (Human),36.1,2785.0,0.0,1567.7,sp|Q8IZQ1|WDFY3_HUMAN WD repeat and FYVE domain-containing protein 3 OS=Homo sapiens OX=9606 GN=WDFY3 PE=1 SV=2,GO:0000421; GO:0005545; GO:0005635; GO:0005654; GO:0005730; GO:0005737; GO:0005776; GO:0005829; GO:0005886; GO:0008270; GO:0016020; GO:0016234; GO:0016605; GO:0030424; GO:0031965; GO:0035973; GO:0043204,aggrephagy [GO:0035973],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; inclusion body [GO:0016234]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; PML body [GO:0016605],1-phosphatidylinositol binding [GO:0005545]; zinc ion binding [GO:0008270],GO:0005635; GO:0005654; GO:0005730; GO:0005773; GO:0005829; GO:0005886; GO:0006914; GO:0008289; GO:0043226,nuclear envelope; nucleoplasm; nucleolus; vacuole; cytosol; plasma membrane; autophagy; lipid binding; organelle
OG_02317,1.7811480868952494,FUN_008908-T1,Peve_00017912,Pocillopora_meandrina_HIv1___TS.g30016.t1,three_way,61.309333333333335,FUN_008908-T1,G8HTB6,,,,,95.7,349.0,1.3e-187,657.1,sp|G8HTB6|ZPP_ACRMI ZP domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_02318,1.1359623615796537,FUN_008909-T1,Peve_00017911,Pocillopora_meandrina_HIv1___RNAseq.g3974.t1,three_way,62.283166666666666,FUN_008909-T1,Q9EQZ7,,,,,32.2,1005.0,1.6e-93,346.7,sp|Q9EQZ7|RIMS2_MOUSE Regulating synaptic membrane exocytosis protein 2 OS=Mus musculus OX=10090 GN=Rims2 PE=1 SV=1,,,,,,
OG_02339,1.220945922310756,FUN_008935-T1,Peve_00036395,Pocillopora_meandrina_HIv1___TS.g5740.t1,three_way,79.28566666666667,FUN_008935-T1,A0JM56,,,,,51.8,1431.0,1.4000000000000001e-186,655.6,sp|A0JM56|LRRC9_XENTR Leucine-rich repeat-containing protein 9 OS=Xenopus tropicalis OX=8364 GN=lrrc9 PE=2 SV=2,,,,,,
OG_02351,1.1932058518677489,FUN_008952-T1,Peve_00037679,Pocillopora_meandrina_HIv1___RNAseq.g4051.t1,three_way,70.46833333333333,FUN_008952-T1,Q8TDM6,,,,,31.0,1363.0,9.8e-134,480.3,sp|Q8TDM6|DLG5_HUMAN Disks large homolog 5 OS=Homo sapiens OX=9606 GN=DLG5 PE=1 SV=4,,,,,,
OG_02358,1.171188715408262,FUN_008961-T1,Peve_00006948,Pocillopora_meandrina_HIv1___RNAseq.g4042.t1,three_way,60.446,,,,,,,,,,,,,,,,,
OG_02369,1.5155782022169395,FUN_008978-T1,Peve_00017852,Pocillopora_meandrina_HIv1___RNAseq.g14265.t1,three_way,33.91433333333333,,,,,,,,,,,,,,,,,
OG_02384,1.2326590730241962,FUN_009006-T1,Peve_00029130,Pocillopora_meandrina_HIv1___RNAseq.g14283.t1,three_way,69.471,FUN_009006-T1,Q96RG2,,,,,34.2,1207.0,2.8e-153,544.7,sp|Q96RG2|PASK_HUMAN PAS domain-containing serine/threonine-protein kinase OS=Homo sapiens OX=9606 GN=PASK PE=1 SV=3,,,,,,
OG_02432,1.5316372435480512,FUN_009438-T1,Peve_00031029,Pocillopora_meandrina_HIv1___RNAseq.g25068.t1,three_way,73.89733333333334,,,,,,,,,,,,,,,,,
OG_02484,1.5666986165345045,FUN_009778-T1,Peve_00026798,Pocillopora_meandrina_HIv1___RNAseq.g24554.t1,three_way,71.61233333333334,FUN_009778-T1,P41216,,,,,47.2,642.0,8e-176,618.6,sp|P41216|ACSL1_MOUSE Long-chain-fatty-acid--CoA ligase 1 OS=Mus musculus OX=10090 GN=Acsl1 PE=1 SV=2,,,,,,
OG_02505,1.3929209004489131,FUN_009961-T1,Peve_00036464,Pocillopora_meandrina_HIv1___RNAseq.g24242.t1,three_way,77.88566666666667,FUN_009961-T1,Q90ZC7,KCMA1_XENLA,,"Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (xSlo)",Xenopus laevis (African clawed frog),45.5,1111.0,7.3e-262,905.2,sp|Q90ZC7|KCMA1_XENLA Calcium-activated potassium channel subunit alpha-1 OS=Xenopus laevis OX=8355 GN=kcnma1 PE=2 SV=1,GO:0034702; GO:0045211; GO:0046872; GO:0060072; GO:0071805,potassium ion transmembrane transport [GO:0071805],monoatomic ion channel complex [GO:0034702]; postsynaptic membrane [GO:0045211],large conductance calcium-activated potassium channel activity [GO:0060072]; metal ion binding [GO:0046872],GO:0005215; GO:0055085,transporter activity; transmembrane transport
OG_02526,1.761367586957636,FUN_010598-T1,Peve_00032709,Pocillopora_meandrina_HIv1___RNAseq.g21501.t1,three_way,41.12233333333334,FUN_010598-T1,O82504,,,,,24.5,420.0,8.599999999999999e-24,113.6,sp|O82504|RDR2_ARATH RNA-dependent RNA polymerase 2 OS=Arabidopsis thaliana OX=3702 GN=RDR2 PE=1 SV=1,,,,,,
OG_02536,1.322630249043267,FUN_010615-T1,Peve_00013370,Pocillopora_meandrina_HIv1___RNAseq.g21487.t1,three_way,60.214333333333336,FUN_010615-T1,Q8HZ58,,,,,23.2,293.0,1.3e-09,67.0,sp|Q8HZ58|CCHCR_PONPY Coiled-coil alpha-helical rod protein 1 OS=Pongo pygmaeus OX=9600 GN=CCHCR1 PE=3 SV=1,,,,,,
OG_02571,1.0952958771629562,FUN_010674-T1,Peve_00044786,Pocillopora_meandrina_HIv1___RNAseq.g21350.t1,three_way,81.68766666666667,FUN_010674-T1,O75116,ROCK2_HUMAN,,"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)",Homo sapiens (Human),50.3,445.0,8.199999999999999e-109,396.7,sp|O75116|ROCK2_HUMAN Rho-associated protein kinase 2 OS=Homo sapiens OX=9606 GN=ROCK2 PE=1 SV=4,GO:0000281; GO:0001837; GO:0001934; GO:0002020; GO:0002931; GO:0003180; GO:0003723; GO:0004674; GO:0005198; GO:0005524; GO:0005634; GO:0005737; GO:0005813; GO:0005829; GO:0005856; GO:0005886; GO:0006468; GO:0006939; GO:0007266; GO:0008270; GO:0010595; GO:0010613; GO:0010628; GO:0010629; GO:0010825; GO:0016525; GO:0030036; GO:0030155; GO:0030335; GO:0030866; GO:0031032; GO:0031267; GO:0031644; GO:0032723; GO:0032956; GO:0036464; GO:0042752; GO:0043410; GO:0044788; GO:0045019; GO:0045616; GO:0048156; GO:0048511; GO:0048598; GO:0050321; GO:0051298; GO:0051492; GO:0051496; GO:0051893; GO:0061133; GO:0061157; GO:0070168; GO:0071394; GO:0071559; GO:0072518; GO:0072659; GO:0090271; GO:0097746; GO:0106310; GO:0110061; GO:0150033; GO:1900037; GO:1901888; GO:1902004; GO:1902966; GO:1902993; GO:1903140; GO:1903347; GO:1905145; GO:1905205; GO:1990776; GO:2000114; GO:2000145,actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; aortic valve morphogenesis [GO:0003180]; blood vessel diameter maintenance [GO:0097746]; cellular response to acetylcholine [GO:1905145]; cellular response to testosterone stimulus [GO:0071394]; centrosome duplication [GO:0051298]; cortical actin cytoskeleton organization [GO:0030866]; embryonic morphogenesis [GO:0048598]; epithelial to mesenchymal transition [GO:0001837]; mitotic cytokinesis [GO:0000281]; modulation by host of viral process [GO:0044788]; mRNA destabilization [GO:0061157]; negative regulation of angiogenesis [GO:0016525]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of gene expression [GO:0010629]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of protein localization to lysosome [GO:0150033]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell migration [GO:0030335]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of connective tissue replacement [GO:1905205]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of fibroblast growth factor production [GO:0090271]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of angiotensin-activated signaling pathway [GO:0110061]; regulation of cell adhesion [GO:0030155]; regulation of cell junction assembly [GO:1901888]; regulation of cell motility [GO:2000145]; regulation of cellular response to hypoxia [GO:1900037]; regulation of circadian rhythm [GO:0042752]; regulation of establishment of cell polarity [GO:2000114]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of focal adhesion assembly [GO:0051893]; regulation of keratinocyte differentiation [GO:0045616]; regulation of nervous system process [GO:0031644]; regulation of stress fiber assembly [GO:0051492]; response to angiotensin [GO:1990776]; response to ischemia [GO:0002931]; response to transforming growth factor beta [GO:0071559]; Rho protein signal transduction [GO:0007266]; rhythmic process [GO:0048511]; smooth muscle contraction [GO:0006939],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; endopeptidase activator activity [GO:0061133]; protease binding [GO:0002020]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; Rho-dependent protein serine/threonine kinase activity [GO:0072518]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; zinc ion binding [GO:0008270],GO:0000910; GO:0003012; GO:0003013; GO:0003723; GO:0003824; GO:0005198; GO:0005634; GO:0005815; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0008092; GO:0016740; GO:0030154; GO:0043226; GO:0072659; GO:0098772; GO:0140096,"cytokinesis; muscle system process; circulatory system process; RNA binding; catalytic activity; structural molecule activity; nucleus; microtubule organizing center; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cytoskeletal protein binding; transferase activity; cell differentiation; organelle; protein localization to plasma membrane; molecular function regulator activity; catalytic activity, acting on a protein"
OG_02599,1.3924046308495466,FUN_010720-T1,Peve_00029905,Pocillopora_meandrina_HIv1___RNAseq.g20949.t2,three_way,83.7885,FUN_010720-T1,P58197,AP2A_RAT,,Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2),Rattus norvegicus (Rat),63.4,227.0,3.3e-68,260.8,sp|P58197|AP2A_RAT Transcription factor AP-2-alpha OS=Rattus norvegicus OX=10116 GN=Tfap2a PE=1 SV=1,GO:0000122; GO:0000976; GO:0000977; GO:0000978; GO:0000981; GO:0000987; GO:0001227; GO:0001228; GO:0001501; GO:0001822; GO:0001843; GO:0002089; GO:0003151; GO:0003334; GO:0003404; GO:0003409; GO:0003677; GO:0003682; GO:0003700; GO:0003713; GO:0003714; GO:0005634; GO:0005905; GO:0006355; GO:0006357; GO:0006366; GO:0007173; GO:0007399; GO:0007423; GO:0007605; GO:0008283; GO:0008285; GO:0009880; GO:0010172; GO:0010628; GO:0010761; GO:0010763; GO:0010842; GO:0010944; GO:0014032; GO:0014044; GO:0021506; GO:0021559; GO:0021623; GO:0021884; GO:0030501; GO:0032496; GO:0035115; GO:0035136; GO:0042059; GO:0042127; GO:0042472; GO:0042802; GO:0043066; GO:0043524; GO:0043525; GO:0043565; GO:0043588; GO:0045595; GO:0045664; GO:0045892; GO:0045893; GO:0045944; GO:0048485; GO:0048596; GO:0048701; GO:0048705; GO:0048730; GO:0051402; GO:0060021; GO:0060235; GO:0060325; GO:0060349; GO:0061029; GO:0061303; GO:0070172; GO:0071281; GO:0071711; GO:0072210; GO:1990837; GO:2000378,anterior neuropore closure [GO:0021506]; basement membrane organization [GO:0071711]; bone morphogenesis [GO:0060349]; cell population proliferation [GO:0008283]; cellular response to iron ion [GO:0071281]; cornea development in camera-type eye [GO:0061303]; embryonic body morphogenesis [GO:0010172]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic forelimb morphogenesis [GO:0035115]; embryonic pattern specification [GO:0009880]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermis morphogenesis [GO:0048730]; eyelid development in camera-type eye [GO:0061029]; face morphogenesis [GO:0060325]; fibroblast migration [GO:0010761]; forebrain neuron development [GO:0021884]; forelimb morphogenesis [GO:0035136]; inner ear morphogenesis [GO:0042472]; keratinocyte development [GO:0003334]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lens morphogenesis in camera-type eye [GO:0002089]; metanephric nephron development [GO:0072210]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neural tube closure [GO:0001843]; neuron apoptotic process [GO:0051402]; oculomotor nerve formation [GO:0021623]; optic cup structural organization [GO:0003409]; optic vesicle morphogenesis [GO:0003404]; outflow tract morphogenesis [GO:0003151]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of neuron differentiation [GO:0045664]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; retina layer formation [GO:0010842]; roof of mouth development [GO:0060021]; Schwann cell development [GO:0014044]; sensory organ development [GO:0007423]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; skin development [GO:0043588]; sympathetic nervous system development [GO:0048485]; transcription by RNA polymerase II [GO:0006366]; trigeminal nerve development [GO:0021559],clathrin-coated pit [GO:0005905]; nucleus [GO:0005634],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]",GO:0003677; GO:0005634; GO:0006351; GO:0006355; GO:0012501; GO:0030198; GO:0043226; GO:0048856; GO:0048870; GO:0050877; GO:0060090; GO:0140110,DNA binding; nucleus; DNA-templated transcription; regulation of DNA-templated transcription; programmed cell death; extracellular matrix organization; organelle; anatomical structure development; cell motility; nervous system process; molecular adaptor activity; transcription regulator activity
OG_02606,1.2666260091328772,FUN_010735-T1,Peve_00038977,Pocillopora_meandrina_HIv1___RNAseq.g20941.t1,three_way,82.79933333333334,FUN_010735-T1,Q9V9J3,SRC42_DROME,,Tyrosine-protein kinase Src42A (EC 2.7.10.2) (Tyrosine-protein kinase Src41) (Dsrc41),Drosophila melanogaster (Fruit fly),64.1,468.0,4.3999999999999985e-177,622.5,sp|Q9V9J3|SRC42_DROME Tyrosine-protein kinase Src42A OS=Drosophila melanogaster OX=7227 GN=Src42A PE=1 SV=1,GO:0004713; GO:0004715; GO:0005102; GO:0005524; GO:0005737; GO:0005829; GO:0005886; GO:0007169; GO:0007391; GO:0007395; GO:0007411; GO:0007424; GO:0007435; GO:0007476; GO:0016477; GO:0030154; GO:0034332; GO:0036335; GO:0042059; GO:0042742; GO:0043277; GO:0045742; GO:0045874; GO:0045886; GO:0046529; GO:0048167; GO:0048749; GO:0051017; GO:0070374; GO:0090136; GO:0106016,"actin filament bundle assembly [GO:0051017]; adherens junction organization [GO:0034332]; apoptotic cell clearance [GO:0043277]; axon guidance [GO:0007411]; cell differentiation [GO:0030154]; cell migration [GO:0016477]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; compound eye development [GO:0048749]; defense response to bacterium [GO:0042742]; dorsal closure [GO:0007391]; dorsal closure, spreading of leading edge cells [GO:0007395]; epithelial cell-cell adhesion [GO:0090136]; imaginal disc fusion, thorax closure [GO:0046529]; imaginal disc-derived wing morphogenesis [GO:0007476]; intestinal stem cell homeostasis [GO:0036335]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of synaptic assembly at neuromuscular junction [GO:0045886]; open tracheal system development [GO:0007424]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of sevenless signaling pathway [GO:0045874]; regulation of synaptic plasticity [GO:0048167]; salivary gland morphogenesis [GO:0007435]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein tyrosine kinase activity [GO:0004713]; signaling receptor binding [GO:0005102],GO:0003824; GO:0005829; GO:0005886; GO:0007155; GO:0016192; GO:0016740; GO:0030154; GO:0034330; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; cytosol; plasma membrane; cell adhesion; vesicle-mediated transport; transferase activity; cell differentiation; cell junction organization; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_02607,1.2028667582657493,FUN_010736-T1,Peve_00038978,Pocillopora_meandrina_HIv1___RNAseq.g20940.t1,three_way,50.23233333333334,FUN_010736-T1,Q95209,SORL_RABIT,,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA),Oryctolagus cuniculus (Rabbit),28.3,762.0,9.3e-88,327.4,sp|Q95209|SORL_RABIT Sortilin-related receptor OS=Oryctolagus cuniculus OX=9986 GN=SORL1 PE=1 SV=1,GO:0000139; GO:0002024; GO:0005615; GO:0005768; GO:0005769; GO:0005771; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006605; GO:0006622; GO:0006892; GO:0006897; GO:0010897; GO:0014910; GO:0016020; GO:0030514; GO:0030658; GO:0031901; GO:0032585; GO:0038020; GO:0045053; GO:0046628; GO:0055038; GO:1904179; GO:1990845,adaptive thermogenesis [GO:1990845]; diet induced thermogenesis [GO:0002024]; endocytosis [GO:0006897]; insulin receptor recycling [GO:0038020]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of triglyceride catabolic process [GO:0010897]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of insulin receptor signaling pathway [GO:0046628]; post-Golgi vesicle-mediated transport [GO:0006892]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; regulation of smooth muscle cell migration [GO:0014910],early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; transport vesicle membrane [GO:0030658],,GO:0005615; GO:0005768; GO:0005783; GO:0005794; GO:0005886; GO:0006886; GO:0016192; GO:0031410; GO:0043226,extracellular space; endosome; endoplasmic reticulum; Golgi apparatus; plasma membrane; intracellular protein transport; vesicle-mediated transport; cytoplasmic vesicle; organelle
OG_02620,1.0688137288506925,FUN_010763-T1,Peve_00008038,Pocillopora_meandrina_HIv1___RNAseq.g20924.t1,three_way,83.1185,FUN_010763-T1,O46382,,,,,58.7,1985.0,0.0,2090.5,sp|O46382|BIG1_BOVIN Brefeldin A-inhibited guanine nucleotide-exchange protein 1 OS=Bos taurus OX=9913 GN=ARFGEF1 PE=1 SV=1,,,,,,
OG_02657,1.3171644938258802,FUN_010840-T3,Peve_00014596,Pocillopora_meandrina_HIv1___RNAseq.g21008.t1,three_way,71.34866666666667,FUN_010840-T3,Q05B79,DHX36_BOVIN,,ATP-dependent DNA/RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAD/H box polypeptide 36) (DEAH-box protein 36) (G4-resolvase-1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element protein),Bos taurus (Bovine),49.9,1010.0,5.3e-265,915.6,sp|Q05B79|DHX36_BOVIN ATP-dependent DNA/RNA helicase DHX36 OS=Bos taurus OX=9913 GN=DHX36 PE=1 SV=1,GO:0000287; GO:0000781; GO:0000978; GO:0001503; GO:0002151; GO:0002735; GO:0003678; GO:0003697; GO:0003723; GO:0003724; GO:0003725; GO:0003730; GO:0005524; GO:0005634; GO:0005737; GO:0005739; GO:0005829; GO:0006359; GO:0007283; GO:0010494; GO:0010628; GO:0016607; GO:0016887; GO:0017148; GO:0030154; GO:0030424; GO:0030425; GO:0031442; GO:0032727; GO:0034605; GO:0034644; GO:0035925; GO:0042826; GO:0043123; GO:0043204; GO:0043330; GO:0043488; GO:0045087; GO:0045944; GO:0045995; GO:0048027; GO:0051607; GO:0051880; GO:0051891; GO:0060261; GO:0061003; GO:0061158; GO:0070034; GO:0070883; GO:0090669; GO:0140640; GO:1900153; GO:1901534; GO:1903843; GO:1904358; GO:1904582; GO:2000767,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cell differentiation [GO:0030154]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to UV [GO:0034644]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of translation [GO:0017148]; ossification [GO:0001503]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of gene expression [GO:0010628]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of intracellular mRNA localization [GO:1904582]; positive regulation of mRNA 3'-end processing [GO:0031442]; positive regulation of myeloid dendritic cell cytokine production [GO:0002735]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of telomere maintenance via telomere lengthening [GO:1904358]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription initiation by RNA polymerase II [GO:0060261]; regulation of embryonic development [GO:0045995]; regulation of mRNA stability [GO:0043488]; regulation of transcription by RNA polymerase III [GO:0006359]; response to exogenous dsRNA [GO:0043330]; spermatogenesis [GO:0007283]; telomerase RNA stabilization [GO:0090669]","axon [GO:0030424]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; dendrite [GO:0030425]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; perikaryon [GO:0043204]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; catalytic activity, acting on a nucleic acid [GO:0140640]; DNA helicase activity [GO:0003678]; double-stranded RNA binding [GO:0003725]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; histone deacetylase binding [GO:0042826]; magnesium ion binding [GO:0000287]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; pre-miRNA binding [GO:0070883]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; single-stranded DNA binding [GO:0003697]; telomerase RNA binding [GO:0070034]",GO:0002376; GO:0003677; GO:0003723; GO:0003824; GO:0005634; GO:0005739; GO:0005829; GO:0006355; GO:0016787; GO:0016853; GO:0022414; GO:0030154; GO:0043226; GO:0098542; GO:0140097; GO:0140098; GO:0140657,"immune system process; DNA binding; RNA binding; catalytic activity; nucleus; mitochondrion; cytosol; regulation of DNA-templated transcription; hydrolase activity; isomerase activity; reproductive process; cell differentiation; organelle; defense response to other organism; catalytic activity, acting on DNA; catalytic activity, acting on RNA; ATP-dependent activity"
OG_02689,1.2149911654805208,FUN_010949-T1,Peve_00040395,Pocillopora_meandrina_HIv1___RNAseq.g21802.t1,three_way,77.62,FUN_010949-T1,Q7ZU90,CHD1L_DANRE,,Chromodomain-helicase-DNA-binding protein 1-like (EC 3.6.4.-),Danio rerio (Zebrafish) (Brachydanio rerio),52.9,877.0,3.7999999999999996e-235,816.2,sp|Q7ZU90|CHD1L_DANRE Chromodomain-helicase-DNA-binding protein 1-like OS=Danio rerio OX=7955 GN=chd1l PE=2 SV=1,GO:0000166; GO:0003678; GO:0005524; GO:0005634; GO:0006281; GO:0006338; GO:0006974; GO:0007420; GO:0016887; GO:0031491; GO:0035861; GO:0140566; GO:0140658; GO:0160004,brain development [GO:0007420]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; DNA repair [GO:0006281],nucleus [GO:0005634]; site of double-strand break [GO:0035861],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; DNA helicase activity [GO:0003678]; histone reader activity [GO:0140566]; nucleosome binding [GO:0031491]; nucleotide binding [GO:0000166]; poly-ADP-D-ribose modification-dependent protein binding [GO:0160004],GO:0003824; GO:0005634; GO:0006281; GO:0006325; GO:0016787; GO:0016853; GO:0043226; GO:0048856; GO:0060090; GO:0140097; GO:0140657,"catalytic activity; nucleus; DNA repair; chromatin organization; hydrolase activity; isomerase activity; organelle; anatomical structure development; molecular adaptor activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_02720,1.0851861170339656,FUN_011048-T1,Peve_00013435,Pocillopora_meandrina_HIv1___RNAseq.g21483.t1,three_way,68.41766666666666,FUN_011048-T1,Q5PQT2,MTMR3_RAT,,"Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 (EC 3.1.3.95) (Myotubularin-related protein 3) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (Phosphatidylinositol-3-phosphate phosphatase)",Rattus norvegicus (Rat),37.4,1193.0,2.4e-206,720.7,"sp|Q5PQT2|MTMR3_RAT Phosphatidylinositol-3,5-bisphosphate 3-phosphatase MTMR3 OS=Rattus norvegicus OX=10116 GN=Mtmr3 PE=1 SV=1",GO:0004438; GO:0004722; GO:0004725; GO:0005737; GO:0005829; GO:0008138; GO:0008270; GO:0016020; GO:0019903; GO:0042149; GO:0046856; GO:0052629; GO:0060090; GO:0060304; GO:0061952; GO:1904562; GO:2000785,cellular response to glucose starvation [GO:0042149]; midbody abscission [GO:0061952]; phosphatidylinositol 5-phosphate metabolic process [GO:1904562]; phosphatidylinositol dephosphorylation [GO:0046856]; regulation of autophagosome assembly [GO:2000785]; regulation of phosphatidylinositol dephosphorylation [GO:0060304],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],"molecular adaptor activity [GO:0060090]; phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO:0052629]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; protein phosphatase binding [GO:0019903]; protein serine/threonine phosphatase activity [GO:0004722]; protein tyrosine phosphatase activity [GO:0004725]; protein tyrosine/serine/threonine phosphatase activity [GO:0008138]; zinc ion binding [GO:0008270]",GO:0003824; GO:0005829; GO:0006629; GO:0016787; GO:0060090; GO:0061024; GO:0140096,"catalytic activity; cytosol; lipid metabolic process; hydrolase activity; molecular adaptor activity; membrane organization; catalytic activity, acting on a protein"
OG_02744,1.8712410835540705,FUN_011308-T1,Peve_00024988,Pocillopora_meandrina_HIv1___RNAseq.g22351.t1,three_way,73.087,FUN_011308-T1,Q8L7W2,,,,,39.7,214.0,6.0999999999999996e-43,176.0,sp|Q8L7W2|NUDT8_ARATH Nudix hydrolase 8 OS=Arabidopsis thaliana OX=3702 GN=NUDT8 PE=2 SV=2,,,,,,
OG_02777,1.3290575709012045,FUN_011725-T1,Peve_00039709,Pocillopora_meandrina_HIv1___RNAseq.g23849.t1,three_way,80.71566666666666,FUN_011725-T1,Q4R918,KIF25_MACFA,,Kinesin-like protein KIF25,Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey),41.1,604.0,4.1000000000000004e-111,403.7,sp|Q4R918|KIF25_MACFA Kinesin-like protein KIF25 OS=Macaca fascicularis OX=9541 GN=KIF25 PE=1 SV=1,GO:0005524; GO:0005737; GO:0005813; GO:0005874; GO:0007018; GO:0008017; GO:0008569; GO:0046603; GO:0051289; GO:0051294; GO:0051647,establishment of spindle orientation [GO:0051294]; microtubule-based movement [GO:0007018]; negative regulation of mitotic centrosome separation [GO:0046603]; nucleus localization [GO:0051647]; protein homotetramerization [GO:0051289],centrosome [GO:0005813]; cytoplasm [GO:0005737]; microtubule [GO:0005874],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005815; GO:0007010; GO:0007018; GO:0008092; GO:0016853; GO:0065003; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytoskeleton organization; microtubule-based movement; cytoskeletal protein binding; isomerase activity; protein-containing complex assembly; ATP-dependent activity
OG_02779,1.427254267684242,FUN_011729-T1,Peve_00001119,Pocillopora_meandrina_HIv1___RNAseq.g23842.t1,three_way,77.98466666666667,FUN_011729-T1,Q9Y233,PDE10_HUMAN,,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17)",Homo sapiens (Human),39.8,757.0,1.0000000000000001e-159,565.5,"sp|Q9Y233|PDE10_HUMAN cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A OS=Homo sapiens OX=9606 GN=PDE10A PE=1 SV=2",GO:0004114; GO:0004115; GO:0004118; GO:0005829; GO:0006198; GO:0010754; GO:0019933; GO:0030552; GO:0030553; GO:0046069; GO:0046872; GO:0047555; GO:0098978; GO:0106070; GO:0141161,cAMP catabolic process [GO:0006198]; cAMP-mediated signaling [GO:0019933]; cGMP catabolic process [GO:0046069]; negative regulation of cGMP-mediated signaling [GO:0010754]; regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106070]; regulation of cAMP/PKA signal transduction [GO:0141161],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978],"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]",GO:0003824; GO:0005829; GO:0016787; GO:0055086; GO:1901135,catalytic activity; cytosol; hydrolase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_02782,1.030981823131167,FUN_011733-T1,Peve_00001121,Pocillopora_meandrina_HIv1___RNAseq.g23840.t2,three_way,53.03233333333333,FUN_011733-T1,Q6ZPR6,,,,,30.4,1491.0,1.3e-160,569.3,sp|Q6ZPR6|IBTK_MOUSE Inhibitor of Bruton tyrosine kinase OS=Mus musculus OX=10090 GN=Ibtk PE=1 SV=3,,,,,,
OG_02826,1.2222192611933471,FUN_011841-T1,Peve_00020934,Pocillopora_meandrina_HIv1___RNAseq.g23233.t1,three_way,49.15833333333333,,,,,,,,,,,,,,,,,
OG_02865,1.5291384293790649,FUN_011912-T1,Peve_00020699,Pocillopora_meandrina_HIv1___RNAseq.g23360.t1,three_way,69.96266666666666,FUN_011912-T1,Q92562,FIG4_HUMAN,,"Polyphosphoinositide phosphatase (EC 3.1.3.-) (EC 3.1.3.36) (EC 3.1.3.86) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3) (Serine-protein phosphatase FIG4) (EC 3.1.3.16)",Homo sapiens (Human),45.8,1014.0,7.2e-216,752.3,sp|Q92562|FIG4_HUMAN Polyphosphoinositide phosphatase OS=Homo sapiens OX=9606 GN=FIG4 PE=1 SV=1,GO:0000139; GO:0004438; GO:0004439; GO:0004722; GO:0005811; GO:0006661; GO:0007033; GO:0007626; GO:0010008; GO:0010976; GO:0031642; GO:0031901; GO:0031902; GO:0032288; GO:0034485; GO:0043231; GO:0043473; GO:0043812; GO:0043813; GO:0046856; GO:0048666; GO:0055037,locomotory behavior [GO:0007626]; myelin assembly [GO:0032288]; negative regulation of myelination [GO:0031642]; neuron development [GO:0048666]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; pigmentation [GO:0043473]; positive regulation of neuron projection development [GO:0010976]; vacuole organization [GO:0007033],early endosome membrane [GO:0031901]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; recycling endosome [GO:0055037],"phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity [GO:0043813]; phosphatidylinositol-3-phosphate phosphatase activity [GO:0004438]; phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO:0004439]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein serine/threonine phosphatase activity [GO:0004722]",GO:0003824; GO:0005768; GO:0005811; GO:0006629; GO:0016787; GO:0031410; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; endosome; lipid droplet; lipid metabolic process; hydrolase activity; cytoplasmic vesicle; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_02872,1.5102291904623728,FUN_011922-T1,Peve_00002208,Pocillopora_meandrina_HIv1___TS.g16203.t1,three_way,84.6935,FUN_011922-T1,Q9C102,GLT1_SCHPO,,Glutamate synthase [NADH] (EC 1.4.1.14) (Glutamine-oxoglutarate aminotransferase) (GOGAT),Schizosaccharomyces pombe (strain 972 / ATCC 24843) (Fission yeast),51.7,2161.0,0.0,2202.6,sp|Q9C102|GLT1_SCHPO Glutamate synthase [NADH] OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) OX=284812 GN=glt1 PE=1 SV=1,GO:0005506; GO:0005739; GO:0005829; GO:0006537; GO:0010181; GO:0016040; GO:0016639; GO:0019676; GO:0050660; GO:0051538; GO:0097054,ammonia assimilation cycle [GO:0019676]; glutamate biosynthetic process [GO:0006537]; L-glutamate biosynthetic process [GO:0097054],cytosol [GO:0005829]; mitochondrion [GO:0005739],"3 iron, 4 sulfur cluster binding [GO:0051538]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; glutamate synthase (NADH) activity [GO:0016040]; iron ion binding [GO:0005506]; oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor [GO:0016639]",GO:0003824; GO:0005739; GO:0005829; GO:0006520; GO:0016491; GO:0043226,catalytic activity; mitochondrion; cytosol; amino acid metabolic process; oxidoreductase activity; organelle
OG_02896,1.3551427413547237,FUN_011953-T1,Peve_00018991,Pocillopora_meandrina_HIv1___RNAseq.g24083.t1,three_way,75.15899999999999,,,,,,,,,,,,,,,,,
OG_02903,1.7982815422237433,FUN_011973-T1,Peve_00001000,Pocillopora_meandrina_HIv1___RNAseq.g23724.t1,three_way,61.82216666666667,FUN_011973-T1,Q54G43,SHKE_DICDI,,Dual specificity protein kinase shkE (EC 2.7.11.1) (SH2 domain-containing protein 5) (SH2 domain-containing protein E),Dictyostelium discoideum (Social amoeba),31.5,251.0,1.8e-23,113.2,sp|Q54G43|SHKE_DICDI Dual specificity protein kinase shkE OS=Dictyostelium discoideum OX=44689 GN=shkE PE=3 SV=1,GO:0004674; GO:0004713; GO:0005524; GO:0005737; GO:0007165; GO:0016020; GO:0106310,signal transduction [GO:0007165],cytoplasm [GO:0005737]; membrane [GO:0016020],ATP binding [GO:0005524]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_02982,1.677956599380277,FUN_012152-T1,Peve_00035458,Pocillopora_meandrina_HIv1___TS.g16648.t1,three_way,75.35416666666667,FUN_012152-T1,Q8NEN0,,,,,32.3,885.0,5.2000000000000004e-117,423.7,sp|Q8NEN0|ARMC2_HUMAN Armadillo repeat-containing protein 2 OS=Homo sapiens OX=9606 GN=ARMC2 PE=1 SV=4,,,,,,
OG_02985,1.252633475384642,FUN_012155-T1,Peve_00040791,Pocillopora_meandrina_HIv1___RNAseq.g23435.t1,three_way,55.4285,FUN_012155-T1,E7FA21,,,,,24.2,854.0,6.6e-38,161.0,sp|E7FA21|SMR8A_DANRE Guanine nucleotide exchange protein smcr8a OS=Danio rerio OX=7955 GN=smcr8a PE=3 SV=1,,,,,,
OG_02993,1.4789974687084233,FUN_012169-T1,Peve_00008636,Pocillopora_meandrina_HIv1___RNAseq.g23452.t1,three_way,71.68166666666667,,,,,,,,,,,,,,,,,
OG_03024,1.124479015640366,FUN_012250-T1,Peve_00020519,Pocillopora_meandrina_HIv1___RNAseq.g23517.t1,three_way,75.335,FUN_012250-T1,Q5T5C0,STXB5_HUMAN,,Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1),Homo sapiens (Human),38.5,1156.0,1.5999999999999999e-208,728.0,sp|Q5T5C0|STXB5_HUMAN Syntaxin-binding protein 5 OS=Homo sapiens OX=9606 GN=STXBP5 PE=1 SV=1,GO:0005096; GO:0005737; GO:0005829; GO:0005886; GO:0005892; GO:0006887; GO:0006893; GO:0008021; GO:0010807; GO:0015031; GO:0017075; GO:0017157; GO:0019905; GO:0031201; GO:0045159; GO:0045921; GO:0098674; GO:0098686; GO:2000300,exocytosis [GO:0006887]; Golgi to plasma membrane transport [GO:0006893]; positive regulation of exocytosis [GO:0045921]; protein transport [GO:0015031]; regulation of exocytosis [GO:0017157]; regulation of synaptic vesicle exocytosis [GO:2000300]; regulation of synaptic vesicle priming [GO:0010807],acetylcholine-gated channel complex [GO:0005892]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extrinsic component of neuronal dense core vesicle membrane [GO:0098674]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; plasma membrane [GO:0005886]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021],GTPase activator activity [GO:0005096]; myosin II binding [GO:0045159]; syntaxin binding [GO:0019905]; syntaxin-1 binding [GO:0017075],GO:0005829; GO:0005886; GO:0008092; GO:0016192; GO:0031410; GO:0043226; GO:0098772,cytosol; plasma membrane; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_03084,1.530885981709198,FUN_012357-T1,Peve_00042558,Pocillopora_meandrina_HIv1___TS.g16156.t2,three_way,49.562333333333335,,,,,,,,,,,,,,,,,
OG_03085,1.1888154105057478,FUN_012358-T1,Peve_00042557,Pocillopora_meandrina_HIv1___RNAseq.g23273.t1,three_way,74.58133333333333,FUN_012358-T1,Q24133,DNAJ1_DROME,,DnaJ protein homolog 1 (DROJ1),Drosophila melanogaster (Fruit fly),53.0,332.0,1.4e-84,314.7,sp|Q24133|DNAJ1_DROME DnaJ protein homolog 1 OS=Drosophila melanogaster OX=7227 GN=DnaJ-1 PE=1 SV=3,GO:0005829; GO:0006457; GO:0009408; GO:0042691; GO:0050821; GO:0051082; GO:0051085; GO:0051087; GO:0140297,chaperone cofactor-dependent protein refolding [GO:0051085]; positive regulation of crystal cell differentiation [GO:0042691]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; response to heat [GO:0009408],cytosol [GO:0005829],DNA-binding transcription factor binding [GO:0140297]; protein-folding chaperone binding [GO:0051087]; unfolded protein binding [GO:0051082],GO:0005829; GO:0006457,cytosol; protein folding
OG_03158,1.0394648962424649,FUN_012554-T1,Peve_00030421,Pocillopora_meandrina_HIv1___RNAseq.g23587.t2,three_way,58.8805,,,,,,,,,,,,,,,,,
OG_03161,1.3721430415056877,FUN_012557-T1,Peve_00030425,Pocillopora_meandrina_HIv1___TS.g16464.t1,three_way,86.991,FUN_012557-T1,Q8IZN3,ZDH14_HUMAN,,Palmitoyltransferase ZDHHC14 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 14) (DHHC-14) (NEW1 domain-containing protein) (NEW1CP) (Zinc finger DHHC domain-containing protein 14),Homo sapiens (Human),65.3,303.0,6.5e-121,435.6,sp|Q8IZN3|ZDH14_HUMAN Palmitoyltransferase ZDHHC14 OS=Homo sapiens OX=9606 GN=ZDHHC14 PE=1 SV=1,GO:0005783; GO:0005789; GO:0005794; GO:0006612; GO:0016409; GO:0018230; GO:0018345; GO:0019706; GO:0032580,peptidyl-L-cysteine S-palmitoylation [GO:0018230]; protein palmitoylation [GO:0018345]; protein targeting to membrane [GO:0006612],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580],palmitoyltransferase activity [GO:0016409]; protein-cysteine S-palmitoyltransferase activity [GO:0019706],GO:0003824; GO:0005783; GO:0005794; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; endoplasmic reticulum; Golgi apparatus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_03184,1.1567304348989953,FUN_012639-T1,Peve_00036806,Pocillopora_meandrina_HIv1___RNAseq.g22909.t1,three_way,74.95033333333333,FUN_012639-T1,Q5THJ4,VP13D_HUMAN,,Intermembrane lipid transfer protein VPS13D (Vacuolar protein sorting-associated protein 13D),Homo sapiens (Human),35.7,4659.0,0.0,2452.2,sp|Q5THJ4|VP13D_HUMAN Intermembrane lipid transfer protein VPS13D OS=Homo sapiens OX=9606 GN=VPS13D PE=1 SV=2,GO:0005739; GO:0006623; GO:0006869; GO:0007005; GO:0045053; GO:0070062; GO:1901526,lipid transport [GO:0006869]; mitochondrion organization [GO:0007005]; positive regulation of mitophagy [GO:1901526]; protein retention in Golgi apparatus [GO:0045053]; protein targeting to vacuole [GO:0006623],extracellular exosome [GO:0070062]; mitochondrion [GO:0005739],,GO:0005739; GO:0006886; GO:0007005; GO:0043226,mitochondrion; intracellular protein transport; mitochondrion organization; organelle
OG_03190,1.06315688902172,FUN_012662-T1,Peve_00020495,Pocillopora_meandrina_HIv1___RNAseq.g22891.t1,three_way,60.961666666666666,FUN_012662-T1,Q8BZ20,,,,,32.8,649.0,2e-78,295.0,sp|Q8BZ20|PAR12_MOUSE Protein mono-ADP-ribosyltransferase PARP12 OS=Mus musculus OX=10090 GN=Parp12 PE=1 SV=3,,,,,,
OG_03203,1.180494112843557,FUN_012689-T1,Peve_00016816,Pocillopora_meandrina_HIv1___RNAseq.g22864.t1,three_way,78.05083333333333,FUN_012689-T1,Q9YHY6,,,,,42.0,1454.0,3.1999999999999995e-300,1033.1,sp|Q9YHY6|CND1_XENLA Condensin complex subunit 1 OS=Xenopus laevis OX=8355 GN=ncapd2 PE=1 SV=1,,,,,,
OG_03218,1.232022756910474,FUN_012742-T1,Peve_00045169,Pocillopora_meandrina_HIv1___RNAseq.g23181.t1,three_way,60.48133333333333,,,,,,,,,,,,,,,,,
OG_03236,1.2789928777028174,FUN_012786-T1,Peve_00018304,Pocillopora_meandrina_HIv1___RNAseq.g12888.t1,three_way,86.545,FUN_012786-T1,Q6IWH7,ANO7_HUMAN,,Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G),Homo sapiens (Human),45.7,879.0,2.2e-213,743.8,sp|Q6IWH7|ANO7_HUMAN Anoctamin-7 OS=Homo sapiens OX=9606 GN=ANO7 PE=1 SV=2,GO:0005229; GO:0005254; GO:0005783; GO:0005829; GO:0005886; GO:0034220; GO:0046983; GO:0061588; GO:0070161; GO:1902476,calcium activated phospholipid scrambling [GO:0061588]; chloride transmembrane transport [GO:1902476]; monoatomic ion transmembrane transport [GO:0034220],anchoring junction [GO:0070161]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886],chloride channel activity [GO:0005254]; intracellularly calcium-gated chloride channel activity [GO:0005229]; protein dimerization activity [GO:0046983],GO:0005215; GO:0005783; GO:0005829; GO:0005886; GO:0043226; GO:0055085; GO:0061024,transporter activity; endoplasmic reticulum; cytosol; plasma membrane; organelle; transmembrane transport; membrane organization
OG_03252,2.0364640573456625,FUN_012983-T1,Peve_00028830,Pocillopora_meandrina_HIv1___RNAseq.g30380.t2,three_way,73.10633333333334,,,,,,,,,,,,,,,,,
OG_03255,1.437971241217772,FUN_013023-T1,Peve_00032574,Pocillopora_meandrina_HIv1___RNAseq.g12958.t1,three_way,85.64083333333333,,,,,,,,,,,,,,,,,
OG_03273,1.2365998277122916,FUN_013146-T1,Peve_00024360,Pocillopora_meandrina_HIv1___RNAseq.g13823.t1,three_way,75.41933333333333,FUN_013146-T1,Q5U247,,,,,34.6,673.0,1e-96,355.9,sp|Q5U247|EXOC8_XENLA Exocyst complex component 8 OS=Xenopus laevis OX=8355 GN=exoc8 PE=2 SV=1,,,,,,
OG_03357,1.1503633542033644,FUN_013594-T1,Peve_00029572,Pocillopora_meandrina_HIv1___RNAseq.g6546.t1,three_way,67.05166666666666,,,,,,,,,,,,,,,,,
OG_03362,1.2507081968527023,FUN_013601-T1,Peve_00018166,Pocillopora_meandrina_HIv1___RNAseq.g13480.t1,three_way,70.76016666666666,,,,,,,,,,,,,,,,,
OG_03406,1.3177072760511737,FUN_014449-T1,Peve_00009606,Pocillopora_meandrina_HIv1___RNAseq.1985_t,three_way,77.316,FUN_014449-T1,Q54BU4,ABCB1_DICDI,,ABC transporter B family member 1 (ABC transporter ABCB.1),Dictyostelium discoideum (Social amoeba),51.9,620.0,1.3e-162,575.1,sp|Q54BU4|ABCB1_DICDI ABC transporter B family member 1 OS=Dictyostelium discoideum OX=44689 GN=abcB1 PE=3 SV=1,GO:0005524; GO:0006935; GO:0006972; GO:0016020; GO:0016887; GO:0031154; GO:0042626; GO:0055085; GO:0140359,chemotaxis [GO:0006935]; culmination involved in sorocarp development [GO:0031154]; hyperosmotic response [GO:0006972]; transmembrane transport [GO:0055085],membrane [GO:0016020],ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626],GO:0003824; GO:0005215; GO:0016787; GO:0048856; GO:0055085; GO:0140657,catalytic activity; transporter activity; hydrolase activity; anatomical structure development; transmembrane transport; ATP-dependent activity
OG_03409,1.7102896843099178,FUN_014456-T1,Peve_00009600,Pocillopora_meandrina_HIv1___RNAseq.g22824.t1,three_way,65.45816666666667,FUN_014456-T1,O35551,RABE1_MOUSE,,Rab GTPase-binding effector protein 1 (Rabaptin-5) (Rabaptin-5alpha),Mus musculus (Mouse),33.5,367.0,7.700000000000001e-38,160.6,sp|O35551|RABE1_MOUSE Rab GTPase-binding effector protein 1 OS=Mus musculus OX=10090 GN=Rabep1 PE=1 SV=2,GO:0005096; GO:0005768; GO:0005769; GO:0005829; GO:0006893; GO:0006897; GO:0006915; GO:0008083; GO:0015031; GO:0016192; GO:0019904; GO:0030139; GO:0032991; GO:0042803; GO:0055037; GO:0098978; GO:0099149; GO:1903441,apoptotic process [GO:0006915]; endocytosis [GO:0006897]; Golgi to plasma membrane transport [GO:0006893]; protein localization to ciliary membrane [GO:1903441]; protein transport [GO:0015031]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endosome [GO:0005768]; glutamatergic synapse [GO:0098978]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037],growth factor activity [GO:0008083]; GTPase activator activity [GO:0005096]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803],GO:0005768; GO:0005829; GO:0012501; GO:0016192; GO:0031410; GO:0043226; GO:0048018; GO:0098772,endosome; cytosol; programmed cell death; vesicle-mediated transport; cytoplasmic vesicle; organelle; receptor ligand activity; molecular function regulator activity
OG_03423,1.0677102378793772,FUN_014477-T1,Peve_00037306,Pocillopora_meandrina_HIv1___RNAseq.g22817.t1,three_way,73.20533333333333,FUN_014477-T1,Q9NZ71,,,,,43.0,1046.0,9.9e-235,815.1,sp|Q9NZ71|RTEL1_HUMAN Regulator of telomere elongation helicase 1 OS=Homo sapiens OX=9606 GN=RTEL1 PE=1 SV=2,,,,,,
OG_03444,1.224508713796926,FUN_014506-T1,Peve_00015332,Pocillopora_meandrina_HIv1___RNAseq.g22634.t1,three_way,64.51866666666666,FUN_014506-T1,Q5XHG1,NSMA3_XENLA,,Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III),Xenopus laevis (African clawed frog),32.9,828.0,6.3e-106,386.7,sp|Q5XHG1|NSMA3_XENLA Sphingomyelin phosphodiesterase 4 OS=Xenopus laevis OX=8355 GN=smpd4 PE=2 SV=2,GO:0000139; GO:0004767; GO:0005635; GO:0005783; GO:0005789; GO:0006685; GO:0042383; GO:0046475; GO:0046513; GO:0046872; GO:0050290; GO:0071356,cellular response to tumor necrosis factor [GO:0071356]; ceramide biosynthetic process [GO:0046513]; glycerophospholipid catabolic process [GO:0046475]; sphingomyelin catabolic process [GO:0006685],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; Golgi membrane [GO:0000139]; nuclear envelope [GO:0005635]; sarcolemma [GO:0042383],metal ion binding [GO:0046872]; sphingomyelin phosphodiesterase activity [GO:0004767]; sphingomyelin phosphodiesterase D activity [GO:0050290],GO:0003824; GO:0005635; GO:0005783; GO:0005886; GO:0006629; GO:0016787; GO:0043226,catalytic activity; nuclear envelope; endoplasmic reticulum; plasma membrane; lipid metabolic process; hydrolase activity; organelle
OG_03500,1.254371762364287,FUN_014610-T1,Peve_00027567,Pocillopora_meandrina_HIv1___TS.g27529.t1,three_way,75.49566666666666,FUN_014610-T1,P27465,,,,,48.5,361.0,3.7e-97,356.7,"sp|P27465|PISD_CRIGR Phosphatidylserine decarboxylase proenzyme, mitochondrial OS=Cricetulus griseus OX=10029 GN=Pisd PE=1 SV=2",,,,,,
OG_03509,1.013217388478593,FUN_014619-T1,Peve_00002405,Pocillopora_meandrina_HIv1___RNAseq.g22775.t1,three_way,73.92766666666667,,,,,,,,,,,,,,,,,
OG_03514,1.610077993367801,FUN_014625-T1,Peve_00002412,Pocillopora_meandrina_HIv1___TS.g27550.t1,three_way,56.03566666666666,,,,,,,,,,,,,,,,,
OG_03579,1.1471556795387146,FUN_014734-T1,Peve_00010435,Pocillopora_meandrina_HIv1___RNAseq.1641_t,three_way,71.44800000000001,,,,,,,,,,,,,,,,,
OG_03686,1.2137651646329497,FUN_014948-T1,Peve_00024855,Pocillopora_meandrina_HIv1___RNAseq.g21115.t1,three_way,80.74033333333334,FUN_014948-T1,Q04336,,,,,46.8,939.0,1.3999999999999998e-250,867.5,sp|Q04336|YM54_YEAST Uncharacterized protein YMR196W OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) OX=559292 GN=YMR196W PE=1 SV=1,,,,,,
OG_03687,1.2772041582463487,FUN_014949-T1,Peve_00006235,Pocillopora_meandrina_HIv1___RNAseq.g21116.t1,three_way,79.29216666666667,FUN_014949-T1,Q9Y6J0,,,,,36.0,1819.0,9e-282,972.2,sp|Q9Y6J0|CABIN_HUMAN Calcineurin-binding protein cabin-1 OS=Homo sapiens OX=9606 GN=CABIN1 PE=1 SV=1,,,,,,
OG_03764,1.0958794047504217,FUN_015089-T1,Peve_00010705,Pocillopora_meandrina_HIv1___RNAseq.g21187.t1,three_way,72.56533333333334,FUN_015089-T1,Q71F56,MD13L_HUMAN,,Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like),Homo sapiens (Human),29.0,2382.0,7.899999999999999e-204,713.4,sp|Q71F56|MD13L_HUMAN Mediator of RNA polymerase II transcription subunit 13-like OS=Homo sapiens OX=9606 GN=MED13L PE=1 SV=1,GO:0003713; GO:0005654; GO:0016592; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],mediator complex [GO:0016592]; nucleoplasm [GO:0005654],transcription coactivator activity [GO:0003713],GO:0005654; GO:0006355; GO:0060090; GO:0140110,nucleoplasm; regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_03767,1.0893304028487192,FUN_015095-T1,Peve_00043821,Pocillopora_meandrina_HIv1___RNAseq.g22283.t1,three_way,81.09083333333334,FUN_015095-T1,Q8IZ69,TRM2A_HUMAN,,tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.35) (mRNA (uracil-5-)-methyltransferase TRMT2A) (EC 2.1.1.-),Homo sapiens (Human),40.3,618.0,9.4e-120,432.6,sp|Q8IZ69|TRM2A_HUMAN tRNA (uracil-5-)-methyltransferase homolog A OS=Homo sapiens OX=9606 GN=TRMT2A PE=1 SV=2,GO:0003723; GO:0005829; GO:0006397; GO:0008033; GO:0008169; GO:0030697; GO:0032259,methylation [GO:0032259]; mRNA processing [GO:0006397]; tRNA processing [GO:0008033],cytosol [GO:0005829],"C-methyltransferase activity [GO:0008169]; RNA binding [GO:0003723]; tRNA (uracil(54)-C5)-methyltransferase activity, S-adenosyl methionine-dependent [GO:0030697]",GO:0003723; GO:0003824; GO:0005829; GO:0006399; GO:0016071; GO:0016740; GO:0140098,"RNA binding; catalytic activity; cytosol; tRNA metabolic process; mRNA metabolic process; transferase activity; catalytic activity, acting on RNA"
OG_03777,1.065756361172738,FUN_015107-T1,Peve_00036875,Pocillopora_meandrina_HIv1___TS.g26879.t1,three_way,68.18,FUN_015107-T1,Q86YT5,S13A5_HUMAN,,Na(+)/citrate cotransporter (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter) (Solute carrier family 13 member 5),Homo sapiens (Human),45.1,618.0,1.4e-138,495.0,sp|Q86YT5|S13A5_HUMAN Na(+)/citrate cotransporter OS=Homo sapiens OX=9606 GN=SLC13A5 PE=1 SV=1,GO:0005343; GO:0005654; GO:0005829; GO:0005886; GO:0015137; GO:0015141; GO:0015729; GO:0015741; GO:0015742; GO:0015744; GO:0015746; GO:0017153; GO:0042802; GO:0055085; GO:0071285,alpha-ketoglutarate transport [GO:0015742]; cellular response to lithium ion [GO:0071285]; citrate transport [GO:0015746]; fumarate transport [GO:0015741]; oxaloacetate transport [GO:0015729]; succinate transport [GO:0015744]; transmembrane transport [GO:0055085],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],citrate transmembrane transporter activity [GO:0015137]; identical protein binding [GO:0042802]; organic acid:sodium symporter activity [GO:0005343]; sodium:dicarboxylate symporter activity [GO:0017153]; succinate transmembrane transporter activity [GO:0015141],GO:0005215; GO:0005654; GO:0005829; GO:0005886; GO:0055085,transporter activity; nucleoplasm; cytosol; plasma membrane; transmembrane transport
OG_03793,2.244740796072106,FUN_015164-T1,Peve_00001860,Pocillopora_meandrina_HIv1___TS.g25730.t1,three_way,68.88416666666667,FUN_015164-T1,Q14667,,,,,30.3,2363.0,1.9999999999999998e-285,984.6,sp|Q14667|BLTP2_HUMAN Bridge-like lipid transfer protein family member 2 OS=Homo sapiens OX=9606 GN=BLTP2 PE=1 SV=3,,,,,,
OG_03804,1.2196532875783508,FUN_015190-T2,Peve_00013035,Pocillopora_meandrina_HIv1___RNAseq.g22302.t2,three_way,57.41966666666666,FUN_015190-T2,Q9Y483,,,,,40.9,110.0,2.1e-18,97.4,sp|Q9Y483|MTF2_HUMAN Metal-response element-binding transcription factor 2 OS=Homo sapiens OX=9606 GN=MTF2 PE=1 SV=3,,,,,,
OG_03832,1.3578946812564032,FUN_015272-T1,Peve_00044766,Pocillopora_meandrina_HIv1___TS.g26974.t1,three_way,61.09433333333334,FUN_015272-T1,Q5ZIA0,MET16_CHICK,,RNA N(6)-adenosine-methyltransferase METTL16 (EC 2.1.1.348) (Methyltransferase 10 domain-containing protein) (Methyltransferase-like protein 16) (U6 small nuclear RNA (adenine-(43)-N(6))-methyltransferase) (EC 2.1.1.346),Gallus gallus (Chicken),47.3,389.0,1.9e-95,351.3,sp|Q5ZIA0|MET16_CHICK RNA N(6)-adenosine-methyltransferase METTL16 OS=Gallus gallus OX=9031 GN=METTL16 PE=2 SV=1,GO:0001734; GO:0003723; GO:0005634; GO:0005737; GO:0006397; GO:0006402; GO:0006556; GO:0010608; GO:0030629; GO:0035613; GO:0048024; GO:0061157; GO:0070475; GO:0120048; GO:0120049,"mRNA catabolic process [GO:0006402]; mRNA destabilization [GO:0061157]; mRNA processing [GO:0006397]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of mRNA splicing, via spliceosome [GO:0048024]; rRNA base methylation [GO:0070475]; S-adenosylmethionine biosynthetic process [GO:0006556]; snRNA (adenine-N6)-methylation [GO:0120049]",cytoplasm [GO:0005737]; nucleus [GO:0005634],mRNA m(6)A methyltransferase activity [GO:0001734]; RNA binding [GO:0003723]; RNA stem-loop binding [GO:0035613]; U6 snRNA (adenine-(43)-N(6))-methyltransferase activity [GO:0120048]; U6 snRNA 3'-end binding [GO:0030629],GO:0003723; GO:0003824; GO:0005634; GO:0006790; GO:0016071; GO:0016073; GO:0016740; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; sulfur compound metabolic process; mRNA metabolic process; snRNA metabolic process; transferase activity; organelle; catalytic activity, acting on RNA"
OG_03884,1.0337606581364394,FUN_015429-T1,Peve_00033649,Pocillopora_meandrina_HIv1___RNAseq.g22262.t1,three_way,84.209,FUN_015429-T1,Q5ZI89,,,,,48.9,1121.0,0.0,1077.0,sp|Q5ZI89|TPC11_CHICK Trafficking protein particle complex subunit 11 OS=Gallus gallus OX=9031 GN=TRAPPC11 PE=2 SV=1,,,,,,
OG_03896,1.1493072902851256,FUN_015474-T1,Peve_00009512,Pocillopora_meandrina_HIv1___TS.g26531.t2,three_way,73.673,FUN_015474-T1,Q14CX7,NAA25_HUMAN,,"N-alpha-acetyltransferase 25, NatB auxiliary subunit (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25) (p120)",Homo sapiens (Human),36.3,980.0,6.4000000000000005e-161,569.7,"sp|Q14CX7|NAA25_HUMAN N-alpha-acetyltransferase 25, NatB auxiliary subunit OS=Homo sapiens OX=9606 GN=NAA25 PE=1 SV=1",GO:0005737; GO:0005794; GO:0005829; GO:0007010; GO:0010698; GO:0031416,cytoskeleton organization [GO:0007010],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; NatB complex [GO:0031416],acetyltransferase activator activity [GO:0010698],GO:0005794; GO:0005829; GO:0007010; GO:0043226; GO:0098772,Golgi apparatus; cytosol; cytoskeleton organization; organelle; molecular function regulator activity
OG_03903,1.7147643463464208,FUN_015977-T1,Peve_00032728,Pocillopora_meandrina_HIv1___RNAseq.g21409.t1,three_way,72.505,,,,,,,,,,,,,,,,,
OG_03926,1.350611195777957,FUN_016038-T1,Peve_00011807,Pocillopora_meandrina_HIv1___RNAseq.g21648.t2,three_way,64.21833333333333,FUN_016038-T1,Q8TDN4,CABL1_HUMAN,,CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1) (Ik3-1),Homo sapiens (Human),43.4,295.0,2.7e-61,237.7,sp|Q8TDN4|CABL1_HUMAN CDK5 and ABL1 enzyme substrate 1 OS=Homo sapiens OX=9606 GN=CABLES1 PE=1 SV=2,GO:0005634; GO:0005829; GO:0007399; GO:0051301; GO:0051726,cell division [GO:0051301]; nervous system development [GO:0007399]; regulation of cell cycle [GO:0051726],cytosol [GO:0005829]; nucleus [GO:0005634],,GO:0005634; GO:0005829; GO:0043226; GO:0048856,nucleus; cytosol; organelle; anatomical structure development
OG_03928,1.1583807331149047,FUN_016043-T1,Peve_00011803,Pocillopora_meandrina_HIv1___RNAseq.g21644.t1,three_way,70.11666666666666,,,,,,,,,,,,,,,,,
OG_03985,1.0925139430776476,FUN_016150-T1,Peve_00013422,Pocillopora_meandrina_HIv1___RNAseq.g22094.t1,three_way,87.48066666666666,,,,,,,,,,,,,,,,,
OG_03988,1.0154251704616908,FUN_016154-T1,Peve_00004478,Pocillopora_meandrina_HIv1___RNAseq.g21231.t1,three_way,69.62266666666667,,,,,,,,,,,,,,,,,
OG_03991,1.1721407074749146,FUN_016163-T1,Peve_00022617,Pocillopora_meandrina_HIv1___RNAseq.g21016.t1,three_way,65.033,FUN_016163-T1,Q9ULI0,ATD2B_HUMAN,,ATPase family AAA domain-containing protein 2B,Homo sapiens (Human),42.8,1254.0,1.0999999999999999e-249,865.1,sp|Q9ULI0|ATD2B_HUMAN ATPase family AAA domain-containing protein 2B OS=Homo sapiens OX=9606 GN=ATAD2B PE=1 SV=4,GO:0003682; GO:0005524; GO:0005634; GO:0005654; GO:0006334; GO:0006337; GO:0016887; GO:0042393; GO:0045815; GO:0070577,nucleosome assembly [GO:0006334]; nucleosome disassembly [GO:0006337]; transcription initiation-coupled chromatin remodeling [GO:0045815],nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; chromatin binding [GO:0003682]; histone binding [GO:0042393]; lysine-acetylated histone binding [GO:0070577],GO:0003824; GO:0005634; GO:0005654; GO:0006325; GO:0016787; GO:0042393; GO:0043226; GO:0065003,catalytic activity; nucleus; nucleoplasm; chromatin organization; hydrolase activity; histone binding; organelle; protein-containing complex assembly
OG_04025,1.2634217042099796,FUN_016332-T1,Peve_00044544,Pocillopora_meandrina_HIv1___RNAseq.g9841.t1,three_way,43.75183333333334,,,,,,,,,,,,,,,,,
OG_04029,1.2472458739852208,FUN_016337-T1,Peve_00044566,Pocillopora_meandrina_HIv1___RNAseq.g9732.t1,three_way,81.75833333333334,,,,,,,,,,,,,,,,,
OG_04050,1.8654994564600271,FUN_016368-T2,Peve_00004346,Pocillopora_meandrina_HIv1___RNAseq.g9681.t1,three_way,71.802,FUN_016368-T2,Q8NEV4,MYO3A_HUMAN,,Myosin-IIIa (EC 2.7.11.1),Homo sapiens (Human),49.4,1096.0,9.1e-305,1048.1,sp|Q8NEV4|MYO3A_HUMAN Myosin-IIIa OS=Homo sapiens OX=9606 GN=MYO3A PE=1 SV=2,GO:0000146; GO:0001917; GO:0003779; GO:0004672; GO:0004674; GO:0005516; GO:0005524; GO:0005737; GO:0007601; GO:0007605; GO:0016459; GO:0016887; GO:0030175; GO:0030832; GO:0031941; GO:0032426; GO:0032433; GO:0043531; GO:0046777; GO:0051491; GO:0060002; GO:0090103; GO:0106310,cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; protein autophosphorylation [GO:0046777]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],cytoplasm [GO:0005737]; filamentous actin [GO:0031941]; filopodium [GO:0030175]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; stereocilium tip [GO:0032426],actin binding [GO:0003779]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; calmodulin binding [GO:0005516]; microfilament motor activity [GO:0000146]; plus-end directed microfilament motor activity [GO:0060002]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003774; GO:0003824; GO:0008092; GO:0016740; GO:0016787; GO:0016853; GO:0050877; GO:0140096; GO:0140657,"cytoskeletal motor activity; catalytic activity; cytoskeletal protein binding; transferase activity; hydrolase activity; isomerase activity; nervous system process; catalytic activity, acting on a protein; ATP-dependent activity"
OG_04068,1.16873425600633,FUN_016389-T1,Peve_00033768,Pocillopora_meandrina_HIv1___RNAseq.g9765.t1,three_way,65.33466666666666,FUN_016389-T1,Q6DGB6,DAA19_DANRE,,Dynein axonemal assembly factor 19 (Coiled-coil domain-containing protein 103) (Protein schmalhans),Danio rerio (Zebrafish) (Brachydanio rerio),48.0,200.0,2.7e-41,170.2,sp|Q6DGB6|DAA19_DANRE Dynein axonemal assembly factor 19 OS=Danio rerio OX=7955 GN=dnaaf19 PE=1 SV=1,GO:0001947; GO:0003143; GO:0003146; GO:0003341; GO:0003351; GO:0005576; GO:0005737; GO:0005930; GO:0007368; GO:0031514; GO:0036157; GO:0036159; GO:0060271; GO:0070286; GO:0090660,axonemal dynein complex assembly [GO:0070286]; cerebrospinal fluid circulation [GO:0090660]; cilium assembly [GO:0060271]; cilium movement [GO:0003341]; determination of left/right symmetry [GO:0007368]; embryonic heart tube morphogenesis [GO:0003143]; epithelial cilium movement involved in extracellular fluid movement [GO:0003351]; heart jogging [GO:0003146]; heart looping [GO:0001947]; inner dynein arm assembly [GO:0036159],axoneme [GO:0005930]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; motile cilium [GO:0031514]; outer dynein arm [GO:0036157],,GO:0005576; GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0050877; GO:0065003,extracellular region; cilium; microtubule-based movement; organelle; cilium organization; nervous system process; protein-containing complex assembly
OG_04075,1.44646474158517,FUN_016400-T1,Peve_00006411,Pocillopora_meandrina_HIv1___RNAseq.g9752.t1,three_way,83.30466666666666,FUN_016400-T1,Q6NUP7,PP4R4_HUMAN,,Serine/threonine-protein phosphatase 4 regulatory subunit 4,Homo sapiens (Human),46.8,667.0,3.4e-166,587.0,sp|Q6NUP7|PP4R4_HUMAN Serine/threonine-protein phosphatase 4 regulatory subunit 4 OS=Homo sapiens OX=9606 GN=PPP4R4 PE=1 SV=1,GO:0001835; GO:0004864; GO:0004865; GO:0005737; GO:0005829; GO:0005929; GO:0008287; GO:0019888; GO:0036064; GO:0043231,blastocyst hatching [GO:0001835],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; protein serine/threonine phosphatase complex [GO:0008287],protein phosphatase inhibitor activity [GO:0004864]; protein phosphatase regulator activity [GO:0019888]; protein serine/threonine phosphatase inhibitor activity [GO:0004865],GO:0005815; GO:0005829; GO:0005929; GO:0043226; GO:0098772,microtubule organizing center; cytosol; cilium; organelle; molecular function regulator activity
OG_04085,1.058552046157046,FUN_016421-T1,Peve_00023006,Pocillopora_meandrina_HIv1___RNAseq.g9803.t1,three_way,72.968,FUN_016421-T1,Q9P2G1,AKIB1_HUMAN,,Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31),Homo sapiens (Human),50.3,746.0,6.800000000000001e-211,735.7,sp|Q9P2G1|AKIB1_HUMAN Ankyrin repeat and IBR domain-containing protein 1 OS=Homo sapiens OX=9606 GN=ANKIB1 PE=1 SV=3,GO:0000151; GO:0005737; GO:0006511; GO:0008270; GO:0016567; GO:0031624; GO:0061630,protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151],ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_04089,1.0965392353625705,FUN_016428-T1,Peve_00004356,Pocillopora_meandrina_HIv1___RNAseq.g9809.t1,three_way,74.45816666666666,FUN_016428-T1,Q15147,,,,,38.6,1257.0,9.2e-231,802.4,"sp|Q15147|PLCB4_HUMAN 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 OS=Homo sapiens OX=9606 GN=PLCB4 PE=1 SV=3",,,,,,
OG_04109,1.6309038561971454,FUN_016475-T1,Peve_00040144,Pocillopora_meandrina_HIv1___RNAseq.g10194.t1,three_way,66.4755,FUN_016475-T1,P0C5Y8,ALS2_RAT,,Alsin (Amyotrophic lateral sclerosis 2 protein homolog),Rattus norvegicus (Rat),30.6,1765.0,3.8e-188,661.0,sp|P0C5Y8|ALS2_RAT Alsin OS=Rattus norvegicus OX=10116 GN=Als2 PE=1 SV=1,GO:0001662; GO:0001701; GO:0001726; GO:0001881; GO:0005085; GO:0005096; GO:0005634; GO:0005737; GO:0005769; GO:0005813; GO:0005829; GO:0006979; GO:0007041; GO:0007409; GO:0007528; GO:0007626; GO:0008104; GO:0014069; GO:0016020; GO:0016050; GO:0016197; GO:0016601; GO:0030027; GO:0030424; GO:0030425; GO:0030426; GO:0031267; GO:0031982; GO:0032991; GO:0035249; GO:0042802; GO:0042803; GO:0043025; GO:0043197; GO:0043231; GO:0043539; GO:0043547; GO:0045860; GO:0048812; GO:0051036; GO:0051260; GO:0098978; GO:0099072,"axonogenesis [GO:0007409]; behavioral fear response [GO:0001662]; endosomal transport [GO:0016197]; in utero embryonic development [GO:0001701]; locomotory behavior [GO:0007626]; lysosomal transport [GO:0007041]; neuromuscular junction development [GO:0007528]; neuron projection morphogenesis [GO:0048812]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; protein homooligomerization [GO:0051260]; protein localization [GO:0008104]; Rac protein signal transduction [GO:0016601]; receptor recycling [GO:0001881]; regulation of endosome size [GO:0051036]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; response to oxidative stress [GO:0006979]; synaptic transmission, glutamatergic [GO:0035249]; vesicle organization [GO:0016050]",axon [GO:0030424]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; vesicle [GO:0031982],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine kinase activator activity [GO:0043539]; small GTPase binding [GO:0031267],GO:0005634; GO:0005768; GO:0005815; GO:0005829; GO:0016192; GO:0023052; GO:0031410; GO:0034330; GO:0043226; GO:0048856; GO:0065003; GO:0098772,nucleus; endosome; microtubule organizing center; cytosol; vesicle-mediated transport; signaling; cytoplasmic vesicle; cell junction organization; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_04129,1.6516632154376112,FUN_016578-T1,Peve_00002516,Pocillopora_meandrina_HIv1___RNAseq.g9694.t1,three_way,71.17683333333333,FUN_016578-T1,Q8K4Q6,NEIL1_MOUSE,,Endonuclease 8-like 1 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil1) (DNA-(apurinic or apyrimidinic site) lyase Neil1) (Endonuclease VIII-like 1) (Nei homolog 1) (NEH1) (Nei-like protein 1),Mus musculus (Mouse),49.5,307.0,1.9000000000000002e-80,301.2,sp|Q8K4Q6|NEIL1_MOUSE Endonuclease 8-like 1 OS=Mus musculus OX=10090 GN=Neil1 PE=2 SV=3,GO:0003684; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0006281; GO:0006284; GO:0006979; GO:0008270; GO:0016829; GO:0019104; GO:0140078,base-excision repair [GO:0006284]; DNA repair [GO:0006281]; response to oxidative stress [GO:0006979],centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA N-glycosylase activity [GO:0019104]; lyase activity [GO:0016829]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0005815; GO:0006281; GO:0016787; GO:0016829; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; microtubule organizing center; DNA repair; hydrolase activity; lyase activity; organelle; catalytic activity, acting on DNA"
OG_04189,1.551601587047103,FUN_016710-T1,Peve_00024194,Pocillopora_meandrina_HIv1___RNAseq.g275.t1,three_way,50.513666666666666,,,,,,,,,,,,,,,,,
OG_04204,1.194904971275107,FUN_016759-T1,Peve_00003676,Pocillopora_meandrina_HIv1___RNAseq.g14956.t1,three_way,68.49566666666666,FUN_016759-T1,Q2QUN2,,,,,25.6,629.0,2.7e-41,172.6,sp|Q2QUN2|LAC24_ORYSJ Laccase-24 OS=Oryza sativa subsp. japonica OX=39947 GN=LAC24 PE=2 SV=1,,,,,,
OG_04205,1.2754916090417816,FUN_016777-T1,Peve_00032303,Pocillopora_meandrina_HIv1___RNAseq.g10047.t1,three_way,85.97500000000001,FUN_016777-T1,Q86SR1,GLT10_HUMAN,,Polypeptide N-acetylgalactosaminyltransferase 10 (EC 2.4.1.41) (Polypeptide GalNAc transferase 10) (GalNAc-T10) (pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10),Homo sapiens (Human),41.8,584.0,1.1e-123,445.3,sp|Q86SR1|GLT10_HUMAN Polypeptide N-acetylgalactosaminyltransferase 10 OS=Homo sapiens OX=9606 GN=GALNT10 PE=1 SV=2,GO:0000139; GO:0004653; GO:0005794; GO:0006493; GO:0016266; GO:0030246; GO:0046872,O-glycan processing [GO:0016266]; protein O-linked glycosylation [GO:0006493],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]; polypeptide N-acetylgalactosaminyltransferase activity [GO:0004653],GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04227,1.0846166937719706,FUN_017022-T1,Peve_00018298,Pocillopora_meandrina_HIv1___RNAseq.g20360.t1,three_way,58.69716666666667,FUN_017022-T1,Q8BV79,,,,,28.2,2731.0,2.9e-254,881.7,sp|Q8BV79|TRNK1_MOUSE TPR and ankyrin repeat-containing protein 1 OS=Mus musculus OX=10090 GN=Trank1 PE=2 SV=3,,,,,,
OG_04235,1.597592639450739,FUN_017756-T1,Peve_00030017,Pocillopora_meandrina_HIv1___RNAseq.g15152.t1,three_way,86.29766666666667,FUN_017756-T1,Q3ZBG9,,,,,63.9,233.0,3.8e-92,339.3,sp|Q3ZBG9|PLS2_BOVIN Phospholipid scramblase 2 OS=Bos taurus OX=9913 GN=PLSCR2 PE=2 SV=1,,,,,,
OG_04256,1.3075068143201125,FUN_017787-T1,Peve_00040530,Pocillopora_meandrina_HIv1___RNAseq.g9522.t1,three_way,41.8165,FUN_017787-T1,Q5VT06,CE350_HUMAN,,Centrosome-associated protein 350 (Cep350) (Centrosome-associated protein of 350 kDa),Homo sapiens (Human),39.4,66.0,1.1e-06,56.2,sp|Q5VT06|CE350_HUMAN Centrosome-associated protein 350 OS=Homo sapiens OX=9606 GN=CEP350 PE=1 SV=1,GO:0005654; GO:0005813; GO:0005814; GO:0005819; GO:0005829; GO:0008017; GO:0016020; GO:0034453; GO:0036064; GO:0043231; GO:0071539; GO:1905515,microtubule anchoring [GO:0034453]; non-motile cilium assembly [GO:1905515]; protein localization to centrosome [GO:0071539],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; spindle [GO:0005819],microtubule binding [GO:0008017],GO:0005654; GO:0005815; GO:0005829; GO:0007010; GO:0008092; GO:0043226; GO:0044782,nucleoplasm; microtubule organizing center; cytosol; cytoskeleton organization; cytoskeletal protein binding; organelle; cilium organization
OG_04276,1.0047007129668002,FUN_017835-T1,Peve_00027711,Pocillopora_meandrina_HIv1___RNAseq.g9593.t1,three_way,65.258,FUN_017835-T1,E1C1L6,ENTP5_CHICK,,Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5),Gallus gallus (Chicken),47.1,380.0,1.0000000000000001e-88,328.6,sp|E1C1L6|ENTP5_CHICK Ectonucleoside triphosphate diphosphohydrolase 5 OS=Gallus gallus OX=9031 GN=ENTPD5 PE=3 SV=1,GO:0004382; GO:0005576; GO:0005783; GO:0006011; GO:0006256; GO:0006487; GO:0036384; GO:0043262; GO:0045134; GO:0051084; GO:1990003,'de novo' post-translational protein folding [GO:0051084]; protein N-linked glycosylation [GO:0006487]; UDP catabolic process [GO:0006256]; UDP-alpha-D-glucose metabolic process [GO:0006011],endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576],ADP phosphatase activity [GO:0043262]; CDP phosphatase activity [GO:0036384]; GDP phosphatase activity [GO:0004382]; IDP phosphatase activity [GO:1990003]; UDP phosphatase activity [GO:0045134],GO:0003824; GO:0005576; GO:0005783; GO:0006457; GO:0009101; GO:0016787; GO:0043226; GO:0055086; GO:1901135,catalytic activity; extracellular region; endoplasmic reticulum; protein folding; glycoprotein biosynthetic process; hydrolase activity; organelle; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_04279,1.1362922577209174,FUN_017840-T1,Peve_00011468,Pocillopora_meandrina_HIv1___RNAseq.g9633.t1,three_way,76.64583333333333,FUN_017840-T1,F4JYJ3,,,,,35.1,225.0,6.599999999999997e-29,129.8,sp|F4JYJ3|SFH11_ARATH Phosphatidylinositol/phosphatidylcholine transfer protein SFH11 OS=Arabidopsis thaliana OX=3702 GN=SFH11 PE=3 SV=1,,,,,,
OG_04281,1.2468428039984714,FUN_017843-T1,Peve_00018632,Pocillopora_meandrina_HIv1___RNAseq.g9587.t3,three_way,50.5255,,,,,,,,,,,,,,,,,
OG_04285,1.7813184834196232,FUN_017848-T2,Peve_00013267,Pocillopora_meandrina_HIv1___RNAseq.g9584.t1a,three_way,68.80566666666667,FUN_017848-T2,Q09328,MGT5A_HUMAN,,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase V) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V) [Cleaved into: Secreted alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (Secreted beta-1,6-N-acetylglucosaminyltransferase V) (Secreted GNT-V)]",Homo sapiens (Human),37.0,873.0,6.1e-166,586.3,"sp|Q09328|MGT5A_HUMAN Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A OS=Homo sapiens OX=9606 GN=MGAT5 PE=1 SV=1",GO:0000139; GO:0004864; GO:0005794; GO:0006487; GO:0016020; GO:0018279; GO:0019082; GO:0030144; GO:0030145; GO:0030335; GO:0070062; GO:1904894,positive regulation of cell migration [GO:0030335]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; protein N-linked glycosylation [GO:0006487]; protein N-linked glycosylation via asparagine [GO:0018279]; viral protein processing [GO:0019082],extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane [GO:0016020],"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity [GO:0030144]; manganese ion binding [GO:0030145]; protein phosphatase inhibitor activity [GO:0004864]",GO:0003824; GO:0005794; GO:0009101; GO:0016740; GO:0043226; GO:0098772; GO:0140096; GO:1901135,"catalytic activity; Golgi apparatus; glycoprotein biosynthetic process; transferase activity; organelle; molecular function regulator activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_04324,1.3160593050146907,FUN_017926-T2,Peve_00001604,Pocillopora_meandrina_HIv1___RNAseq.g288.t1,three_way,71.02733333333333,FUN_017926-T2,Q7TNC6,KI26B_MOUSE,,Kinesin-like protein KIF26B,Mus musculus (Mouse),39.8,814.0,1.3e-130,469.9,sp|Q7TNC6|KI26B_MOUSE Kinesin-like protein KIF26B OS=Mus musculus OX=10090 GN=Kif26b PE=1 SV=3,GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0007018; GO:0008017; GO:0022409; GO:0030010; GO:0072092,establishment of cell polarity [GO:0030010]; microtubule-based movement [GO:0007018]; positive regulation of cell-cell adhesion [GO:0022409]; ureteric bud invasion [GO:0072092],cytoplasm [GO:0005737]; microtubule [GO:0005874],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0007018; GO:0007163; GO:0008092; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule-based movement; establishment or maintenance of cell polarity; cytoskeletal protein binding; isomerase activity; ATP-dependent activity
OG_04335,1.614109739257522,FUN_017947-T1,Peve_00000380,Pocillopora_meandrina_HIv1___RNAseq.g25233.t1,three_way,66.458,FUN_017947-T1,F1M0Z1,TRIO_RAT,,Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein),Rattus norvegicus (Rat),44.3,314.0,2.1999999999999998e-69,265.8,sp|F1M0Z1|TRIO_RAT Triple functional domain protein OS=Rattus norvegicus OX=10116 GN=Trio PE=1 SV=4,GO:0004674; GO:0005085; GO:0005524; GO:0005737; GO:0007411; GO:0019898; GO:0019899; GO:0042995; GO:0045599; GO:0048786; GO:0048812; GO:0050804; GO:0098685; GO:0098794; GO:0098978; GO:0099170; GO:0106310,axon guidance [GO:0007411]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of fat cell differentiation [GO:0045599]; neuron projection morphogenesis [GO:0048812]; postsynaptic modulation of chemical synaptic transmission [GO:0099170],cell projection [GO:0042995]; cytoplasm [GO:0005737]; extrinsic component of membrane [GO:0019898]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; presynaptic active zone [GO:0048786]; Schaffer collateral - CA1 synapse [GO:0098685],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; guanyl-nucleotide exchange factor activity [GO:0005085]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0016740; GO:0098772; GO:0140096,"catalytic activity; transferase activity; molecular function regulator activity; catalytic activity, acting on a protein"
OG_04336,1.3847709194187814,FUN_017948-T1,Peve_00000381,Pocillopora_meandrina_HIv1___RNAseq.g25232.t1,three_way,82.87233333333333,,,,,,,,,,,,,,,,,
OG_04337,1.113691927087594,FUN_017950-T1,Peve_00000377,Pocillopora_meandrina_HIv1___RNAseq.g25230.t1,three_way,61.35916666666667,FUN_017950-T1,Q8T689,,,,,26.9,583.0,8.299999999999999e-46,188.0,sp|Q8T689|ABCG4_DICDI ABC transporter G family member 4 OS=Dictyostelium discoideum OX=44689 GN=abcG4 PE=3 SV=1,,,,,,
OG_04346,1.723871680957212,FUN_017970-T1,Peve_00000395,Pocillopora_meandrina_HIv1___TS.g25528.t2,three_way,63.346833333333336,FUN_017970-T1,Q9VM21,,,,,33.0,624.0,2.1999999999999997e-53,212.2,sp|Q9VM21|GUDU_DROME Armadillo repeat-containing protein gudu OS=Drosophila melanogaster OX=7227 GN=gudu PE=2 SV=1,,,,,,
OG_04367,1.618621572387082,FUN_018023-T1,Peve_00005730,Pocillopora_meandrina_HIv1___RNAseq.g25298.t1,three_way,70.57966666666667,FUN_018023-T1,Q9WU06,AVIL_RAT,,Advillin (Peripheral nervous system villin-like protein) (Pervin),Rattus norvegicus (Rat),40.0,834.0,9e-156,552.4,sp|Q9WU06|AVIL_RAT Advillin OS=Rattus norvegicus OX=10116 GN=Avil PE=2 SV=2,GO:0003779; GO:0005546; GO:0005737; GO:0005884; GO:0005925; GO:0007015; GO:0007399; GO:0008154; GO:0010592; GO:0010976; GO:0015629; GO:0030027; GO:0030424; GO:0042995; GO:0043005; GO:0051014; GO:0051015; GO:0051016; GO:0060271; GO:0071933; GO:1900480,actin filament organization [GO:0007015]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; barbed-end actin filament capping [GO:0051016]; cilium assembly [GO:0060271]; nervous system development [GO:0007399]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron projection development [GO:0010976]; regulation of diacylglycerol biosynthetic process [GO:1900480],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; axon [GO:0030424]; cell projection [GO:0042995]; cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; neuron projection [GO:0043005],"actin binding [GO:0003779]; actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]",GO:0005856; GO:0008092; GO:0008289; GO:0043226; GO:0044782; GO:0048856,cytoskeleton; cytoskeletal protein binding; lipid binding; organelle; cilium organization; anatomical structure development
OG_04385,2.021700749134051,FUN_018091-T1,Peve_00001666,Pocillopora_meandrina_HIv1___TS.g25577.t1,three_way,73.79583333333333,FUN_018091-T1,Q6ZS30,,,,,36.6,2500.0,0.0,1536.9,sp|Q6ZS30|NBEL1_HUMAN Neurobeachin-like protein 1 OS=Homo sapiens OX=9606 GN=NBEAL1 PE=1 SV=3,,,,,,
OG_04397,1.7145663623105285,FUN_018402-T1,Peve_00033494,Pocillopora_meandrina_HIv1___RNAseq.16819_t,three_way,58.857,FUN_018402-T1,Q8BVT6,,,,,27.0,429.0,2.6e-26,122.1,sp|Q8BVT6|PP2D1_MOUSE Protein phosphatase 2C-like domain-containing protein 1 OS=Mus musculus OX=10090 GN=Pp2d1 PE=2 SV=1,,,,,,
OG_04403,1.256476127896182,FUN_018416-T1,Peve_00031691,Pocillopora_meandrina_HIv1___RNAseq.g10170.t1,three_way,54.97866666666667,FUN_018416-T1,Q49A88,CCD14_HUMAN,,Coiled-coil domain-containing protein 14,Homo sapiens (Human),29.7,229.0,3.1e-18,95.5,sp|Q49A88|CCD14_HUMAN Coiled-coil domain-containing protein 14 OS=Homo sapiens OX=9606 GN=CCDC14 PE=1 SV=3,GO:0005737; GO:0005813; GO:0005929; GO:0015630; GO:0021762; GO:0034451; GO:0036064; GO:0071539,protein localization to centrosome [GO:0071539]; substantia nigra development [GO:0021762],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; microtubule cytoskeleton [GO:0015630],,GO:0005815; GO:0005856; GO:0005929; GO:0043226; GO:0048856,microtubule organizing center; cytoskeleton; cilium; organelle; anatomical structure development
OG_04454,1.7634974753450827,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,41.9,508.0,1.3e-103,382.9,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_04454,1.7634974753450827,FUN_019134-T1,Peve_00005117,Pocillopora_meandrina_HIv1___TS.g25657.t1,three_way,65.26366666666667,FUN_019134-T1,P29294,,,,,32.7,107.0,8.6e-10,71.2,"sp|P29294|MYLK_RABIT Myosin light chain kinase, smooth muscle OS=Oryctolagus cuniculus OX=9986 GN=MYLK PE=1 SV=2",,,,,,
OG_04455,1.2046677347117964,FUN_019138-T1,Peve_00032880,Pocillopora_meandrina_HIv1___TS.g25655.t1,three_way,66.97116666666666,FUN_019138-T1,Q80YE7,DAPK1_MOUSE,,Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1),Mus musculus (Mouse),33.5,319.0,3.5e-42,173.7,sp|Q80YE7|DAPK1_MOUSE Death-associated protein kinase 1 OS=Mus musculus OX=10090 GN=Dapk1 PE=1 SV=3,GO:0002357; GO:0002834; GO:0004672; GO:0004683; GO:0005516; GO:0005524; GO:0005525; GO:0005737; GO:0005829; GO:0005886; GO:0006468; GO:0006915; GO:0008625; GO:0010508; GO:0014069; GO:0015629; GO:0017075; GO:0017148; GO:0035556; GO:0042802; GO:0043065; GO:0043066; GO:0071346; GO:0071447; GO:0097190; GO:0098978; GO:0106310; GO:1902042; GO:1904094; GO:1990722; GO:2000310,apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cellular response to hydroperoxide [GO:0071447]; cellular response to type II interferon [GO:0071346]; defense response to tumor cell [GO:0002357]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of translation [GO:0017148]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagic cell death [GO:1904094]; positive regulation of autophagy [GO:0010508]; protein phosphorylation [GO:0006468]; regulation of NMDA receptor activity [GO:2000310]; regulation of response to tumor cell [GO:0002834],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; DAPK1-calmodulin complex [GO:1990722]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ATP binding [GO:0005524]; calcium/calmodulin-dependent protein kinase activity [GO:0004683]; calmodulin binding [GO:0005516]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; syntaxin-1 binding [GO:0017075],GO:0003824; GO:0005829; GO:0005856; GO:0005886; GO:0012501; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton; plasma membrane; programmed cell death; transferase activity; organelle; catalytic activity, acting on a protein"
OG_04474,1.2029160328265032,FUN_020855-T1,Peve_00032916,Pocillopora_meandrina_HIv1___RNAseq.g20813.t1,three_way,66.00766666666667,,,,,,,,,,,,,,,,,
OG_04496,1.2768662346172923,FUN_021928-T1,Peve_00023935,Pocillopora_meandrina_HIv1___RNAseq.g2913.t1,three_way,79.017,FUN_021928-T1,O81884,,,,,44.3,316.0,7.099999999999999e-70,265.8,sp|O81884|GALDH_ARATH L-galactose dehydrogenase OS=Arabidopsis thaliana OX=3702 GN=LGALDH PE=1 SV=1,,,,,,
OG_04547,2.0363794107795026,FUN_022170-T1,Peve_00036602,Pocillopora_meandrina_HIv1___RNAseq.g4779.t1,three_way,50.17433333333334,FUN_022170-T1,B8UU78,,,,,90.7,1117.0,0.0,1992.2,sp|B8UU78|ELP_ACRMI EGF and laminin G domain-containing protein (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_04563,1.0388883839409262,FUN_022204-T1,Peve_00041452,Pocillopora_meandrina_HIv1___TS.g22213.t2,three_way,62.89816666666666,FUN_022204-T1,Q92626,PXDN_HUMAN,,Peroxidasin homolog (EC 1.11.2.-) (Melanoma-associated antigen MG50) (Peroxidasin 1) (hsPxd01) (Vascular peroxidase 1) (p53-responsive gene 2 protein) [Cleaved into: PXDN active fragment],Homo sapiens (Human),28.5,270.0,2.3000000000000003e-22,109.4,sp|Q92626|PXDN_HUMAN Peroxidasin homolog OS=Homo sapiens OX=9606 GN=PXDN PE=1 SV=2,GO:0001525; GO:0001654; GO:0004601; GO:0005152; GO:0005201; GO:0005576; GO:0005604; GO:0005615; GO:0005783; GO:0006955; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0030198; GO:0030199; GO:0031012; GO:0042744; GO:0043237; GO:0046872; GO:0051260; GO:0062023; GO:0070062; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; eye development [GO:0001654]; hydrogen peroxide catabolic process [GO:0042744]; immune response [GO:0006955]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615],"extracellular matrix structural constituent [GO:0005201]; heme binding [GO:0020037]; interleukin-1 receptor antagonist activity [GO:0005152]; lactoperoxidase activity [GO:0140825]; laminin-1 binding [GO:0043237]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]; peroxidase activity [GO:0004601]",GO:0002376; GO:0003824; GO:0005198; GO:0005576; GO:0005615; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0065003; GO:0098772,immune system process; catalytic activity; structural molecule activity; extracellular region; extracellular space; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; protein-containing complex assembly; molecular function regulator activity
OG_04615,1.5764654804161615,FUN_022314-T1,Peve_00021691,Pocillopora_meandrina_HIv1___TS.g22047.t1,three_way,61.79866666666667,,,,,,,,,,,,,,,,,
OG_04625,1.0527406433696491,FUN_022333-T1,Peve_00028601,Pocillopora_meandrina_HIv1___RNAseq.g4652.t1,three_way,61.93866666666667,FUN_022333-T1,Q92609,TBCD5_HUMAN,,TBC1 domain family member 5,Homo sapiens (Human),37.5,610.0,3.2e-104,381.3,sp|Q92609|TBCD5_HUMAN TBC1 domain family member 5 OS=Homo sapiens OX=9606 GN=TBC1D5 PE=1 SV=1,GO:0002092; GO:0005096; GO:0005776; GO:0005794; GO:0005829; GO:0006914; GO:0010008; GO:0015031; GO:0016236; GO:0030904; GO:0035612; GO:0042147; GO:0042594; GO:0043231; GO:0044877; GO:1905394,"autophagy [GO:0006914]; macroautophagy [GO:0016236]; positive regulation of receptor internalization [GO:0002092]; protein transport [GO:0015031]; response to starvation [GO:0042594]; retrograde transport, endosome to Golgi [GO:0042147]",autophagosome [GO:0005776]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; retromer complex [GO:0030904],AP-2 adaptor complex binding [GO:0035612]; GTPase activator activity [GO:0005096]; protein-containing complex binding [GO:0044877]; retromer complex binding [GO:1905394],GO:0005773; GO:0005794; GO:0005829; GO:0006914; GO:0016192; GO:0043226; GO:0098772,vacuole; Golgi apparatus; cytosol; autophagy; vesicle-mediated transport; organelle; molecular function regulator activity
OG_04626,1.4220675765941722,FUN_022334-T2,Peve_00028599,Pocillopora_meandrina_HIv1___RNAseq.g4653.t1,three_way,68.03833333333333,FUN_022334-T2,Q149M9,,,,,31.2,944.0,1.1e-108,397.1,sp|Q149M9|NWD1_HUMAN NACHT domain- and WD repeat-containing protein 1 OS=Homo sapiens OX=9606 GN=NWD1 PE=1 SV=3,,,,,,
OG_04639,1.3046275606115008,FUN_022365-T1,Peve_00021988,Pocillopora_meandrina_HIv1___TS.g22011.t1,three_way,64.79716666666667,FUN_022365-T1,A2RRU4,SCAP_RAT,,Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein),Rattus norvegicus (Rat),35.1,1375.0,2.4999999999999998e-147,525.0,sp|A2RRU4|SCAP_RAT Sterol regulatory element-binding protein cleavage-activating protein OS=Rattus norvegicus OX=10116 GN=Scap PE=2 SV=1,GO:0000139; GO:0001666; GO:0005789; GO:0006629; GO:0006955; GO:0008203; GO:0012507; GO:0019217; GO:0032868; GO:0032933; GO:0032934; GO:0032936; GO:0032991; GO:0033552; GO:0042304; GO:0044877; GO:0045540; GO:0045542; GO:0090110,cholesterol metabolic process [GO:0008203]; COPII-coated vesicle cargo loading [GO:0090110]; immune response [GO:0006955]; lipid metabolic process [GO:0006629]; positive regulation of cholesterol biosynthetic process [GO:0045542]; regulation of cholesterol biosynthetic process [GO:0045540]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of fatty acid metabolic process [GO:0019217]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to vitamin B3 [GO:0033552]; SREBP signaling pathway [GO:0032933],endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; Golgi membrane [GO:0000139]; protein-containing complex [GO:0032991]; SREBP-SCAP complex [GO:0032936],protein-containing complex binding [GO:0044877]; sterol binding [GO:0032934],GO:0002376; GO:0006629; GO:0008289,immune system process; lipid metabolic process; lipid binding
OG_04642,1.5703220633867838,FUN_022368-T1,Peve_00013237,Pocillopora_meandrina_HIv1___RNAseq.g9293.t2,three_way,55.12766666666666,FUN_022368-T1,B2GV47,,,,,31.2,523.0,1.9000000000000001e-66,255.8,sp|B2GV47|RADX_RAT RPA-related protein RADX OS=Rattus norvegicus OX=10116 GN=Radx PE=2 SV=1,,,,,,
OG_04662,1.6135224367786958,FUN_022408-T1,Peve_00037583,Pocillopora_meandrina_HIv1___RNAseq.g4541.t1,three_way,68.21366666666667,FUN_022408-T1,F1QJX5,UBR3_DANRE,,E3 ubiquitin-protein ligase ubr3 (EC 2.3.2.27) (E3 ubiquitin-protein transferase ubr3),Danio rerio (Zebrafish) (Brachydanio rerio),36.5,844.0,4.4000000000000004e-125,451.1,sp|F1QJX5|UBR3_DANRE E3 ubiquitin-protein ligase ubr3 OS=Danio rerio OX=7955 GN=ubr3 PE=2 SV=2,GO:0000151; GO:0005737; GO:0008270; GO:0016567; GO:0048592; GO:0061630; GO:0071596,eye morphogenesis [GO:0048592]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the N-end rule pathway [GO:0071596],cytoplasm [GO:0005737]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0016740; GO:0030163; GO:0140096,"catalytic activity; transferase activity; protein catabolic process; catalytic activity, acting on a protein"
OG_04692,1.674865111039043,FUN_022484-T1,Peve_00002924,Pocillopora_meandrina_HIv1___RNAseq.g4295.t1,three_way,86.47083333333333,FUN_022484-T1,Q8VID6,PDE11_RAT,,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)",Rattus norvegicus (Rat),47.6,930.0,9.3e-242,838.2,"sp|Q8VID6|PDE11_RAT Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A OS=Rattus norvegicus OX=10116 GN=Pde11a PE=1 SV=1",GO:0004115; GO:0004118; GO:0005829; GO:0010754; GO:0019933; GO:0030553; GO:0043204; GO:0046872; GO:0047555; GO:0141162,cAMP-mediated signaling [GO:0019933]; negative regulation of cAMP/PKA signal transduction [GO:0141162]; negative regulation of cGMP-mediated signaling [GO:0010754],cytosol [GO:0005829]; perikaryon [GO:0043204],"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cGMP binding [GO:0030553]; metal ion binding [GO:0046872]",GO:0003824; GO:0005829; GO:0016787,catalytic activity; cytosol; hydrolase activity
OG_04699,1.0499264628092118,FUN_022499-T1,Peve_00033031,Pocillopora_meandrina_HIv1___RNAseq.g4275.t1,three_way,69.74766666666667,FUN_022499-T1,A4IH82,,,,,29.7,290.0,3.3e-22,107.8,sp|A4IH82|3BP5L_XENTR SH3 domain-binding protein 5-like OS=Xenopus tropicalis OX=8364 GN=sh3bp5l PE=2 SV=1,,,,,,
OG_04723,1.2281861832828436,FUN_022586-T1,Peve_00020593,Pocillopora_meandrina_HIv1___RNAseq.g4434.t2,three_way,67.00133333333333,FUN_022586-T1,Q9BE31,,,,,29.9,632.0,8e-77,289.7,sp|Q9BE31|RHG12_MACFA Rho GTPase-activating protein 12 OS=Macaca fascicularis OX=9541 GN=ARHGAP12 PE=2 SV=1,,,,,,
OG_04737,2.4148637992475948,FUN_022613-T1,Peve_00012263,Pocillopora_meandrina_HIv1___RNAseq.g4397.t1,three_way,68.725,FUN_022613-T1,A0A0R4IKU3,RECK_DANRE,,Reversion-inducing cysteine-rich protein with Kazal motifs,Danio rerio (Zebrafish) (Brachydanio rerio),38.2,961.0,2.3000000000000002e-201,704.1,sp|A0A0R4IKU3|RECK_DANRE Reversion-inducing cysteine-rich protein with Kazal motifs OS=Danio rerio OX=7955 GN=reck PE=1 SV=3,GO:0001944; GO:0001955; GO:0002040; GO:0004866; GO:0004867; GO:0005886; GO:0008191; GO:0015026; GO:0016055; GO:0030198; GO:0045765; GO:0051726; GO:0060070; GO:0060828; GO:0090049; GO:0090210; GO:0098552; GO:1904684; GO:1990791; GO:1990909,blood vessel maturation [GO:0001955]; canonical Wnt signaling pathway [GO:0060070]; dorsal root ganglion development [GO:1990791]; extracellular matrix organization [GO:0030198]; negative regulation of metalloendopeptidase activity [GO:1904684]; regulation of angiogenesis [GO:0045765]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of cell cycle [GO:0051726]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of establishment of blood-brain barrier [GO:0090210]; sprouting angiogenesis [GO:0002040]; vasculature development [GO:0001944]; Wnt signaling pathway [GO:0016055],plasma membrane [GO:0005886]; side of membrane [GO:0098552]; Wnt signalosome [GO:1990909],coreceptor activity [GO:0015026]; endopeptidase inhibitor activity [GO:0004866]; metalloendopeptidase inhibitor activity [GO:0008191]; serine-type endopeptidase inhibitor activity [GO:0004867],GO:0005886; GO:0030198; GO:0048856; GO:0060089; GO:0098772,plasma membrane; extracellular matrix organization; anatomical structure development; molecular transducer activity; molecular function regulator activity
OG_04758,1.637169554248187,FUN_022647-T1,Peve_00036577,Pocillopora_meandrina_HIv1___RNAseq.g4454.t1,three_way,72.587,FUN_022647-T1,Q15434,,,,,61.2,232.0,9.8e-69,262.7,"sp|Q15434|RBMS2_HUMAN RNA-binding motif, single-stranded-interacting protein 2 OS=Homo sapiens OX=9606 GN=RBMS2 PE=1 SV=1",,,,,,
OG_04785,1.069042463282969,FUN_022697-T1,Peve_00045103,Pocillopora_meandrina_HIv1___RNAseq.g4828.t1,three_way,67.73633333333333,FUN_022697-T1,Q9XJ54,,,,,53.3,120.0,8.5e-26,117.9,sp|Q9XJ54|NTF2_ORYSJ Nuclear transport factor 2 OS=Oryza sativa subsp. japonica OX=39947 GN=NTF2 PE=2 SV=1,,,,,,
OG_04795,1.0908081263847191,FUN_022711-T1,Peve_00006886,Pocillopora_meandrina_HIv1___TS.g22231.t1,three_way,42.857,,,,,,,,,,,,,,,,,
OG_04802,1.1004425867119212,FUN_022761-T1,Peve_00006882,Pocillopora_meandrina_HIv1___RNAseq.g4814.t1,three_way,80.2745,,,,,,,,,,,,,,,,,
OG_04808,1.5808748272127242,FUN_022767-T1,Peve_00014658,Pocillopora_meandrina_HIv1___RNAseq.g4729.t1,three_way,73.63166666666666,FUN_022767-T1,Q7ZX22,WDR24_XENLA,,GATOR2 complex protein WDR24 (EC 2.3.2.27),Xenopus laevis (African clawed frog),38.4,799.0,4.6e-160,566.6,sp|Q7ZX22|WDR24_XENLA GATOR2 complex protein WDR24 OS=Xenopus laevis OX=8355 GN=wdr24 PE=2 SV=1,GO:0005765; GO:0005774; GO:0005829; GO:0006914; GO:0008270; GO:0016239; GO:0031669; GO:0034198; GO:0061630; GO:0061700; GO:0085020; GO:1904263,autophagy [GO:0006914]; cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; positive regulation of macroautophagy [GO:0016239]; positive regulation of TORC1 signaling [GO:1904263]; protein K6-linked ubiquitination [GO:0085020],cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; lysosomal membrane [GO:0005765]; vacuolar membrane [GO:0005774],ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0003824; GO:0005829; GO:0006914; GO:0016740; GO:0140096,"catalytic activity; cytosol; autophagy; transferase activity; catalytic activity, acting on a protein"
OG_04851,1.033358118596151,FUN_022863-T1,Peve_00025604,Pocillopora_meandrina_HIv1___RNAseq.g3607.t1,three_way,83.18433333333333,FUN_022863-T1,Q5F450,PAN2_CHICK,,PAN2-PAN3 deadenylation complex catalytic subunit PAN2 (EC 3.1.13.4) (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-specific ribonuclease) (Poly(A)-nuclease deadenylation complex subunit 2) (PAN deadenylation complex subunit 2),Gallus gallus (Chicken),51.1,1129.0,0.0,1086.6,sp|Q5F450|PAN2_CHICK PAN2-PAN3 deadenylation complex catalytic subunit PAN2 OS=Gallus gallus OX=9031 GN=PAN2 PE=2 SV=1,GO:0000175; GO:0000289; GO:0000932; GO:0003676; GO:0004535; GO:0005634; GO:0006397; GO:0010606; GO:0031251; GO:0046872,mRNA processing [GO:0006397]; nuclear-transcribed mRNA poly(A) tail shortening [GO:0000289]; positive regulation of cytoplasmic mRNA processing body assembly [GO:0010606],nucleus [GO:0005634]; P-body [GO:0000932]; PAN complex [GO:0031251],3'-5'-RNA exonuclease activity [GO:0000175]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; poly(A)-specific ribonuclease activity [GO:0004535],GO:0003824; GO:0005634; GO:0016071; GO:0016787; GO:0043226; GO:0140098,"catalytic activity; nucleus; mRNA metabolic process; hydrolase activity; organelle; catalytic activity, acting on RNA"
OG_04869,1.5875118853360732,FUN_022896-T1,Peve_00001719,Pocillopora_meandrina_HIv1___RNAseq.g3697.t1,three_way,53.845,,,,,,,,,,,,,,,,,
OG_04874,1.3883580539519178,FUN_022903-T1,Peve_00001842,Pocillopora_meandrina_HIv1___RNAseq.g3702.t1,three_way,81.031,FUN_022903-T1,Q6ZQN7,SO4C1_HUMAN,,Solute carrier organic anion transporter family member 4C1 (SLCO4C1) (OATP-H) (Organic anion transporter M1) (OATP-M1) (Organic anion transporting polypeptide 4C1) (OATP4C1) (Solute carrier family 21 member 20),Homo sapiens (Human),35.1,615.0,6.1e-111,403.3,sp|Q6ZQN7|SO4C1_HUMAN Solute carrier organic anion transporter family member 4C1 OS=Homo sapiens OX=9606 GN=SLCO4C1 PE=1 SV=1,GO:0005886; GO:0006811; GO:0007283; GO:0008514; GO:0015347; GO:0016323; GO:0030154; GO:0035577; GO:0035579; GO:0043252; GO:0070062,cell differentiation [GO:0030154]; monoatomic ion transport [GO:0006811]; sodium-independent organic anion transport [GO:0043252]; spermatogenesis [GO:0007283],azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; extracellular exosome [GO:0070062]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579],organic anion transmembrane transporter activity [GO:0008514]; sodium-independent organic anion transmembrane transporter activity [GO:0015347],GO:0005215; GO:0005886; GO:0022414; GO:0030154; GO:0043226,transporter activity; plasma membrane; reproductive process; cell differentiation; organelle
OG_04942,1.26456202243329,FUN_023017-T1,Peve_00010018,Pocillopora_meandrina_HIv1___RNAseq.g3833.t1,three_way,60.31033333333333,FUN_023017-T1,Q1PSW8,LIN41_MOUSE,,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (mLin41) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),Mus musculus (Mouse),21.1,313.0,9.5e-09,63.2,sp|Q1PSW8|LIN41_MOUSE E3 ubiquitin-protein ligase TRIM71 OS=Mus musculus OX=10090 GN=Trim71 PE=1 SV=1,GO:0000082; GO:0000932; GO:0001843; GO:0004842; GO:0008270; GO:0008543; GO:0021915; GO:0030371; GO:0035196; GO:0035198; GO:0035278; GO:0051246; GO:0051865; GO:0060964; GO:0061158; GO:0061630; GO:0072089; GO:2000177; GO:2000637,3'-UTR-mediated mRNA destabilization [GO:0061158]; fibroblast growth factor receptor signaling pathway [GO:0008543]; G1/S transition of mitotic cell cycle [GO:0000082]; miRNA processing [GO:0035196]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; positive regulation of miRNA-mediated gene silencing [GO:2000637]; protein autoubiquitination [GO:0051865]; regulation of miRNA-mediated gene silencing [GO:0060964]; regulation of neural precursor cell proliferation [GO:2000177]; regulation of protein metabolic process [GO:0051246]; stem cell proliferation [GO:0072089],P-body [GO:0000932],miRNA binding [GO:0035198]; translation repressor activity [GO:0030371]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0016740; GO:0031047; GO:0043226; GO:0045182; GO:0048856; GO:0140096,"RNA binding; catalytic activity; transferase activity; regulatory ncRNA-mediated gene silencing; organelle; translation regulator activity; anatomical structure development; catalytic activity, acting on a protein"
OG_04989,1.225939470364598,FUN_023119-T1,Peve_00021102,Pocillopora_meandrina_HIv1___RNAseq.g1692.t1,three_way,61.756166666666665,FUN_023119-T1,Q92547,TOPB1_HUMAN,,DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1),Homo sapiens (Human),33.8,1669.0,2e-207,724.9,sp|Q92547|TOPB1_HUMAN DNA topoisomerase 2-binding protein 1 OS=Homo sapiens OX=9606 GN=TOPBP1 PE=1 SV=3,GO:0000076; GO:0000077; GO:0000724; GO:0000794; GO:0000922; GO:0001673; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005737; GO:0005813; GO:0005886; GO:0006259; GO:0006270; GO:0006281; GO:0006974; GO:0007095; GO:0010212; GO:0015629; GO:0016604; GO:0016605; GO:0033314; GO:0035825; GO:0035861; GO:0042802; GO:0043539; GO:0051276; GO:0070532; GO:0090734; GO:0097680; GO:0097681; GO:0140031; GO:0140463; GO:0141112; GO:1990166,broken chromosome clustering [GO:0141112]; chromosome organization [GO:0051276]; DNA damage checkpoint signaling [GO:0000077]; DNA damage response [GO:0006974]; DNA metabolic process [GO:0006259]; DNA repair [GO:0006281]; DNA replication checkpoint signaling [GO:0000076]; DNA replication initiation [GO:0006270]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via homologous recombination [GO:0000724]; homologous recombination [GO:0035825]; mitotic DNA replication checkpoint signaling [GO:0033314]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; protein localization to site of double-strand break [GO:1990166]; response to ionizing radiation [GO:0010212],actin cytoskeleton [GO:0015629]; BRCA1-B complex [GO:0070532]; centrosome [GO:0005813]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; spindle pole [GO:0000922],chromatin-protein adaptor activity [GO:0140463]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; phosphorylation-dependent protein binding [GO:0140031]; protein serine/threonine kinase activator activity [GO:0043539],GO:0000228; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0005815; GO:0005856; GO:0005886; GO:0006281; GO:0006310; GO:0043226; GO:0060090; GO:0098772,nuclear chromosome; DNA binding; nucleus; nucleoplasm; chromosome; microtubule organizing center; cytoskeleton; plasma membrane; DNA repair; DNA recombination; organelle; molecular adaptor activity; molecular function regulator activity
OG_04999,1.7284489172550264,FUN_023134-T1,Peve_00008524,Pocillopora_meandrina_HIv1___RNAseq.g1753.t1,three_way,84.611,FUN_023134-T1,P26632,EGR1_DANRE,,Early growth response protein 1 (EGR-1) (Zinc finger protein Krox-24),Danio rerio (Zebrafish) (Brachydanio rerio),46.4,125.0,1.4e-15,85.5,sp|P26632|EGR1_DANRE Early growth response protein 1 OS=Danio rerio OX=7955 GN=egr1 PE=2 SV=2,GO:0000978; GO:0000981; GO:0005634; GO:0005737; GO:0006357; GO:0008270; GO:0010385; GO:0010842; GO:0032922; GO:0043010; GO:0043565; GO:0044729; GO:0045893; GO:0045944; GO:0048703; GO:0060059; GO:1990841,camera-type eye development [GO:0043010]; circadian regulation of gene expression [GO:0032922]; embryonic retina morphogenesis in camera-type eye [GO:0060059]; embryonic viscerocranium morphogenesis [GO:0048703]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; retina layer formation [GO:0010842],cytoplasm [GO:0005737]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; zinc ion binding [GO:0008270]",GO:0003677; GO:0005634; GO:0006355; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; organelle; anatomical structure development; transcription regulator activity
OG_05000,1.358669583790434,FUN_023136-T1,Peve_00008523,Pocillopora_meandrina_HIv1___RNAseq.g1752.t1,three_way,64.003,,,,,,,,,,,,,,,,,
OG_05005,1.617167520406111,FUN_023153-T1,Peve_00014158,Pocillopora_meandrina_HIv1___RNAseq.g17694.t1,three_way,72.7995,FUN_023153-T1,Q9Y2H2,SAC2_HUMAN,,Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2),Homo sapiens (Human),48.1,774.0,2e-204,714.5,sp|Q9Y2H2|SAC2_HUMAN Phosphatidylinositide phosphatase SAC2 OS=Homo sapiens OX=9606 GN=INPP5F PE=1 SV=3,GO:0001921; GO:0005769; GO:0005905; GO:0006661; GO:0008344; GO:0014898; GO:0030424; GO:0030425; GO:0031161; GO:0031901; GO:0034595; GO:0034596; GO:0042532; GO:0042803; GO:0043025; GO:0043231; GO:0043491; GO:0043812; GO:0045334; GO:0046856; GO:0048015; GO:0048681; GO:0052833; GO:0055037; GO:0072583; GO:2000145; GO:2001135,adult locomotory behavior [GO:0008344]; cardiac muscle hypertrophy in response to stress [GO:0014898]; clathrin-dependent endocytosis [GO:0072583]; negative regulation of axon regeneration [GO:0048681]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol dephosphorylation [GO:0046856]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of receptor recycling [GO:0001921]; regulation of cell motility [GO:2000145]; regulation of endocytic recycling [GO:2001135],axon [GO:0030424]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; recycling endosome [GO:0055037],inositol monophosphate 4-phosphatase activity [GO:0052833]; phosphatidylinositol phosphate 4-phosphatase activity [GO:0034596]; phosphatidylinositol phosphate 5-phosphatase activity [GO:0034595]; phosphatidylinositol-4-phosphate phosphatase activity [GO:0043812]; protein homodimerization activity [GO:0042803],GO:0003012; GO:0003824; GO:0005768; GO:0006629; GO:0016192; GO:0016787; GO:0031410; GO:0043226,muscle system process; catalytic activity; endosome; lipid metabolic process; vesicle-mediated transport; hydrolase activity; cytoplasmic vesicle; organelle
OG_05014,1.0259755099203722,FUN_023173-T1,Peve_00009976,Pocillopora_meandrina_HIv1___TS.g25350.t1,three_way,83.18433333333333,FUN_023173-T1,O93309,SMC3_XENLA,,Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3),Xenopus laevis (African clawed frog),50.2,630.0,2.6e-150,533.9,sp|O93309|SMC3_XENLA Structural maintenance of chromosomes protein 3 OS=Xenopus laevis OX=8355 GN=smc3 PE=1 SV=2,GO:0000775; GO:0000785; GO:0003690; GO:0005524; GO:0005634; GO:0006275; GO:0006281; GO:0007064; GO:0016887; GO:0030892; GO:0030893; GO:0051301; GO:0051321,cell division [GO:0051301]; DNA repair [GO:0006281]; meiotic cell cycle [GO:0051321]; mitotic sister chromatid cohesion [GO:0007064]; regulation of DNA replication [GO:0006275],"chromatin [GO:0000785]; chromosome, centromeric region [GO:0000775]; meiotic cohesin complex [GO:0030893]; mitotic cohesin complex [GO:0030892]; nucleus [GO:0005634]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; double-stranded DNA binding [GO:0003690],GO:0003677; GO:0003824; GO:0005634; GO:0006281; GO:0016787; GO:0022414; GO:0043226,DNA binding; catalytic activity; nucleus; DNA repair; hydrolase activity; reproductive process; organelle
OG_05059,1.2311830511497976,FUN_023256-T1,Peve_00019260,Pocillopora_meandrina_HIv1___TS.g25273.t1,three_way,37.922666666666665,,,,,,,,,,,,,,,,,
OG_05103,1.4327350687978258,FUN_023358-T2,Peve_00005335,Pocillopora_meandrina_HIv1___TS.g17018.t1,three_way,80.87916666666666,FUN_023358-T2,Q96A58,RERG_HUMAN,,Ras-related and estrogen-regulated growth inhibitor (EC 3.6.5.2),Homo sapiens (Human),36.9,160.0,2.8000000000000002e-28,127.1,sp|Q96A58|RERG_HUMAN Ras-related and estrogen-regulated growth inhibitor OS=Homo sapiens OX=9606 GN=RERG PE=1 SV=1,GO:0001650; GO:0003924; GO:0003925; GO:0005525; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0007264; GO:0008285; GO:0009725; GO:0019003; GO:0030308; GO:0030331,negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; response to hormone [GO:0009725]; small GTPase-mediated signal transduction [GO:0007264],cytosol [GO:0005829]; fibrillar center [GO:0001650]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; nuclear estrogen receptor binding [GO:0030331],GO:0003824; GO:0003924; GO:0005634; GO:0005654; GO:0005829; GO:0005886; GO:0016787; GO:0043226; GO:0098772,catalytic activity; GTPase activity; nucleus; nucleoplasm; cytosol; plasma membrane; hydrolase activity; organelle; molecular function regulator activity
OG_05138,1.2264072332990177,FUN_023410-T1,Peve_00017394,Pocillopora_meandrina_HIv1___RNAseq.g17575.t1,three_way,54.03783333333333,FUN_023410-T1,Q1LYG0,,,,,34.5,313.0,3.9e-50,201.8,sp|Q1LYG0|SPD2A_DANRE SH3 and PX domain-containing protein 2A OS=Danio rerio OX=7955 GN=sh3pxd2a PE=3 SV=2,,,,,,
OG_05159,1.013614292886449,FUN_023449-T1,Peve_00037222,Pocillopora_meandrina_HIv1___RNAseq.g17631.t2,three_way,40.68716666666667,,,,,,,,,,,,,,,,,
OG_05161,1.096835351075968,FUN_023459-T1,Peve_00037224,Pocillopora_meandrina_HIv1___RNAseq.g17544.t1,three_way,95.354,FUN_023459-T1,O75643,U520_HUMAN,,U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD),Homo sapiens (Human),74.1,2143.0,0.0,3215.6,sp|O75643|U520_HUMAN U5 small nuclear ribonucleoprotein 200 kDa helicase OS=Homo sapiens OX=9606 GN=SNRNP200 PE=1 SV=2,GO:0000354; GO:0000388; GO:0000398; GO:0001649; GO:0003723; GO:0003724; GO:0004386; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0005682; GO:0005886; GO:0005929; GO:0016020; GO:0016887; GO:0042802; GO:0046540; GO:0071005; GO:0071006; GO:0071013,"cis assembly of pre-catalytic spliceosome [GO:0000354]; mRNA splicing, via spliceosome [GO:0000398]; osteoblast differentiation [GO:0001649]; spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) [GO:0000388]",catalytic step 2 spliceosome [GO:0071013]; cilium [GO:0005929]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; helicase activity [GO:0004386]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0005886; GO:0005929; GO:0016071; GO:0016787; GO:0016853; GO:0030154; GO:0043226; GO:0065003; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; plasma membrane; cilium; mRNA metabolic process; hydrolase activity; isomerase activity; cell differentiation; organelle; protein-containing complex assembly; catalytic activity, acting on RNA; ATP-dependent activity"
OG_05191,1.858342734077072,FUN_023557-T1,Peve_00037255,Pocillopora_meandrina_HIv1___RNAseq.g520.t1,three_way,63.37466666666667,FUN_023557-T1,Q5TEA3,,,,,35.3,1191.0,5.8e-204,713.0,sp|Q5TEA3|DAAF9_HUMAN Dynein axonemal assembly factor 9 OS=Homo sapiens OX=9606 GN=DNAAF9 PE=1 SV=1,,,,,,
OG_05200,1.490369643358521,FUN_023581-T1,Peve_00035146,Pocillopora_meandrina_HIv1___RNAseq.g3529.t1,three_way,51.781333333333336,,,,,,,,,,,,,,,,,
OG_05208,1.9151265973414413,FUN_023592-T1,Peve_00023919,Pocillopora_meandrina_HIv1___RNAseq.g3311.t1,three_way,44.60383333333333,FUN_023592-T1,E9PVX6,KI67_MOUSE,,Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67 homolog) (Antigen KI-67 homolog) (Antigen Ki67 homolog),Mus musculus (Mouse),42.2,135.0,5.7e-18,95.9,sp|E9PVX6|KI67_MOUSE Proliferation marker protein Ki-67 OS=Mus musculus OX=10090 GN=Mki67 PE=1 SV=1,GO:0000775; GO:0000793; GO:0003677; GO:0003723; GO:0005524; GO:0005634; GO:0005730; GO:0005737; GO:0007059; GO:0007088; GO:0008283; GO:0050673; GO:0051321; GO:0072089; GO:0072574; GO:0140693; GO:1902275; GO:1990705,cell population proliferation [GO:0008283]; cholangiocyte proliferation [GO:1990705]; chromosome segregation [GO:0007059]; epithelial cell proliferation [GO:0050673]; hepatocyte proliferation [GO:0072574]; meiotic cell cycle [GO:0051321]; regulation of chromatin organization [GO:1902275]; regulation of mitotic nuclear division [GO:0007088]; stem cell proliferation [GO:0072089],"chromosome, centromeric region [GO:0000775]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleus [GO:0005634]",ATP binding [GO:0005524]; DNA binding [GO:0003677]; molecular condensate scaffold activity [GO:0140693]; RNA binding [GO:0003723],GO:0003677; GO:0003723; GO:0005634; GO:0005694; GO:0005730; GO:0007059; GO:0022414; GO:0043226; GO:0060090,DNA binding; RNA binding; nucleus; chromosome; nucleolus; chromosome segregation; reproductive process; organelle; molecular adaptor activity
OG_05254,1.1044279920516784,FUN_023702-T1,Peve_00017411,Pocillopora_meandrina_HIv1___RNAseq.g17589.t1,three_way,69.48033333333333,FUN_023702-T1,Q3KP44,ANR55_HUMAN,,Ankyrin repeat domain-containing protein 55,Homo sapiens (Human),25.1,259.0,1.5e-16,89.0,sp|Q3KP44|ANR55_HUMAN Ankyrin repeat domain-containing protein 55 OS=Homo sapiens OX=9606 GN=ANKRD55 PE=1 SV=3,,,,,,
OG_05256,1.5660739705882187,FUN_023759-T1,Peve_00044461,Pocillopora_meandrina_HIv1___RNAseq.g3497.t1,three_way,51.79566666666666,FUN_023759-T1,E7FBY6,AGRA2_DANRE,,Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124),Danio rerio (Zebrafish) (Brachydanio rerio),26.0,889.0,4.7e-66,255.4,sp|E7FBY6|AGRA2_DANRE Adhesion G protein-coupled receptor A2 OS=Danio rerio OX=7955 GN=adgra2 PE=1 SV=2,GO:0001525; GO:0004930; GO:0005886; GO:0007399; GO:0060070; GO:1990909,angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; nervous system development [GO:0007399],plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909],G protein-coupled receptor activity [GO:0004930],GO:0005886; GO:0048856; GO:0060089,plasma membrane; anatomical structure development; molecular transducer activity
OG_05268,1.641406229209302,FUN_023921-T1,Peve_00026572,Pocillopora_meandrina_HIv1___TS.g27910.t1,three_way,65.93933333333332,,,,,,,,,,,,,,,,,
OG_05301,1.036729288053814,FUN_023971-T1,Peve_00025477,Pocillopora_meandrina_HIv1___RNAseq.g18534.t1,three_way,57.55416666666667,FUN_023971-T1,P15384,,,,,33.7,395.0,9.300000000000001e-57,222.6,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_05337,1.7120515562622989,FUN_024053-T1,Peve_00000160,Pocillopora_meandrina_HIv1___RNAseq.g19257.t2,three_way,68.68216666666666,FUN_024053-T1,Q8CIQ7,DOCK3_MOUSE,,Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP),Mus musculus (Mouse),42.0,1682.0,0.0,1276.5,sp|Q8CIQ7|DOCK3_MOUSE Dedicator of cytokinesis protein 3 OS=Mus musculus OX=10090 GN=Dock3 PE=1 SV=1,GO:0005085; GO:0005096; GO:0005737; GO:0005829; GO:0007264; GO:0017124,small GTPase-mediated signal transduction [GO:0007264],cytoplasm [GO:0005737]; cytosol [GO:0005829],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; SH3 domain binding [GO:0017124],GO:0005829; GO:0098772,cytosol; molecular function regulator activity
OG_05342,1.556128579926062,FUN_024071-T1,Peve_00014630,Pocillopora_meandrina_HIv1___RNAseq.23622_t,three_way,47.72133333333333,,,,,,,,,,,,,,,,,
OG_05348,1.240382097657284,FUN_024111-T1,Peve_00000186,Pocillopora_meandrina_HIv1___RNAseq.g19189.t1,three_way,75.39166666666667,FUN_024111-T1,O00408,PDE2A_HUMAN,,"cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)",Homo sapiens (Human),45.4,868.0,9.700000000000001e-196,685.3,"sp|O00408|PDE2A_HUMAN cGMP-dependent 3',5'-cyclic phosphodiesterase OS=Homo sapiens OX=9606 GN=PDE2A PE=1 SV=1",GO:0000122; GO:0000287; GO:0003170; GO:0003281; GO:0004115; GO:0004118; GO:0005634; GO:0005737; GO:0005741; GO:0005743; GO:0005759; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0007193; GO:0008270; GO:0010628; GO:0010752; GO:0010754; GO:0010821; GO:0019933; GO:0019934; GO:0030224; GO:0030552; GO:0030553; GO:0030911; GO:0035904; GO:0036006; GO:0042301; GO:0042734; GO:0042802; GO:0042803; GO:0043116; GO:0043117; GO:0046069; GO:0047555; GO:0048471; GO:0050729; GO:0061028; GO:0071260; GO:0071320; GO:0071321; GO:0071466; GO:0071560; GO:0097011; GO:0097060; GO:0106072; GO:1904613,"adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; aorta development [GO:0035904]; cAMP-mediated signaling [GO:0019933]; cellular response to 2,3,7,8-tetrachlorodibenzodioxine [GO:1904613]; cellular response to cAMP [GO:0071320]; cellular response to cGMP [GO:0071321]; cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to macrophage colony-stimulating factor stimulus [GO:0036006]; cellular response to mechanical stimulus [GO:0071260]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to xenobiotic stimulus [GO:0071466]; cGMP catabolic process [GO:0046069]; cGMP-mediated signaling [GO:0019934]; establishment of endothelial barrier [GO:0061028]; heart valve development [GO:0003170]; monocyte differentiation [GO:0030224]; negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0106072]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular permeability [GO:0043116]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of vascular permeability [GO:0043117]; regulation of cGMP-mediated signaling [GO:0010752]; regulation of mitochondrion organization [GO:0010821]; ventricular septum development [GO:0003281]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial outer membrane [GO:0005741]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; synaptic membrane [GO:0097060],"3',5'-cGMP-stimulated cyclic-nucleotide phosphodiesterase activity [GO:0004118]; 3',5'-cyclic-AMP phosphodiesterase activity [GO:0004115]; 3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; cAMP binding [GO:0030552]; cGMP binding [GO:0030553]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; phosphate ion binding [GO:0042301]; protein homodimerization activity [GO:0042803]; TPR domain binding [GO:0030911]; zinc ion binding [GO:0008270]",GO:0003013; GO:0003824; GO:0005634; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0006355; GO:0016787; GO:0030154; GO:0043226; GO:0048856; GO:0055086; GO:1901135,circulatory system process; catalytic activity; nucleus; endoplasmic reticulum; Golgi apparatus; cytosol; plasma membrane; regulation of DNA-templated transcription; hydrolase activity; cell differentiation; organelle; anatomical structure development; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05384,1.0535559644095542,FUN_024201-T1,Peve_00031885,Pocillopora_meandrina_HIv1___RNAseq.g18895.t1,three_way,52.33616666666667,FUN_024201-T1,Q5RG49,,,,,28.2,1294.0,6.1e-121,437.2,sp|Q5RG49|ACSF4_DANRE Beta-alanine-activating enzyme OS=Danio rerio OX=7955 GN=aasdh PE=3 SV=1,,,,,,
OG_05397,1.6059657148601447,FUN_024224-T1,Peve_00031887,Pocillopora_meandrina_HIv1___TS.g28304.t1,three_way,65.771,FUN_024224-T1,O60343,TBCD4_HUMAN,,TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160),Homo sapiens (Human),33.6,1274.0,8.199999999999999e-148,526.6,sp|O60343|TBCD4_HUMAN TBC1 domain family member 4 OS=Homo sapiens OX=9606 GN=TBC1D4 PE=1 SV=2,GO:0005096; GO:0005794; GO:0005829; GO:0016192; GO:0031339; GO:0031982; GO:0032869,cellular response to insulin stimulus [GO:0032869]; negative regulation of vesicle fusion [GO:0031339]; vesicle-mediated transport [GO:0016192],cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],GTPase activator activity [GO:0005096],GO:0005794; GO:0005829; GO:0016192; GO:0043226; GO:0098772,Golgi apparatus; cytosol; vesicle-mediated transport; organelle; molecular function regulator activity
OG_05436,1.6122698175608348,FUN_024389-T1,Peve_00018044,Pocillopora_meandrina_HIv1___RNAseq.g18620.t1,three_way,74.58266666666667,FUN_024389-T1,O70433,,,,,39.0,269.0,1.3e-68,262.3,sp|O70433|FHL2_MOUSE Four and a half LIM domains protein 2 OS=Mus musculus OX=10090 GN=Fhl2 PE=1 SV=1,,,,,,
OG_05443,1.4469979120816212,FUN_024398-T2,Peve_00021812,Pocillopora_meandrina_HIv1___RNAseq.g18631.t1,three_way,82.838,FUN_024398-T2,Q66GS9,CP135_HUMAN,,Centrosomal protein of 135 kDa (Cep135) (Centrosomal protein 4),Homo sapiens (Human),37.8,566.0,6.9e-91,337.4,sp|Q66GS9|CP135_HUMAN Centrosomal protein of 135 kDa OS=Homo sapiens OX=9606 GN=CEP135 PE=1 SV=2,GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0008017; GO:0010457; GO:0015631; GO:0042802; GO:0042803; GO:1902857; GO:1904951,centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857],centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829],identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631],GO:0005815; GO:0005829; GO:0008092; GO:0043226,microtubule organizing center; cytosol; cytoskeletal protein binding; organelle
OG_05445,1.9652831229010943,FUN_024401-T1,Peve_00033232,Pocillopora_meandrina_HIv1___RNAseq.g18633.t1,three_way,75.52233333333334,FUN_024401-T1,P20595,GCYB1_RAT,,Guanylate cyclase soluble subunit beta-1 (GCS-beta-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit beta-3) (GCS-beta-3) (Soluble guanylate cyclase small subunit),Rattus norvegicus (Rat),46.0,620.0,2.1e-138,494.6,sp|P20595|GCYB1_RAT Guanylate cyclase soluble subunit beta-1 OS=Rattus norvegicus OX=10116 GN=Gucy1b1 PE=1 SV=2,GO:0004383; GO:0005525; GO:0005829; GO:0006182; GO:0008074; GO:0019934; GO:0020037; GO:0032991; GO:0038060; GO:0044877; GO:0046872; GO:0051879; GO:0070026; GO:0070482; GO:0071732; GO:0098831; GO:0098978,cellular response to nitric oxide [GO:0071732]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; nitric oxide-cGMP-mediated signaling [GO:0038060]; response to oxygen levels [GO:0070482],"cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; guanylate cyclase complex, soluble [GO:0008074]; presynaptic active zone cytoplasmic component [GO:0098831]; protein-containing complex [GO:0032991]",GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; heme binding [GO:0020037]; Hsp90 protein binding [GO:0051879]; metal ion binding [GO:0046872]; nitric oxide binding [GO:0070026]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005829; GO:0009975; GO:0016829; GO:0055086; GO:1901135,catalytic activity; cytosol; cyclase activity; lyase activity; nucleobase-containing small molecule metabolic process; carbohydrate derivative metabolic process
OG_05446,1.1439375011540571,FUN_024402-T1,Peve_00007147,Pocillopora_meandrina_HIv1___RNAseq.g18634.t1,three_way,78.25166666666667,FUN_024402-T1,O54865,,,,,51.5,532.0,1.4e-146,521.2,sp|O54865|GCYB1_MOUSE Guanylate cyclase soluble subunit beta-1 OS=Mus musculus OX=10090 GN=Gucy1b1 PE=1 SV=1,,,,,,
OG_05452,1.0803481337246648,FUN_024410-T1,Peve_00015480,Pocillopora_meandrina_HIv1___TS.g28029.t1a,three_way,83.57366666666667,,,,,,,,,,,,,,,,,
OG_05453,2.4894208338079142,FUN_024411-T1,Peve_00011775,Pocillopora_meandrina_HIv1___RNAseq.g18636.t1,three_way,77.30883333333334,FUN_024411-T1,Q7T163,KDISB_DANRE,,Kinase D-interacting substrate of 220 kDa B (Ankyrin repeat-rich membrane-spanning protein B),Danio rerio (Zebrafish) (Brachydanio rerio),35.3,893.0,4.3999999999999996e-141,504.6,sp|Q7T163|KDISB_DANRE Kinase D-interacting substrate of 220 kDa B OS=Danio rerio OX=7955 GN=kidins220b PE=1 SV=3,GO:0005770; GO:0007399; GO:0019887; GO:0030165; GO:0031902; GO:0038180,nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399],late endosome [GO:0005770]; late endosome membrane [GO:0031902],PDZ domain binding [GO:0030165]; protein kinase regulator activity [GO:0019887],GO:0005768; GO:0031410; GO:0043226; GO:0048856; GO:0098772,endosome; cytoplasmic vesicle; organelle; anatomical structure development; molecular function regulator activity
OG_05462,1.4764287078002036,FUN_024445-T1,Peve_00025478,Pocillopora_meandrina_HIv1___RNAseq.g18708.t1,three_way,87.55799999999999,FUN_024445-T1,Q14643,,,,,59.9,2841.0,0.0,3137.1,"sp|Q14643|ITPR1_HUMAN Inositol 1,4,5-trisphosphate-gated calcium channel ITPR1 OS=Homo sapiens OX=9606 GN=ITPR1 PE=1 SV=3",,,,,,
OG_05473,1.064095572810784,FUN_024456-T1,Peve_00010312,Pocillopora_meandrina_HIv1___RNAseq.g18574.t1,three_way,77.98883333333333,FUN_024456-T1,A7S6A1,,,,,59.2,903.0,2.2000000000000002e-272,939.9,sp|A7S6A1|U518_NEMVE FHIP family protein v1g243165 OS=Nematostella vectensis OX=45351 GN=v1g243165 PE=3 SV=1,,,,,,
OG_05486,1.6045271107109902,FUN_024483-T1,Peve_00010585,Pocillopora_meandrina_HIv1___RNAseq.g19068.t1,three_way,49.94483333333333,FUN_024483-T1,Q9UHB7,,,,,27.0,248.0,1.4e-13,80.5,sp|Q9UHB7|AFF4_HUMAN AF4/FMR2 family member 4 OS=Homo sapiens OX=9606 GN=AFF4 PE=1 SV=1,,,,,,
OG_05492,1.0122149043355473,FUN_024524-T1,Peve_00034558,Pocillopora_meandrina_HIv1___RNAseq.g18542.t1,three_way,74.3655,FUN_024524-T1,Q96PY6,NEK1_HUMAN,,Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55),Homo sapiens (Human),32.6,1424.0,3.4000000000000003e-128,461.5,sp|Q96PY6|NEK1_HUMAN Serine/threonine-protein kinase Nek1 OS=Homo sapiens OX=9606 GN=NEK1 PE=1 SV=2,GO:0000242; GO:0004672; GO:0004674; GO:0004713; GO:0005524; GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005829; GO:0005929; GO:0006468; GO:0016301; GO:0034451; GO:0046872; GO:0051301; GO:0060271; GO:0071889; GO:0106310,cell division [GO:0051301]; cilium assembly [GO:0060271]; protein phosphorylation [GO:0006468],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentriolar material [GO:0000242],14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; kinase activity [GO:0016301]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713],GO:0003824; GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0140096,"catalytic activity; nucleus; nucleoplasm; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; catalytic activity, acting on a protein"
OG_05503,1.3505956052019892,FUN_024567-T1,Peve_00036070,Pocillopora_meandrina_HIv1___RNAseq.g19088.t1,three_way,78.1325,FUN_024567-T1,Q8WXW3,PIBF1_HUMAN,,Progesterone-induced-blocking factor 1 (PIBF) (Centrosomal protein of 90 kDa) (CEP90),Homo sapiens (Human),39.1,713.0,3.8000000000000003e-119,430.6,sp|Q8WXW3|PIBF1_HUMAN Progesterone-induced-blocking factor 1 OS=Homo sapiens OX=9606 GN=PIBF1 PE=1 SV=2,GO:0002376; GO:0005136; GO:0005615; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0007080; GO:0031393; GO:0032695; GO:0032733; GO:0032815; GO:0034451; GO:0036064; GO:0042531; GO:0042532; GO:0042976; GO:0060271; GO:0071539; GO:0090307; GO:1905515,activation of Janus kinase activity [GO:0042976]; cilium assembly [GO:0060271]; immune system process [GO:0002376]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic spindle assembly [GO:0090307]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of prostaglandin biosynthetic process [GO:0031393]; negative regulation of tyrosine phosphorylation of STAT protein [GO:0042532]; non-motile cilium assembly [GO:1905515]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein localization to centrosome [GO:0071539],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634],interleukin-4 receptor binding [GO:0005136],GO:0002376; GO:0005615; GO:0005634; GO:0005815; GO:0007010; GO:0043226; GO:0044782,immune system process; extracellular space; nucleus; microtubule organizing center; cytoskeleton organization; organelle; cilium organization
OG_05522,1.3742274675632526,FUN_024625-T1,Peve_00012720,Pocillopora_meandrina_HIv1___TS.g28341.t1,three_way,37.063,,,,,,,,,,,,,,,,,
OG_05533,1.0969213360467076,FUN_024719-T1,Peve_00012704,Pocillopora_meandrina_HIv1___RNAseq.g18947.t1,three_way,64.05266666666667,FUN_024719-T1,A7MBB3,,,,,31.4,175.0,8.8e-10,65.9,sp|A7MBB3|T150B_BOVIN Modulator of macroautophagy TMEM150B OS=Bos taurus OX=9913 GN=TMEM150B PE=2 SV=1,,,,,,
OG_05562,1.1373496867910846,FUN_024781-T1,Peve_00015076,Pocillopora_meandrina_HIv1___TS.g28189.t2,three_way,75.94966666666666,FUN_024781-T1,Q5F3U9,,,,,42.0,1148.0,3.5999999999999997e-242,840.1,sp|Q5F3U9|PDS5B_CHICK Sister chromatid cohesion protein PDS5 homolog B OS=Gallus gallus OX=9031 GN=PDS5B PE=2 SV=3,,,,,,
OG_05572,2.0834449400788304,FUN_024815-T1,Peve_00026076,Pocillopora_meandrina_HIv1___RNAseq.g18772.t1,three_way,69.34433333333334,FUN_024815-T1,Q96PE2,ARHGH_HUMAN,,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),Homo sapiens (Human),40.1,1066.0,9.2e-179,630.2,sp|Q96PE2|ARHGH_HUMAN Rho guanine nucleotide exchange factor 17 OS=Homo sapiens OX=9606 GN=ARHGEF17 PE=1 SV=1,GO:0005085; GO:0005737; GO:0005829; GO:0030036; GO:0051056,actin cytoskeleton organization [GO:0030036]; regulation of small GTPase mediated signal transduction [GO:0051056],cytoplasm [GO:0005737]; cytosol [GO:0005829],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0007010; GO:0098772,cytosol; cytoskeleton organization; molecular function regulator activity
OG_05588,1.0200065789040054,FUN_025031-T1,Peve_00004654,Pocillopora_meandrina_HIv1___TS.g28790.t2,three_way,69.56233333333333,FUN_025031-T1,Q6R1L1,,,,,55.9,195.0,5.1999999999999996e-46,186.4,sp|Q6R1L1|TAF7_CRIGR Transcription initiation factor TFIID subunit 7 OS=Cricetulus griseus OX=10029 GN=TAF7 PE=1 SV=1,,,,,,
OG_05601,1.154329854810514,FUN_025233-T1,Peve_00034838,Pocillopora_meandrina_HIv1___RNAseq.g13605.t1,three_way,74.29116666666667,FUN_025233-T1,P49916,DNLI3_HUMAN,,DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3),Homo sapiens (Human),56.4,922.0,2.1e-265,916.8,sp|P49916|DNLI3_HUMAN DNA ligase 3 OS=Homo sapiens OX=9606 GN=LIG3 PE=1 SV=2,GO:0000724; GO:0003677; GO:0003909; GO:0003910; GO:0005524; GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0006273; GO:0006284; GO:0006287; GO:0006302; GO:0007005; GO:0008270; GO:0043504; GO:0051301; GO:0070421; GO:0071897; GO:0090298; GO:0097681,"base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell division [GO:0051301]; DNA biosynthetic process [GO:0071897]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; double-strand break repair via homologous recombination [GO:0000724]; lagging strand elongation [GO:0006273]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of mitochondrial DNA replication [GO:0090298]",DNA ligase III-XRCC1 complex [GO:0070421]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; DNA binding [GO:0003677]; DNA ligase (ATP) activity [GO:0003910]; DNA ligase activity [GO:0003909]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005739; GO:0006281; GO:0006310; GO:0007005; GO:0016874; GO:0043226; GO:0140097,"DNA binding; catalytic activity; nucleus; nucleoplasm; mitochondrion; DNA repair; DNA recombination; mitochondrion organization; ligase activity; organelle; catalytic activity, acting on DNA"
OG_05602,1.5733562671419397,FUN_025259-T1,Peve_00031195,Pocillopora_meandrina_HIv1___TS.g2586.t1,three_way,76.54266666666668,FUN_025259-T1,Q8NCX0,,,,,27.3,956.0,1.9e-10,70.1,sp|Q8NCX0|CC150_HUMAN Coiled-coil domain-containing protein 150 OS=Homo sapiens OX=9606 GN=CCDC150 PE=1 SV=2,,,,,,
OG_05616,1.477068407194998,FUN_025304-T1,Peve_00040949,Pocillopora_meandrina_HIv1___RNAseq.g13460.t1,three_way,85.93833333333333,FUN_025304-T1,Q9I7S6,,,,,53.0,372.0,3.1e-112,407.1,"sp|Q9I7S6|PDE9A_DROME High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A OS=Drosophila melanogaster OX=7227 GN=Pde9 PE=2 SV=2",,,,,,
OG_05669,1.1918215122560472,FUN_025459-T1,Peve_00005466,Pocillopora_meandrina_HIv1___RNAseq.g13245.t1,three_way,94.06666666666666,FUN_025459-T1,Q2KJ93,CDC42_BOVIN,,Cell division control protein 42 homolog (EC 3.6.5.2),Bos taurus (Bovine),90.6,191.0,9e-99,360.9,sp|Q2KJ93|CDC42_BOVIN Cell division control protein 42 homolog OS=Bos taurus OX=9913 GN=CDC42 PE=1 SV=1,GO:0003924; GO:0003925; GO:0005525; GO:0005737; GO:0005813; GO:0005886; GO:0006897; GO:0006911; GO:0007015; GO:0007165; GO:0007264; GO:0016020; GO:0019901; GO:0030010; GO:0030425; GO:0030496; GO:0031258; GO:0032467; GO:0034329; GO:0045198; GO:0048549; GO:0051233; GO:0051489; GO:0051491; GO:0051988; GO:0060997; GO:0072686; GO:1900026,"actin filament organization [GO:0007015]; cell junction assembly [GO:0034329]; dendritic spine morphogenesis [GO:0060997]; endocytosis [GO:0006897]; establishment of cell polarity [GO:0030010]; establishment of epithelial cell apical/basal polarity [GO:0045198]; phagocytosis, engulfment [GO:0006911]; positive regulation of cytokinesis [GO:0032467]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of pinocytosis [GO:0048549]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]",centrosome [GO:0005813]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; lamellipodium membrane [GO:0031258]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; plasma membrane [GO:0005886]; spindle midzone [GO:0051233],G protein activity [GO:0003925]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901],GO:0003824; GO:0003924; GO:0005815; GO:0005886; GO:0007163; GO:0016192; GO:0016787; GO:0030154; GO:0034330; GO:0043226; GO:0061024; GO:0098772,catalytic activity; GTPase activity; microtubule organizing center; plasma membrane; establishment or maintenance of cell polarity; vesicle-mediated transport; hydrolase activity; cell differentiation; cell junction organization; organelle; membrane organization; molecular function regulator activity
OG_05678,1.1204047240634942,FUN_025511-T1,Peve_00002249,Pocillopora_meandrina_HIv1___RNAseq.g13212.t1,three_way,56.655,FUN_025511-T1,Q8TCQ1,MARH1_HUMAN,,E3 ubiquitin-protein ligase MARCHF1 (EC 2.3.2.27) (Membrane-associated RING finger protein 1) (Membrane-associated RING-CH protein I) (MARCH-I) (RING finger protein 171) (RING-type E3 ubiquitin transferase MARCHF1),Homo sapiens (Human),28.2,206.0,7.7e-14,79.7,sp|Q8TCQ1|MARH1_HUMAN E3 ubiquitin-protein ligase MARCHF1 OS=Homo sapiens OX=9606 GN=MARCHF1 PE=1 SV=1,GO:0000209; GO:0002495; GO:0005737; GO:0005764; GO:0005765; GO:0005768; GO:0005783; GO:0005789; GO:0005794; GO:0005886; GO:0006955; GO:0008270; GO:0031901; GO:0031902; GO:0032588; GO:0042287; GO:0043231; GO:0061630,antigen processing and presentation of peptide antigen via MHC class II [GO:0002495]; immune response [GO:0006955]; protein polyubiquitination [GO:0000209],cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; trans-Golgi network membrane [GO:0032588],MHC protein binding [GO:0042287]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005764; GO:0005768; GO:0005773; GO:0005783; GO:0005794; GO:0005886; GO:0016740; GO:0031410; GO:0043226; GO:0140096,"immune system process; catalytic activity; lysosome; endosome; vacuole; endoplasmic reticulum; Golgi apparatus; plasma membrane; transferase activity; cytoplasmic vesicle; organelle; catalytic activity, acting on a protein"
OG_05679,1.947407596301873,FUN_025516-T1,Peve_00002247,Pocillopora_meandrina_HIv1___RNAseq.g13210.t1,three_way,89.46916666666667,,,,,,,,,,,,,,,,,
OG_05685,1.0371662483470991,FUN_025530-T1,Peve_00009476,Pocillopora_meandrina_HIv1___TS.g2807.t1,three_way,91.53566666666669,FUN_025530-T1,Q5U395,,,,,73.8,244.0,2.7000000000000002e-104,379.8,sp|Q5U395|CNEPA_DANRE CTD nuclear envelope phosphatase 1A OS=Danio rerio OX=7955 GN=ctdnep1a PE=2 SV=1,,,,,,
OG_05691,1.8364175641376963,FUN_025542-T1,Peve_00032958,Pocillopora_meandrina_HIv1___RNAseq.g13798.t1,three_way,69.249,,,,,,,,,,,,,,,,,
OG_05734,1.0016127289262713,FUN_025660-T1,Peve_00042171,Pocillopora_meandrina_HIv1___RNAseq.g23068.t1,three_way,78.61866666666667,FUN_025660-T1,B0DOB4,NPHP4_XENLA,,Nephrocystin-4,Xenopus laevis (African clawed frog),41.9,1048.0,1.8e-222,774.2,sp|B0DOB4|NPHP4_XENLA Nephrocystin-4 OS=Xenopus laevis OX=8355 GN=nphp4 PE=2 SV=1,GO:0005737; GO:0035869; GO:0036064; GO:0090090; GO:0097546; GO:0097730; GO:1904491,negative regulation of canonical Wnt signaling pathway [GO:0090090]; protein localization to ciliary transition zone [GO:1904491],ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; non-motile cilium [GO:0097730],,GO:0005815; GO:0005929; GO:0043226,microtubule organizing center; cilium; organelle
OG_05751,1.2407951400335695,FUN_025683-T2,Peve_00000457,Pocillopora_meandrina_HIv1___RNAseq.g13113.t1,three_way,56.72566666666667,FUN_025683-T2,O57460,TLL1_DANRE,,Dorsal-ventral patterning tolloid-like protein 1 (EC 3.4.24.-) (Mini fin protein),Danio rerio (Zebrafish) (Brachydanio rerio),34.0,141.0,1.2e-16,89.7,sp|O57460|TLL1_DANRE Dorsal-ventral patterning tolloid-like protein 1 OS=Danio rerio OX=7955 GN=tll1 PE=2 SV=1,GO:0001568; GO:0001707; GO:0001885; GO:0004222; GO:0005509; GO:0005576; GO:0005615; GO:0006508; GO:0008233; GO:0008237; GO:0008270; GO:0009953; GO:0016485; GO:0030513; GO:0035124; GO:0035162; GO:0036342; GO:0048264,blood vessel development [GO:0001568]; determination of ventral identity [GO:0048264]; dorsal/ventral pattern formation [GO:0009953]; embryonic caudal fin morphogenesis [GO:0035124]; embryonic hemopoiesis [GO:0035162]; endothelial cell development [GO:0001885]; mesoderm formation [GO:0001707]; positive regulation of BMP signaling pathway [GO:0030513]; post-anal tail morphogenesis [GO:0036342]; protein processing [GO:0016485]; proteolysis [GO:0006508],extracellular region [GO:0005576]; extracellular space [GO:0005615],calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005576; GO:0005615; GO:0016787; GO:0048856; GO:0051604; GO:0140096,"catalytic activity; extracellular region; extracellular space; hydrolase activity; anatomical structure development; protein maturation; catalytic activity, acting on a protein"
OG_05757,1.842034608582448,FUN_025692-T1,Peve_00005578,Pocillopora_meandrina_HIv1___RNAseq.g13161.t2,three_way,54.39333333333333,,,,,,,,,,,,,,,,,
OG_05761,1.4252862184885162,FUN_025702-T1,Peve_00004694,Pocillopora_meandrina_HIv1___RNAseq.g13827.t1,three_way,44.88766666666667,FUN_025702-T1,Q08D19,,,,,43.6,110.0,8.7e-14,80.1,sp|Q08D19|GOLI4_XENTR Golgi integral membrane protein 4 OS=Xenopus tropicalis OX=8364 GN=golim4 PE=2 SV=2,,,,,,
OG_05779,1.2003330389868931,FUN_025750-T1,Peve_00007726,Pocillopora_meandrina_HIv1___RNAseq.g10411.t1,three_way,86.325,FUN_025750-T1,O57656,,,,,52.3,392.0,2.1999999999999998e-107,390.6,"sp|O57656|GPDA_TAKRU Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic OS=Takifugu rubripes OX=31033 GN=gpd1 PE=3 SV=1",,,,,,
OG_05786,1.366926897475016,FUN_025762-T1,Peve_00041464,Pocillopora_meandrina_HIv1___RNAseq.g10422.t1,three_way,66.92333333333333,FUN_025762-T1,Q6PFM4,,,,,42.4,361.0,1.3999999999999999e-61,238.4,sp|Q6PFM4|LNPB_DANRE Endoplasmic reticulum junction formation protein lunapark-B OS=Danio rerio OX=7955 GN=lnpkb PE=2 SV=2,,,,,,
OG_05810,1.0875581554646925,FUN_025810-T1,Peve_00002517,Pocillopora_meandrina_HIv1___RNAseq.g9333.t1,three_way,83.25233333333333,FUN_025810-T1,Q9Y6W3,CAN7_HUMAN,,Calpain-7 (EC 3.4.22.-) (PalB homolog) (PalBH),Homo sapiens (Human),52.7,522.0,7.499999999999999e-143,508.8,sp|Q9Y6W3|CAN7_HUMAN Calpain-7 OS=Homo sapiens OX=9606 GN=CAPN7 PE=1 SV=1,GO:0004175; GO:0004197; GO:0004198; GO:0005634; GO:0005813; GO:0005829; GO:0006508; GO:0010634; GO:0070062; GO:0090541; GO:0097264,positive regulation of epithelial cell migration [GO:0010634]; proteolysis [GO:0006508]; self proteolysis [GO:0097264],centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],calcium-dependent cysteine-type endopeptidase activity [GO:0004198]; cysteine-type endopeptidase activity [GO:0004197]; endopeptidase activity [GO:0004175]; MIT domain binding [GO:0090541],GO:0003824; GO:0005634; GO:0005815; GO:0005829; GO:0016787; GO:0043226; GO:0140096,"catalytic activity; nucleus; microtubule organizing center; cytosol; hydrolase activity; organelle; catalytic activity, acting on a protein"
OG_05818,1.140494343955451,FUN_025825-T2,Peve_00036287,Pocillopora_meandrina_HIv1___RNAseq.g9345.t1,three_way,78.706,FUN_025825-T2,P54513,,,,,32.3,195.0,9.9e-15,83.6,sp|P54513|YQHO_BACSU Uncharacterized protein YqhO OS=Bacillus subtilis (strain 168) OX=224308 GN=yqhO PE=3 SV=1,,,,,,
OG_05819,1.3243048633548786,FUN_025826-T1,Peve_00036290,Pocillopora_meandrina_HIv1___RNAseq.g9346.t1,three_way,60.5495,FUN_025826-T1,B8V7Q1,,,,,39.9,3257.0,0.0,2112.0,sp|B8V7Q1|PCDL_ACRMI Protocadherin-like protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_05821,1.0566593433736835,FUN_025836-T1,Peve_00028304,Pocillopora_meandrina_HIv1___RNAseq.g10325.t1b,three_way,67.41033333333334,FUN_025836-T1,Q9DBC0,SELO_MOUSE,,"Protein adenylyltransferase SelO, mitochondrial (EC 2.7.7.-) (EC 2.7.7.108) (Selenoprotein O) (SelO)",Mus musculus (Mouse),46.7,642.0,4.0999999999999995e-148,526.6,"sp|Q9DBC0|SELO_MOUSE Protein adenylyltransferase SelO, mitochondrial OS=Mus musculus OX=10090 GN=Selenoo PE=1 SV=4",GO:0005524; GO:0005694; GO:0005739; GO:0046872; GO:0070733,,chromosome [GO:0005694]; mitochondrion [GO:0005739],AMPylase activity [GO:0070733]; ATP binding [GO:0005524]; metal ion binding [GO:0046872],GO:0003824; GO:0005694; GO:0005739; GO:0016740; GO:0043226,catalytic activity; chromosome; mitochondrion; transferase activity; organelle
OG_05829,1.082087145286536,FUN_025847-T1,Peve_00012182,Pocillopora_meandrina_HIv1___TS.g13754.t1,three_way,63.074,FUN_025847-T1,Q9NZA1,CLIC5_HUMAN,,Chloride intracellular channel protein 5 (Glutaredoxin-like oxidoreductase CLIC5) (EC 1.8.-.-),Homo sapiens (Human),34.1,223.0,1.5e-20,101.3,sp|Q9NZA1|CLIC5_HUMAN Chloride intracellular channel protein 5 OS=Homo sapiens OX=9606 GN=CLIC5 PE=1 SV=3,GO:0005254; GO:0005739; GO:0005794; GO:0005813; GO:0005938; GO:0006821; GO:0007565; GO:0007601; GO:0007605; GO:0015629; GO:0016324; GO:0016491; GO:0032420; GO:0034707; GO:0070062,chloride transport [GO:0006821]; female pregnancy [GO:0007565]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell cortex [GO:0005938]; centrosome [GO:0005813]; chloride channel complex [GO:0034707]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; stereocilium [GO:0032420],chloride channel activity [GO:0005254]; oxidoreductase activity [GO:0016491],GO:0003824; GO:0005215; GO:0005739; GO:0005794; GO:0005815; GO:0005856; GO:0016491; GO:0022414; GO:0043226; GO:0050877,catalytic activity; transporter activity; mitochondrion; Golgi apparatus; microtubule organizing center; cytoskeleton; oxidoreductase activity; reproductive process; organelle; nervous system process
OG_05846,1.079230099218599,FUN_025915-T1,Peve_00010172,Pocillopora_meandrina_HIv1___RNAseq.g10468.t1,three_way,86.59700000000001,FUN_025915-T1,Q6DDF0,,,,,41.7,489.0,1.6999999999999998e-96,354.8,sp|Q6DDF0|WDR37_XENLA WD repeat-containing protein 37 OS=Xenopus laevis OX=8355 GN=wdr37 PE=2 SV=1,,,,,,
OG_05864,1.6437815738084556,FUN_025971-T1,Peve_00002910,Pocillopora_meandrina_HIv1___RNAseq.g10510.t1,three_way,71.926,FUN_025971-T1,Q6XYQ8,SYT10_HUMAN,,Synaptotagmin-10 (Synaptotagmin X) (SytX),Homo sapiens (Human),34.1,229.0,9.900000000000001e-28,125.2,sp|Q6XYQ8|SYT10_HUMAN Synaptotagmin-10 OS=Homo sapiens OX=9606 GN=SYT10 PE=1 SV=1,GO:0000149; GO:0001786; GO:0005509; GO:0005544; GO:0005546; GO:0005886; GO:0006887; GO:0007268; GO:0007608; GO:0016192; GO:0017158; GO:0030658; GO:0042803; GO:0045956; GO:0046982; GO:0061891; GO:0070382; GO:0098793; GO:0098978,chemical synaptic transmission [GO:0007268]; exocytosis [GO:0006887]; positive regulation of calcium ion-dependent exocytosis [GO:0045956]; regulation of calcium ion-dependent exocytosis [GO:0017158]; sensory perception of smell [GO:0007608]; vesicle-mediated transport [GO:0016192],exocytic vesicle [GO:0070382]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; transport vesicle membrane [GO:0030658],"calcium ion binding [GO:0005509]; calcium ion sensor activity [GO:0061891]; calcium-dependent phospholipid binding [GO:0005544]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; SNARE binding [GO:0000149]",GO:0005886; GO:0008289; GO:0016192; GO:0023052; GO:0031410; GO:0043226; GO:0050877; GO:0098772; GO:0140299,plasma membrane; lipid binding; vesicle-mediated transport; signaling; cytoplasmic vesicle; organelle; nervous system process; molecular function regulator activity; molecular sensor activity
OG_05865,1.3714848051491548,FUN_025974-T1,Peve_00002327,Pocillopora_meandrina_HIv1___RNAseq.g10508.t1,three_way,78.03366666666666,,,,,,,,,,,,,,,,,
OG_05867,1.1190598277873085,FUN_025976-T1,Peve_00002325,Pocillopora_meandrina_HIv1___RNAseq.g10506.t1,three_way,64.18716666666667,FUN_025976-T1,Q13873,BMPR2_HUMAN,,Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II),Homo sapiens (Human),38.1,494.0,1.9e-88,328.2,sp|Q13873|BMPR2_HUMAN Bone morphogenetic protein receptor type-2 OS=Homo sapiens OX=9606 GN=BMPR2 PE=1 SV=2,GO:0001568; GO:0001649; GO:0001707; GO:0001893; GO:0001935; GO:0001946; GO:0001974; GO:0002063; GO:0003085; GO:0003151; GO:0003176; GO:0003177; GO:0003183; GO:0003186; GO:0003197; GO:0003252; GO:0005024; GO:0005524; GO:0005615; GO:0005654; GO:0005886; GO:0005901; GO:0005905; GO:0005912; GO:0007178; GO:0009267; GO:0009925; GO:0009952; GO:0009986; GO:0010628; GO:0010634; GO:0014069; GO:0014916; GO:0016324; GO:0016362; GO:0019838; GO:0030154; GO:0030166; GO:0030308; GO:0030424; GO:0030425; GO:0030501; GO:0030509; GO:0036122; GO:0042127; GO:0043025; GO:0043235; GO:0045296; GO:0045669; GO:0045778; GO:0045906; GO:0045944; GO:0046872; GO:0048286; GO:0048662; GO:0048842; GO:0048863; GO:0051148; GO:0060173; GO:0060350; GO:0060391; GO:0060412; GO:0060413; GO:0060426; GO:0060836; GO:0060840; GO:0060841; GO:0061036; GO:0061298; GO:0071363; GO:0071773; GO:0072577; GO:0098821; GO:1902731; GO:1905314; GO:1990782,anterior/posterior pattern specification [GO:0009952]; aortic valve development [GO:0003176]; artery development [GO:0060840]; atrial septum morphogenesis [GO:0060413]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell surface receptor protein serine/threonine kinase signaling pathway [GO:0007178]; cellular response to BMP stimulus [GO:0071773]; cellular response to growth factor stimulus [GO:0071363]; cellular response to starvation [GO:0009267]; chondrocyte development [GO:0002063]; endocardial cushion development [GO:0003197]; endochondral bone morphogenesis [GO:0060350]; endothelial cell apoptotic process [GO:0072577]; endothelial cell proliferation [GO:0001935]; limb development [GO:0060173]; lung alveolus development [GO:0048286]; lung vasculature development [GO:0060426]; lymphangiogenesis [GO:0001946]; lymphatic endothelial cell differentiation [GO:0060836]; maternal placenta development [GO:0001893]; mesoderm formation [GO:0001707]; mitral valve morphogenesis [GO:0003183]; negative regulation of cell growth [GO:0030308]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of vasoconstriction [GO:0045906]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteoglycan biosynthetic process [GO:0030166]; pulmonary valve development [GO:0003177]; regulation of cell population proliferation [GO:0042127]; regulation of lung blood pressure [GO:0014916]; retina vasculature development in camera-type eye [GO:0061298]; semi-lunar valve development [GO:1905314]; stem cell differentiation [GO:0048863]; tricuspid valve morphogenesis [GO:0003186]; venous blood vessel development [GO:0060841]; ventricular septum morphogenesis [GO:0060412],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; axon [GO:0030424]; basal plasma membrane [GO:0009925]; caveola [GO:0005901]; cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; dendrite [GO:0030425]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; receptor complex [GO:0043235],"activin receptor activity, type II [GO:0016362]; ATP binding [GO:0005524]; BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; metal ion binding [GO:0046872]; protein tyrosine kinase binding [GO:1990782]; transforming growth factor beta receptor activity [GO:0005024]",GO:0003013; GO:0003824; GO:0005615; GO:0005654; GO:0005886; GO:0006355; GO:0009101; GO:0012501; GO:0016740; GO:0022414; GO:0030154; GO:0043226; GO:0048856; GO:0060089; GO:0140096; GO:1901135,"circulatory system process; catalytic activity; extracellular space; nucleoplasm; plasma membrane; regulation of DNA-templated transcription; glycoprotein biosynthetic process; programmed cell death; transferase activity; reproductive process; cell differentiation; organelle; anatomical structure development; molecular transducer activity; catalytic activity, acting on a protein; carbohydrate derivative metabolic process"
OG_05898,1.007626404512598,FUN_026074-T1,Peve_00002027,Pocillopora_meandrina_HIv1___RNAseq.g10562.t1,three_way,77.955,FUN_026074-T1,Q7TNE1,SUCHY_MOUSE,,Succinyl-CoA:glutarate CoA-transferase (EC 2.8.3.-) (Dicarboxyl-CoA:dicarboxylic acid coenzyme A transferase SUGCT) (Succinate--hydroxymethylglutarate CoA-transferase) (EC 2.8.3.13),Mus musculus (Mouse),65.4,237.0,5.4e-88,325.9,sp|Q7TNE1|SUCHY_MOUSE Succinyl-CoA:glutarate CoA-transferase OS=Mus musculus OX=10090 GN=Sugct PE=1 SV=2,GO:0005739; GO:0047369,,mitochondrion [GO:0005739],succinate-hydroxymethylglutarate CoA-transferase activity [GO:0047369],GO:0003824; GO:0005739; GO:0016740; GO:0043226,catalytic activity; mitochondrion; transferase activity; organelle
OG_05899,1.0929866601244522,FUN_026076-T1,Peve_00002022,Pocillopora_meandrina_HIv1___RNAseq.g10561.t1,three_way,58.79216666666667,FUN_026076-T1,Q9NVE5,,,,,35.0,1254.0,1.6e-196,688.3,sp|Q9NVE5|UBP40_HUMAN Ubiquitin carboxyl-terminal hydrolase 40 OS=Homo sapiens OX=9606 GN=USP40 PE=1 SV=3,,,,,,
OG_05903,1.4535898529709554,FUN_026088-T1,Peve_00004126,Pocillopora_meandrina_HIv1___RNAseq.g10571.t1,three_way,73.563,FUN_026088-T1,Q5FVG2,E41L5_RAT,,Band 4.1-like protein 5 (Erythrocyte membrane protein band 4.1-like 5),Rattus norvegicus (Rat),47.5,358.0,2.8e-86,321.6,sp|Q5FVG2|E41L5_RAT Band 4.1-like protein 5 OS=Rattus norvegicus OX=10116 GN=Epb41l5 PE=1 SV=2,GO:0000902; GO:0001701; GO:0001756; GO:0001837; GO:0001839; GO:0001917; GO:0001954; GO:0003382; GO:0003383; GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0005912; GO:0005925; GO:0006931; GO:0007398; GO:0007492; GO:0007498; GO:0007509; GO:0008092; GO:0009826; GO:0010608; GO:0010634; GO:0019904; GO:0022408; GO:0030036; GO:0031032; GO:0031252; GO:0032525; GO:0032587; GO:0048318; GO:0048319; GO:0048339; GO:0048617; GO:0051894; GO:0070201; GO:0070986; GO:0071560,"actin cytoskeleton organization [GO:0030036]; actomyosin structure organization [GO:0031032]; apical constriction [GO:0003383]; axial mesoderm development [GO:0048318]; axial mesoderm morphogenesis [GO:0048319]; cell morphogenesis [GO:0000902]; cellular response to transforming growth factor beta stimulus [GO:0071560]; ectoderm development [GO:0007398]; embryonic foregut morphogenesis [GO:0048617]; endoderm development [GO:0007492]; epithelial cell morphogenesis [GO:0003382]; epithelial to mesenchymal transition [GO:0001837]; in utero embryonic development [GO:0001701]; left/right axis specification [GO:0070986]; mesoderm development [GO:0007498]; mesoderm migration involved in gastrulation [GO:0007509]; negative regulation of cell-cell adhesion [GO:0022408]; neural plate morphogenesis [GO:0001839]; paraxial mesoderm development [GO:0048339]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of focal adhesion assembly [GO:0051894]; post-transcriptional regulation of gene expression [GO:0010608]; regulation of establishment of protein localization [GO:0070201]; somite rostral/caudal axis specification [GO:0032525]; somitogenesis [GO:0001756]; substrate-dependent cell migration, cell attachment to substrate [GO:0006931]; unidimensional cell growth [GO:0009826]",adherens junction [GO:0005912]; cell leading edge [GO:0031252]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleoplasm [GO:0005654]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587],cytoskeletal protein binding [GO:0008092]; protein domain specific binding [GO:0019904],GO:0005654; GO:0005829; GO:0005856; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0030154; GO:0043226; GO:0048856; GO:0048870,nucleoplasm; cytosol; cytoskeleton; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; cell differentiation; organelle; anatomical structure development; cell motility
OG_05910,1.2303069717798416,FUN_026101-T1,Peve_00013338,Pocillopora_meandrina_HIv1___RNAseq.g10579.t1,three_way,87.09166666666667,FUN_026101-T1,Q96JG6,,,,,51.6,965.0,9.3e-269,927.9,sp|Q96JG6|VPS50_HUMAN Syndetin OS=Homo sapiens OX=9606 GN=VPS50 PE=1 SV=3,,,,,,
OG_05942,1.74905495179184,FUN_026179-T1,Peve_00012698,Pocillopora_meandrina_HIv1___RNAseq.g3034.t1,three_way,82.133,FUN_026179-T1,O02695,,,,,58.0,440.0,8.500000000000001e-133,476.1,sp|O02695|PTPR2_MACNE Receptor-type tyrosine-protein phosphatase N2 OS=Macaca nemestrina OX=9545 GN=PTPRN2 PE=2 SV=1,,,,,,
OG_05945,1.1623368261756648,FUN_026188-T1,Peve_00007220,Pocillopora_meandrina_HIv1___RNAseq.g9603.t1,three_way,49.890166666666666,,,,,,,,,,,,,,,,,
OG_05954,1.0927534183131895,FUN_026297-T1,Peve_00030617,Pocillopora_meandrina_HIv1___TS.g18167.t1,three_way,62.13683333333333,FUN_026297-T1,Q28824,MYLK_BOVIN,,"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]",Bos taurus (Bovine),43.7,332.0,4e-75,284.3,"sp|Q28824|MYLK_BOVIN Myosin light chain kinase, smooth muscle OS=Bos taurus OX=9913 GN=MYLK PE=1 SV=1",GO:0001725; GO:0003779; GO:0004687; GO:0005516; GO:0005524; GO:0005737; GO:0014820; GO:0030027; GO:0032154; GO:0046872,tonic smooth muscle contraction [GO:0014820],cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; stress fiber [GO:0001725],actin binding [GO:0003779]; ATP binding [GO:0005524]; calmodulin binding [GO:0005516]; metal ion binding [GO:0046872]; myosin light chain kinase activity [GO:0004687],GO:0003012; GO:0003824; GO:0008092; GO:0016740; GO:0140096,"muscle system process; catalytic activity; cytoskeletal protein binding; transferase activity; catalytic activity, acting on a protein"
OG_05966,1.42819835490934,FUN_026369-T2,Peve_00027912,Pocillopora_meandrina_HIv1___RNAseq.g3119.t1,three_way,54.78633333333333,FUN_026369-T2,Q9H8Y5,ANKZ1_HUMAN,,tRNA endonuclease ANKZF1 (EC 3.1.-.-) (Ankyrin repeat and zinc finger domain-containing protein 1) (Zinc finger protein 744),Homo sapiens (Human),36.6,711.0,4.3e-67,257.7,sp|Q9H8Y5|ANKZ1_HUMAN tRNA endonuclease ANKZF1 OS=Homo sapiens OX=9606 GN=ANKZF1 PE=1 SV=1,GO:0004521; GO:0005737; GO:0006515; GO:0008270; GO:0016020; GO:0036503; GO:0070301; GO:0072344; GO:0140101,cellular response to hydrogen peroxide [GO:0070301]; ERAD pathway [GO:0036503]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; rescue of stalled ribosome [GO:0072344],cytoplasm [GO:0005737]; membrane [GO:0016020],"catalytic activity, acting on a tRNA [GO:0140101]; RNA endonuclease activity [GO:0004521]; zinc ion binding [GO:0008270]",GO:0003824; GO:0030163; GO:0140098,"catalytic activity; protein catabolic process; catalytic activity, acting on RNA"
OG_05983,1.642757564874462,FUN_026415-T1,Peve_00006089,Pocillopora_meandrina_HIv1___RNAseq.g3014.t1,three_way,79.76233333333333,FUN_026415-T1,Q9EPR4,S23A2_MOUSE,,Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Sodium-dependent vitamin C transporter 2) (SVCT-2) (mSVCT2) (Yolk sac permease-like molecule 2),Mus musculus (Mouse),54.1,549.0,1.1e-163,578.2,sp|Q9EPR4|S23A2_MOUSE Solute carrier family 23 member 2 OS=Mus musculus OX=10090 GN=Slc23a2 PE=1 SV=2,GO:0005737; GO:0006979; GO:0007155; GO:0008015; GO:0008520; GO:0009925; GO:0015229; GO:0015882; GO:0016323; GO:0016324; GO:0019852; GO:0071361; GO:1903861,blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cellular response to ethanol [GO:0071361]; L-ascorbic acid metabolic process [GO:0019852]; L-ascorbic acid transmembrane transport [GO:0015882]; positive regulation of dendrite extension [GO:1903861]; response to oxidative stress [GO:0006979],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737],L-ascorbate:sodium symporter activity [GO:0008520]; L-ascorbic acid transmembrane transporter activity [GO:0015229],GO:0003013; GO:0005215; GO:0005975; GO:0007155; GO:0055085,circulatory system process; transporter activity; carbohydrate metabolic process; cell adhesion; transmembrane transport
OG_06060,1.359266480599936,FUN_026826-T1,Peve_00021661,Pocillopora_meandrina_HIv1___RNAseq.g2905.t1,three_way,81.5875,FUN_026826-T1,Q6PHS6,,,,,41.4,950.0,6.9e-205,715.7,sp|Q6PHS6|SNX13_MOUSE Sorting nexin-13 OS=Mus musculus OX=10090 GN=Snx13 PE=2 SV=1,,,,,,
OG_06068,1.2280074490534143,FUN_026916-T1,Peve_00014703,Pocillopora_meandrina_HIv1___RNAseq.g11017.t1,three_way,54.9965,,,,,,,,,,,,,,,,,
OG_06072,1.320108273734488,FUN_026981-T1,Peve_00013217,Pocillopora_meandrina_HIv1___RNAseq.g9421.t1,three_way,51.642,,,,,,,,,,,,,,,,,
OG_06098,1.3253041162154804,FUN_027734-T1,Peve_00036493,Pocillopora_meandrina_HIv1___RNAseq.g13905.t1,three_way,66.03566666666666,FUN_027734-T1,Q86YF9,DZIP1_HUMAN,,Cilium assembly protein DZIP1 (DAZ-interacting protein 1/2) (DAZ-interacting zinc finger protein 1),Homo sapiens (Human),28.4,334.0,1.3e-27,127.1,sp|Q86YF9|DZIP1_HUMAN Cilium assembly protein DZIP1 OS=Homo sapiens OX=9606 GN=DZIP1 PE=1 SV=1,GO:0005634; GO:0005654; GO:0005737; GO:0005813; GO:0005814; GO:0005829; GO:0007224; GO:0007281; GO:0007283; GO:0007507; GO:0008270; GO:0016607; GO:0032053; GO:0034451; GO:0036064; GO:0043231; GO:0045184; GO:0045724; GO:0051649; GO:0060090; GO:0060271; GO:0061512; GO:0062063; GO:0097539; GO:0097546; GO:0120316; GO:0140706; GO:1903566,ciliary basal body organization [GO:0032053]; cilium assembly [GO:0060271]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; germ cell development [GO:0007281]; heart development [GO:0007507]; positive regulation of cilium assembly [GO:0045724]; positive regulation of protein localization to cilium [GO:1903566]; protein localization to cilium [GO:0061512]; protein-containing complex localization to centriolar satellite [GO:0140706]; smoothened signaling pathway [GO:0007224]; sperm flagellum assembly [GO:0120316]; spermatogenesis [GO:0007283],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; ciliary transition fiber [GO:0097539]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],BBSome binding [GO:0062063]; molecular adaptor activity [GO:0060090]; zinc ion binding [GO:0008270],GO:0005634; GO:0005654; GO:0005815; GO:0005829; GO:0022414; GO:0043226; GO:0044782; GO:0048856; GO:0060090,nucleus; nucleoplasm; microtubule organizing center; cytosol; reproductive process; organelle; cilium organization; anatomical structure development; molecular adaptor activity
OG_06114,1.65534279929095,FUN_027831-T1,Peve_00020551,Pocillopora_meandrina_HIv1___RNAseq.g13868.t1,three_way,74.62966666666667,FUN_027831-T1,Q9H892,,,,,27.8,753.0,8.2e-63,243.4,sp|Q9H892|TTC12_HUMAN Tetratricopeptide repeat protein 12 OS=Homo sapiens OX=9606 GN=TTC12 PE=1 SV=2,,,,,,
OG_06138,1.440742140247181,FUN_027960-T1,Peve_00017205,Pocillopora_meandrina_HIv1___RNAseq.g14049.t1,three_way,88.88733333333333,,,,,,,,,,,,,,,,,
OG_06198,1.4481327531116608,FUN_028130-T1,Peve_00004260,Pocillopora_meandrina_HIv1___RNAseq.g15556.t1,three_way,59.60266666666666,FUN_028130-T1,A4IGL7,PXDN_XENTR,,Peroxidasin (EC 1.11.2.-) [Cleaved into: PXDN active fragment],Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),26.8,276.0,4.9e-14,81.6,sp|A4IGL7|PXDN_XENTR Peroxidasin OS=Xenopus tropicalis OX=8364 GN=pxdn PE=2 SV=1,GO:0001525; GO:0005576; GO:0005604; GO:0005783; GO:0006979; GO:0007155; GO:0009986; GO:0016684; GO:0020037; GO:0031012; GO:0042744; GO:0046872; GO:0051260; GO:0070207; GO:0070831; GO:0071711; GO:0140825,angiogenesis [GO:0001525]; basement membrane assembly [GO:0070831]; basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; hydrogen peroxide catabolic process [GO:0042744]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; response to oxidative stress [GO:0006979],basement membrane [GO:0005604]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576],"heme binding [GO:0020037]; lactoperoxidase activity [GO:0140825]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on peroxide as acceptor [GO:0016684]",GO:0003824; GO:0005576; GO:0005783; GO:0007155; GO:0016209; GO:0016491; GO:0030198; GO:0030312; GO:0031012; GO:0043226; GO:0065003,catalytic activity; extracellular region; endoplasmic reticulum; cell adhesion; antioxidant activity; oxidoreductase activity; extracellular matrix organization; external encapsulating structure; extracellular matrix; organelle; protein-containing complex assembly
OG_06232,1.2708958368335617,FUN_028185-T1,Peve_00001293,Pocillopora_meandrina_HIv1___TS.g11524.t1,three_way,76.6565,FUN_028185-T1,Q86YW9,MD12L_HUMAN,,Mediator of RNA polymerase II transcription subunit 12-like protein (Mediator complex subunit 12-like protein) (Thyroid hormone receptor-associated-like protein) (Trinucleotide repeat-containing gene 11 protein-like),Homo sapiens (Human),39.9,1865.0,0.0,1122.5,sp|Q86YW9|MD12L_HUMAN Mediator of RNA polymerase II transcription subunit 12-like protein OS=Homo sapiens OX=9606 GN=MED12L PE=1 SV=2,GO:0003713; GO:0008013; GO:0016592; GO:0045944,positive regulation of transcription by RNA polymerase II [GO:0045944],mediator complex [GO:0016592],beta-catenin binding [GO:0008013]; transcription coactivator activity [GO:0003713],GO:0006355; GO:0060090; GO:0140110,regulation of DNA-templated transcription; molecular adaptor activity; transcription regulator activity
OG_06234,2.4552479937515,FUN_028187-T1,Peve_00000861,Pocillopora_meandrina_HIv1___RNAseq.g16542.t1,three_way,56.39333333333333,FUN_028187-T1,Q9YH85,,,,,27.1,284.0,4.2e-15,84.0,sp|Q9YH85|TECTA_CHICK Alpha-tectorin OS=Gallus gallus OX=9031 GN=TECTA PE=1 SV=1,,,,,,
OG_06284,1.3742376100777711,FUN_028470-T1,Peve_00036788,Pocillopora_meandrina_HIv1___RNAseq.g16126.t1,three_way,85.66233333333334,FUN_028470-T1,Q17LW0,,,,,59.3,1107.0,1.4e-292,1007.3,sp|Q17LW0|MYO7A_AEDAE Myosin-VIIa OS=Aedes aegypti OX=7159 GN=ck PE=3 SV=1,,,,,,
OG_06360,1.143947147852682,FUN_028963-T1,Peve_00025110,Pocillopora_meandrina_HIv1___RNAseq.g25566.t1,three_way,55.882666666666665,,,,,,,,,,,,,,,,,
OG_06373,2.077537858418678,FUN_028978-T1,Peve_00029291,Pocillopora_meandrina_HIv1___RNAseq.g25600.t1,three_way,57.49583333333333,FUN_028978-T1,P35331,,,,,29.0,978.0,1.4e-95,352.8,sp|P35331|NRCAM_CHICK Neuronal cell adhesion molecule OS=Gallus gallus OX=9031 PE=1 SV=1,,,,,,
OG_06375,1.4702197886917736,FUN_028980-T1,Peve_00015446,Pocillopora_meandrina_HIv1___RNAseq.g25620.t1,three_way,72.642,FUN_028980-T1,Q9UHQ4,BAP29_HUMAN,,B-cell receptor-associated protein 29 (BCR-associated protein 29) (Bap29),Homo sapiens (Human),47.0,168.0,9.6e-32,138.7,sp|Q9UHQ4|BAP29_HUMAN B-cell receptor-associated protein 29 OS=Homo sapiens OX=9606 GN=BCAP29 PE=1 SV=2,GO:0001649; GO:0005789; GO:0006886; GO:0006888; GO:0006915; GO:0016020; GO:0070973,apoptotic process [GO:0006915]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; osteoblast differentiation [GO:0001649]; protein localization to endoplasmic reticulum exit site [GO:0070973],endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],,GO:0006886; GO:0012501; GO:0016192; GO:0030154,intracellular protein transport; programmed cell death; vesicle-mediated transport; cell differentiation
OG_06384,1.5882929837492843,FUN_029014-T1,Peve_00003118,Pocillopora_meandrina_HIv1___TS.g9087.t1,three_way,52.617,FUN_029014-T1,B8VIW9,,,,,40.2,1040.0,3.2999999999999996e-188,660.6,sp|B8VIW9|FP_ACRMI Fibronectin type III domain-containing protein OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_06400,2.0744348287019103,FUN_029061-T1,Peve_00043258,Pocillopora_meandrina_HIv1___RNAseq.g25810.t1,three_way,65.944,FUN_029061-T1,A8MTJ6,FOXI3_HUMAN,,Forkhead box protein I3,Homo sapiens (Human),42.1,145.0,1.6e-20,101.7,sp|A8MTJ6|FOXI3_HUMAN Forkhead box protein I3 OS=Homo sapiens OX=9606 GN=FOXI3 PE=1 SV=3,GO:0000978; GO:0000981; GO:0001942; GO:0005634; GO:0006357; GO:0009653; GO:0009957; GO:0030154; GO:0042475; GO:0048538; GO:0060017; GO:0060037; GO:1905040,anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; epidermal cell fate specification [GO:0009957]; hair follicle development [GO:0001942]; odontogenesis of dentin-containing tooth [GO:0042475]; otic placode development [GO:1905040]; parathyroid gland development [GO:0060017]; pharyngeal system development [GO:0060037]; regulation of transcription by RNA polymerase II [GO:0006357]; thymus development [GO:0048538],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_06442,1.000690384323047,FUN_029149-T1,Peve_00000508,Pocillopora_meandrina_HIv1___RNAseq.g25732.t1,three_way,83.18866666666666,FUN_029149-T1,Q62717,,,,,54.3,1182.0,0.0,1248.0,sp|Q62717|CAPS1_RAT Calcium-dependent secretion activator 1 OS=Rattus norvegicus OX=10116 GN=Cadps PE=1 SV=1,,,,,,
OG_06455,1.1002495483930512,FUN_029177-T1,Peve_00031203,Pocillopora_meandrina_HIv1___TS.g8937.t1,three_way,73.50366666666666,FUN_029177-T1,Q9DC53,,,,,63.0,519.0,6.399999999999999e-190,665.2,sp|Q9DC53|CPNE8_MOUSE Copine-8 OS=Mus musculus OX=10090 GN=Cpne8 PE=2 SV=3,,,,,,
OG_06469,1.16089816299112,FUN_029208-T1,Peve_00013633,Pocillopora_meandrina_HIv1___RNAseq.g25538.t1,three_way,48.8415,,,,,,,,,,,,,,,,,
OG_06489,1.760992835349994,FUN_029264-T1,Peve_00030745,Pocillopora_meandrina_HIv1___RNAseq.g15034.t1,three_way,71.40766666666667,,,,,,,,,,,,,,,,,
OG_06533,1.2550399455542682,FUN_029393-T1,Peve_00044525,Pocillopora_meandrina_HIv1___TS.g2905.t4a,three_way,66.75,FUN_029393-T1,F1MCA7,,,,,55.2,87.0,8.5e-18,94.4,sp|F1MCA7|LRRC7_BOVIN Leucine-rich repeat-containing protein 7 OS=Bos taurus OX=9913 GN=LRRC7 PE=3 SV=3,,,,,,
OG_06533,1.2550399455542682,FUN_029393-T1,Peve_00044525,Pocillopora_meandrina_HIv1___TS.g2905.t4a,three_way,66.75,FUN_029393-T1,F1MCA7,,,,,56.2,48.0,2e-06,56.6,sp|F1MCA7|LRRC7_BOVIN Leucine-rich repeat-containing protein 7 OS=Bos taurus OX=9913 GN=LRRC7 PE=3 SV=3,,,,,,
OG_06536,1.1946116521005037,FUN_029396-T1,Peve_00044520,Pocillopora_meandrina_HIv1___RNAseq.g17138.t1,three_way,63.98033333333333,FUN_029396-T1,Q7SZC5,,,,,32.8,673.0,7.2e-84,313.2,sp|Q7SZC5|NDC1_DANRE Nucleoporin NDC1 OS=Danio rerio OX=7955 GN=ndc1 PE=2 SV=1,,,,,,
OG_06574,1.482150028832177,FUN_029519-T1,Peve_00022876,Pocillopora_meandrina_HIv1___TS.g2888.t1,three_way,93.70616666666666,FUN_029519-T1,Q9JHU4,DYHC1_MOUSE,,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)",Mus musculus (Mouse),73.3,4665.0,0.0,6825.7,sp|Q9JHU4|DYHC1_MOUSE Cytoplasmic dynein 1 heavy chain 1 OS=Mus musculus OX=10090 GN=Dync1h1 PE=1 SV=2,GO:0003341; GO:0005524; GO:0005737; GO:0005813; GO:0005868; GO:0005874; GO:0008569; GO:0016887; GO:0030175; GO:0030286; GO:0032388; GO:0033962; GO:0034063; GO:0042802; GO:0045505; GO:0051293; GO:0051301; GO:0051959; GO:0060236; GO:0090235; GO:0120162; GO:1905832,cell division [GO:0051301]; cilium movement [GO:0003341]; establishment of spindle localization [GO:0051293]; P-body assembly [GO:0033962]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of intracellular transport [GO:0032388]; positive regulation of spindle assembly [GO:1905832]; regulation of metaphase plate congression [GO:0090235]; regulation of mitotic spindle organization [GO:0060236]; stress granule assembly [GO:0034063],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic dynein complex [GO:0005868]; dynein complex [GO:0030286]; filopodium [GO:0030175]; microtubule [GO:0005874],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; dynein intermediate chain binding [GO:0045505]; dynein light intermediate chain binding [GO:0051959]; identical protein binding [GO:0042802]; minus-end-directed microtubule motor activity [GO:0008569],GO:0003774; GO:0003824; GO:0005815; GO:0007010; GO:0007018; GO:0016787; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; cytoskeleton organization; microtubule-based movement; hydrolase activity; isomerase activity; ATP-dependent activity
OG_06577,2.1825023288864767,FUN_029524-T1,Peve_00010676,Pocillopora_meandrina_HIv1___RNAseq.g17110.t1,three_way,64.472,,,,,,,,,,,,,,,,,
OG_06583,1.2540023928151345,FUN_029554-T1,Peve_00023354,Pocillopora_meandrina_HIv1___RNAseq.g17263.t1,three_way,73.25566666666667,FUN_029554-T1,Q6NRK1,ADIPA_XENLA,,Afadin- and alpha-actinin-binding protein A (ADIP-A) (Afadin DIL domain-interacting protein A) (SSX2-interacting protein A) (XSSX2IP),Xenopus laevis (African clawed frog),33.5,424.0,5.9e-51,203.8,sp|Q6NRK1|ADIPA_XENLA Afadin- and alpha-actinin-binding protein A OS=Xenopus laevis OX=8355 GN=ssx2ip-a PE=1 SV=1,GO:0005737; GO:0005874; GO:0005912; GO:0007098; GO:0007155; GO:0034451; GO:0035735; GO:0036064; GO:0051011,cell adhesion [GO:0007155]; centrosome cycle [GO:0007098]; intraciliary transport involved in cilium assembly [GO:0035735],adherens junction [GO:0005912]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; microtubule [GO:0005874],microtubule minus-end binding [GO:0051011],GO:0005815; GO:0007018; GO:0007155; GO:0008092,microtubule organizing center; microtubule-based movement; cell adhesion; cytoskeletal protein binding
OG_06606,1.284250632480046,FUN_029754-T1,Peve_00019513,Pocillopora_meandrina_HIv1___RNAseq.g17315.t1,three_way,73.25083333333333,FUN_029754-T1,D3ZYR1,FCHO2_RAT,,F-BAR domain only protein 2,Rattus norvegicus (Rat),35.2,1026.0,1.2e-117,426.0,sp|D3ZYR1|FCHO2_RAT F-BAR domain only protein 2 OS=Rattus norvegicus OX=10116 GN=Fcho2 PE=1 SV=1,GO:0001786; GO:0005546; GO:0005737; GO:0005886; GO:0005905; GO:0010324; GO:0030136; GO:0035091; GO:0042802; GO:0045202; GO:0048268; GO:0048488; GO:0072583; GO:0072659; GO:0098793,clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; membrane invagination [GO:0010324]; protein localization to plasma membrane [GO:0072659]; synaptic vesicle endocytosis [GO:0048488],clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; synapse [GO:0045202],"identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]",GO:0005886; GO:0008289; GO:0016192; GO:0031410; GO:0043226; GO:0061024; GO:0065003; GO:0072659,plasma membrane; lipid binding; vesicle-mediated transport; cytoplasmic vesicle; organelle; membrane organization; protein-containing complex assembly; protein localization to plasma membrane
OG_06616,1.0115883922128277,FUN_029772-T1,Peve_00013611,Pocillopora_meandrina_HIv1___RNAseq.g17328.t1a,three_way,49.64566666666666,FUN_029772-T1,P98063,BMP1_MOUSE,,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),Mus musculus (Mouse),21.8,458.0,5e-18,94.7,sp|P98063|BMP1_MOUSE Bone morphogenetic protein 1 OS=Mus musculus OX=10090 GN=Bmp1 PE=1 SV=2,GO:0001503; GO:0004222; GO:0005125; GO:0005509; GO:0005615; GO:0005794; GO:0006508; GO:0008083; GO:0008233; GO:0008270; GO:0030154; GO:0031982; GO:0042802; GO:0051216; GO:0061036; GO:0062023,cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508],collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982],calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270],GO:0003824; GO:0005615; GO:0005794; GO:0016787; GO:0030154; GO:0043226; GO:0048018; GO:0048856; GO:0098772; GO:0140096,"catalytic activity; extracellular space; Golgi apparatus; hydrolase activity; cell differentiation; organelle; receptor ligand activity; anatomical structure development; molecular function regulator activity; catalytic activity, acting on a protein"
OG_06676,2.343438490896656,FUN_031079-T1,Peve_00028146,Pocillopora_meandrina_HIv1___RNAseq.27627_t,three_way,61.867666666666665,,,,,,,,,,,,,,,,,
OG_06692,1.162837940284127,FUN_031240-T1,Peve_00043069,Pocillopora_meandrina_HIv1___RNAseq.g5193.t1,three_way,67.849,FUN_031240-T1,P42335,,,,,50.9,399.0,9.1e-107,389.0,sp|P42335|IP3KB_RAT Inositol-trisphosphate 3-kinase B OS=Rattus norvegicus OX=10116 GN=Itpkb PE=1 SV=3,,,,,,
OG_06702,1.027869997419534,FUN_031269-T1,Peve_00036737,Pocillopora_meandrina_HIv1___TS.g23896.t1,three_way,69.62383333333334,FUN_031269-T1,Q3T906,GNPTA_HUMAN,,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta],Homo sapiens (Human),39.7,1334.0,1e-257,891.7,sp|Q3T906|GNPTA_HUMAN N-acetylglucosamine-1-phosphotransferase subunits alpha/beta OS=Homo sapiens OX=9606 GN=GNPTAB PE=1 SV=1,GO:0000139; GO:0003976; GO:0005509; GO:0005794; GO:0007040; GO:0016256; GO:0033299; GO:0046835,carbohydrate phosphorylation [GO:0046835]; lysosome organization [GO:0007040]; N-glycan processing to lysosome [GO:0016256]; secretion of lysosomal enzymes [GO:0033299],Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],calcium ion binding [GO:0005509]; UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity [GO:0003976],GO:0003824; GO:0005794; GO:0005975; GO:0007040; GO:0009101; GO:0016740; GO:0043226; GO:1901135,catalytic activity; Golgi apparatus; carbohydrate metabolic process; lysosome organization; glycoprotein biosynthetic process; transferase activity; organelle; carbohydrate derivative metabolic process
OG_06752,1.182270117353159,FUN_031561-T1,Peve_00025442,Pocillopora_meandrina_HIv1___RNAseq.g5074.t2,three_way,66.97466666666666,FUN_031561-T1,Q8TCS8,PNPT1_HUMAN,,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein)",Homo sapiens (Human),44.5,366.0,1e-83,312.0,"sp|Q8TCS8|PNPT1_HUMAN Polyribonucleotide nucleotidyltransferase 1, mitochondrial OS=Homo sapiens OX=9606 GN=PNPT1 PE=1 SV=2",GO:0000175; GO:0000957; GO:0000958; GO:0000962; GO:0000964; GO:0000965; GO:0003723; GO:0004654; GO:0005737; GO:0005739; GO:0005758; GO:0005759; GO:0005789; GO:0005829; GO:0005840; GO:0006397; GO:0006401; GO:0006402; GO:0007005; GO:0008266; GO:0034046; GO:0034599; GO:0035198; GO:0035458; GO:0035927; GO:0035928; GO:0042802; GO:0043457; GO:0045025; GO:0051260; GO:0051591; GO:0060416; GO:0061014; GO:0070207; GO:0071042; GO:0097222; GO:0097421; GO:2000627; GO:2000772,cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; liver regeneration [GO:0097421]; mitochondrial mRNA catabolic process [GO:0000958]; mitochondrial mRNA polyadenylation [GO:0097222]; mitochondrial RNA 3'-end processing [GO:0000965]; mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial RNA catabolic process [GO:0000957]; mitochondrion organization [GO:0007005]; mRNA catabolic process [GO:0006402]; mRNA processing [GO:0006397]; nuclear polyadenylation-dependent mRNA catabolic process [GO:0071042]; positive regulation of miRNA catabolic process [GO:2000627]; positive regulation of mitochondrial RNA catabolic process [GO:0000962]; positive regulation of mRNA catabolic process [GO:0061014]; protein homooligomerization [GO:0051260]; protein homotrimerization [GO:0070207]; regulation of cellular respiration [GO:0043457]; regulation of cellular senescence [GO:2000772]; response to cAMP [GO:0051591]; response to growth hormone [GO:0060416]; RNA catabolic process [GO:0006401]; RNA import into mitochondrion [GO:0035927]; rRNA import into mitochondrion [GO:0035928],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; mitochondrial degradosome [GO:0045025]; mitochondrial intermembrane space [GO:0005758]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; ribosome [GO:0005840],3'-5'-RNA exonuclease activity [GO:0000175]; identical protein binding [GO:0042802]; miRNA binding [GO:0035198]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; polyribonucleotide nucleotidyltransferase activity [GO:0004654]; RNA binding [GO:0003723],GO:0003723; GO:0003824; GO:0005739; GO:0005829; GO:0005840; GO:0007005; GO:0016071; GO:0016740; GO:0016787; GO:0043226; GO:0048856; GO:0055085; GO:0065003; GO:0140053; GO:0140098,"RNA binding; catalytic activity; mitochondrion; cytosol; ribosome; mitochondrion organization; mRNA metabolic process; transferase activity; hydrolase activity; organelle; anatomical structure development; transmembrane transport; protein-containing complex assembly; mitochondrial gene expression; catalytic activity, acting on RNA"
OG_06754,1.9875167123653965,FUN_031565-T1,Peve_00021513,Pocillopora_meandrina_HIv1___RNAseq.g5072.t1,three_way,87.24600000000001,FUN_031565-T1,Q01728,,,,,54.5,932.0,1.8e-266,920.2,sp|Q01728|NAC1_RAT Sodium/calcium exchanger 1 OS=Rattus norvegicus OX=10116 GN=Slc8a1 PE=1 SV=3,,,,,,
OG_06782,1.905205436054216,FUN_031649-T1,Peve_00043575,Pocillopora_meandrina_HIv1___TS.g24400.t2a,three_way,66.82783333333333,FUN_031649-T1,Q96PN7,TREF1_HUMAN,,Transcriptional-regulating factor 1 (Breast cancer anti-estrogen resistance 2) (Transcriptional-regulating protein 132) (Zinc finger protein rapa) (Zinc finger transcription factor TReP-132),Homo sapiens (Human),29.4,486.0,4e-39,165.6,sp|Q96PN7|TREF1_HUMAN Transcriptional-regulating factor 1 OS=Homo sapiens OX=9606 GN=TRERF1 PE=1 SV=1,GO:0000118; GO:0001223; GO:0001650; GO:0003677; GO:0003713; GO:0003714; GO:0005634; GO:0005654; GO:0005667; GO:0005829; GO:0006357; GO:0008270; GO:0033142; GO:0045892; GO:0045893; GO:0045944; GO:0050847; GO:0071393,cellular response to progesterone stimulus [GO:0071393]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; fibrillar center [GO:0001650]; histone deacetylase complex [GO:0000118]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription regulator complex [GO:0005667],DNA binding [GO:0003677]; nuclear progesterone receptor binding [GO:0033142]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],GO:0003677; GO:0005634; GO:0005654; GO:0005829; GO:0006355; GO:0043226; GO:0060090; GO:0140110,DNA binding; nucleus; nucleoplasm; cytosol; regulation of DNA-templated transcription; organelle; molecular adaptor activity; transcription regulator activity
OG_06792,1.5371127552218304,FUN_031678-T1,Peve_00012833,Pocillopora_meandrina_HIv1___RNAseq.g5745.t1,three_way,69.84783333333333,FUN_031678-T1,Q5R4I2,RNF8_PONAB,,E3 ubiquitin-protein ligase RNF8 (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8),Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii),29.4,446.0,2.1e-21,105.5,sp|Q5R4I2|RNF8_PONAB E3 ubiquitin-protein ligase RNF8 OS=Pongo abelii OX=9601 GN=RNF8 PE=2 SV=1,GO:0000151; GO:0000781; GO:0003682; GO:0005634; GO:0005737; GO:0005829; GO:0006302; GO:0006303; GO:0006511; GO:0006974; GO:0008270; GO:0010212; GO:0030496; GO:0034244; GO:0035092; GO:0035861; GO:0040029; GO:0042393; GO:0042803; GO:0043130; GO:0045190; GO:0045739; GO:0051301; GO:0061630; GO:0070534; GO:0070936; GO:0085020; GO:0140861; GO:1905168,cell division [GO:0051301]; DNA damage response [GO:0006974]; DNA repair-dependent chromatin remodeling [GO:0140861]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; epigenetic regulation of gene expression [GO:0040029]; isotype switching [GO:0045190]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; response to ionizing radiation [GO:0010212]; sperm DNA condensation [GO:0035092]; ubiquitin-dependent protein catabolic process [GO:0006511],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; midbody [GO:0030496]; nucleus [GO:0005634]; site of double-strand break [GO:0035861]; ubiquitin ligase complex [GO:0000151]",chromatin binding [GO:0003682]; histone binding [GO:0042393]; protein homodimerization activity [GO:0042803]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],GO:0002376; GO:0003824; GO:0005634; GO:0005829; GO:0006281; GO:0006310; GO:0006325; GO:0006355; GO:0016740; GO:0042393; GO:0043226; GO:0140096,"immune system process; catalytic activity; nucleus; cytosol; DNA repair; DNA recombination; chromatin organization; regulation of DNA-templated transcription; transferase activity; histone binding; organelle; catalytic activity, acting on a protein"
OG_06813,1.0157876116256568,FUN_031713-T1,Peve_00002672,Pocillopora_meandrina_HIv1___RNAseq.g5451.t1,three_way,71.65333333333334,,,,,,,,,,,,,,,,,
OG_06851,1.010863970946344,FUN_031800-T1,Peve_00019322,Pocillopora_meandrina_HIv1___RNAseq.g5573.t1,three_way,74.092,FUN_031800-T1,Q99986,VRK1_HUMAN,,Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1),Homo sapiens (Human),53.3,336.0,1.4000000000000001e-101,371.3,sp|Q99986|VRK1_HUMAN Serine/threonine-protein kinase VRK1 OS=Homo sapiens OX=9606 GN=VRK1 PE=1 SV=1,GO:0000785; GO:0004672; GO:0004674; GO:0005524; GO:0005634; GO:0005654; GO:0005730; GO:0005737; GO:0005795; GO:0005829; GO:0006338; GO:0006468; GO:0006974; GO:0007077; GO:0007165; GO:0015030; GO:0016301; GO:0019901; GO:0030576; GO:0031175; GO:0031492; GO:0035175; GO:0042393; GO:0046777; GO:0051301; GO:0072354; GO:0090166; GO:0106310; GO:0120187; GO:0141003; GO:2001222,Cajal body organization [GO:0030576]; cell division [GO:0051301]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; Golgi disassembly [GO:0090166]; mitotic nuclear membrane disassembly [GO:0007077]; neuron projection development [GO:0031175]; positive regulation of protein localization to chromatin [GO:0120187]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of neuron migration [GO:2001222]; signal transduction [GO:0007165],Cajal body [GO:0015030]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi stack [GO:0005795]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; histone binding [GO:0042393]; histone H2AX kinase activity [GO:0141003]; histone H3S10 kinase activity [GO:0035175]; histone H3T3 kinase activity [GO:0072354]; kinase activity [GO:0016301]; nucleosomal DNA binding [GO:0031492]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005730; GO:0005829; GO:0006325; GO:0016740; GO:0042393; GO:0043226; GO:0061024; GO:0140096,"DNA binding; catalytic activity; nucleus; nucleoplasm; nucleolus; cytosol; chromatin organization; transferase activity; histone binding; organelle; membrane organization; catalytic activity, acting on a protein"
OG_06859,1.0473723215512205,FUN_031849-T1,Peve_00030292,Pocillopora_meandrina_HIv1___RNAseq.g5608.t1,three_way,82.18233333333333,FUN_031849-T1,Q8BX37,,,,,55.5,402.0,4.6e-141,502.7,sp|Q8BX37|ACP7_MOUSE Acid phosphatase type 7 OS=Mus musculus OX=10090 GN=Acp7 PE=2 SV=2,,,,,,
OG_06874,1.6584595866149392,FUN_031877-T1,Peve_00012644,Pocillopora_meandrina_HIv1___RNAseq.g5447.t1,three_way,82.98033333333333,FUN_031877-T1,Q9VT65,CANB_DROME,,Calpain-B (EC 3.4.22.-) (Calcium-activated neutral proteinase B) (CANP B) [Cleaved into: Calpain-B catalytic subunit 1; Calpain-B catalytic subunit 2],Drosophila melanogaster (Fruit fly),40.7,685.0,5.4e-154,546.2,sp|Q9VT65|CANB_DROME Calpain-B OS=Drosophila melanogaster OX=7227 GN=CalpB PE=1 SV=2,GO:0004198; GO:0005509; GO:0005737; GO:0006508; GO:0007298; GO:0016020; GO:0016322; GO:0016540,border follicle cell migration [GO:0007298]; neuron remodeling [GO:0016322]; protein autoprocessing [GO:0016540]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; membrane [GO:0016020],calcium ion binding [GO:0005509]; calcium-dependent cysteine-type endopeptidase activity [GO:0004198],GO:0003824; GO:0016787; GO:0048870; GO:0051604; GO:0140096,"catalytic activity; hydrolase activity; cell motility; protein maturation; catalytic activity, acting on a protein"
OG_06888,1.152523021272317,FUN_031925-T1,Peve_00004245,Pocillopora_meandrina_HIv1___TS.g21220.t1,three_way,43.71983333333333,,,,,,,,,,,,,,,,,
OG_06892,1.0738705547102023,FUN_031931-T1,Peve_00004235,Pocillopora_meandrina_HIv1___RNAseq.g18238.t1,three_way,59.82666666666667,FUN_031931-T1,Q498L0,,,,,51.9,104.0,1.7000000000000002e-22,110.2,sp|Q498L0|C170B_XENLA Centrosomal protein of 170 kDa protein B OS=Xenopus laevis OX=8355 GN=cep170b PE=2 SV=1,,,,,,
OG_06922,2.1166258873368315,FUN_032012-T1,Peve_00028791,Pocillopora_meandrina_HIv1___RNAseq.g30267.t1,three_way,74.29599999999999,FUN_032012-T1,Q20191,,,,,44.3,228.0,1.5e-45,185.7,sp|Q20191|NAS13_CAEEL Zinc metalloproteinase nas-13 OS=Caenorhabditis elegans OX=6239 GN=nas-13 PE=2 SV=5,,,,,,
OG_06955,1.3243955577817883,FUN_032074-T1,Peve_00018829,Pocillopora_meandrina_HIv1___RNAseq.g6016.t1,three_way,67.94316666666667,FUN_032074-T1,P78504,JAG1_HUMAN,,Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339),Homo sapiens (Human),41.2,204.0,9.5e-42,174.5,sp|P78504|JAG1_HUMAN Protein jagged-1 OS=Homo sapiens OX=9606 GN=JAG1 PE=1 SV=3,GO:0001525; GO:0001709; GO:0001953; GO:0001974; GO:0002011; GO:0002085; GO:0002456; GO:0003180; GO:0003184; GO:0003215; GO:0005112; GO:0005198; GO:0005509; GO:0005543; GO:0005576; GO:0005886; GO:0005912; GO:0007219; GO:0007399; GO:0008083; GO:0016020; GO:0016324; GO:0022408; GO:0030097; GO:0030216; GO:0030336; GO:0032495; GO:0035909; GO:0042127; GO:0042491; GO:0045445; GO:0045446; GO:0045599; GO:0045602; GO:0045639; GO:0045665; GO:0045669; GO:0045747; GO:0045944; GO:0050678; GO:0060090; GO:0060411; GO:0061073; GO:0061101; GO:0061156; GO:0061309; GO:0061444; GO:0062043; GO:0072006; GO:0072015; GO:0072017; GO:0072070; GO:0097150; GO:2000737,angiogenesis [GO:0001525]; aorta morphogenesis [GO:0035909]; aortic valve morphogenesis [GO:0003180]; blood vessel remodeling [GO:0001974]; cardiac neural crest cell development involved in outflow tract morphogenesis [GO:0061309]; cardiac right ventricle morphogenesis [GO:0003215]; cardiac septum morphogenesis [GO:0060411]; cell fate determination [GO:0001709]; ciliary body morphogenesis [GO:0061073]; distal tubule development [GO:0072017]; endocardial cushion cell development [GO:0061444]; endothelial cell differentiation [GO:0045446]; hemopoiesis [GO:0030097]; inhibition of neuroepithelial cell differentiation [GO:0002085]; inner ear auditory receptor cell differentiation [GO:0042491]; keratinocyte differentiation [GO:0030216]; loop of Henle development [GO:0072070]; morphogenesis of an epithelial sheet [GO:0002011]; myoblast differentiation [GO:0045445]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of endothelial cell differentiation [GO:0045602]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of stem cell differentiation [GO:2000737]; nephron development [GO:0072006]; nervous system development [GO:0007399]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; podocyte development [GO:0072015]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of transcription by RNA polymerase II [GO:0045944]; pulmonary artery morphogenesis [GO:0061156]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell population proliferation [GO:0042127]; regulation of epithelial cell proliferation [GO:0050678]; response to muramyl dipeptide [GO:0032495]; T cell mediated immunity [GO:0002456],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; extracellular region [GO:0005576]; membrane [GO:0016020]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; molecular adaptor activity [GO:0060090]; Notch binding [GO:0005112]; phospholipid binding [GO:0005543]; structural molecule activity [GO:0005198],GO:0002376; GO:0005198; GO:0005576; GO:0005886; GO:0006355; GO:0008289; GO:0030154; GO:0048018; GO:0048856; GO:0060090; GO:0098772,immune system process; structural molecule activity; extracellular region; plasma membrane; regulation of DNA-templated transcription; lipid binding; cell differentiation; receptor ligand activity; anatomical structure development; molecular adaptor activity; molecular function regulator activity
OG_06986,1.6148857113142527,FUN_032125-T1,Peve_00040713,Pocillopora_meandrina_HIv1___RNAseq.g5366.t1,three_way,78.05966666666667,FUN_032125-T1,Q6DF57,,,,,46.3,95.0,4e-16,85.9,sp|Q6DF57|GPT11_XENTR G patch domain-containing protein 11 OS=Xenopus tropicalis OX=8364 GN=gpatch11 PE=2 SV=1,,,,,,
OG_06991,1.218927899855774,FUN_032133-T1,Peve_00029139,Pocillopora_meandrina_HIv1___RNAseq.g5353.t1,three_way,78.61566666666667,FUN_032133-T1,Q9ULQ1,,,,,28.8,552.0,2.7000000000000004e-44,181.8,sp|Q9ULQ1|TPC1_HUMAN Two pore channel protein 1 OS=Homo sapiens OX=9606 GN=TPCN1 PE=1 SV=3,,,,,,
OG_06993,2.1776344904731237,FUN_032139-T1,Peve_00007913,Pocillopora_meandrina_HIv1___TS.g24062.t1,three_way,49.26766666666666,,,,,,,,,,,,,,,,,
OG_07030,1.1539215130080342,FUN_032222-T1,Peve_00015538,Pocillopora_meandrina_HIv1___RNAseq.g24283.t1,three_way,63.73566666666667,FUN_032222-T1,Q8BVA5,LDAH_MOUSE,,Lipid droplet-associated hydrolase (EC 3.1.1.13) (Lipid droplet-associated serine hydrolase) (mLDAH),Mus musculus (Mouse),39.9,288.0,2.1e-50,201.1,sp|Q8BVA5|LDAH_MOUSE Lipid droplet-associated hydrolase OS=Mus musculus OX=10090 GN=Ldah PE=1 SV=1,GO:0004771; GO:0005783; GO:0005811; GO:0019915; GO:0035356; GO:0042632; GO:0090077; GO:0160077,cholesterol homeostasis [GO:0042632]; foam cell differentiation [GO:0090077]; intracellular triglyceride homeostasis [GO:0035356]; lipid droplet fusion [GO:0160077]; lipid storage [GO:0019915],endoplasmic reticulum [GO:0005783]; lipid droplet [GO:0005811],sterol ester esterase activity [GO:0004771],GO:0003824; GO:0005783; GO:0005811; GO:0016787; GO:0030154; GO:0043226,catalytic activity; endoplasmic reticulum; lipid droplet; hydrolase activity; cell differentiation; organelle
OG_07046,1.0241148330355063,FUN_032249-T1,Peve_00042108,Pocillopora_meandrina_HIv1___TS.g12806.t2,three_way,79.56116666666667,FUN_032249-T1,Q4H4B6,SCRIB_DANRE,,Protein scribble homolog (Scribble1),Danio rerio (Zebrafish) (Brachydanio rerio),37.1,938.0,2.3e-130,468.8,sp|Q4H4B6|SCRIB_DANRE Protein scribble homolog OS=Danio rerio OX=7955 GN=scrib PE=1 SV=1,GO:0000132; GO:0001736; GO:0001764; GO:0001841; GO:0001944; GO:0005737; GO:0005886; GO:0005911; GO:0005912; GO:0008283; GO:0014069; GO:0016020; GO:0016323; GO:0016477; GO:0019901; GO:0030027; GO:0033564; GO:0035089; GO:0043065; GO:0043113; GO:0045197; GO:0045930; GO:0046982; GO:0048884; GO:0050918; GO:0060027; GO:0060561; GO:0071679; GO:0090630; GO:0097475; GO:0098609; GO:0098793; GO:0098887,"activation of GTPase activity [GO:0090630]; anterior/posterior axon guidance [GO:0033564]; apoptotic process involved in morphogenesis [GO:0060561]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; commissural neuron axon guidance [GO:0071679]; convergent extension involved in gastrulation [GO:0060027]; establishment of apical/basal cell polarity [GO:0035089]; establishment of mitotic spindle orientation [GO:0000132]; establishment of planar polarity [GO:0001736]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; motor neuron migration [GO:0097475]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube formation [GO:0001841]; neuromast development [GO:0048884]; neuron migration [GO:0001764]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; receptor clustering [GO:0043113]; vasculature development [GO:0001944]",adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; lamellipodium [GO:0030027]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793],protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901],GO:0005886; GO:0006886; GO:0007010; GO:0007155; GO:0007163; GO:0012501; GO:0016192; GO:0043226; GO:0048856; GO:0048870; GO:0072659,plasma membrane; intracellular protein transport; cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; programmed cell death; vesicle-mediated transport; organelle; anatomical structure development; cell motility; protein localization to plasma membrane
OG_07066,1.9209871061818384,FUN_032299-T1,Peve_00020128,Pocillopora_meandrina_HIv1___RNAseq.g24900.t1,three_way,50.632333333333335,FUN_032299-T1,Q3ZT31,SNX25_MOUSE,,Sorting nexin-25,Mus musculus (Mouse),27.2,125.0,1.3e-07,60.8,sp|Q3ZT31|SNX25_MOUSE Sorting nexin-25 OS=Mus musculus OX=10090 GN=Snx25 PE=1 SV=3,GO:0005768; GO:0010008; GO:0015031; GO:0030512; GO:0032801; GO:0034713; GO:0035091,negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; protein transport [GO:0015031]; receptor catabolic process [GO:0032801],endosome [GO:0005768]; endosome membrane [GO:0010008],phosphatidylinositol binding [GO:0035091]; type I transforming growth factor beta receptor binding [GO:0034713],GO:0005768; GO:0008289; GO:0031410; GO:0043226,endosome; lipid binding; cytoplasmic vesicle; organelle
OG_07087,1.3839133686779752,FUN_032344-T1,Peve_00021401,Pocillopora_meandrina_HIv1___RNAseq.g29796.t1,three_way,74.12733333333334,FUN_032344-T1,Q9H3R1,,,,,40.3,749.0,4.3000000000000005e-161,570.1,sp|Q9H3R1|NDST4_HUMAN Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 OS=Homo sapiens OX=9606 GN=NDST4 PE=1 SV=1,,,,,,
OG_07088,1.3017380569301256,FUN_032345-T1,Peve_00021405,Pocillopora_meandrina_HIv1___RNAseq.g29797.t2,three_way,70.41966666666667,FUN_032345-T1,Q9V3L1,NDST_DROME,,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase) (Sulfateless) [Includes: Heparan sulfate N-deacetylase (EC 3.-.-.-); Heparan sulfate N-sulfotransferase (EC 2.8.2.-)],Drosophila melanogaster (Fruit fly),46.3,901.0,9.6e-236,818.1,sp|Q9V3L1|NDST_DROME Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase OS=Drosophila melanogaster OX=7227 GN=sfl PE=1 SV=1,GO:0000137; GO:0000139; GO:0005783; GO:0005794; GO:0006024; GO:0006790; GO:0007283; GO:0007367; GO:0007427; GO:0007474; GO:0007509; GO:0008543; GO:0008587; GO:0015012; GO:0015016; GO:0016055; GO:0019213; GO:0030210; GO:0045570; GO:0102140,"epithelial cell migration, open tracheal system [GO:0007427]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glycosaminoglycan biosynthetic process [GO:0006024]; heparan sulfate proteoglycan biosynthetic process [GO:0015012]; heparin proteoglycan biosynthetic process [GO:0030210]; imaginal disc-derived wing margin morphogenesis [GO:0008587]; imaginal disc-derived wing vein specification [GO:0007474]; mesoderm migration involved in gastrulation [GO:0007509]; regulation of imaginal disc growth [GO:0045570]; segment polarity determination [GO:0007367]; spermatogenesis [GO:0007283]; sulfur compound metabolic process [GO:0006790]; Wnt signaling pathway [GO:0016055]",endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi membrane [GO:0000139],deacetylase activity [GO:0019213]; heparan sulfate N-deacetylase activity [GO:0102140]; heparan sulfate N-sulfotransferase activity [GO:0015016],GO:0003824; GO:0005783; GO:0005794; GO:0006790; GO:0009101; GO:0016740; GO:0016787; GO:0022414; GO:0043226; GO:0048870; GO:1901135,catalytic activity; endoplasmic reticulum; Golgi apparatus; sulfur compound metabolic process; glycoprotein biosynthetic process; transferase activity; hydrolase activity; reproductive process; organelle; cell motility; carbohydrate derivative metabolic process
OG_07102,1.3009772232547547,FUN_032363-T1,Peve_00045030,Pocillopora_meandrina_HIv1___RNAseq.g29819.t1,three_way,59.871500000000005,FUN_032363-T1,Q6N021,TET2_HUMAN,,Methylcytosine dioxygenase TET2 (EC 1.14.11.80),Homo sapiens (Human),32.8,825.0,5.8e-99,364.4,sp|Q6N021|TET2_HUMAN Methylcytosine dioxygenase TET2 OS=Homo sapiens OX=9606 GN=TET2 PE=1 SV=3,GO:0002521; GO:0003677; GO:0005634; GO:0005654; GO:0005694; GO:0006493; GO:0008198; GO:0008270; GO:0030099; GO:0044029; GO:0045944; GO:0070579; GO:0141167,"chromosomal 5-methylcytosine DNA demethylation, oxidation pathway [GO:0141167]; leukocyte differentiation [GO:0002521]; myeloid cell differentiation [GO:0030099]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein O-linked glycosylation [GO:0006493]",chromosome [GO:0005694]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],5-methylcytosine dioxygenase activity [GO:0070579]; DNA binding [GO:0003677]; ferrous iron binding [GO:0008198]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0005634; GO:0005654; GO:0005694; GO:0006325; GO:0006355; GO:0009101; GO:0016491; GO:0030154; GO:0043226; GO:0140097; GO:1901135,"DNA binding; catalytic activity; nucleus; nucleoplasm; chromosome; chromatin organization; regulation of DNA-templated transcription; glycoprotein biosynthetic process; oxidoreductase activity; cell differentiation; organelle; catalytic activity, acting on DNA; carbohydrate derivative metabolic process"
OG_07103,1.733134960926452,FUN_032365-T1,Peve_00020147,Pocillopora_meandrina_HIv1___RNAseq.g29821.t1,three_way,68.24633333333333,FUN_032365-T1,Q2KIA4,SCD5_BOVIN,,Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (Stearoyl-CoA 9-desaturase),Bos taurus (Bovine),56.5,283.0,1.6e-100,367.5,sp|Q2KIA4|SCD5_BOVIN Stearoyl-CoA desaturase 5 OS=Bos taurus OX=9913 GN=SCD5 PE=2 SV=1,GO:0004768; GO:0005506; GO:0005789; GO:0006636; GO:0016491,unsaturated fatty acid biosynthetic process [GO:0006636],endoplasmic reticulum membrane [GO:0005789],iron ion binding [GO:0005506]; oxidoreductase activity [GO:0016491]; stearoyl-CoA 9-desaturase activity [GO:0004768],GO:0003824; GO:0006629; GO:0016491,catalytic activity; lipid metabolic process; oxidoreductase activity
OG_07104,1.2155587748038457,FUN_032371-T1,Peve_00036465,Pocillopora_meandrina_HIv1___RNAseq.g24259.t1,three_way,67.01666666666667,FUN_032371-T1,Q04786,,,,,38.5,881.0,3.5e-156,553.9,sp|Q04786|HEX_VIBVL Beta-hexosaminidase OS=Vibrio vulnificus OX=672 GN=hex PE=3 SV=1,,,,,,
OG_07138,1.3712545321658756,FUN_032464-T1,Peve_00009180,Pocillopora_meandrina_HIv1___TS.g12111.t1,three_way,65.44783333333334,FUN_032464-T1,E1BB03,ZRAB3_BOVIN,,DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2) (AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3 (EC 3.6.4.-); Endonuclease ZRANB3 (EC 3.1.-.-)],Bos taurus (Bovine),45.5,521.0,7.4999999999999995e-115,416.0,sp|E1BB03|ZRAB3_BOVIN DNA annealing helicase and endonuclease ZRANB3 OS=Bos taurus OX=9913 GN=ZRANB3 PE=3 SV=3,GO:0004386; GO:0004520; GO:0005524; GO:0006281; GO:0006974; GO:0008270; GO:0009411; GO:0031297; GO:0036310; GO:0043596; GO:0070530,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; replication fork processing [GO:0031297]; response to UV [GO:0009411],nuclear replication fork [GO:0043596],ATP binding [GO:0005524]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; DNA endonuclease activity [GO:0004520]; helicase activity [GO:0004386]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; zinc ion binding [GO:0008270],GO:0003677; GO:0003824; GO:0006281; GO:0016853; GO:0140097; GO:0140657,"DNA binding; catalytic activity; DNA repair; isomerase activity; catalytic activity, acting on DNA; ATP-dependent activity"
OG_07144,1.5414671877960604,FUN_032474-T1,Peve_00036450,Pocillopora_meandrina_HIv1___RNAseq.g24244.t1,three_way,56.147333333333336,,,,,,,,,,,,,,,,,
OG_07165,1.3588006614629249,FUN_032583-T1,Peve_00026847,Pocillopora_meandrina_HIv1___RNAseq.g24648.t1,three_way,42.123333333333335,,,,,,,,,,,,,,,,,
OG_07177,1.103510796612308,FUN_032628-T1,Peve_00033703,Pocillopora_meandrina_HIv1___RNAseq.g29789.t1,three_way,82.41583333333334,FUN_032628-T1,Q9EQW7,KI13A_MOUSE,,Kinesin-like protein KIF13A,Mus musculus (Mouse),47.9,1454.0,0.0,1170.6,sp|Q9EQW7|KI13A_MOUSE Kinesin-like protein KIF13A OS=Mus musculus OX=10090 GN=Kif13a PE=1 SV=1,GO:0000139; GO:0003777; GO:0005524; GO:0005813; GO:0005874; GO:0006886; GO:0008017; GO:0008333; GO:0010008; GO:0030496; GO:0032438; GO:0032465; GO:0032588; GO:0035459; GO:0043001; GO:0051301; GO:0072383,cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; Golgi to plasma membrane protein transport [GO:0043001]; intracellular protein transport [GO:0006886]; melanosome organization [GO:0032438]; plus-end-directed vesicle transport along microtubule [GO:0072383]; regulation of cytokinesis [GO:0032465]; vesicle cargo loading [GO:0035459],centrosome [GO:0005813]; endosome membrane [GO:0010008]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; midbody [GO:0030496]; trans-Golgi network membrane [GO:0032588],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0005815; GO:0006886; GO:0007018; GO:0008092; GO:0016192; GO:0016853; GO:0072659; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule organizing center; intracellular protein transport; microtubule-based movement; cytoskeletal protein binding; vesicle-mediated transport; isomerase activity; protein localization to plasma membrane; ATP-dependent activity
OG_07179,1.2990964093826818,FUN_032632-T1,Peve_00033689,Pocillopora_meandrina_HIv1___RNAseq.g24117.t1,three_way,60.99433333333333,FUN_032632-T1,Q5ZIJ9,,,,,45.3,1029.0,1.5e-112,409.1,sp|Q5ZIJ9|MIB2_CHICK E3 ubiquitin-protein ligase MIB2 OS=Gallus gallus OX=9031 GN=MIB2 PE=2 SV=1,,,,,,
OG_07203,1.459465936601697,FUN_032738-T1,Peve_00029918,Pocillopora_meandrina_HIv1___RNAseq.g29876.t1,three_way,86.90433333333334,FUN_032738-T1,P49739,,,,,65.5,823.0,6e-285,981.5,sp|P49739|MCM3M_XENLA Maternal DNA replication licensing factor mcm3 OS=Xenopus laevis OX=8355 GN=mmcm3 PE=1 SV=2,,,,,,
OG_07215,1.0140129946739826,FUN_032774-T1,Peve_00010354,Pocillopora_meandrina_HIv1___RNAseq.g29728.t1,three_way,61.269333333333336,,,,,,,,,,,,,,,,,
OG_07222,1.1575603456032024,FUN_032815-T1,Peve_00014570,Pocillopora_meandrina_HIv1___RNAseq.g29707.t1,three_way,69.17233333333334,FUN_032815-T1,Q5HYM0,ZC12B_HUMAN,,Probable ribonuclease ZC3H12B (EC 3.1.-.-) (MCP-induced protein 2) (Zinc finger CCCH domain-containing protein 12B),Homo sapiens (Human),59.1,220.0,8.099999999999997e-69,263.1,sp|Q5HYM0|ZC12B_HUMAN Probable ribonuclease ZC3H12B OS=Homo sapiens OX=9606 GN=ZC3H12B PE=1 SV=3,GO:0003729; GO:0004521; GO:0005634; GO:0008270; GO:0036464,,cytoplasmic ribonucleoprotein granule [GO:0036464]; nucleus [GO:0005634],mRNA binding [GO:0003729]; RNA endonuclease activity [GO:0004521]; zinc ion binding [GO:0008270],GO:0003723; GO:0003824; GO:0005634; GO:0043226; GO:0140098,"RNA binding; catalytic activity; nucleus; organelle; catalytic activity, acting on RNA"
OG_07236,1.0742469276017317,FUN_032909-T1,Peve_00014534,Pocillopora_meandrina_HIv1___TS.g12926.t1,three_way,60.93333333333333,,,,,,,,,,,,,,,,,
OG_07241,1.2731371778528269,FUN_032971-T1,Peve_00017817,Pocillopora_meandrina_HIv1___RNAseq.g29687.t1,three_way,75.51633333333334,FUN_032971-T1,Q8IX29,,,,,52.3,214.0,1.3e-58,228.4,sp|Q8IX29|FBX16_HUMAN F-box only protein 16 OS=Homo sapiens OX=9606 GN=FBXO16 PE=1 SV=1,,,,,,
OG_07248,1.0884128322238054,FUN_032987-T2,Peve_00014549,Pocillopora_meandrina_HIv1___RNAseq.g24997.t1,three_way,40.58166666666667,,,,,,,,,,,,,,,,,
OG_07259,1.22842864354374,FUN_033036-T1,Peve_00017502,Pocillopora_meandrina_HIv1___RNAseq.g24450.t1,three_way,76.906,FUN_033036-T1,Q96QG7,,,,,53.2,329.0,2.6e-101,370.2,sp|Q96QG7|MTMR9_HUMAN Myotubularin-related protein 9 OS=Homo sapiens OX=9606 GN=MTMR9 PE=1 SV=1,,,,,,
OG_07266,1.240915313180203,FUN_033114-T1,Peve_00019518,Pocillopora_meandrina_HIv1___RNAseq.g24261.t1,three_way,54.964666666666666,FUN_033114-T1,Q1EG27,MYO3B_MOUSE,,Myosin-IIIb (EC 2.7.11.1),Mus musculus (Mouse),33.6,769.0,3.6e-116,421.4,sp|Q1EG27|MYO3B_MOUSE Myosin-IIIb OS=Mus musculus OX=10090 GN=Myo3b PE=1 SV=2,GO:0000146; GO:0001750; GO:0001917; GO:0003779; GO:0004674; GO:0005524; GO:0005829; GO:0007601; GO:0007605; GO:0016459; GO:0030832; GO:0032426; GO:0032433; GO:0051491; GO:0060088; GO:0090103; GO:0106310,auditory receptor cell stereocilium organization [GO:0060088]; cochlea morphogenesis [GO:0090103]; positive regulation of filopodium assembly [GO:0051491]; regulation of actin filament length [GO:0030832]; sensory perception of sound [GO:0007605]; visual perception [GO:0007601],cytosol [GO:0005829]; filopodium tip [GO:0032433]; myosin complex [GO:0016459]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]; stereocilium tip [GO:0032426],actin binding [GO:0003779]; ATP binding [GO:0005524]; microfilament motor activity [GO:0000146]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003774; GO:0003824; GO:0005829; GO:0008092; GO:0016740; GO:0016853; GO:0050877; GO:0140096; GO:0140657,"cytoskeletal motor activity; catalytic activity; cytosol; cytoskeletal protein binding; transferase activity; isomerase activity; nervous system process; catalytic activity, acting on a protein; ATP-dependent activity"
OG_07283,1.1630964600675286,FUN_033510-T1,Peve_00041772,Pocillopora_meandrina_HIv1___RNAseq.g24351.t1,three_way,50.45783333333333,FUN_033510-T1,G3V9H8,RET_RAT,,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],Rattus norvegicus (Rat),39.7,343.0,3.3e-68,261.5,sp|G3V9H8|RET_RAT Proto-oncogene tyrosine-protein kinase receptor Ret OS=Rattus norvegicus OX=10116 GN=Ret PE=1 SV=1,GO:0000165; GO:0001657; GO:0001755; GO:0001838; GO:0004714; GO:0005509; GO:0005524; GO:0005769; GO:0005886; GO:0007156; GO:0007158; GO:0007169; GO:0007399; GO:0009410; GO:0010008; GO:0010628; GO:0010976; GO:0014042; GO:0030155; GO:0030182; GO:0030335; GO:0030424; GO:0030425; GO:0033619; GO:0033630; GO:0035799; GO:0035860; GO:0042551; GO:0043025; GO:0043235; GO:0043410; GO:0045793; GO:0045893; GO:0048265; GO:0048484; GO:0050770; GO:0051897; GO:0060041; GO:0060384; GO:0061146; GO:0071300; GO:0072300; GO:0098797; GO:0160144,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to retinoic acid [GO:0071300]; embryonic epithelial tube formation [GO:0001838]; enteric nervous system development [GO:0048484]; GDF15-GFRAL signaling pathway [GO:0160144]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; innervation [GO:0060384]; MAPK cascade [GO:0000165]; membrane protein proteolysis [GO:0033619]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron cell-cell adhesion [GO:0007158]; neuron differentiation [GO:0030182]; neuron maturation [GO:0042551]; Peyer's patch morphogenesis [GO:0061146]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of cell size [GO:0045793]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of metanephric glomerulus development [GO:0072300]; positive regulation of neuron maturation [GO:0014042]; positive regulation of neuron projection development [GO:0010976]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of axonogenesis [GO:0050770]; regulation of cell adhesion [GO:0030155]; response to pain [GO:0048265]; response to xenobiotic stimulus [GO:0009410]; retina development in camera-type eye [GO:0060041]; ureter maturation [GO:0035799]; ureteric bud development [GO:0001657],axon [GO:0030424]; dendrite [GO:0030425]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; receptor complex [GO:0043235],ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; transmembrane receptor protein tyrosine kinase activity [GO:0004714],GO:0003824; GO:0005768; GO:0005886; GO:0006355; GO:0007155; GO:0016740; GO:0030154; GO:0031410; GO:0043226; GO:0048856; GO:0048870; GO:0060089; GO:0140096,"catalytic activity; endosome; plasma membrane; regulation of DNA-templated transcription; cell adhesion; transferase activity; cell differentiation; cytoplasmic vesicle; organelle; anatomical structure development; cell motility; molecular transducer activity; catalytic activity, acting on a protein"
OG_07315,1.1533488764231403,FUN_033707-T1,Peve_00042846,Pocillopora_meandrina_HIv1___TS.g18650.t1,three_way,55.01383333333333,FUN_033707-T1,Q6S5C2,GNPTG_MOUSE,,N-acetylglucosamine-1-phosphotransferase subunit gamma (GlcNAc-1-phosphotransferase subunit gamma) (M6PR domain-containing protein 1) (UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma),Mus musculus (Mouse),40.2,276.0,7.9e-49,196.1,sp|Q6S5C2|GNPTG_MOUSE N-acetylglucosamine-1-phosphotransferase subunit gamma OS=Mus musculus OX=10090 GN=Gnptg PE=1 SV=1,GO:0005576; GO:0005794; GO:0042803; GO:0046835,carbohydrate phosphorylation [GO:0046835],extracellular region [GO:0005576]; Golgi apparatus [GO:0005794],protein homodimerization activity [GO:0042803],GO:0005576; GO:0005794; GO:0005975; GO:0043226,extracellular region; Golgi apparatus; carbohydrate metabolic process; organelle
OG_07319,1.3032475294372847,FUN_033712-T1,Peve_00040124,Pocillopora_meandrina_HIv1___TS.g8618.t1,three_way,47.82833333333333,FUN_033712-T1,Q96QP1,ALPK1_HUMAN,,Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase),Homo sapiens (Human),34.7,404.0,4.399999999999997e-47,191.8,sp|Q96QP1|ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens OX=9606 GN=ALPK1 PE=1 SV=3,GO:0000922; GO:0002753; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0036064; GO:0043123; GO:0045087; GO:0048029; GO:0060271; GO:0106310,cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922],ATP binding [GO:0005524]; monosaccharide binding [GO:0048029]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0098542; GO:0140096,"immune system process; catalytic activity; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; defense response to other organism; catalytic activity, acting on a protein"
OG_07319,1.3032475294372847,FUN_033712-T1,Peve_00040124,Pocillopora_meandrina_HIv1___TS.g8618.t1,three_way,47.82833333333333,FUN_033712-T1,Q96QP1,ALPK1_HUMAN,,Alpha-protein kinase 1 (EC 2.7.11.1) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase),Homo sapiens (Human),36.6,243.0,1.1e-37,160.6,sp|Q96QP1|ALPK1_HUMAN Alpha-protein kinase 1 OS=Homo sapiens OX=9606 GN=ALPK1 PE=1 SV=3,GO:0000922; GO:0002753; GO:0004674; GO:0005524; GO:0005813; GO:0005829; GO:0005929; GO:0036064; GO:0043123; GO:0045087; GO:0048029; GO:0060271; GO:0106310,cilium assembly [GO:0060271]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; spindle pole [GO:0000922],ATP binding [GO:0005524]; monosaccharide binding [GO:0048029]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0002376; GO:0003824; GO:0005815; GO:0005829; GO:0005929; GO:0016740; GO:0043226; GO:0044782; GO:0098542; GO:0140096,"immune system process; catalytic activity; microtubule organizing center; cytosol; cilium; transferase activity; organelle; cilium organization; defense response to other organism; catalytic activity, acting on a protein"
OG_07349,1.605602784645495,FUN_033756-T1,Peve_00004915,Pocillopora_meandrina_HIv1___RNAseq.g28747.t1,three_way,85.5945,FUN_033756-T1,Q13136,LIPA1_HUMAN,,Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1),Homo sapiens (Human),45.4,1218.0,1.3e-187,658.7,sp|Q13136|LIPA1_HUMAN Liprin-alpha-1 OS=Homo sapiens OX=9606 GN=PPFIA1 PE=1 SV=1,GO:0005737; GO:0005829; GO:0005925; GO:0005938; GO:0007160; GO:0007165; GO:0030424; GO:0032991; GO:0043622; GO:0048786; GO:0050808; GO:0051497; GO:0097444; GO:0098685; GO:0099072; GO:1903077,cell-matrix adhesion [GO:0007160]; cortical microtubule organization [GO:0043622]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of stress fiber assembly [GO:0051497]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; signal transduction [GO:0007165]; synapse organization [GO:0050808],axon [GO:0030424]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; spine apparatus [GO:0097444],,GO:0005829; GO:0007010; GO:0007155; GO:0034330; GO:0043226,cytosol; cytoskeleton organization; cell adhesion; cell junction organization; organelle
OG_07359,1.561922010586621,FUN_033770-T1,Peve_00006489,Pocillopora_meandrina_HIv1___RNAseq.g26661.t1,three_way,47.22,FUN_033770-T1,P10733,,,,,27.9,204.0,1.2e-17,92.4,sp|P10733|SEVE_DICDI Severin OS=Dictyostelium discoideum OX=44689 GN=sevA PE=1 SV=1,,,,,,
OG_07420,1.2548883359066294,FUN_033882-T1,Peve_00043308,Pocillopora_meandrina_HIv1___RNAseq.g28395.t1,three_way,83.125,FUN_033882-T1,P08510,,,,,61.8,395.0,1.9e-120,434.5,sp|P08510|KCNAS_DROME Potassium voltage-gated channel protein Shaker OS=Drosophila melanogaster OX=7227 GN=Sh PE=1 SV=3,,,,,,
OG_07430,1.2596204714301162,FUN_033917-T1,Peve_00022631,Pocillopora_meandrina_HIv1___TS.g19347.t2a,three_way,44.82383333333333,,,,,,,,,,,,,,,,,
OG_07442,1.175852898655306,FUN_033934-T1,Peve_00020984,Pocillopora_meandrina_HIv1___RNAseq.g26581.t1,three_way,92.2815,FUN_033934-T1,Q9IB89,,,,,45.0,169.0,3.2000000000000005e-33,144.4,sp|Q9IB89|ZIC5_XENLA Zinc finger protein ZIC 5 OS=Xenopus laevis OX=8355 GN=zic5 PE=2 SV=1,,,,,,
OG_07464,1.043792632057019,FUN_033968-T1,Peve_00015220,Pocillopora_meandrina_HIv1___RNAseq.g28549.t1,three_way,90.424,FUN_033968-T1,Q9Y2H1,ST38L_HUMAN,,Serine/threonine-protein kinase 38-like (EC 2.7.11.1) (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2),Homo sapiens (Human),71.3,442.0,1.3e-188,660.6,sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens OX=9606 GN=STK38L PE=1 SV=3,GO:0000287; GO:0003779; GO:0004674; GO:0005524; GO:0005737; GO:0005829; GO:0006468; GO:0010507; GO:0015629; GO:0016020; GO:0035556; GO:0051128; GO:0106310,intracellular signal transduction [GO:0035556]; negative regulation of autophagy [GO:0010507]; protein phosphorylation [GO:0006468]; regulation of cellular component organization [GO:0051128],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],actin binding [GO:0003779]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005829; GO:0005856; GO:0008092; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; cytosol; cytoskeleton; cytoskeletal protein binding; transferase activity; organelle; catalytic activity, acting on a protein"
OG_07469,1.603570812596904,FUN_033979-T1,Peve_00004846,Pocillopora_meandrina_HIv1___RNAseq.g26111.t1,three_way,80.1855,FUN_033979-T1,O70247,,,,,40.7,570.0,5.3000000000000004e-111,403.3,sp|O70247|SC5A6_RAT Sodium-dependent multivitamin transporter OS=Rattus norvegicus OX=10116 GN=Slc5a6 PE=1 SV=1,,,,,,
OG_07483,1.285590036157273,FUN_034008-T1,Peve_00033154,Pocillopora_meandrina_HIv1___RNAseq.g26086.t1,three_way,63.45133333333334,FUN_034008-T1,P46023,,,,,46.7,347.0,3.7e-84,314.7,sp|P46023|GR101_LYMST G-protein coupled receptor GRL101 OS=Lymnaea stagnalis OX=6523 PE=2 SV=1,,,,,,
OG_07512,1.5225967782611831,FUN_034055-T1,Peve_00015322,Pocillopora_meandrina_HIv1___RNAseq.g26028.t2,three_way,81.44633333333333,FUN_034055-T1,O08873,MADD_RAT,,MAP kinase-activating death domain protein (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (RabGEP),Rattus norvegicus (Rat),38.5,1719.0,1.8e-285,984.2,sp|O08873|MADD_RAT MAP kinase-activating death domain protein OS=Rattus norvegicus OX=10116 GN=Madd PE=1 SV=1,GO:0005085; GO:0005829; GO:0005886; GO:0008021; GO:0016020; GO:0032483; GO:0042981; GO:0043410; GO:0045202; GO:0048490; GO:0051726; GO:0060125; GO:0097194; GO:1902041; GO:1902277; GO:1904115; GO:2001234; GO:2001236,anterograde synaptic vesicle transport [GO:0048490]; execution phase of apoptosis [GO:0097194]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of pancreatic amylase secretion [GO:1902277]; positive regulation of MAPK cascade [GO:0043410]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of extrinsic apoptotic signaling pathway [GO:2001236]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of Rab protein signal transduction [GO:0032483],axon cytoplasm [GO:1904115]; cytosol [GO:0005829]; membrane [GO:0016020]; plasma membrane [GO:0005886]; synapse [GO:0045202]; synaptic vesicle [GO:0008021],guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0007018; GO:0031410; GO:0043226; GO:0098772,cytosol; plasma membrane; microtubule-based movement; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_07520,1.012174969359723,FUN_034090-T1,Peve_00037070,Pocillopora_meandrina_HIv1___RNAseq.g26061.t1,three_way,75.31133333333334,FUN_034090-T1,Q9I9H8,,,,,36.6,1258.0,6.2000000000000005e-146,520.4,sp|Q9I9H8|APAF_DANRE Apoptotic protease-activating factor 1 OS=Danio rerio OX=7955 GN=apaf1 PE=2 SV=1,,,,,,
OG_07542,1.0474331512855282,FUN_034123-T1,Peve_00039584,Pocillopora_meandrina_HIv1___TS.g18693.t1,three_way,50.32483333333333,FUN_034123-T1,Q9NSA2,KCND1_HUMAN,,A-type voltage-gated potassium channel KCND1 (Potassium voltage-gated channel subfamily D member 1) (Shal-type potassium channel KCND1) (Voltage-gated potassium channel subunit Kv4.1),Homo sapiens (Human),44.4,376.0,1.7e-73,279.3,sp|Q9NSA2|KCND1_HUMAN A-type voltage-gated potassium channel KCND1 OS=Homo sapiens OX=9606 GN=KCND1 PE=1 SV=2,GO:0001508; GO:0005250; GO:0005886; GO:0008076; GO:0043025; GO:0043197; GO:0045211; GO:0046872; GO:0051260; GO:0071805,action potential [GO:0001508]; potassium ion transmembrane transport [GO:0071805]; protein homooligomerization [GO:0051260],dendritic spine [GO:0043197]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; voltage-gated potassium channel complex [GO:0008076],A-type (transient outward) potassium channel activity [GO:0005250]; metal ion binding [GO:0046872],GO:0005215; GO:0005886; GO:0055085; GO:0065003,transporter activity; plasma membrane; transmembrane transport; protein-containing complex assembly
OG_07548,1.3919897458534158,FUN_034130-T1,Peve_00006386,Pocillopora_meandrina_HIv1___RNAseq.g26664.t1,three_way,57.29133333333333,,,,,,,,,,,,,,,,,
OG_07553,1.3013382110267309,FUN_034144-T1,Peve_00018769,Pocillopora_meandrina_HIv1___RNAseq.g26305.t1,three_way,57.939,FUN_034144-T1,Q9UPZ3,HPS5_HUMAN,,BLOC-2 complex member HPS5 (Alpha-integrin-binding protein 63) (Hermansky-Pudlak syndrome 5 protein) (Ruby-eye protein 2 homolog) (Ru2),Homo sapiens (Human),32.0,425.0,2.9e-54,216.1,sp|Q9UPZ3|HPS5_HUMAN BLOC-2 complex member HPS5 OS=Homo sapiens OX=9606 GN=HPS5 PE=1 SV=2,GO:0005737; GO:0005769; GO:0005829; GO:0007596; GO:0031084; GO:0046907; GO:0048066; GO:0060155; GO:1903232,blood coagulation [GO:0007596]; developmental pigmentation [GO:0048066]; intracellular transport [GO:0046907]; melanosome assembly [GO:1903232]; platelet dense granule organization [GO:0060155],BLOC-2 complex [GO:0031084]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769],,GO:0005768; GO:0005829; GO:0031410; GO:0043226,endosome; cytosol; cytoplasmic vesicle; organelle
OG_07554,3.1534692990130497,FUN_034149-T1,Peve_00026010,Pocillopora_meandrina_HIv1___TS.g23718.t1b,three_way,50.663833333333336,,,,,,,,,,,,,,,,,
OG_07567,1.772329434367376,FUN_034229-T1,Peve_00040765,Pocillopora_meandrina_HIv1___RNAseq.g28437.t1,three_way,83.228,FUN_034229-T1,Q8IWQ3,BRSK2_HUMAN,,Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A),Homo sapiens (Human),50.3,650.0,3.4999999999999997e-169,596.7,sp|Q8IWQ3|BRSK2_HUMAN Serine/threonine-protein kinase BRSK2 OS=Homo sapiens OX=9606 GN=BRSK2 PE=1 SV=3,GO:0000086; GO:0000287; GO:0004674; GO:0005524; GO:0005737; GO:0005783; GO:0005813; GO:0006468; GO:0006887; GO:0007409; GO:0010975; GO:0019901; GO:0021953; GO:0030010; GO:0030036; GO:0030182; GO:0036503; GO:0043462; GO:0048156; GO:0048471; GO:0050321; GO:0050770; GO:0051117; GO:0051301; GO:0060590; GO:0061178; GO:0070059; GO:0090176; GO:0106310; GO:0150034; GO:1904152; GO:2000807,"actin cytoskeleton organization [GO:0030036]; axonogenesis [GO:0007409]; cell division [GO:0051301]; central nervous system neuron differentiation [GO:0021953]; ERAD pathway [GO:0036503]; establishment of cell polarity [GO:0030010]; exocytosis [GO:0006887]; G2/M transition of mitotic cell cycle [GO:0000086]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; neuron differentiation [GO:0030182]; protein phosphorylation [GO:0006468]; regulation of ATP-dependent activity [GO:0043462]; regulation of axonogenesis [GO:0050770]; regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0061178]; regulation of neuron projection development [GO:0010975]; regulation of retrograde protein transport, ER to cytosol [GO:1904152]; regulation of synaptic vesicle clustering [GO:2000807]",centrosome [GO:0005813]; cytoplasm [GO:0005737]; distal axon [GO:0150034]; endoplasmic reticulum [GO:0005783]; perinuclear region of cytoplasm [GO:0048471],ATP binding [GO:0005524]; ATPase binding [GO:0051117]; ATPase regulator activity [GO:0060590]; magnesium ion binding [GO:0000287]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321],GO:0003824; GO:0005783; GO:0005815; GO:0007010; GO:0007163; GO:0008092; GO:0016192; GO:0016740; GO:0030154; GO:0030163; GO:0043226; GO:0098772; GO:0140096,"catalytic activity; endoplasmic reticulum; microtubule organizing center; cytoskeleton organization; establishment or maintenance of cell polarity; cytoskeletal protein binding; vesicle-mediated transport; transferase activity; cell differentiation; protein catabolic process; organelle; molecular function regulator activity; catalytic activity, acting on a protein"
OG_07596,1.808941208607032,FUN_034303-T1,Peve_00019148,Pocillopora_meandrina_HIv1___RNAseq.g28500.t1,three_way,76.81366666666666,FUN_034303-T1,Q15256,,,,,35.3,544.0,8.4e-69,263.1,sp|Q15256|PTPRR_HUMAN Receptor-type tyrosine-protein phosphatase R OS=Homo sapiens OX=9606 GN=PTPRR PE=1 SV=2,,,,,,
OG_07605,1.16142550510732,FUN_034322-T1,Peve_00015003,Pocillopora_meandrina_HIv1___RNAseq.g28482.t1,three_way,81.48233333333333,FUN_034322-T1,Q14008,,,,,45.2,2083.0,0.0,1544.3,sp|Q14008|CKAP5_HUMAN Cytoskeleton-associated protein 5 OS=Homo sapiens OX=9606 GN=CKAP5 PE=1 SV=3,,,,,,
OG_07619,1.2411477797923565,FUN_034359-T1,Peve_00026451,Pocillopora_meandrina_HIv1___RNAseq.g26125.t2,three_way,53.81183333333333,FUN_034359-T1,Q7Z6G8,ANS1B_HUMAN,,Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1),Homo sapiens (Human),37.4,417.0,4.7e-65,251.9,sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2,GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013,ephrin receptor signaling pathway [GO:0048013],Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ephrin receptor binding [GO:0046875],GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0043226,nucleoplasm; microtubule organizing center; cytosol; plasma membrane; organelle
OG_07619,1.2411477797923565,FUN_034359-T1,Peve_00026451,Pocillopora_meandrina_HIv1___RNAseq.g26125.t2,three_way,53.81183333333333,FUN_034359-T1,Q7Z6G8,ANS1B_HUMAN,,Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1),Homo sapiens (Human),56.3,158.0,7.6e-15,85.1,sp|Q7Z6G8|ANS1B_HUMAN Ankyrin repeat and sterile alpha motif domain-containing protein 1B OS=Homo sapiens OX=9606 GN=ANKS1B PE=1 SV=2,GO:0005654; GO:0005813; GO:0005829; GO:0005886; GO:0014069; GO:0015030; GO:0043197; GO:0046875; GO:0048013,ephrin receptor signaling pathway [GO:0048013],Cajal body [GO:0015030]; centrosome [GO:0005813]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],ephrin receptor binding [GO:0046875],GO:0005654; GO:0005815; GO:0005829; GO:0005886; GO:0043226,nucleoplasm; microtubule organizing center; cytosol; plasma membrane; organelle
OG_07629,1.1799144588601609,FUN_034379-T1,Peve_00027166,Pocillopora_meandrina_HIv1___RNAseq.g26152.t1,three_way,68.00166666666667,FUN_034379-T1,Q86TZ1,,,,,49.0,206.0,4.2e-56,222.6,sp|Q86TZ1|TTC6_HUMAN Tetratricopeptide repeat protein 6 OS=Homo sapiens OX=9606 GN=TTC6 PE=1 SV=1,,,,,,
OG_07652,1.0344280914629838,FUN_034486-T1,Peve_00043236,Pocillopora_meandrina_HIv1___RNAseq.g28569.t1,three_way,78.29433333333334,FUN_034486-T1,Q13613,,,,,45.0,387.0,6.2e-98,360.5,sp|Q13613|MTMR1_HUMAN Phosphatidylinositol-3-phosphate phosphatase MTMR1 OS=Homo sapiens OX=9606 GN=MTMR1 PE=1 SV=4,,,,,,
OG_07679,1.0154292345917806,FUN_034797-T1,Peve_00007517,Pocillopora_meandrina_HIv1___RNAseq.g12297.t1,three_way,79.21333333333334,FUN_034797-T1,D3ZDI6,MYLIP_RAT,,E3 ubiquitin-protein ligase MYLIP (EC 2.3.2.27) (Inducible degrader of the LDL-receptor) (Idol) (Myosin regulatory light chain interacting protein) (MIR) (RING-type E3 ubiquitin transferase MYLIP),Rattus norvegicus (Rat),43.0,440.0,5.1e-96,353.2,sp|D3ZDI6|MYLIP_RAT E3 ubiquitin-protein ligase MYLIP OS=Rattus norvegicus OX=10116 GN=Mylip PE=2 SV=1,GO:0004842; GO:0005737; GO:0005856; GO:0005886; GO:0006511; GO:0007399; GO:0008092; GO:0008270; GO:0010977; GO:0010989; GO:0016567; GO:0031648; GO:0032803; GO:0042632; GO:0045732; GO:0061630,cholesterol homeostasis [GO:0042632]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of neuron projection development [GO:0010977]; nervous system development [GO:0007399]; positive regulation of protein catabolic process [GO:0045732]; protein destabilization [GO:0031648]; protein ubiquitination [GO:0016567]; regulation of low-density lipoprotein particle receptor catabolic process [GO:0032803]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; plasma membrane [GO:0005886],cytoskeletal protein binding [GO:0008092]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],GO:0003824; GO:0005856; GO:0005886; GO:0008092; GO:0016740; GO:0043226; GO:0048856; GO:0140096,"catalytic activity; cytoskeleton; plasma membrane; cytoskeletal protein binding; transferase activity; organelle; anatomical structure development; catalytic activity, acting on a protein"
OG_07714,1.151088334601169,FUN_034867-T1,Peve_00005778,Pocillopora_meandrina_HIv1___RNAseq.g27146.t1,three_way,75.34383333333334,FUN_034867-T1,Q28193,FURIN_BOVIN,,Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE) (Trans Golgi network protease furin),Bos taurus (Bovine),49.8,616.0,5.7e-165,582.8,sp|Q28193|FURIN_BOVIN Furin OS=Bos taurus OX=9913 GN=FURIN PE=1 SV=1,GO:0000139; GO:0004252; GO:0005576; GO:0005802; GO:0005886; GO:0008201; GO:0010008; GO:0016486; GO:0046872; GO:0140447; GO:1904399,cytokine precursor processing [GO:0140447]; peptide hormone processing [GO:0016486],endosome membrane [GO:0010008]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252],GO:0003824; GO:0005576; GO:0005886; GO:0016787; GO:0051604; GO:0140096,"catalytic activity; extracellular region; plasma membrane; hydrolase activity; protein maturation; catalytic activity, acting on a protein"
OG_07736,1.1796458386354485,FUN_034913-T1,Peve_00039132,Pocillopora_meandrina_HIv1___RNAseq.g12143.t1,three_way,89.33033333333333,FUN_034913-T1,Q21305,SOX2_CAEEL,,Transcription factor sox-2,Caenorhabditis elegans,71.1,90.0,2.6000000000000002e-30,134.0,sp|Q21305|SOX2_CAEEL Transcription factor sox-2 OS=Caenorhabditis elegans OX=6239 GN=sox-2 PE=1 SV=2,GO:0000122; GO:0000977; GO:0000978; GO:0001228; GO:0005634; GO:0007420; GO:0030182; GO:0036498; GO:0045944; GO:0048665,brain development [GO:0007420]; IRE1-mediated unfolded protein response [GO:0036498]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; neuron fate specification [GO:0048665]; positive regulation of transcription by RNA polymerase II [GO:0045944],nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]",GO:0003677; GO:0005634; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0140110,DNA binding; nucleus; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; transcription regulator activity
OG_07762,1.0022532724742466,FUN_034956-T1,Peve_00036680,Pocillopora_meandrina_HIv1___RNAseq.g27836.t1,three_way,74.127,FUN_034956-T1,P39949,CCNE1_RAT,,G1/S-specific cyclin-E1,Rattus norvegicus (Rat),51.8,311.0,1.5e-85,318.2,sp|P39949|CCNE1_RAT G1/S-specific cyclin-E1 OS=Rattus norvegicus OX=10116 GN=Ccne1 PE=1 SV=2,GO:0000082; GO:0000122; GO:0000307; GO:0000723; GO:0001547; GO:0001889; GO:0005634; GO:0005737; GO:0005813; GO:0005815; GO:0006270; GO:0007129; GO:0009410; GO:0014074; GO:0016055; GO:0016301; GO:0016538; GO:0019901; GO:0031100; GO:0031670; GO:0032355; GO:0032570; GO:0032880; GO:0033197; GO:0034097; GO:0044877; GO:0045471; GO:0045597; GO:0048545; GO:0051301; GO:0051412; GO:0051597; GO:0051726; GO:0070192; GO:0097134; GO:1900087; GO:1902462,animal organ regeneration [GO:0031100]; antral ovarian follicle growth [GO:0001547]; cell division [GO:0051301]; cellular response to nutrient [GO:0031670]; chromosome organization involved in meiotic cell cycle [GO:0070192]; DNA replication initiation [GO:0006270]; G1/S transition of mitotic cell cycle [GO:0000082]; homologous chromosome pairing at meiosis [GO:0007129]; liver development [GO:0001889]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell differentiation [GO:0045597]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; response to corticosterone [GO:0051412]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to methylmercury [GO:0051597]; response to progesterone [GO:0032570]; response to purine-containing compound [GO:0014074]; response to steroid hormone [GO:0048545]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; telomere maintenance [GO:0000723]; Wnt signaling pathway [GO:0016055],centrosome [GO:0005813]; cyclin E1-CDK2 complex [GO:0097134]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nucleus [GO:0005634],cyclin-dependent protein serine/threonine kinase regulator activity [GO:0016538]; kinase activity [GO:0016301]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877],GO:0003824; GO:0005634; GO:0005815; GO:0006355; GO:0016740; GO:0022414; GO:0032200; GO:0043226; GO:0048856; GO:0098772,catalytic activity; nucleus; microtubule organizing center; regulation of DNA-templated transcription; transferase activity; reproductive process; telomere organization; organelle; anatomical structure development; molecular function regulator activity
OG_07828,1.83699363049782,FUN_035130-T3,Peve_00005902,Pocillopora_meandrina_HIv1___TS.g14990.t1,three_way,58.65316666666666,FUN_035130-T3,Q8TEP8,,,,,32.3,871.0,3.2e-116,422.5,sp|Q8TEP8|CE192_HUMAN Centrosomal protein of 192 kDa OS=Homo sapiens OX=9606 GN=CEP192 PE=1 SV=3,,,,,,
OG_07870,1.1613509695146385,FUN_035228-T1,Peve_00026317,Pocillopora_meandrina_HIv1___RNAseq.g27602.t1,three_way,56.61966666666667,FUN_035228-T1,Q2YDQ5,,,,,52.0,50.0,1.1e-07,59.7,sp|Q2YDQ5|FBXL5_DANRE F-box/LRR-repeat protein 5 OS=Danio rerio OX=7955 GN=fbxl5 PE=2 SV=2,,,,,,
OG_07898,1.532954914790103,FUN_035279-T1,Peve_00001128,Pocillopora_meandrina_HIv1___RNAseq.g10444.t1,three_way,76.0005,FUN_035279-T1,Q9Z2W0,,,,,60.3,441.0,8.4e-151,535.0,sp|Q9Z2W0|DNPEP_MOUSE Aspartyl aminopeptidase OS=Mus musculus OX=10090 GN=Dnpep PE=1 SV=2,,,,,,
OG_07904,1.2104718480684518,FUN_035341-T1,Peve_00029661,Pocillopora_meandrina_HIv1___TS.g3597.t1,three_way,81.158,FUN_035341-T1,Q3URV1,BROMI_MOUSE,,Protein broad-minded (TBC1 domain family member 32),Mus musculus (Mouse),41.3,269.0,9.2e-49,195.3,sp|Q3URV1|BROMI_MOUSE Protein broad-minded OS=Mus musculus OX=10090 GN=Tbc1d32 PE=1 SV=2,GO:0001822; GO:0002088; GO:0003406; GO:0005737; GO:0005929; GO:0007224; GO:0007368; GO:0007507; GO:0021532; GO:0021915; GO:0035082; GO:0042733; GO:0043010; GO:0060021; GO:0060041; GO:0060271; GO:0060831; GO:0061512; GO:1905515,axoneme assembly [GO:0035082]; camera-type eye development [GO:0043010]; cilium assembly [GO:0060271]; determination of left/right symmetry [GO:0007368]; embryonic digit morphogenesis [GO:0042733]; heart development [GO:0007507]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; neural tube development [GO:0021915]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; protein localization to cilium [GO:0061512]; retina development in camera-type eye [GO:0060041]; retinal pigment epithelium development [GO:0003406]; roof of mouth development [GO:0060021]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in dorsal/ventral neural tube patterning [GO:0060831],cilium [GO:0005929]; cytoplasm [GO:0005737],,GO:0005929; GO:0007010; GO:0043226; GO:0044782; GO:0048856,cilium; cytoskeleton organization; organelle; cilium organization; anatomical structure development
OG_07956,1.5864961659202126,FUN_035500-T1,Peve_00033958,Pocillopora_meandrina_HIv1___RNAseq.g26993.t1,three_way,59.97516666666667,FUN_035500-T1,Q5R2J4,,,,,34.4,430.0,2.7999999999999997e-68,261.2,sp|Q5R2J4|APCD1_PELSI Protein APCDD1 OS=Pelodiscus sinensis OX=13735 GN=APCDD1 PE=2 SV=1,,,,,,
OG_07977,1.1363104864464222,FUN_035598-T2,Peve_00027482,Pocillopora_meandrina_HIv1___TS.g15377.t1,three_way,86.6325,FUN_035598-T2,Q92620,PRP16_HUMAN,,Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38),Homo sapiens (Human),76.7,951.0,0.0,1411.7,sp|Q92620|PRP16_HUMAN Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 OS=Homo sapiens OX=9606 GN=DHX38 PE=1 SV=2,GO:0000398; GO:0003723; GO:0003724; GO:0005524; GO:0005634; GO:0005654; GO:0005681; GO:0016020; GO:0016887; GO:0034458; GO:0071013,"mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681],3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],GO:0003723; GO:0003824; GO:0005634; GO:0005654; GO:0016071; GO:0016787; GO:0016853; GO:0043226; GO:0140098; GO:0140657,"RNA binding; catalytic activity; nucleus; nucleoplasm; mRNA metabolic process; hydrolase activity; isomerase activity; organelle; catalytic activity, acting on RNA; ATP-dependent activity"
OG_07996,1.2215754939108268,FUN_035637-T1,Peve_00029721,Pocillopora_meandrina_HIv1___RNAseq.g28085.t1,three_way,59.298,,,,,,,,,,,,,,,,,
OG_08045,1.282251361158932,FUN_035724-T1,Peve_00044102,Pocillopora_meandrina_HIv1___RNAseq.g2697.t1,three_way,72.28183333333334,,,,,,,,,,,,,,,,,
OG_08079,1.1097024484482,FUN_035803-T1,Peve_00017711,Pocillopora_meandrina_HIv1___TS.g3258.t1,three_way,42.588,,,,,,,,,,,,,,,,,
OG_08083,2.3465161753585737,FUN_035810-T1,Peve_00037792,Pocillopora_meandrina_HIv1___RNAseq.g11929.t1,three_way,63.96066666666667,FUN_035810-T1,O15943,CADN_DROME,,Neural-cadherin (Cadherin-N) (dN-cadherin),Drosophila melanogaster (Fruit fly),31.2,2035.0,2.2e-241,838.2,sp|O15943|CADN_DROME Neural-cadherin OS=Drosophila melanogaster OX=7227 GN=CadN PE=1 SV=2,GO:0005509; GO:0005886; GO:0005911; GO:0007156; GO:0007411; GO:0007412; GO:0007413; GO:0016020; GO:0016318; GO:0016339; GO:0030424; GO:0030425; GO:0031290; GO:0042803; GO:0044331; GO:0045296; GO:0045463; GO:0045467; GO:0048675; GO:0048814; GO:0048841; GO:0048846; GO:0050774; GO:0098609,axon extension [GO:0048675]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axon target recognition [GO:0007412]; axonal fasciculation [GO:0007413]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of dendrite morphogenesis [GO:0050774]; ommatidial rotation [GO:0016318]; R7 cell development [GO:0045467]; R8 cell development [GO:0045463]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of dendrite morphogenesis [GO:0048814]; retinal ganglion cell axon guidance [GO:0031290],axon [GO:0030424]; cell-cell junction [GO:0005911]; dendrite [GO:0030425]; membrane [GO:0016020]; plasma membrane [GO:0005886],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803],GO:0005886; GO:0007155; GO:0048856,plasma membrane; cell adhesion; anatomical structure development
OG_08090,1.667029211355737,FUN_035822-T1,Peve_00037801,Pocillopora_meandrina_HIv1___RNAseq.g11932.t1,three_way,75.45,FUN_035822-T1,Q6PJI9,WDR59_HUMAN,,GATOR2 complex protein WDR59 (WD repeat-containing protein 59),Homo sapiens (Human),39.0,885.0,8.999999999999999e-151,535.8,sp|Q6PJI9|WDR59_HUMAN GATOR2 complex protein WDR59 OS=Homo sapiens OX=9606 GN=WDR59 PE=1 SV=2,GO:0005765; GO:0005774; GO:0005829; GO:0008270; GO:0031669; GO:0034198; GO:0035591; GO:0035859; GO:0043231; GO:0061700; GO:1904262; GO:1904263,cellular response to amino acid starvation [GO:0034198]; cellular response to nutrient levels [GO:0031669]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of TORC1 signaling [GO:1904263],cytosol [GO:0005829]; GATOR2 complex [GO:0061700]; intracellular membrane-bounded organelle [GO:0043231]; lysosomal membrane [GO:0005765]; Seh1-associated complex [GO:0035859]; vacuolar membrane [GO:0005774],signaling adaptor activity [GO:0035591]; zinc ion binding [GO:0008270],GO:0005829; GO:0043226; GO:0060090,cytosol; organelle; molecular adaptor activity
OG_08091,1.25471662704883,FUN_035824-T1,Peve_00037802,Pocillopora_meandrina_HIv1___RNAseq.g11933.t1,three_way,90.67833333333334,FUN_035824-T1,P08239,,,,,72.6,354.0,3e-148,526.2,sp|P08239|GNAO_BOVIN Guanine nucleotide-binding protein G(o) subunit alpha OS=Bos taurus OX=9913 GN=GNAO1 PE=1 SV=4,,,,,,
OG_08148,1.2568658433039042,FUN_035917-T1,Peve_00006725,Pocillopora_meandrina_HIv1___TS.g3382.t1,three_way,58.83166666666667,FUN_035917-T1,Q3ZBF3,,,,,41.2,245.0,2.2e-49,197.6,sp|Q3ZBF3|RM38_BOVIN Large ribosomal subunit protein mL38 OS=Bos taurus OX=9913 GN=MRPL38 PE=1 SV=2,,,,,,
OG_08170,1.0768693487157914,FUN_035976-T1,Peve_00006611,Pocillopora_meandrina_HIv1___RNAseq.g12335.t1,three_way,78.89066666666666,FUN_035976-T1,Q8BVR6,,,,,56.2,489.0,3e-152,540.0,sp|Q8BVR6|RSPRY_MOUSE RING finger and SPRY domain-containing protein 1 OS=Mus musculus OX=10090 GN=Rspry1 PE=1 SV=1,,,,,,
OG_08216,1.8157282687668257,FUN_036074-T3,Peve_00018966,Pocillopora_meandrina_HIv1___RNAseq.g27412.t1,three_way,78.726,FUN_036074-T3,Q8CG73,FTM_MOUSE,,Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein),Mus musculus (Mouse),37.4,1341.0,1.0999999999999998e-198,695.7,sp|Q8CG73|FTM_MOUSE Protein fantom OS=Mus musculus OX=10090 GN=Rpgrip1l PE=1 SV=2,GO:0001701; GO:0001736; GO:0001822; GO:0001889; GO:0005737; GO:0005813; GO:0005829; GO:0005886; GO:0005911; GO:0005923; GO:0005929; GO:0005930; GO:0007163; GO:0007368; GO:0007420; GO:0008589; GO:0016607; GO:0021532; GO:0021537; GO:0021549; GO:0021670; GO:0021772; GO:0022038; GO:0031870; GO:0035108; GO:0035115; GO:0035116; GO:0035869; GO:0036064; GO:0043010; GO:0043584; GO:0045744; GO:0060039; GO:0060271; GO:0060322; GO:0090102; GO:1905515,brain development [GO:0007420]; camera-type eye development [GO:0043010]; cerebellum development [GO:0021549]; cilium assembly [GO:0060271]; cochlea development [GO:0090102]; corpus callosum development [GO:0022038]; determination of left/right symmetry [GO:0007368]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of planar polarity [GO:0001736]; establishment or maintenance of cell polarity [GO:0007163]; head development [GO:0060322]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lateral ventricle development [GO:0021670]; limb morphogenesis [GO:0035108]; liver development [GO:0001889]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neural tube patterning [GO:0021532]; non-motile cilium assembly [GO:1905515]; nose development [GO:0043584]; olfactory bulb development [GO:0021772]; pericardium development [GO:0060039]; regulation of smoothened signaling pathway [GO:0008589]; telencephalon development [GO:0021537],axoneme [GO:0005930]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cilium [GO:0005929]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886],thromboxane A2 receptor binding [GO:0031870],GO:0005815; GO:0005829; GO:0005886; GO:0005929; GO:0007163; GO:0043226; GO:0044782; GO:0048856,microtubule organizing center; cytosol; plasma membrane; cilium; establishment or maintenance of cell polarity; organelle; cilium organization; anatomical structure development
OG_08226,1.5966254239300504,FUN_036097-T2,Peve_00032194,Pocillopora_meandrina_HIv1___RNAseq.g27437.t1,three_way,61.02516666666666,FUN_036097-T2,Q801E2,ANLN_XENLA,,Anillin,Xenopus laevis (African clawed frog),34.7,432.0,4.6e-56,221.5,sp|Q801E2|ANLN_XENLA Anillin OS=Xenopus laevis OX=8355 GN=anln PE=1 SV=1,GO:0000281; GO:0000915; GO:0003779; GO:0005634; GO:0005826; GO:0005938; GO:0031106; GO:0032059; GO:1904172,actomyosin contractile ring assembly [GO:0000915]; mitotic cytokinesis [GO:0000281]; positive regulation of bleb assembly [GO:1904172]; septin ring organization [GO:0031106],actomyosin contractile ring [GO:0005826]; bleb [GO:0032059]; cell cortex [GO:0005938]; nucleus [GO:0005634],actin binding [GO:0003779],GO:0000910; GO:0005634; GO:0007010; GO:0008092; GO:0043226,cytokinesis; nucleus; cytoskeleton organization; cytoskeletal protein binding; organelle
OG_08227,1.3578469575520844,FUN_036099-T1,Peve_00032195,Pocillopora_meandrina_HIv1___RNAseq.g27436.t1,three_way,72.92099999999999,FUN_036099-T1,Q66JZ4,,,,,33.3,475.0,4.2000000000000004e-60,233.8,"sp|Q66JZ4|TCAIM_MOUSE T-cell activation inhibitor, mitochondrial OS=Mus musculus OX=10090 GN=TCAIM PE=1 SV=1",,,,,,
OG_08231,1.33585124597139,FUN_036106-T1,Peve_00003695,Pocillopora_meandrina_HIv1___RNAseq.g27429.t1,three_way,71.5815,FUN_036106-T1,Q68D86,C102B_HUMAN,,Coiled-coil domain-containing protein 102B,Homo sapiens (Human),37.2,390.0,5.6e-42,173.7,sp|Q68D86|C102B_HUMAN Coiled-coil domain-containing protein 102B OS=Homo sapiens OX=9606 GN=CCDC102B PE=1 SV=4,GO:0005737; GO:0005814; GO:0010457; GO:0120283,centriole-centriole cohesion [GO:0010457],centriole [GO:0005814]; cytoplasm [GO:0005737],protein serine/threonine kinase binding [GO:0120283],GO:0043226,organelle
OG_08237,1.5251149430226854,FUN_036116-T1,Peve_00000283,Pocillopora_meandrina_HIv1___RNAseq.g27423.t1,three_way,63.0515,FUN_036116-T1,O34313,NTPES_BACSU,,"Trifunctional nucleotide phosphoesterase protein YfkN [Includes: 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-nucleotidase (EC 3.1.3.6) (EC 3.1.4.16); 5'-nucleotidase (EC 3.1.3.5)]",Bacillus subtilis (strain 168),27.1,510.0,4.6e-36,154.8,sp|O34313|NTPES_BACSU Trifunctional nucleotide phosphoesterase protein YfkN OS=Bacillus subtilis (strain 168) OX=224308 GN=yfkN PE=1 SV=1,GO:0000166; GO:0005576; GO:0008253; GO:0008254; GO:0008663; GO:0009166; GO:0030288; GO:0046872,nucleotide catabolic process [GO:0009166],extracellular region [GO:0005576]; outer membrane-bounded periplasmic space [GO:0030288],"2',3'-cyclic-nucleotide 2'-phosphodiesterase activity [GO:0008663]; 3'-nucleotidase activity [GO:0008254]; 5'-nucleotidase activity [GO:0008253]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]",GO:0003824; GO:0005576; GO:0016787; GO:0055086,catalytic activity; extracellular region; hydrolase activity; nucleobase-containing small molecule metabolic process
OG_08277,1.010498736948534,FUN_036195-T1,Peve_00011109,Pocillopora_meandrina_HIv1___RNAseq.g27367.t1,three_way,72.57383333333334,FUN_036195-T1,Q3UMR0,ANR27_MOUSE,,Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein) (VPS9-ankyrin-repeat protein),Mus musculus (Mouse),42.3,787.0,1.5999999999999999e-96,355.9,sp|Q3UMR0|ANR27_MOUSE Ankyrin repeat domain-containing protein 27 OS=Mus musculus OX=10090 GN=Ankrd27 PE=1 SV=2,GO:0000149; GO:0005085; GO:0005096; GO:0005764; GO:0005769; GO:0005770; GO:0005829; GO:0005886; GO:0010976; GO:0015031; GO:0030133; GO:0030659; GO:0031267; GO:0032456; GO:0035544; GO:0035646; GO:0042470; GO:0043005; GO:0045022; GO:0048812; GO:0050775; GO:0097422,early endosome to late endosome transport [GO:0045022]; endocytic recycling [GO:0032456]; endosome to melanosome transport [GO:0035646]; negative regulation of SNARE complex assembly [GO:0035544]; neuron projection morphogenesis [GO:0048812]; positive regulation of dendrite morphogenesis [GO:0050775]; positive regulation of neuron projection development [GO:0010976]; protein transport [GO:0015031],cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; early endosome [GO:0005769]; late endosome [GO:0005770]; lysosome [GO:0005764]; melanosome [GO:0042470]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]; tubular endosome [GO:0097422],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149],GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0005886; GO:0016192; GO:0031410; GO:0043226; GO:0098772,lysosome; endosome; vacuole; cytosol; plasma membrane; vesicle-mediated transport; cytoplasmic vesicle; organelle; molecular function regulator activity
OG_08305,1.422943454964707,FUN_036260-T1,Peve_00012320,Pocillopora_meandrina_HIv1___RNAseq.g27582.t1,three_way,82.303,FUN_036260-T1,Q8WXH2,JPH3_HUMAN,,Junctophilin-3 (JP-3) (Junctophilin type 3) (Trinucleotide repeat-containing gene 22 protein),Homo sapiens (Human),66.7,57.0,9.9e-20,99.4,sp|Q8WXH2|JPH3_HUMAN Junctophilin-3 OS=Homo sapiens OX=9606 GN=JPH3 PE=1 SV=2,GO:0005789; GO:0005886; GO:0007612; GO:0007613; GO:0010880; GO:0010882; GO:0014701; GO:0016020; GO:0030314; GO:0035640; GO:0040011; GO:0048167; GO:0048168; GO:0050885; GO:0060402,calcium ion transport into cytosol [GO:0060402]; exploration behavior [GO:0035640]; learning [GO:0007612]; locomotion [GO:0040011]; memory [GO:0007613]; neuromuscular process controlling balance [GO:0050885]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of synaptic plasticity [GO:0048167],endoplasmic reticulum membrane [GO:0005789]; junctional membrane complex [GO:0030314]; junctional sarcoplasmic reticulum membrane [GO:0014701]; membrane [GO:0016020]; plasma membrane [GO:0005886],,GO:0005886; GO:0050877; GO:0055085,plasma membrane; nervous system process; transmembrane transport
OG_08326,1.3451797159516945,FUN_036756-T1,Peve_00001059,Pocillopora_meandrina_HIv1___RNAseq.g27066.t1,three_way,84.369,FUN_036756-T1,Q08CH8,,,,,50.0,340.0,3.7e-95,349.7,sp|Q08CH8|ZTRF1_DANRE Zinc finger TRAF-type-containing protein 1 OS=Danio rerio OX=7955 GN=zftraf1 PE=2 SV=2,,,,,,
OG_08332,1.004531664000578,FUN_036826-T1,Peve_00006971,Pocillopora_meandrina_HIv1___TS.g13145.t5b,three_way,63.583666666666666,FUN_036826-T1,O15111,IKKA_HUMAN,,Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK-1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16),Homo sapiens (Human),35.9,754.0,3.8999999999999995e-129,463.8,sp|O15111|IKKA_HUMAN Inhibitor of nuclear factor kappa-B kinase subunit alpha OS=Homo sapiens OX=9606 GN=CHUK PE=1 SV=2,GO:0003009; GO:0004672; GO:0004674; GO:0005524; GO:0005654; GO:0005737; GO:0005829; GO:0006954; GO:0006955; GO:0007249; GO:0008384; GO:0008385; GO:0009410; GO:0009615; GO:0009636; GO:0009653; GO:0009898; GO:0010034; GO:0032088; GO:0032727; GO:0033194; GO:0033209; GO:0034142; GO:0035631; GO:0038061; GO:0042803; GO:0043123; GO:0043200; GO:0044877; GO:0045087; GO:0045944; GO:0046982; GO:0051092; GO:0051146; GO:0061847; GO:0071356; GO:0097110; GO:0098586; GO:1990459,anatomical structure morphogenesis [GO:0009653]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to acetate [GO:0010034]; response to amino acid [GO:0043200]; response to cholecystokinin [GO:0061847]; response to hydroperoxide [GO:0033194]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle contraction [GO:0003009]; striated muscle cell differentiation [GO:0051146]; toll-like receptor 4 signaling pathway [GO:0034142]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; IkappaB kinase activity [GO:0008384]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110]; transferrin receptor binding [GO:1990459],GO:0002376; GO:0003012; GO:0003824; GO:0005654; GO:0005829; GO:0006355; GO:0006954; GO:0016740; GO:0030154; GO:0098542; GO:0140096,"immune system process; muscle system process; catalytic activity; nucleoplasm; cytosol; regulation of DNA-templated transcription; inflammatory response; transferase activity; cell differentiation; defense response to other organism; catalytic activity, acting on a protein"
OG_08340,1.2289655551000669,FUN_036857-T1,Peve_00001064,Pocillopora_meandrina_HIv1___RNAseq.g27062.t1,three_way,73.51566666666666,FUN_036857-T1,Q8BTI7,,,,,29.1,158.0,2.6e-07,58.9,sp|Q8BTI7|ANR52_MOUSE Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C OS=Mus musculus OX=10090 GN=Ankrd52 PE=1 SV=1,,,,,,
OG_08361,2.130827753948693,FUN_036910-T1,Peve_00018417,Pocillopora_meandrina_HIv1___RNAseq.g10815.t1,three_way,60.812666666666665,,,,,,,,,,,,,,,,,
OG_08373,1.234878666669095,FUN_036934-T1,Peve_00040009,Pocillopora_meandrina_HIv1___RNAseq.g10839.t1,three_way,68.39766666666667,,,,,,,,,,,,,,,,,
OG_08391,1.4200590072738104,FUN_037001-T1,Peve_00002157,Pocillopora_meandrina_HIv1___RNAseq.g26679.t1,three_way,50.65266666666667,,,,,,,,,,,,,,,,,
OG_08437,1.5282265835299331,FUN_037196-T1,Peve_00004715,Pocillopora_meandrina_HIv1___RNAseq.g11075.t2,three_way,81.52866666666667,FUN_037196-T1,Q15111,PLCL1_HUMAN,,Inactive phospholipase C-like protein 1 (PLC-L1) (Phospholipase C-deleted in lung carcinoma) (Phospholipase C-related but catalytically inactive protein) (PRIP),Homo sapiens (Human),49.5,1043.0,1.4e-302,1040.4,sp|Q15111|PLCL1_HUMAN Inactive phospholipase C-like protein 1 OS=Homo sapiens OX=9606 GN=PLCL1 PE=1 SV=3,GO:0004435; GO:0004629; GO:0005737; GO:0007214; GO:0032228; GO:0035556; GO:0046488; GO:0048015; GO:0051209; GO:0120163,"gamma-aminobutyric acid signaling pathway [GO:0007214]; intracellular signal transduction [GO:0035556]; negative regulation of cold-induced thermogenesis [GO:0120163]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; regulation of synaptic transmission, GABAergic [GO:0032228]; release of sequestered calcium ion into cytosol [GO:0051209]",cytoplasm [GO:0005737],"phosphatidylinositol-4,5-bisphosphate phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]",GO:0003824; GO:0006629; GO:0016787; GO:0023052; GO:0055085,catalytic activity; lipid metabolic process; hydrolase activity; signaling; transmembrane transport
OG_08449,1.595941173228042,FUN_037213-T1,Peve_00012946,Pocillopora_meandrina_HIv1___RNAseq.g11060.t1,three_way,80.752,FUN_037213-T1,Q9UQB3,CTND2_HUMAN,,Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),Homo sapiens (Human),43.2,586.0,1.7999999999999998e-127,459.5,sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3,GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609,cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296],GO:0005634; GO:0005886; GO:0007155; GO:0034330; GO:0043226,nucleus; plasma membrane; cell adhesion; cell junction organization; organelle
OG_08449,1.595941173228042,FUN_037213-T1,Peve_00012946,Pocillopora_meandrina_HIv1___RNAseq.g11060.t1,three_way,80.752,FUN_037213-T1,Q9UQB3,CTND2_HUMAN,,Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),Homo sapiens (Human),49.5,105.0,7.2e-15,85.5,sp|Q9UQB3|CTND2_HUMAN Catenin delta-2 OS=Homo sapiens OX=9606 GN=CTNND2 PE=1 SV=3,GO:0005634; GO:0005737; GO:0005886; GO:0005912; GO:0007155; GO:0007165; GO:0008013; GO:0014069; GO:0016055; GO:0030425; GO:0043204; GO:0045296; GO:0050808; GO:0060828; GO:0060997; GO:0098609,cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; dendritic spine morphogenesis [GO:0060997]; regulation of canonical Wnt signaling pathway [GO:0060828]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; Wnt signaling pathway [GO:0016055],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296],GO:0005634; GO:0005886; GO:0007155; GO:0034330; GO:0043226,nucleus; plasma membrane; cell adhesion; cell junction organization; organelle
OG_08469,1.270108139533141,FUN_037281-T1,Peve_00001634,Pocillopora_meandrina_HIv1___RNAseq.g26881.t1,three_way,79.723,,,,,,,,,,,,,,,,,
OG_08478,1.41056474443993,FUN_037305-T1,Peve_00045269,Pocillopora_meandrina_HIv1___RNAseq.g10723.t1,three_way,44.54433333333333,,,,,,,,,,,,,,,,,
OG_08481,1.0210916578243896,FUN_037310-T1,Peve_00011736,Pocillopora_meandrina_HIv1___RNAseq.g10709.t1,three_way,72.46583333333334,FUN_037310-T1,Q08CX1,,,,,28.3,853.0,6.6e-61,237.3,sp|Q08CX1|RASEF_XENTR Ras and EF-hand domain-containing protein OS=Xenopus tropicalis OX=8364 GN=rasef PE=2 SV=1,,,,,,
OG_08482,1.339329758646372,FUN_037313-T1,Peve_00006178,Pocillopora_meandrina_HIv1___RNAseq.g10707.t1,three_way,74.689,FUN_037313-T1,Q32PP9,,,,,66.0,94.0,6.7e-27,122.5,sp|Q32PP9|SOX14_DANRE Transcription factor Sox-14 OS=Danio rerio OX=7955 GN=sox14 PE=2 SV=1,,,,,,
OG_08491,2.104207095328157,FUN_037330-T1,Peve_00006234,Pocillopora_meandrina_HIv1___RNAseq.g10692.t1,three_way,60.120000000000005,FUN_037330-T1,Q8IVV2,,,,,39.6,273.0,5.8e-47,192.2,sp|Q8IVV2|LOXH1_HUMAN Lipoxygenase homology domain-containing protein 1 OS=Homo sapiens OX=9606 GN=LOXHD1 PE=2 SV=4,,,,,,
OG_08508,1.1169825367036816,FUN_037416-T2,Peve_00028857,Pocillopora_meandrina_HIv1___RNAseq.g10945.t1,three_way,60.57983333333333,FUN_037416-T2,Q569T7,,,,,33.2,400.0,7.700000000000001e-48,193.0,sp|Q569T7|MFS4B_XENLA Sodium-dependent glucose transporter 1 OS=Xenopus laevis OX=8355 GN=mfsd4b PE=2 SV=1,,,,,,
OG_08516,2.17802925099256,FUN_037445-T1,Peve_00027035,Pocillopora_meandrina_HIv1___RNAseq.g10976.t1,three_way,56.40266666666667,FUN_037445-T1,Q56UN5,M3K19_HUMAN,,"Mitogen-activated protein kinase kinase kinase 19 (EC 2.7.11.1) (Regulated in COPD, protein kinase) (SPS1/STE20-related protein kinase YSK4)",Homo sapiens (Human),61.7,274.0,1.7999999999999997e-95,353.2,sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens OX=9606 GN=MAP3K19 PE=2 SV=1,GO:0000165; GO:0004709; GO:0005524; GO:0106310,MAPK cascade [GO:0000165],,ATP binding [GO:0005524]; MAP kinase kinase kinase activity [GO:0004709]; protein serine kinase activity [GO:0106310],GO:0003824; GO:0016740; GO:0140096,"catalytic activity; transferase activity; catalytic activity, acting on a protein"
OG_08520,1.0029448758807384,FUN_037452-T1,Peve_00044119,Pocillopora_meandrina_HIv1___RNAseq.g1368.t1,three_way,59.91483333333333,FUN_037452-T1,Q9IA95,,,,,32.7,266.0,2.4e-45,184.1,sp|Q9IA95|SFRP3_CHICK Secreted frizzled-related protein 3 OS=Gallus gallus OX=9031 GN=FRZB PE=2 SV=1,,,,,,
OG_08521,1.4958118052844414,FUN_037454-T1,Peve_00044133,Pocillopora_meandrina_HIv1___RNAseq.g1366.t1,three_way,42.83116666666667,,,,,,,,,,,,,,,,,
OG_08598,1.5519974326930688,FUN_037740-T1,Peve_00037367,Pocillopora_meandrina_HIv1___RNAseq.g1331.t2,three_way,82.32733333333333,,,,,,,,,,,,,,,,,
OG_08607,1.3321188222118536,FUN_037753-T1,Peve_00038304,Pocillopora_meandrina_HIv1___RNAseq.g1341.t1,three_way,59.559333333333335,FUN_037753-T1,A7SKJ3,DPH2_NEMVE,,2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (Diphthamide biosynthesis protein 2) (Diphtheria toxin resistance protein 2) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2),Nematostella vectensis (Starlet sea anemone),44.1,313.0,3.200000000000001e-65,250.4,sp|A7SKJ3|DPH2_NEMVE 2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 OS=Nematostella vectensis OX=45351 GN=dph2 PE=3 SV=1,GO:0017183; GO:0046872; GO:0051539; GO:0090560; GO:0120513,protein histidyl modification to diphthamide [GO:0017183],2-(3-amino-3-carboxypropyl)histidine synthase complex [GO:0120513],"2-(3-amino-3-carboxypropyl)histidine synthase activity [GO:0090560]; 4 iron, 4 sulfur cluster binding [GO:0051539]; metal ion binding [GO:0046872]",GO:0003824; GO:0016740,catalytic activity; transferase activity
OG_08620,1.1600770838447594,FUN_037775-T1,Peve_00040704,Pocillopora_meandrina_HIv1___RNAseq.g1512.t1,three_way,79.25166666666667,FUN_037775-T1,P48630,,,,,49.3,377.0,7.5e-100,365.5,"sp|P48630|FD6E1_SOYBN Omega-6 fatty acid desaturase, endoplasmic reticulum isozyme 1 OS=Glycine max OX=3847 GN=FAD2-1 PE=2 SV=1",,,,,,
OG_08633,1.6055525723648765,FUN_037802-T1,Peve_00026129,Pocillopora_meandrina_HIv1___RNAseq.g1562.t1,three_way,59.398,,,,,,,,,,,,,,,,,
OG_08639,2.2453717219452347,FUN_037812-T1,Peve_00007681,Pocillopora_meandrina_HIv1___RNAseq.g1463.t1,three_way,71.19466666666666,FUN_037812-T1,B3EWZ6,,,,,97.5,7299.0,0.0,14917.2,sp|B3EWZ6|MLRP2_ACRMI MAM and LDL-receptor class A domain-containing protein 2 (Fragment) OS=Acropora millepora OX=45264 PE=1 SV=1,,,,,,
OG_08644,1.1666154394588355,FUN_037835-T1,Peve_00000571,Pocillopora_meandrina_HIv1___RNAseq.g1459.t1,three_way,87.0945,FUN_037835-T1,A0JNC1,CDS2_BOVIN,,Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2),Bos taurus (Bovine),57.1,410.0,3.5e-138,493.0,sp|A0JNC1|CDS2_BOVIN Phosphatidate cytidylyltransferase 2 OS=Bos taurus OX=9913 GN=CDS2 PE=2 SV=1,GO:0004605; GO:0005783; GO:0005789; GO:0016020; GO:0016024; GO:0140042,CDP-diacylglycerol biosynthetic process [GO:0016024]; lipid droplet formation [GO:0140042],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020],phosphatidate cytidylyltransferase activity [GO:0004605],GO:0003824; GO:0005783; GO:0006629; GO:0016740; GO:0043226,catalytic activity; endoplasmic reticulum; lipid metabolic process; transferase activity; organelle
OG_08667,1.5278924251724302,FUN_037903-T1,Peve_00028717,Pocillopora_meandrina_HIv1___RNAseq.g28653.t1,three_way,61.3495,FUN_037903-T1,Q5XK85,,,,,25.0,1134.0,1.4e-34,150.2,sp|Q5XK85|KATIP_XENLA Protein KATNIP homolog OS=Xenopus laevis OX=8355 PE=2 SV=1,,,,,,
OG_08674,1.3607018006754483,FUN_037910-T1,Peve_00004651,Pocillopora_meandrina_HIv1___TS.g5680.t1,three_way,79.7845,FUN_037910-T1,Q8IV35,,,,,30.2,865.0,1.6e-100,369.4,sp|Q8IV35|CF337_HUMAN Cilia- and flagella-associated protein 337 OS=Homo sapiens OX=9606 GN=CFAP337 PE=1 SV=2,,,,,,
OG_08713,1.0083997312360364,FUN_037965-T1,Peve_00009707,Pocillopora_meandrina_HIv1___RNAseq.g26234.t1,three_way,48.86333333333334,,,,,,,,,,,,,,,,,
OG_08722,1.0456939028352643,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),36.1,280.0,6.1e-42,174.9,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_08722,1.0456939028352643,FUN_037975-T1,Peve_00013890,Pocillopora_meandrina_HIv1___RNAseq.g26184.t1,three_way,52.15416666666667,FUN_037975-T1,Q8IY33,MILK2_HUMAN,,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),Homo sapiens (Human),43.2,148.0,5.4e-22,108.6,sp|Q8IY33|MILK2_HUMAN MICAL-like protein 2 OS=Homo sapiens OX=9606 GN=MICALL2 PE=1 SV=1,GO:0001725; GO:0005886; GO:0005911; GO:0005923; GO:0030036; GO:0030041; GO:0031005; GO:0031175; GO:0031267; GO:0032456; GO:0032482; GO:0034446; GO:0042805; GO:0043005; GO:0046872; GO:0051015; GO:0055037; GO:0070830; GO:0097750; GO:1903955,actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; bicellular tight junction assembly [GO:0070830]; endocytic recycling [GO:0032456]; endosome membrane tubulation [GO:0097750]; neuron projection development [GO:0031175]; positive regulation of protein targeting to mitochondrion [GO:1903955]; Rab protein signal transduction [GO:0032482]; substrate adhesion-dependent cell spreading [GO:0034446],bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; stress fiber [GO:0001725],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; filamin binding [GO:0031005]; metal ion binding [GO:0046872]; small GTPase binding [GO:0031267],GO:0005768; GO:0005886; GO:0007010; GO:0007155; GO:0008092; GO:0016192; GO:0031410; GO:0034330; GO:0043226; GO:0061024; GO:0065003,endosome; plasma membrane; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; vesicle-mediated transport; cytoplasmic vesicle; cell junction organization; organelle; membrane organization; protein-containing complex assembly
OG_08731,1.802054803188996,FUN_037988-T1,Peve_00025059,Pocillopora_meandrina_HIv1___RNAseq.g26272.t1,three_way,38.300666666666665,,,,,,,,,,,,,,,,,
OG_08751,2.0931755380051387,FUN_038018-T1,Peve_00022791,Pocillopora_meandrina_HIv1___RNAseq.g26531.t1,three_way,70.62033333333333,FUN_038018-T1,A7UA95,RADIL_DANRE,,Ras-associating and dilute domain-containing protein,Danio rerio (Zebrafish) (Brachydanio rerio),28.0,1225.0,3e-109,398.7,sp|A7UA95|RADIL_DANRE Ras-associating and dilute domain-containing protein OS=Danio rerio OX=7955 GN=radil PE=2 SV=1,GO:0001755; GO:0005874; GO:0007165; GO:0034446; GO:0051020,neural crest cell migration [GO:0001755]; signal transduction [GO:0007165]; substrate adhesion-dependent cell spreading [GO:0034446],microtubule [GO:0005874],GTPase binding [GO:0051020],GO:0007155; GO:0048870,cell adhesion; cell motility
OG_08783,1.0204715660878596,FUN_038072-T1,Peve_00000952,Pocillopora_meandrina_HIv1___TS.g5330.t1,three_way,63.88366666666666,FUN_038072-T1,A2A870,,,,,41.9,74.0,6.3e-06,55.5,sp|A2A870|FBF1_MOUSE Fas-binding factor 1 OS=Mus musculus OX=10090 GN=Fbf1 PE=1 SV=1,,,,,,
OG_08806,1.2918917818950235,FUN_038127-T1,Peve_00003031,Pocillopora_meandrina_HIv1___RNAseq.g770.t1,three_way,67.37616666666666,FUN_038127-T1,Q9FKY3,,,,,25.2,373.0,1.3999999999999999e-24,115.9,sp|Q9FKY3|AVT3A_ARATH Amino acid transporter AVT3A OS=Arabidopsis thaliana OX=3702 GN=AVT3A PE=1 SV=1,,,,,,
OG_08813,1.1246269060419576,FUN_038139-T1,Peve_00043370,Pocillopora_meandrina_HIv1___RNAseq.g761.t1,three_way,73.74383333333333,FUN_038139-T1,Q12767,,,,,33.1,1424.0,3.2e-177,624.4,sp|Q12767|TMM94_HUMAN Transmembrane protein 94 OS=Homo sapiens OX=9606 GN=TMEM94 PE=1 SV=1,,,,,,
OG_08824,1.3428381928794022,FUN_038161-T1,Peve_00033052,Pocillopora_meandrina_HIv1___RNAseq.g1154.t1,three_way,72.33833333333334,FUN_038161-T1,Q8BHY8,SNX14_MOUSE,,Sorting nexin-14,Mus musculus (Mouse),35.9,892.0,3e-144,514.2,sp|Q8BHY8|SNX14_MOUSE Sorting nexin-14 OS=Mus musculus OX=10090 GN=Snx14 PE=1 SV=2,GO:0005764; GO:0005765; GO:0005770; GO:0005829; GO:0015031; GO:0030425; GO:0031902; GO:0045202; GO:0080025; GO:0097352; GO:0098794; GO:0099170,autophagosome maturation [GO:0097352]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; protein transport [GO:0015031],cytosol [GO:0005829]; dendrite [GO:0030425]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; postsynapse [GO:0098794]; synapse [GO:0045202],"phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]",GO:0005764; GO:0005768; GO:0005773; GO:0005829; GO:0008289; GO:0031410; GO:0043226,lysosome; endosome; vacuole; cytosol; lipid binding; cytoplasmic vesicle; organelle
OG_08832,1.0204752575505105,FUN_038170-T1,Peve_00025787,Pocillopora_meandrina_HIv1___RNAseq.g1073.t1,three_way,75.25566666666666,FUN_038170-T1,Q71RS6,NCKX5_HUMAN,,Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5),Homo sapiens (Human),38.0,440.0,2.3e-83,312.0,sp|Q71RS6|NCKX5_HUMAN Sodium/potassium/calcium exchanger 5 OS=Homo sapiens OX=9606 GN=SLC24A5 PE=1 SV=1,GO:0005262; GO:0005802; GO:0006811; GO:0006874; GO:0008273; GO:0015293; GO:0032588; GO:0034220; GO:0042438; GO:0042470; GO:0048022; GO:0070509; GO:0070588,calcium ion import [GO:0070509]; calcium ion transmembrane transport [GO:0070588]; intracellular calcium ion homeostasis [GO:0006874]; melanin biosynthetic process [GO:0042438]; monoatomic ion transmembrane transport [GO:0034220]; monoatomic ion transport [GO:0006811]; negative regulation of melanin biosynthetic process [GO:0048022],melanosome [GO:0042470]; trans-Golgi network [GO:0005802]; trans-Golgi network membrane [GO:0032588],"calcium channel activity [GO:0005262]; calcium, potassium:sodium antiporter activity [GO:0008273]; symporter activity [GO:0015293]",GO:0005215; GO:0031410; GO:0043226; GO:0055085,transporter activity; cytoplasmic vesicle; organelle; transmembrane transport
OG_08852,1.645109752065004,FUN_038217-T1,Peve_00038841,Pocillopora_meandrina_HIv1___RNAseq.g901.t2,three_way,66.15016666666666,FUN_038217-T1,Q9UKN7,,,,,32.5,2688.0,0.0,1096.6,sp|Q9UKN7|MYO15_HUMAN Unconventional myosin-XV OS=Homo sapiens OX=9606 GN=MYO15A PE=1 SV=2,,,,,,
OG_08856,1.398322691481029,FUN_038241-T1,Peve_00029455,Pocillopora_meandrina_HIv1___RNAseq.g907.t1,three_way,65.7855,FUN_038241-T1,Q8AV58,SDK1_CHICK,,Protein sidekick-1,Gallus gallus (Chicken),30.8,1999.0,6.3e-250,866.7,sp|Q8AV58|SDK1_CHICK Protein sidekick-1 OS=Gallus gallus OX=9031 GN=SDK1 PE=1 SV=1,GO:0005886; GO:0007156; GO:0007416; GO:0010842; GO:0042802; GO:0045202,homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; retina layer formation [GO:0010842]; synapse assembly [GO:0007416],plasma membrane [GO:0005886]; synapse [GO:0045202],identical protein binding [GO:0042802],GO:0005886; GO:0007155; GO:0034330,plasma membrane; cell adhesion; cell junction organization
OG_08871,1.221146183240881,FUN_038268-T1,Peve_00008000,Pocillopora_meandrina_HIv1___TS.g5412.t1,three_way,67.79916666666666,FUN_038268-T1,Q8N5R6,,,,,28.3,782.0,1.1e-70,270.0,sp|Q8N5R6|CCD33_HUMAN Coiled-coil domain-containing protein 33 OS=Homo sapiens OX=9606 GN=CCDC33 PE=1 SV=3,,,,,,
OG_08884,1.532991801770185,FUN_038286-T1,Peve_00041723,Pocillopora_meandrina_HIv1___RNAseq.g28308.t1,three_way,69.07466666666667,FUN_038286-T1,Q9UHJ3,SMBT1_HUMAN,,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),Homo sapiens (Human),52.2,69.0,7.9e-14,81.3,sp|Q9UHJ3|SMBT1_HUMAN Scm-like with four MBT domains protein 1 OS=Homo sapiens OX=9606 GN=SFMBT1 PE=1 SV=2,GO:0003682; GO:0003714; GO:0005634; GO:0005654; GO:0006325; GO:0007283; GO:0030154; GO:0042393; GO:0045892; GO:0048635,cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of muscle organ development [GO:0048635]; spermatogenesis [GO:0007283],nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone binding [GO:0042393]; transcription corepressor activity [GO:0003714],GO:0005634; GO:0005654; GO:0006325; GO:0006355; GO:0022414; GO:0030154; GO:0042393; GO:0043226; GO:0060090; GO:0140110,nucleus; nucleoplasm; chromatin organization; regulation of DNA-templated transcription; reproductive process; cell differentiation; histone binding; organelle; molecular adaptor activity; transcription regulator activity
OG_08898,1.0605357946662723,FUN_038311-T1,Peve_00020693,Pocillopora_meandrina_HIv1___RNAseq.g1142.t1,three_way,76.04366666666667,FUN_038311-T1,Q8R5K6,,,,,43.3,217.0,3.7999999999999996e-39,163.3,sp|Q8R5K6|TOB1_RAT Protein Tob1 OS=Rattus norvegicus OX=10116 GN=Tob1 PE=1 SV=1,,,,,,
OG_08911,1.079483073018849,FUN_038345-T1,Peve_00000092,Pocillopora_meandrina_HIv1___RNAseq.g1104.t1,three_way,95.93,FUN_038345-T1,A4IHR1,IT70A_XENTR,,Intraflagellar transport protein 70A (Tetratricopeptide repeat protein 30A) (TPR repeat protein 30A),Xenopus tropicalis (Western clawed frog) (Silurana tropicalis),78.8,646.0,2e-307,1055.8,sp|A4IHR1|IT70A_XENTR Intraflagellar transport protein 70A OS=Xenopus tropicalis OX=8364 GN=ift70a PE=2 SV=1,GO:0001501; GO:0001822; GO:0005879; GO:0005929; GO:0018095; GO:0042073; GO:0060271,cilium assembly [GO:0060271]; intraciliary transport [GO:0042073]; kidney development [GO:0001822]; protein polyglutamylation [GO:0018095]; skeletal system development [GO:0001501],axonemal microtubule [GO:0005879]; cilium [GO:0005929],,GO:0005929; GO:0007018; GO:0043226; GO:0044782; GO:0048856,cilium; microtubule-based movement; organelle; cilium organization; anatomical structure development
OG_08925,1.3897105094756188,FUN_038382-T1,Peve_00000067,Pocillopora_meandrina_HIv1___RNAseq.g28293.t1,three_way,74.66466666666666,FUN_038382-T1,O09118,NET1_MOUSE,,Netrin-1,Mus musculus (Mouse),49.0,571.0,1.2000000000000005e-167,591.3,sp|O09118|NET1_MOUSE Netrin-1 OS=Mus musculus OX=10090 GN=Ntn1 PE=1 SV=3,GO:0001764; GO:0005576; GO:0005604; GO:0005654; GO:0005737; GO:0005829; GO:0006915; GO:0006930; GO:0007097; GO:0007265; GO:0007409; GO:0007411; GO:0008283; GO:0014009; GO:0015629; GO:0030334; GO:0030517; GO:0030879; GO:0032488; GO:0033564; GO:0042472; GO:0045202; GO:0045773; GO:0051963; GO:0060252; GO:0060603; GO:0061643; GO:0062023; GO:0071944; GO:0097475; GO:0098609; GO:0098978; GO:1903975; GO:2000147,"anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; Cdc42 protein signal transduction [GO:0032488]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; glial cell proliferation [GO:0014009]; inner ear morphogenesis [GO:0042472]; mammary gland development [GO:0030879]; mammary gland duct morphogenesis [GO:0060603]; motor neuron migration [GO:0097475]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of glial cell proliferation [GO:0060252]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of glial cell migration [GO:1903975]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]",actin cytoskeleton [GO:0015629]; basement membrane [GO:0005604]; cell periphery [GO:0071944]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; synapse [GO:0045202],,GO:0005576; GO:0005654; GO:0005829; GO:0005856; GO:0007155; GO:0012501; GO:0030312; GO:0031012; GO:0043226; GO:0048856; GO:0048870,extracellular region; nucleoplasm; cytosol; cytoskeleton; cell adhesion; programmed cell death; external encapsulating structure; extracellular matrix; organelle; anatomical structure development; cell motility
OG_08927,1.3068449991741808,FUN_038385-T1,Peve_00000064,Pocillopora_meandrina_HIv1___RNAseq.g28289.t1,three_way,68.722,FUN_038385-T1,Q7JQ32,GC76C_DROME,,Receptor-type guanylate cyclase Gyc76C (EC 4.6.1.2) (DrGC-1),Drosophila melanogaster (Fruit fly),39.3,1091.0,6.199999999999997e-206,719.9,sp|Q7JQ32|GC76C_DROME Receptor-type guanylate cyclase Gyc76C OS=Drosophila melanogaster OX=7227 GN=Gyc76C PE=1 SV=1,GO:0001653; GO:0004383; GO:0005524; GO:0005525; GO:0005886; GO:0006182; GO:0007168; GO:0007411; GO:0007428; GO:0007435; GO:0007526; GO:0008045; GO:0009651; GO:0016199; GO:0030198; GO:0030215; GO:0030510; GO:0035556; GO:0038023; GO:0046872; GO:0050830,"axon guidance [GO:0007411]; axon midline choice point recognition [GO:0016199]; cGMP biosynthetic process [GO:0006182]; defense response to Gram-positive bacterium [GO:0050830]; extracellular matrix organization [GO:0030198]; intracellular signal transduction [GO:0035556]; larval somatic muscle development [GO:0007526]; motor neuron axon guidance [GO:0008045]; primary branching, open tracheal system [GO:0007428]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of BMP signaling pathway [GO:0030510]; response to salt stress [GO:0009651]; salivary gland morphogenesis [GO:0007435]",plasma membrane [GO:0005886],ATP binding [GO:0005524]; GTP binding [GO:0005525]; guanylate cyclase activity [GO:0004383]; metal ion binding [GO:0046872]; peptide receptor activity [GO:0001653]; semaphorin receptor binding [GO:0030215]; signaling receptor activity [GO:0038023],GO:0003824; GO:0005886; GO:0009975; GO:0016829; GO:0030198; GO:0048856; GO:0055086; GO:0060089; GO:1901135,catalytic activity; plasma membrane; cyclase activity; lyase activity; extracellular matrix organization; anatomical structure development; nucleobase-containing small molecule metabolic process; molecular transducer activity; carbohydrate derivative metabolic process
OG_08930,2.117455878787261,FUN_038392-T1,Peve_00000048,Pocillopora_meandrina_HIv1___RNAseq.g28264.t1,three_way,76.04899999999999,FUN_038392-T1,P16065,,,,,36.6,998.0,4.3999999999999996e-160,567.0,sp|P16065|GCY_STRPU Speract receptor OS=Strongylocentrotus purpuratus OX=7668 PE=2 SV=1,,,,,,
OG_08936,1.0434667716748307,FUN_038400-T1,Peve_00000036,Pocillopora_meandrina_HIv1___RNAseq.g28274.t1,three_way,75.47866666666667,FUN_038400-T1,Q6P5D8,SMHD1_MOUSE,,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-),Mus musculus (Mouse),23.5,2075.0,6.200000000000001e-86,321.6,sp|Q6P5D8|SMHD1_MOUSE Structural maintenance of chromosomes flexible hinge domain-containing protein 1 OS=Mus musculus OX=10090 GN=Smchd1 PE=1 SV=2,GO:0000781; GO:0001740; GO:0003677; GO:0005524; GO:0006302; GO:0016604; GO:0016887; GO:0035861; GO:0042803; GO:0043584; GO:0045739; GO:0051276; GO:0060818; GO:2000042; GO:2001034,chromosome organization [GO:0051276]; double-strand break repair [GO:0006302]; inactivation of paternal X chromosome by genomic imprinting [GO:0060818]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; nose development [GO:0043584]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034],"Barr body [GO:0001740]; chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; site of double-strand break [GO:0035861]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803],GO:0000228; GO:0003677; GO:0003824; GO:0005694; GO:0006281; GO:0006325; GO:0016787; GO:0043226; GO:0048856,nuclear chromosome; DNA binding; catalytic activity; chromosome; DNA repair; chromatin organization; hydrolase activity; organelle; anatomical structure development
OG_08977,1.1617380086290043,FUN_038488-T1,Peve_00013519,Pocillopora_meandrina_HIv1___TS.g8002.t1a,three_way,57.826,FUN_038488-T1,Q8JHF2,,,,,52.1,263.0,1.5e-77,291.6,"sp|Q8JHF2|LFNG_DANRE Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe OS=Danio rerio OX=7955 GN=lfng PE=2 SV=2",,,,,,
OG_08983,1.7684389003584962,FUN_038502-T1,Peve_00013538,Pocillopora_meandrina_HIv1___RNAseq.g28192.t1,three_way,75.99333333333333,FUN_038502-T1,Q7RTV0,PHF5A_HUMAN,,PHD finger-like domain-containing protein 5A (PHD finger-like domain protein 5A) (Splicing factor 3B-associated 14 kDa protein) (SF3b14b),Homo sapiens (Human),97.1,104.0,8.6e-59,229.9,sp|Q7RTV0|PHF5A_HUMAN PHD finger-like domain-containing protein 5A OS=Homo sapiens OX=9606 GN=PHF5A PE=1 SV=1,GO:0000398; GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0005681; GO:0005684; GO:0005686; GO:0005689; GO:0008270; GO:0016363; GO:0016607; GO:0045893; GO:0048863; GO:0071005; GO:0071011; GO:1903241,"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of DNA-templated transcription [GO:0045893]; stem cell differentiation [GO:0048863]; U2-type prespliceosome assembly [GO:1903241]",nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal complex [GO:0005681]; U12-type spliceosomal complex [GO:0005689]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684],DNA binding [GO:0003677]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],GO:0003677; GO:0003723; GO:0005634; GO:0005654; GO:0006355; GO:0016071; GO:0030154; GO:0043226; GO:0065003,DNA binding; RNA binding; nucleus; nucleoplasm; regulation of DNA-templated transcription; mRNA metabolic process; cell differentiation; organelle; protein-containing complex assembly
OG_08987,1.063651111719624,FUN_038507-T2,Peve_00041684,Pocillopora_meandrina_HIv1___RNAseq.g28173.t1,three_way,75.75433333333334,FUN_038507-T2,Q4R7R1,,,,,61.6,357.0,4.3e-122,439.5,sp|Q4R7R1|D42E1_MACFA Short-chain dehydrogenase/reductase family 42E member 1 OS=Macaca fascicularis OX=9541 GN=SDR42E1 PE=2 SV=1,,,,,,
OG_08994,1.850667938675636,FUN_038524-T1,Peve_00041750,Pocillopora_meandrina_HIv1___RNAseq.g28186.t1,three_way,79.337,FUN_038524-T1,Q8BKX6,SMG1_MOUSE,,Serine/threonine-protein kinase SMG1 (SMG-1) (EC 2.7.11.1) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein) (Nonsense mediated mRNA decay-associated PI3K-related kinase SMG1),Mus musculus (Mouse),37.7,3713.0,0.0,2274.6,sp|Q8BKX6|SMG1_MOUSE Serine/threonine-protein kinase SMG1 OS=Mus musculus OX=10090 GN=Smg1 PE=1 SV=3,GO:0000184; GO:0004674; GO:0005524; GO:0005654; GO:0006281; GO:0032204; GO:0033391; GO:0042162; GO:0046854; GO:0046872; GO:0106310,"DNA repair [GO:0006281]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; regulation of telomere maintenance [GO:0032204]",chromatoid body [GO:0033391]; nucleoplasm [GO:0005654],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; telomeric DNA binding [GO:0042162],GO:0003677; GO:0003824; GO:0005654; GO:0006281; GO:0006629; GO:0016071; GO:0016740; GO:0043226; GO:0140096,"DNA binding; catalytic activity; nucleoplasm; DNA repair; lipid metabolic process; mRNA metabolic process; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09029,1.4032307590386537,FUN_038622-T1,Peve_00042048,Pocillopora_meandrina_HIv1___RNAseq.g1159.t1,three_way,78.449,FUN_038622-T1,P22448,,,,,31.8,349.0,7.2e-41,169.5,sp|P22448|RARB_CHICK Retinoic acid receptor beta OS=Gallus gallus OX=9031 GN=RARB PE=2 SV=2,,,,,,
OG_09110,2.229732436709737,FUN_039036-T1,Peve_00028756,Pocillopora_meandrina_HIv1___RNAseq.g28692.t1,three_way,82.128,FUN_039036-T1,Q8N8E3,,,,,40.0,442.0,1.5e-65,251.9,sp|Q8N8E3|CE112_HUMAN Centrosomal protein of 112 kDa OS=Homo sapiens OX=9606 GN=CEP112 PE=1 SV=2,,,,,,
OG_09121,1.3733274175846764,FUN_039269-T1,Peve_00002766,Pocillopora_meandrina_HIv1___RNAseq.14855_t,three_way,50.418,FUN_039269-T1,P15384,,,,,32.5,428.0,1e-50,202.6,sp|P15384|KCNA3_RAT Potassium voltage-gated channel subfamily A member 3 OS=Rattus norvegicus OX=10116 GN=Kcna3 PE=1 SV=2,,,,,,
OG_09140,1.04494544397175,FUN_039779-T1,Peve_00017588,Pocillopora_meandrina_HIv1___RNAseq.g7461.t1,three_way,84.48583333333333,FUN_039779-T1,O95263,,,,,46.7,904.0,5.4e-218,759.2,"sp|O95263|PDE8B_HUMAN High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B OS=Homo sapiens OX=9606 GN=PDE8B PE=1 SV=2",,,,,,
OG_09180,1.0695976154906115,FUN_039860-T1,Peve_00014924,Pocillopora_meandrina_HIv1___TS.g1030.t3,three_way,76.61816666666667,,,,,,,,,,,,,,,,,
OG_09214,1.5433143387205592,FUN_039931-T1,Peve_00036243,Pocillopora_meandrina_HIv1___RNAseq.g7332.t1,three_way,58.890166666666666,FUN_039931-T1,Q9P202,WHRN_HUMAN,,Whirlin (Autosomal recessive deafness type 31 protein),Homo sapiens (Human),40.3,578.0,1.5999999999999999e-96,355.9,sp|Q9P202|WHRN_HUMAN Whirlin OS=Homo sapiens OX=9606 GN=WHRN PE=1 SV=4,GO:0001895; GO:0001917; GO:0002141; GO:0002142; GO:0005737; GO:0005884; GO:0005886; GO:0005929; GO:0007605; GO:0010628; GO:0021694; GO:0030426; GO:0032391; GO:0032420; GO:0032426; GO:0036064; GO:0042802; GO:0045184; GO:0045202; GO:0050910; GO:0050953; GO:0051649; GO:0060088; GO:0060113; GO:0060122; GO:1990075; GO:1990227; GO:1990696,auditory receptor cell stereocilium organization [GO:0060088]; cerebellar Purkinje cell layer formation [GO:0021694]; detection of mechanical stimulus involved in sensory perception of sound [GO:0050910]; establishment of localization in cell [GO:0051649]; establishment of protein localization [GO:0045184]; inner ear receptor cell differentiation [GO:0060113]; inner ear receptor cell stereocilium organization [GO:0060122]; paranodal junction maintenance [GO:1990227]; positive regulation of gene expression [GO:0010628]; retina homeostasis [GO:0001895]; sensory perception of light stimulus [GO:0050953]; sensory perception of sound [GO:0007605],actin filament [GO:0005884]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; growth cone [GO:0030426]; periciliary membrane compartment [GO:1990075]; photoreceptor connecting cilium [GO:0032391]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886]; stereocilia ankle link [GO:0002141]; stereocilia ankle link complex [GO:0002142]; stereocilium [GO:0032420]; stereocilium tip [GO:0032426]; synapse [GO:0045202]; USH2 complex [GO:1990696],identical protein binding [GO:0042802],GO:0005815; GO:0005886; GO:0005929; GO:0030154; GO:0034330; GO:0043226; GO:0050877,microtubule organizing center; plasma membrane; cilium; cell differentiation; cell junction organization; organelle; nervous system process
OG_09254,1.0180315796497763,FUN_040053-T1,Peve_00016113,Pocillopora_meandrina_HIv1___RNAseq.g8469.t1,three_way,77.773,,,,,,,,,,,,,,,,,
OG_09338,1.2583184608389124,FUN_040301-T1,Peve_00038647,Pocillopora_meandrina_HIv1___RNAseq.g9075.t1,three_way,65.522,FUN_040301-T1,Q80T21,ATL4_MOUSE,,ADAMTS-like protein 4 (ADAMTSL-4) (Thrombospondin repeat-containing protein 1),Mus musculus (Mouse),33.5,731.0,7.7e-109,396.4,sp|Q80T21|ATL4_MOUSE ADAMTS-like protein 4 OS=Mus musculus OX=10090 GN=Adamtsl4 PE=2 SV=1,GO:0002020; GO:0002064; GO:0005576; GO:0005614; GO:0006915; GO:0030198; GO:0031012; GO:0043065; GO:0070285,apoptotic process [GO:0006915]; epithelial cell development [GO:0002064]; extracellular matrix organization [GO:0030198]; pigment cell development [GO:0070285]; positive regulation of apoptotic process [GO:0043065],extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; interstitial matrix [GO:0005614],protease binding [GO:0002020],GO:0005576; GO:0012501; GO:0030198; GO:0030312; GO:0031012; GO:0048856,extracellular region; programmed cell death; extracellular matrix organization; external encapsulating structure; extracellular matrix; anatomical structure development
OG_09383,1.1589766014265397,FUN_040672-T1,Peve_00015418,Pocillopora_meandrina_HIv1___RNAseq.g6459.t1,three_way,56.578833333333336,,,,,,,,,,,,,,,,,
OG_09387,1.7255067460554248,FUN_040680-T1,Peve_00009589,Pocillopora_meandrina_HIv1___RNAseq.g6447.t1,three_way,74.92949999999999,FUN_040680-T1,Q13972,RGRF1_HUMAN,,Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (Ras-specific nucleotide exchange factor CDC25),Homo sapiens (Human),40.1,1471.0,1.8e-260,901.0,sp|Q13972|RGRF1_HUMAN Ras-specific guanine nucleotide-releasing factor 1 OS=Homo sapiens OX=9606 GN=RASGRF1 PE=1 SV=2,GO:0005085; GO:0005829; GO:0005886; GO:0007165; GO:0007265; GO:0007616; GO:0030426; GO:0031175; GO:0034976; GO:0035022; GO:0035254; GO:0043005; GO:0043409; GO:0043410; GO:0044342; GO:0046578; GO:0046579; GO:0048167; GO:0048168,long-term memory [GO:0007616]; negative regulation of MAPK cascade [GO:0043409]; neuron projection development [GO:0031175]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of Ras protein signal transduction [GO:0046579]; Ras protein signal transduction [GO:0007265]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of Ras protein signal transduction [GO:0046578]; regulation of synaptic plasticity [GO:0048167]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; type B pancreatic cell proliferation [GO:0044342],cytosol [GO:0005829]; growth cone [GO:0030426]; neuron projection [GO:0043005]; plasma membrane [GO:0005886],glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085],GO:0005829; GO:0005886; GO:0050877; GO:0098772,cytosol; plasma membrane; nervous system process; molecular function regulator activity
OG_09409,1.144159544523106,FUN_040861-T1,Peve_00002298,Pocillopora_meandrina_HIv1___RNAseq.g6554.t1,three_way,84.35516666666666,FUN_040861-T1,Q5RE70,,,,,41.1,995.0,2.5e-211,737.3,sp|Q5RE70|INT3_PONAB Integrator complex subunit 3 OS=Pongo abelii OX=9601 GN=INTS3 PE=2 SV=1,,,,,,
OG_09427,1.430104927883402,FUN_041311-T1,Peve_00036795,Pocillopora_meandrina_HIv1___RNAseq.g16009.t1,three_way,64.30933333333334,FUN_041311-T1,A7MFZ8,,,,,30.6,288.0,3.9e-34,147.1,sp|A7MFZ8|GHRA_CROS8 Glyoxylate/hydroxypyruvate reductase A OS=Cronobacter sakazakii (strain ATCC BAA-894) OX=290339 GN=ghrA PE=3 SV=1,,,,,,
OG_09489,1.1888846745246893,FUN_041524-T1,Peve_00000980,Pocillopora_meandrina_HIv1___RNAseq.g15379.t1,three_way,54.44833333333333,FUN_041524-T1,O43933,,,,,28.6,255.0,4.9e-20,100.5,sp|O43933|PEX1_HUMAN Peroxisomal ATPase PEX1 OS=Homo sapiens OX=9606 GN=PEX1 PE=1 SV=1,,,,,,
OG_09494,1.002151725419219,FUN_041533-T1,Peve_00017080,Pocillopora_meandrina_HIv1___RNAseq.g15375.t1,three_way,44.41416666666667,,,,,,,,,,,,,,,,,
OG_09501,1.0292965576155793,FUN_041545-T1,Peve_00000890,Pocillopora_meandrina_HIv1___RNAseq.g15994.t2,three_way,60.269666666666666,FUN_041545-T1,Q80TI0,ASTRB_MOUSE,,Protein Aster-B (GRAM domain-containing protein 1B),Mus musculus (Mouse),34.0,679.0,3.2e-86,321.2,sp|Q80TI0|ASTRB_MOUSE Protein Aster-B OS=Mus musculus OX=10090 GN=Gramd1b PE=1 SV=2,GO:0001786; GO:0005789; GO:0005886; GO:0015485; GO:0042632; GO:0070300; GO:0071397; GO:0120020; GO:0140268,cellular response to cholesterol [GO:0071397]; cholesterol homeostasis [GO:0042632],endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum-plasma membrane contact site [GO:0140268]; plasma membrane [GO:0005886],cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; phosphatidic acid binding [GO:0070300]; phosphatidylserine binding [GO:0001786],GO:0005215; GO:0005886; GO:0008289,transporter activity; plasma membrane; lipid binding
OG_09507,1.0336601005937016,FUN_041552-T1,Peve_00025202,Pocillopora_meandrina_HIv1___RNAseq.g15999.t1,three_way,89.03266666666666,FUN_041552-T1,Q8NBZ7,,,,,78.6,243.0,1.1e-113,411.0,sp|Q8NBZ7|UXS1_HUMAN UDP-glucuronic acid decarboxylase 1 OS=Homo sapiens OX=9606 GN=UXS1 PE=1 SV=1,,,,,,
OG_09508,1.1939081539429754,FUN_041556-T1,Peve_00033126,Pocillopora_meandrina_HIv1___RNAseq.g16080.t1,three_way,62.22316666666666,FUN_041556-T1,Q6P549,SHIP2_MOUSE,,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2)",Mus musculus (Mouse),30.0,330.0,1.1e-19,99.0,"sp|Q6P549|SHIP2_MOUSE Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 OS=Mus musculus OX=10090 GN=Inppl1 PE=1 SV=1",GO:0000132; GO:0000922; GO:0001958; GO:0002376; GO:0003779; GO:0005634; GO:0005737; GO:0005794; GO:0005829; GO:0005886; GO:0006006; GO:0006629; GO:0006661; GO:0006897; GO:0006915; GO:0007015; GO:0007155; GO:0008285; GO:0009791; GO:0009925; GO:0010467; GO:0010629; GO:0016607; GO:0017124; GO:0030027; GO:0030175; GO:0032868; GO:0032880; GO:0034485; GO:0042169; GO:0043491; GO:0046856; GO:0070371; GO:0097178; GO:0110053,actin filament organization [GO:0007015]; apoptotic process [GO:0006915]; cell adhesion [GO:0007155]; endochondral ossification [GO:0001958]; endocytosis [GO:0006897]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; gene expression [GO:0010467]; glucose metabolic process [GO:0006006]; immune system process [GO:0002376]; lipid metabolic process [GO:0006629]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol dephosphorylation [GO:0046856]; post-embryonic development [GO:0009791]; regulation of actin filament organization [GO:0110053]; regulation of protein localization [GO:0032880]; response to insulin [GO:0032868]; ruffle assembly [GO:0097178],basal plasma membrane [GO:0009925]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; spindle pole [GO:0000922],"actin binding [GO:0003779]; phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity [GO:0034485]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]",GO:0002376; GO:0003824; GO:0005634; GO:0005794; GO:0005829; GO:0005886; GO:0005975; GO:0006629; GO:0007010; GO:0007155; GO:0008092; GO:0012501; GO:0016192; GO:0016787; GO:0043226,immune system process; catalytic activity; nucleus; Golgi apparatus; cytosol; plasma membrane; carbohydrate metabolic process; lipid metabolic process; cytoskeleton organization; cell adhesion; cytoskeletal protein binding; programmed cell death; vesicle-mediated transport; hydrolase activity; organelle
OG_09535,1.0506423905433258,FUN_041622-T1,Peve_00036084,Pocillopora_meandrina_HIv1___TS.g10312.t1b,three_way,81.132,FUN_041622-T1,P41247,PLPL4_HUMAN,,Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Calcium-independent phospholipase A2-eta) (iPLA2-eta) (EC 3.1.1.4) (Protein GS2),Homo sapiens (Human),48.4,248.0,4.7999999999999995e-61,236.1,sp|P41247|PLPL4_HUMAN Patatin-like phospholipase domain-containing protein 4 OS=Homo sapiens OX=9606 GN=PNPLA4 PE=1 SV=3,GO:0004623; GO:0004806; GO:0005737; GO:0005739; GO:0005811; GO:0005829; GO:0016020; GO:0016411; GO:0019433; GO:0047376; GO:0050253; GO:0051264; GO:0051265; GO:0055088,lipid homeostasis [GO:0055088]; triglyceride catabolic process [GO:0019433],cytoplasm [GO:0005737]; cytosol [GO:0005829]; lipid droplet [GO:0005811]; membrane [GO:0016020]; mitochondrion [GO:0005739],"acylglycerol O-acyltransferase activity [GO:0016411]; all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity [GO:0047376]; diolein transacylation activity [GO:0051265]; mono-olein transacylation activity [GO:0051264]; phospholipase A2 activity [GO:0004623]; retinyl-palmitate esterase activity [GO:0050253]; triacylglycerol lipase activity [GO:0004806]",GO:0003824; GO:0005739; GO:0005811; GO:0005829; GO:0006629; GO:0016740; GO:0016787; GO:0043226,catalytic activity; mitochondrion; lipid droplet; cytosol; lipid metabolic process; transferase activity; hydrolase activity; organelle
OG_09540,1.945280468656324,FUN_041634-T1,Peve_00023645,Pocillopora_meandrina_HIv1___RNAseq.g14222.t1,three_way,82.26466666666667,FUN_041634-T1,Q9H0K1,SIK2_HUMAN,,Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2),Homo sapiens (Human),46.9,631.0,4.8999999999999996e-135,483.4,sp|Q9H0K1|SIK2_HUMAN Serine/threonine-protein kinase SIK2 OS=Homo sapiens OX=9606 GN=SIK2 PE=1 SV=1,GO:0000287; GO:0004674; GO:0005524; GO:0005634; GO:0005737; GO:0005789; GO:0006468; GO:0035556; GO:0046626; GO:0046777; GO:0106310,intracellular signal transduction [GO:0035556]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of insulin receptor signaling pathway [GO:0046626],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; nucleus [GO:0005634],ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],GO:0003824; GO:0005634; GO:0016740; GO:0043226; GO:0140096,"catalytic activity; nucleus; transferase activity; organelle; catalytic activity, acting on a protein"
OG_09551,1.3757012341211083,FUN_041651-T1,Peve_00000466,Pocillopora_meandrina_HIv1___RNAseq.g14153.t1,three_way,42.71266666666666,,,,,,,,,,,,,,,,,
OG_09595,1.4222164616833266,FUN_041741-T2,Peve_00002194,Pocillopora_meandrina_HIv1___TS.g10807.t1,three_way,87.13516666666666,FUN_041741-T2,Q9WVF7,DPOE1_MOUSE,,DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (3'-5' exodeoxyribonuclease) (EC 3.1.11.-) (DNA polymerase II subunit A),Mus musculus (Mouse),61.3,2303.0,0.0,2863.2,sp|Q9WVF7|DPOE1_MOUSE DNA polymerase epsilon catalytic subunit A OS=Mus musculus OX=10090 GN=Pole PE=1 SV=3,GO:0000082; GO:0000166; GO:0000731; GO:0003677; GO:0003682; GO:0003887; GO:0005654; GO:0005886; GO:0006261; GO:0006287; GO:0006297; GO:0008270; GO:0008622; GO:0016787; GO:0048568; GO:0051539,"base-excision repair, gap-filling [GO:0006287]; DNA synthesis involved in DNA repair [GO:0000731]; DNA-templated DNA replication [GO:0006261]; embryonic organ development [GO:0048568]; G1/S transition of mitotic cell cycle [GO:0000082]; nucleotide-excision repair, DNA gap filling [GO:0006297]",epsilon DNA polymerase complex [GO:0008622]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],"4 iron, 4 sulfur cluster binding [GO:0051539]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA-directed DNA polymerase activity [GO:0003887]; hydrolase activity [GO:0016787]; nucleotide binding [GO:0000166]; zinc ion binding [GO:0008270]",GO:0003677; GO:0003824; GO:0005654; GO:0005886; GO:0006260; GO:0016740; GO:0016787; GO:0048856; GO:0140097,"DNA binding; catalytic activity; nucleoplasm; plasma membrane; DNA replication; transferase activity; hydrolase activity; anatomical structure development; catalytic activity, acting on DNA"
OG_09619,1.0906747663631144,FUN_041779-T1,Peve_00042838,Pocillopora_meandrina_HIv1___RNAseq.g15878.t1,three_way,82.13516666666666,FUN_041779-T1,P23098,,,,,25.2,3572.0,0.0,1097.8,"sp|P23098|DYHC_TRIGR Dynein beta chain, ciliary OS=Tripneustes gratilla OX=7673 PE=1 SV=1",,,,,,
OG_09624,1.3497068125996097,FUN_041788-T1,Peve_00038539,Pocillopora_meandrina_HIv1___RNAseq.g15771.t1,three_way,71.78066666666666,FUN_041788-T1,Q8BX90,FND3A_MOUSE,,Fibronectin type-III domain-containing protein 3A,Mus musculus (Mouse),35.3,996.0,1.6e-163,578.6,sp|Q8BX90|FND3A_MOUSE Fibronectin type-III domain-containing protein 3A OS=Mus musculus OX=10090 GN=Fndc3a PE=1 SV=3,GO:0000139; GO:0001669; GO:0005829; GO:0007286; GO:0009566; GO:0012506; GO:0031410; GO:0060009; GO:0098609,cell-cell adhesion [GO:0098609]; fertilization [GO:0009566]; Sertoli cell development [GO:0060009]; spermatid development [GO:0007286],acrosomal vesicle [GO:0001669]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; Golgi membrane [GO:0000139]; vesicle membrane [GO:0012506],,GO:0005829; GO:0007155; GO:0022414; GO:0031410; GO:0043226; GO:0048856,cytosol; cell adhesion; reproductive process; cytoplasmic vesicle; organelle; anatomical structure development
OG_09636,1.4709564669910304,FUN_041827-T1,Peve_00039124,Pocillopora_meandrina_HIv1___RNAseq.g15809.t1,three_way,78.95666666666666,FUN_041827-T1,Q9UL03,,,,,53.7,536.0,5.9e-156,552.4,sp|Q9UL03|INT6_HUMAN Integrator complex subunit 6 OS=Homo sapiens OX=9606 GN=INTS6 PE=1 SV=1,,,,,,
OG_09650,1.272947683301482,FUN_041848-T1,Peve_00010478,Pocillopora_meandrina_HIv1___RNAseq.g15073.t1,three_way,64.9195,FUN_041848-T1,P78543,BTG2_HUMAN,,Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3),Homo sapiens (Human),41.4,116.0,4e-19,96.3,sp|P78543|BTG2_HUMAN Protein BTG2 OS=Homo sapiens OX=9606 GN=BTG2 PE=1 SV=1,GO:0000122; GO:0003714; GO:0005634; GO:0005737; GO:0005829; GO:0006281; GO:0006974; GO:0007405; GO:0007406; GO:0008285; GO:0008306; GO:0009612; GO:0009952; GO:0017148; GO:0021542; GO:0021954; GO:0031175; GO:0035914; GO:0043434; GO:0043524; GO:0051602; GO:0060213; GO:0070062; GO:1904628,anterior/posterior pattern specification [GO:0009952]; associative learning [GO:0008306]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; central nervous system neuron development [GO:0021954]; dentate gyrus development [GO:0021542]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; neuroblast proliferation [GO:0007405]; neuron projection development [GO:0031175]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; response to electrical stimulus [GO:0051602]; response to mechanical stimulus [GO:0009612]; response to peptide hormone [GO:0043434]; skeletal muscle cell differentiation [GO:0035914],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],transcription corepressor activity [GO:0003714],GO:0005634; GO:0005829; GO:0006281; GO:0006355; GO:0030154; GO:0043226; GO:0048856; GO:0050877; GO:0060090; GO:0140110,nucleus; cytosol; DNA repair; regulation of DNA-templated transcription; cell differentiation; organelle; anatomical structure development; nervous system process; molecular adaptor activity; transcription regulator activity
OG_09653,1.1623269225245134,FUN_041854-T1,Peve_00025833,Pocillopora_meandrina_HIv1___RNAseq.g15067.t2,three_way,60.3945,FUN_041854-T1,Q8N137,CNTRB_HUMAN,,Centrobin (Centrosomal BRCA2-interacting protein) (LYST-interacting protein 8),Homo sapiens (Human),35.5,242.0,1.8e-21,106.7,sp|Q8N137|CNTRB_HUMAN Centrobin OS=Homo sapiens OX=9606 GN=CNTROB PE=1 SV=1,GO:0005813; GO:0005814; GO:0005829; GO:0007099; GO:0019904; GO:0036064; GO:0051299; GO:1902017; GO:1902410,centriole replication [GO:0007099]; centrosome separation [GO:0051299]; mitotic cytokinetic process [GO:1902410]; regulation of cilium assembly [GO:1902017],centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829],protein domain specific binding [GO:0019904],GO:0005815; GO:0005829; GO:0043226,microtubule organizing center; cytosol; organelle
OG_09654,1.0778692540726755,FUN_041857-T1,Peve_00025834,Pocillopora_meandrina_HIv1___RNAseq.g15066.t2,three_way,58.90233333333333,FUN_041857-T1,Q5EA49,,,,,30.3,185.0,2.1e-14,80.9,sp|Q5EA49|MIS12_BOVIN Protein MIS12 homolog OS=Bos taurus OX=9913 GN=MIS12 PE=2 SV=1,,,,,,
OG_09683,1.8212733075231515,FUN_041908-T1,Peve_00007888,Pocillopora_meandrina_HIv1___RNAseq.g15648.t1,three_way,83.73049999999999,FUN_041908-T1,Q17QZ4,,,,,57.2,383.0,2e-95,351.3,sp|Q17QZ4|TFDP1_BOVIN Transcription factor Dp-1 OS=Bos taurus OX=9913 GN=TFDP1 PE=2 SV=1,,,,,,
OG_09692,1.104180499366045,FUN_041921-T1,Peve_00007872,Pocillopora_meandrina_HIv1___RNAseq.g15623.t1a,three_way,76.00366666666666,FUN_041921-T1,Q68F70,,,,,40.3,1001.0,6.6e-185,649.4,sp|Q68F70|INT4_XENLA Integrator complex subunit 4 OS=Xenopus laevis OX=8355 GN=ints4 PE=2 SV=1,,,,,,
OG_09757,2.0781928241842715,FUN_042029-T1,Peve_00025063,Pocillopora_meandrina_HIv1___RNAseq.g15174.t1,three_way,47.64533333333333,FUN_042029-T1,Q9QYM2,,,,,31.9,354.0,1.1e-38,163.7,sp|Q9QYM2|PARG_RAT Poly(ADP-ribose) glycohydrolase OS=Rattus norvegicus OX=10116 GN=Parg PE=1 SV=1,,,,,,
OG_09798,1.5563149266931438,FUN_042606-T1,Peve_00034915,Pocillopora_meandrina_HIv1___RNAseq.g16848.t1,three_way,70.83866666666667,FUN_042606-T1,O77627,,,,,34.6,318.0,4.900000000000003e-22,107.5,sp|O77627|JUN_BOVIN Transcription factor Jun OS=Bos taurus OX=9913 GN=JUN PE=2 SV=2,,,,,,
OG_09803,1.5770848420690655,FUN_042614-T1,Peve_00034928,Pocillopora_meandrina_HIv1___RNAseq.g17030.t1,three_way,75.631,FUN_042614-T1,A0A1D5PXA5,TRPV4_CHICK,,Transient receptor potential cation channel subfamily V member 4 (TrpV4) (Vanilloid receptor-related osmotically activated channel) (VR-OAC),Gallus gallus (Chicken),20.4,313.0,1.5e-08,63.2,sp|A0A1D5PXA5|TRPV4_CHICK Transient receptor potential cation channel subfamily V member 4 OS=Gallus gallus OX=9031 GN=TRPV4 PE=1 SV=1,GO:0005261; GO:0005262; GO:0005516; GO:0005524; GO:0005886; GO:0005912; GO:0005929; GO:0006874; GO:0007015; GO:0007231; GO:0008289; GO:0016324; GO:0017124; GO:0035091; GO:0046872; GO:0098703,actin filament organization [GO:0007015]; calcium ion import across plasma membrane [GO:0098703]; intracellular calcium ion homeostasis [GO:0006874]; osmosensory signaling pathway [GO:0007231],adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cilium [GO:0005929]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; calcium channel activity [GO:0005262]; calmodulin binding [GO:0005516]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; monoatomic cation channel activity [GO:0005261]; phosphatidylinositol binding [GO:0035091]; SH3 domain binding [GO:0017124],GO:0005215; GO:0005886; GO:0005929; GO:0008289; GO:0043226; GO:0055085,transporter activity; plasma membrane; cilium; lipid binding; organelle; transmembrane transport
OG_09840,1.091952431671584,FUN_042821-T1,Peve_00019575,Pocillopora_meandrina_HIv1___RNAseq.g7439.t2,three_way,61.8725,FUN_042821-T1,A2RV61,,,,,30.5,1466.0,5.5e-152,540.4,sp|A2RV61|GAPD1_XENLA GTPase-activating protein and VPS9 domain-containing protein 1 OS=Xenopus laevis OX=8355 GN=gapvd1 PE=2 SV=1,,,,,,
OG_09841,1.4008553528959025,FUN_042822-T2,Peve_00019576,Pocillopora_meandrina_HIv1___TS.g1194.t1,three_way,82.61283333333333,FUN_042822-T2,Q28WQ1,KIF1A_DROPS,,Kinesin-like protein unc-104,Drosophila pseudoobscura pseudoobscura (Fruit fly),47.8,1673.0,0.0,1395.2,sp|Q28WQ1|KIF1A_DROPS Kinesin-like protein unc-104 OS=Drosophila pseudoobscura pseudoobscura OX=46245 GN=unc-104 PE=3 SV=1,GO:0003777; GO:0005524; GO:0005737; GO:0005874; GO:0005875; GO:0008017; GO:0047496; GO:0048489,synaptic vesicle transport [GO:0048489]; vesicle transport along microtubule [GO:0047496],cytoplasm [GO:0005737]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875],ATP binding [GO:0005524]; microtubule binding [GO:0008017]; microtubule motor activity [GO:0003777],GO:0003774; GO:0003824; GO:0007018; GO:0008092; GO:0016853; GO:0140657,cytoskeletal motor activity; catalytic activity; microtubule-based movement; cytoskeletal protein binding; isomerase activity; ATP-dependent activity
OG_09849,1.2440881824688983,FUN_042840-T1,Peve_00007266,Pocillopora_meandrina_HIv1___RNAseq.g7261.t1,three_way,47.549,,,,,,,,,,,,,,,,,
OG_09857,1.072987702660942,FUN_042851-T2,Peve_00023271,Pocillopora_meandrina_HIv1___RNAseq.g7248.t1,three_way,55.37016666666667,FUN_042851-T2,P62285,,,,,47.2,733.0,1.3e-174,616.7,sp|P62285|ASPM_BOVIN Abnormal spindle-like microcephaly-associated protein homolog (Fragment) OS=Bos taurus OX=9913 GN=ASPM PE=2 SV=1,,,,,,
OG_09857,1.072987702660942,FUN_042851-T2,Peve_00023271,Pocillopora_meandrina_HIv1___RNAseq.g7248.t1,three_way,55.37016666666667,FUN_042851-T2,P62285,,,,,26.6,466.0,1.1e-35,155.2,sp|P62285|ASPM_BOVIN Abnormal spindle-like microcephaly-associated protein homolog (Fragment) OS=Bos taurus OX=9913 GN=ASPM PE=2 SV=1,,,,,,
OG_09893,1.2186171359362232,FUN_042972-T1,Peve_00039022,Pocillopora_meandrina_HIv1___RNAseq.g7104.t1,three_way,74.01466666666667,FUN_042972-T1,A5PMR2,UBP33_DANRE,,Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33),Danio rerio (Zebrafish) (Brachydanio rerio),44.1,884.0,6.5e-205,715.7,sp|A5PMR2|UBP33_DANRE Ubiquitin carboxyl-terminal hydrolase 33 OS=Danio rerio OX=7955 GN=usp33 PE=2 SV=1,GO:0004197; GO:0004843; GO:0005813; GO:0006508; GO:0006897; GO:0007399; GO:0007411; GO:0008270; GO:0008277; GO:0016477; GO:0016579; GO:0048471; GO:0051298; GO:0070536; GO:0071108,axon guidance [GO:0007411]; cell migration [GO:0016477]; centrosome duplication [GO:0051298]; endocytosis [GO:0006897]; nervous system development [GO:0007399]; protein deubiquitination [GO:0016579]; protein K48-linked deubiquitination [GO:0071108]; protein K63-linked deubiquitination [GO:0070536]; proteolysis [GO:0006508]; regulation of G protein-coupled receptor signaling pathway [GO:0008277],centrosome [GO:0005813]; perinuclear region of cytoplasm [GO:0048471],cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; zinc ion binding [GO:0008270],GO:0003824; GO:0005815; GO:0016192; GO:0016787; GO:0048856; GO:0048870; GO:0140096,"catalytic activity; microtubule organizing center; vesicle-mediated transport; hydrolase activity; anatomical structure development; cell motility; catalytic activity, acting on a protein"
OG_09895,1.3755481295890404,FUN_042989-T1,Peve_00031072,Pocillopora_meandrina_HIv1___RNAseq.g7089.t1,three_way,80.24966666666667,FUN_042989-T1,Q8BS35,,,,,54.4,397.0,1.2e-125,451.4,sp|Q8BS35|ALKMO_MOUSE Alkylglycerol monooxygenase OS=Mus musculus OX=10090 GN=Agmo PE=1 SV=1,,,,,,
OG_09912,1.1072430572970722,FUN_043010-T1,Peve_00017768,Pocillopora_meandrina_HIv1___RNAseq.g7034.t1,three_way,65.28,FUN_043010-T1,Q8CGF6,WDR47_MOUSE,,WD repeat-containing protein 47 (Neuronal enriched MAP interacting protein) (Nemitin),Mus musculus (Mouse),31.1,1178.0,1.9e-103,379.0,sp|Q8CGF6|WDR47_MOUSE WD repeat-containing protein 47 OS=Mus musculus OX=10090 GN=Wdr47 PE=1 SV=2,GO:0000226; GO:0005737; GO:0005874; GO:0006914; GO:0007026; GO:0007420; GO:0007626; GO:0008344; GO:0021801; GO:0021960; GO:0021987; GO:0022038; GO:0030424; GO:0030425; GO:0030426; GO:0031175; GO:0043005; GO:0043025; GO:0044877; GO:0061351; GO:0061744; GO:0097150; GO:0120168,adult locomotory behavior [GO:0008344]; anterior commissure morphogenesis [GO:0021960]; autophagy [GO:0006914]; brain development [GO:0007420]; cerebral cortex development [GO:0021987]; cerebral cortex radial glia-guided migration [GO:0021801]; corpus callosum development [GO:0022038]; detection of hot stimulus involved in thermoception [GO:0120168]; locomotory behavior [GO:0007626]; microtubule cytoskeleton organization [GO:0000226]; motor behavior [GO:0061744]; negative regulation of microtubule depolymerization [GO:0007026]; neural precursor cell proliferation [GO:0061351]; neuron projection development [GO:0031175]; neuronal stem cell population maintenance [GO:0097150],axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; growth cone [GO:0030426]; microtubule [GO:0005874]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025],protein-containing complex binding [GO:0044877],GO:0006914; GO:0007010; GO:0048856; GO:0048870,autophagy; cytoskeleton organization; anatomical structure development; cell motility
OG_09948,1.9019216096898948,FUN_043115-T2,Peve_00026298,Pocillopora_meandrina_HIv1___RNAseq.g7890.t1,three_way,78.194,FUN_043115-T2,Q9NQH7,XPP3_HUMAN,,Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3),Homo sapiens (Human),46.0,461.0,1.6e-124,448.0,sp|Q9NQH7|XPP3_HUMAN Xaa-Pro aminopeptidase 3 OS=Homo sapiens OX=9606 GN=XPNPEP3 PE=1 SV=1,GO:0003094; GO:0004177; GO:0005737; GO:0005739; GO:0005829; GO:0006508; GO:0016485; GO:0030145; GO:0042803; GO:0070006,glomerular filtration [GO:0003094]; protein processing [GO:0016485]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739],aminopeptidase activity [GO:0004177]; manganese ion binding [GO:0030145]; metalloaminopeptidase activity [GO:0070006]; protein homodimerization activity [GO:0042803],GO:0003014; GO:0003824; GO:0005739; GO:0005829; GO:0016787; GO:0043226; GO:0051604; GO:0140096,"renal system process; catalytic activity; mitochondrion; cytosol; hydrolase activity; organelle; protein maturation; catalytic activity, acting on a protein"
OG_09969,1.0025525099330752,FUN_043151-T1,Peve_00011388,Pocillopora_meandrina_HIv1___RNAseq.g6826.t2,three_way,67.76333333333334,FUN_043151-T1,Q00685,,,,,27.6,1792.0,7.4e-160,567.0,sp|Q00685|CO3_LETCA Complement C3 (Fragment) OS=Lethenteron camtschaticum OX=980415 GN=C3 PE=2 SV=1,,,,,,
OG_09983,1.4663901785019124,FUN_043175-T1,Peve_00025846,Pocillopora_meandrina_HIv1___RNAseq.g6800.t1,three_way,71.23483333333334,FUN_043175-T1,Q28036,SL9A1_BOVIN,,Sodium/hydrogen exchanger 1 (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1),Bos taurus (Bovine),47.8,557.0,4.8999999999999995e-141,503.4,sp|Q28036|SL9A1_BOVIN Sodium/hydrogen exchanger 1 OS=Bos taurus OX=9913 GN=SLC9A1 PE=2 SV=2,GO:0005516; GO:0005543; GO:0005654; GO:0005737; GO:0005886; GO:0006883; GO:0006885; GO:0010447; GO:0010613; GO:0010882; GO:0015385; GO:0015386; GO:0016323; GO:0016324; GO:0030346; GO:0035994; GO:0036376; GO:0042802; GO:0045121; GO:0045944; GO:0048306; GO:0048863; GO:0051259; GO:0051453; GO:0055007; GO:0070886; GO:0071468; GO:0071805; GO:0071872; GO:0086092; GO:0090533; GO:0098719; GO:0098735,cardiac muscle cell differentiation [GO:0055007]; cellular response to acidic pH [GO:0071468]; cellular response to epinephrine stimulus [GO:0071872]; intracellular sodium ion homeostasis [GO:0006883]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of the force of heart contraction [GO:0098735]; positive regulation of transcription by RNA polymerase II [GO:0045944]; potassium ion transmembrane transport [GO:0071805]; protein complex oligomerization [GO:0051259]; regulation of cardiac muscle contraction by calcium ion signaling [GO:0010882]; regulation of intracellular pH [GO:0051453]; regulation of pH [GO:0006885]; regulation of the force of heart contraction by cardiac conduction [GO:0086092]; response to acidic pH [GO:0010447]; response to muscle stretch [GO:0035994]; sodium ion export across plasma membrane [GO:0036376]; sodium ion import across plasma membrane [GO:0098719]; stem cell differentiation [GO:0048863],apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cation-transporting ATPase complex [GO:0090533]; cytoplasm [GO:0005737]; membrane raft [GO:0045121]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],calcium-dependent protein binding [GO:0048306]; calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; phospholipid binding [GO:0005543]; potassium:proton antiporter activity [GO:0015386]; protein phosphatase 2B binding [GO:0030346]; sodium:proton antiporter activity [GO:0015385],GO:0005215; GO:0005654; GO:0005886; GO:0006355; GO:0008289; GO:0030154; GO:0055085; GO:0065003,transporter activity; nucleoplasm; plasma membrane; regulation of DNA-templated transcription; lipid binding; cell differentiation; transmembrane transport; protein-containing complex assembly
OG_09987,1.0001956208859992,FUN_043181-T1,Peve_00043024,Pocillopora_meandrina_HIv1___RNAseq.g18637.t1,three_way,60.36716666666666,FUN_043181-T1,Q8MIQ9,,,,,52.9,493.0,4.6e-133,476.9,sp|Q8MIQ9|P_PIG P protein OS=Sus scrofa OX=9823 GN=Oca2 PE=2 SV=3,,,,,,
OG_10001,1.0304208378285942,FUN_043234-T1,Peve_00001448,Pocillopora_meandrina_HIv1___RNAseq.g6754.t1,three_way,72.01266666666666,FUN_043234-T1,Q9R0N8,SYT6_MOUSE,,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),Mus musculus (Mouse),39.5,309.0,3.7e-52,207.2,sp|Q9R0N8|SYT6_MOUSE Synaptotagmin-6 OS=Mus musculus OX=10090 GN=Syt6 PE=1 SV=2,GO:0001786; GO:0005544; GO:0005829; GO:0005886; GO:0007340; GO:0009898; GO:0016020; GO:0030672; GO:0042802; GO:0042803; GO:0046872; GO:0046982; GO:0048306; GO:0097038,acrosome reaction [GO:0007340],cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; membrane [GO:0016020]; perinuclear endoplasmic reticulum [GO:0097038]; plasma membrane [GO:0005886]; synaptic vesicle membrane [GO:0030672],calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatidylserine binding [GO:0001786]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803],GO:0005829; GO:0005886; GO:0008289; GO:0022414,cytosol; plasma membrane; lipid binding; reproductive process
OG_10020,1.4865989958550268,FUN_043261-T1,Peve_00032607,Pocillopora_meandrina_HIv1___RNAseq.g8893.t1,three_way,65.95816666666667,FUN_043261-T1,Q7Z7G8,VP13B_HUMAN,,Intermembrane lipid transfer protein VPS13B (Cohen syndrome protein 1) (Vacuolar protein sorting-associated protein 13B),Homo sapiens (Human),28.7,4270.0,0.0,1449.5,sp|Q7Z7G8|VP13B_HUMAN Intermembrane lipid transfer protein VPS13B OS=Homo sapiens OX=9606 GN=VPS13B PE=1 SV=2,GO:0000139; GO:0001675; GO:0002080; GO:0005765; GO:0006869; GO:0007030; GO:0007399; GO:0007417; GO:0007517; GO:0007613; GO:0016192; GO:0021542; GO:0031175; GO:0031901; GO:0032266; GO:0032458; GO:0032588; GO:0033106; GO:0033116; GO:0035176; GO:0035264; GO:0036438; GO:0055038; GO:0060323; GO:0060612; GO:0090168,acrosome assembly [GO:0001675]; adipose tissue development [GO:0060612]; central nervous system development [GO:0007417]; dentate gyrus development [GO:0021542]; Golgi organization [GO:0007030]; Golgi reassembly [GO:0090168]; head morphogenesis [GO:0060323]; lipid transport [GO:0006869]; maintenance of lens transparency [GO:0036438]; memory [GO:0007613]; multicellular organism growth [GO:0035264]; muscle organ development [GO:0007517]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; slow endocytic recycling [GO:0032458]; social behavior [GO:0035176]; vesicle-mediated transport [GO:0016192],acrosomal membrane [GO:0002080]; cis-Golgi network membrane [GO:0033106]; early endosome membrane [GO:0031901]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; recycling endosome membrane [GO:0055038]; trans-Golgi network membrane [GO:0032588],phosphatidylinositol-3-phosphate binding [GO:0032266],GO:0008289; GO:0016192; GO:0022414; GO:0048856; GO:0050877,lipid binding; vesicle-mediated transport; reproductive process; anatomical structure development; nervous system process
OG_10039,2.364977638224196,FUN_043309-T1,Peve_00007495,Pocillopora_meandrina_HIv1___RNAseq.g8924.t1,three_way,66.18766666666667,FUN_043309-T1,P33450,FAT_DROME,,Cadherin-related tumor suppressor (Protein fat) [Cleaved into: Ft-mito],Drosophila melanogaster (Fruit fly),27.1,816.0,1.3e-70,270.0,sp|P33450|FAT_DROME Cadherin-related tumor suppressor OS=Drosophila melanogaster OX=7227 GN=ft PE=1 SV=3,GO:0001736; GO:0001737; GO:0005509; GO:0005739; GO:0005886; GO:0007156; GO:0007157; GO:0007164; GO:0007446; GO:0007447; GO:0007476; GO:0008285; GO:0009888; GO:0010629; GO:0016324; GO:0016327; GO:0016336; GO:0016339; GO:0032880; GO:0035159; GO:0035209; GO:0035220; GO:0035332; GO:0040008; GO:0042067; GO:0043065; GO:0044331; GO:0045296; GO:0045317; GO:0045570; GO:0045571; GO:0045926; GO:0046621; GO:0048105; GO:0090175; GO:0090176; GO:0090251; GO:0098609,"calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; equator specification [GO:0045317]; establishment of body hair planar orientation [GO:0048105]; establishment of imaginal disc-derived wing hair orientation [GO:0001737]; establishment of ommatidial planar polarity [GO:0042067]; establishment of planar polarity [GO:0001736]; establishment of tissue polarity [GO:0007164]; establishment or maintenance of polarity of larval imaginal disc epithelium [GO:0016336]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; imaginal disc growth [GO:0007446]; imaginal disc pattern formation [GO:0007447]; imaginal disc-derived wing morphogenesis [GO:0007476]; microtubule cytoskeleton organization involved in establishment of planar polarity [GO:0090176]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of growth [GO:0045926]; negative regulation of imaginal disc growth [GO:0045571]; negative regulation of organ growth [GO:0046621]; positive regulation of apoptotic process [GO:0043065]; positive regulation of hippo signaling [GO:0035332]; protein localization involved in establishment of planar polarity [GO:0090251]; pupal development [GO:0035209]; regulation of establishment of planar polarity [GO:0090175]; regulation of growth [GO:0040008]; regulation of imaginal disc growth [GO:0045570]; regulation of protein localization [GO:0032880]; regulation of tube length, open tracheal system [GO:0035159]; tissue development [GO:0009888]; wing disc development [GO:0035220]",apical plasma membrane [GO:0016324]; apicolateral plasma membrane [GO:0016327]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509],GO:0005739; GO:0005886; GO:0007010; GO:0007155; GO:0007163; GO:0043226; GO:0048856,mitochondrion; plasma membrane; cytoskeleton organization; cell adhesion; establishment or maintenance of cell polarity; organelle; anatomical structure development
OG_10041,1.2971607836340944,FUN_043312-T1,Peve_00007499,Pocillopora_meandrina_HIv1___RNAseq.g8928.t1,three_way,77.94933333333333,FUN_043312-T1,P36916,,,,,53.7,488.0,4.9e-143,509.6,sp|P36916|GNL1_MOUSE Guanine nucleotide-binding protein-like 1 OS=Mus musculus OX=10090 GN=Gnl1 PE=1 SV=4,,,,,,
OG_10055,1.6274023524323409,FUN_043349-T1,Peve_00043040,Pocillopora_meandrina_HIv1___TS.g20680.t2,three_way,60.5675,FUN_043349-T1,P20909,,,,,33.1,236.0,3.2e-34,149.4,sp|P20909|COBA1_RAT Collagen alpha-1(XI) chain OS=Rattus norvegicus OX=10116 GN=Col11a1 PE=1 SV=2,,,,,,
OG_10079,1.4282020589013371,FUN_043389-T1,Peve_00024250,Pocillopora_meandrina_HIv1___RNAseq.g9000.t1,three_way,64.57716666666667,FUN_043389-T1,Q64322,,,,,41.2,131.0,5.3e-15,83.6,sp|Q64322|NPDC1_MOUSE Neural proliferation differentiation and control protein 1 OS=Mus musculus OX=10090 GN=Npdc1 PE=2 SV=2,,,,,,
OG_10087,2.75297854540407,FUN_043414-T1,Peve_00045005,Pocillopora_meandrina_HIv1___RNAseq.g7825.t1,three_way,56.5365,FUN_043414-T1,Q69Z28,ATS16_MOUSE,,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),Mus musculus (Mouse),30.5,1138.0,9.8e-129,463.0,sp|Q69Z28|ATS16_MOUSE A disintegrin and metalloproteinase with thrombospondin motifs 16 OS=Mus musculus OX=10090 GN=Adamts16 PE=2 SV=2,GO:0001658; GO:0003073; GO:0004222; GO:0005576; GO:0006508; GO:0030198; GO:0046872; GO:0048232; GO:1902017,branching involved in ureteric bud morphogenesis [GO:0001658]; extracellular matrix organization [GO:0030198]; male gamete generation [GO:0048232]; proteolysis [GO:0006508]; regulation of cilium assembly [GO:1902017]; regulation of systemic arterial blood pressure [GO:0003073],extracellular region [GO:0005576],metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222],GO:0003824; GO:0005576; GO:0016787; GO:0022414; GO:0030198; GO:0140096,"catalytic activity; extracellular region; hydrolase activity; reproductive process; extracellular matrix organization; catalytic activity, acting on a protein"
OG_10089,1.058680434991928,FUN_043418-T1,Peve_00026856,Pocillopora_meandrina_HIv1___RNAseq.g7830.t1,three_way,78.10233333333333,,,,,,,,,,,,,,,,,
OG_10110,2.053015673457213,FUN_043480-T1,Peve_00021725,Pocillopora_meandrina_HIv1___RNAseq.g7918.t1,three_way,87.28833333333333,FUN_043480-T1,Q8UVR3,,,,,49.4,237.0,7.3e-58,226.1,sp|Q8UVR3|LMX1B_XENLA LIM homeobox transcription factor 1-beta.1 OS=Xenopus laevis OX=8355 GN=lmx1b.1 PE=2 SV=1,,,,,,
OG_10119,1.1892416345903374,FUN_043495-T1,Peve_00024915,Pocillopora_meandrina_HIv1___TS.g1707.t3,three_way,64.6395,FUN_043495-T1,Q7Z7A1,CNTRL_HUMAN,,Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110),Homo sapiens (Human),33.3,916.0,5.599999999999997e-29,132.9,sp|Q7Z7A1|CNTRL_HUMAN Centriolin OS=Homo sapiens OX=9606 GN=CNTRL PE=1 SV=2,GO:0001822; GO:0003281; GO:0005794; GO:0005813; GO:0005815; GO:0005829; GO:0005886; GO:0016020; GO:0034451; GO:0035904; GO:0036064; GO:0048471; GO:0051301; GO:0060976; GO:0090543; GO:0090619; GO:0097431; GO:0120103,aorta development [GO:0035904]; cell division [GO:0051301]; coronary vasculature development [GO:0060976]; kidney development [GO:0001822]; ventricular septum development [GO:0003281],centriolar satellite [GO:0034451]; centriolar subdistal appendage [GO:0120103]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cytosol [GO:0005829]; Flemming body [GO:0090543]; Golgi apparatus [GO:0005794]; meiotic spindle pole [GO:0090619]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; mitotic spindle pole [GO:0097431]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],,GO:0005794; GO:0005815; GO:0005829; GO:0005886; GO:0043226; GO:0048856,Golgi apparatus; microtubule organizing center; cytosol; plasma membrane; organelle; anatomical structure development
OG_10181,1.6229865911299015,FUN_043595-T1,Peve_00002201,Pocillopora_meandrina_HIv1___TS.g695.t1,three_way,48.877833333333335,FUN_043595-T1,Q22328,,,,,26.1,601.0,1.6e-52,209.9,sp|Q22328|LEV9_CAEEL Protein lev-9 OS=Caenorhabditis elegans OX=6239 GN=lev-9 PE=1 SV=3,,,,,,
OG_10182,1.3025546607259813,FUN_043597-T1,Peve_00007614,Pocillopora_meandrina_HIv1___RNAseq.g6953.t1,three_way,44.255,FUN_043597-T1,Q80T79,CSMD3_MOUSE,,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),Mus musculus (Mouse),31.6,730.0,4.6e-97,357.5,sp|Q80T79|CSMD3_MOUSE CUB and sushi domain-containing protein 3 OS=Mus musculus OX=10090 GN=Csmd3 PE=1 SV=3,GO:0005886; GO:0050773,regulation of dendrite development [GO:0050773],plasma membrane [GO:0005886],,GO:0005886,plasma membrane
OG_10195,1.2947424750763077,FUN_043619-T1,Peve_00008225,Pocillopora_meandrina_HIv1___RNAseq.g6932.t1,three_way,88.456,FUN_043619-T1,Q6DJ06,,,,,63.2,125.0,1e-48,194.5,sp|Q6DJ06|LMO42_XENTR LIM domain transcription factor LMO4.2 OS=Xenopus tropicalis OX=8364 GN=lmo4.2 PE=2 SV=1,,,,,,
OG_10196,1.4266645735233354,FUN_043620-T1,Peve_00008227,Pocillopora_meandrina_HIv1___RNAseq.g6930.t1,three_way,51.489333333333335,,,,,,,,,,,,,,,,,
OG_10198,1.8509932432730056,FUN_043622-T1,Peve_00008234,Pocillopora_meandrina_HIv1___RNAseq.g6927.t1,three_way,76.94266666666667,FUN_043622-T1,Q9VUX3,NOTUM_DROME,,Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (Protein Notum) (Protein wingful) (dNOTUM),Drosophila melanogaster (Fruit fly),28.2,347.0,8.8e-26,119.8,sp|Q9VUX3|NOTUM_DROME Palmitoleoyl-protein carboxylesterase NOTUM OS=Drosophila melanogaster OX=7227 GN=Notum PE=1 SV=3,GO:0005615; GO:0007419; GO:0009986; GO:0016055; GO:0035220; GO:0035222; GO:0045880; GO:0048076; GO:0048190; GO:0048546; GO:0090090; GO:1990697; GO:1990699,digestive tract morphogenesis [GO:0048546]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of smoothened signaling pathway [GO:0045880]; protein depalmitoleylation [GO:1990697]; regulation of compound eye pigmentation [GO:0048076]; ventral cord development [GO:0007419]; wing disc development [GO:0035220]; wing disc dorsal/ventral pattern formation [GO:0048190]; wing disc pattern formation [GO:0035222]; Wnt signaling pathway [GO:0016055],cell surface [GO:0009986]; extracellular space [GO:0005615],palmitoleyl hydrolase activity [GO:1990699],GO:0003824; GO:0005615; GO:0016787; GO:0030163; GO:0048856,catalytic activity; extracellular space; hydrolase activity; protein catabolic process; anatomical structure development
OG_10216,1.6584746420359588,FUN_043662-T1,Peve_00001429,Pocillopora_meandrina_HIv1___RNAseq.g7395.t2,three_way,79.739,FUN_043662-T1,P98198,AT8B2_HUMAN,,Phospholipid-transporting ATPase ID (EC 7.6.2.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2),Homo sapiens (Human),52.5,1179.0,0.0,1144.4,sp|P98198|AT8B2_HUMAN Phospholipid-transporting ATPase ID OS=Homo sapiens OX=9606 GN=ATP8B2 PE=1 SV=2,GO:0000287; GO:0005524; GO:0005730; GO:0005789; GO:0005794; GO:0005802; GO:0005829; GO:0005886; GO:0007030; GO:0016887; GO:0034220; GO:0045332; GO:0090554; GO:0140326; GO:0140345; GO:1990531,Golgi organization [GO:0007030]; monoatomic ion transmembrane transport [GO:0034220]; phospholipid translocation [GO:0045332],cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; phospholipid-translocating ATPase complex [GO:1990531]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled intramembrane lipid transporter activity [GO:0140326]; magnesium ion binding [GO:0000287]; phosphatidylcholine flippase activity [GO:0140345]; phosphatidylcholine floppase activity [GO:0090554],GO:0003824; GO:0005215; GO:0005730; GO:0005794; GO:0005829; GO:0005886; GO:0016787; GO:0043226; GO:0055085; GO:0061024; GO:0140657,catalytic activity; transporter activity; nucleolus; Golgi apparatus; cytosol; plasma membrane; hydrolase activity; organelle; transmembrane transport; membrane organization; ATP-dependent activity
